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AIMS OF THE THESIS
This thesis is aimed at examining the intracellular effects of
chronic vanadate treatment in a cultured human cervical
epithelial cell line (HeLa), with particular regard to cation
transport. Following this the possible involvement of vanadate,
cation transport, and phosphatidylinositol in the aetiology of
bipolar manic-depressive psychosis is investigated using cultured
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects.
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ABSTRACT
The symptoms, classification, occurrence and possible
aetiologies of bipolar manic-depressive psychosis have been
reviewed, with particular emphasis on the possible role of the
vanadate ion (VS+) and cation transport in the illness. The
effect of vanadate on cation transport in intact cells has been
determined using the well-characterised HeLa cell line. Cation
transport in virally transformed lymphob1astoid cell lines from
13 bipolar manic-depressive patients and 13 control subjects has
been examined, under normal conditions and after treatment (24
hours) with lithium, ouabain or vanadate. The
phosphatidylinositol system has also been examined in these cell
lines, in view of the therapeutic effect of lithium, and its
known inhibitory actions on inositol I-phosphatase.
In HeLa cells, no effects of vanadate on cation transport were
seen until concentra tions greater than 3.2 x 10-6M. This was
attributed to the intracellular reduction of VS+ to V4+ shown to
occur using ESR. Similar decreases were seen in all the K+
influx pathways, with maximum decreases of approximately 30% at
10-4M vanadate extracel1ularly. Significant toxicity was also
seen at these concentrations, with a maximum decrease in cell
number of 40% at lO-4M vanadate. No change in the energy charge
was seen and changes in ATP levels occurred subsequently to the
changes in cell number, with a decrease of 40% at 10-4M vanadate.
Using the lymphoblastoid cell lines, no significant
differences were seen in any of the cation transport parameters
examined, with the exception of mean sodium pump number which was
i
30% greater in the bipolar group compared with the control group.
Lithium or vanadate treatment produced either no effect or
inconsistent changes in cation transport. Ouabain treatment
produced similar decreases in sodium pump number in both groups.
Inositol uptake was similar in both groups, but the percentage
incorporation into phosphoinositides was reducerl in bipolar cell
lines compared with controls.
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LIST OF ABBREVIATIONS
Abbreviations are as illustrated in the text. In addition,
the more extensively-used abbreviations are listed below.
Abbreviations of measurements follow the S.I. system of
nomenclature.
ADP Adenosine 5'-diphosphate
AMP Adenosine 5'-monophosphate
ATP Adenosine 5'-triphosphate
AUFS Absorbance units full scale
Maximum binding
CDP Cytidine 5'-diphosphate
CMP Cytidine 5'-monophosphate
cpm Counts per minute
CSF Cerebrospinal fluid
CTP Cytidine 5'-triphosphate
DAG Diacylglycerol
DIOS 4,4'-Oiisothiocyanatostilbene-2,2'-disulfonic acid
DOPAC Dehydroxyphenylacetic acid
DST Dexamethasone suppression test
Cl- equilibrium potential
K+ equilibrium potential
Equilibrium membrane potential
Na+ equilibrium potential
EGF Epidermal growth factor
Endoplasmic reticulum
ESR Electron spin resonance
GOP Guanosine 5'-diphosphate
GFR Glomerular filtration rate
Hi
Gpp(NH)p
GSH
G~
HEPES
HPLC
HPTLC
HVA
IBMX
IP
lew
MAO I
MHPG
N~
NADH
N~P
NADPH
PCA
Guanosine 5'-monophosphate
Guanyl imidodiphosphate
Glutathione (reduced)
Guanosine 5'-triphosphate
N-2-Hydroxyethylpiperazine-N'-2-ethanesulfonic acid
High performance liquid chromatography
.
High performance thin layer chromatography
Homovanillic acid
Isobutylmethylxanthine
Internal diameter
Inositol I-phosphate
Inositol 1,4-bisphosphate
Inositol l,4,5-trisphosphate or the 1,3,4 isomer
Inositol 1,3,4,5-tetrakisphosphate
Inositol pentakisphosphate
Inositol hexakisphosphate
Affinity constant
Dissociation constant
Inhibitory constant
Michaelis-Menten constant
Litre of cell water
Monoamine oxidase inhibitor
3-methoxy-4-hydroxyphenylglycol
Nicotinamide adenine dinucleotide
Nicotinamide adenine dinucleotide (reduced form)
Nicotinamide adenine dinucleotide phosphate
Nicotinamide adenine dinucleotide phosphate (reduced)
Perchloric acid
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PDE
PDGF
PtdIns
Phosphodiesterase
Platelet-derived growth factor
Phosphatidylinositol
PtdIns(4)P Phosphatidylinositol-4-phosphate
PtdIns(4,5)P2 Phosphatidylinositol-4,5-bisphosphate
rpm
RVD
RVI
S.D.
S.E.M.
TBA
TLC
UV
VMA
5-HT
5-HIAA
5-HTP
]0
[ ]i
Revolutions per minute
Regulatory volume decrease
Regulatory volume increase
Standard deviation
Standard error of the mean
Tetrabutylammonium hydroxide
Thin layer chromatography
Ultra-violet
Vanillylmandelic acid
5-Hydroxytryptamine
5-Hydroxyindoleacetic acid
5-Hydroxytryptophan
Extracellular concentration
Intracellular concentration
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CHAPTER 1. GENERAL INTRODUCTION
In this general introduction an overall review of bipolar
manic-depressive psychosis is presented - the symptoms,
classification, genetic background and possible aetiologies.
The chemistry and biological importance of vanadium is then
illustrated followed by a discussion of the possible involvement
of the vanadate ion in the aetiology of bipolar manic-depressive
psychosis.
1.1. Symptoms and classification of bipolar manic-depressive
psychosis
The typical central symptoms of mania can be grouped according
to whether mood, activity or thought is affected. They are,
respectively: a). humour, euphoria, irritability, anger when
thwarted, poor impulse control, heightened sensory impres~ions
and loss of inhibition, b). increased et.e rgy , decreased sleep,
pressure of speech, increased social contact, sexual overactivity
and excessive spending of money, and, c), poor judgement,
unrealistic planning, distractability, flight of ideas, and
grandiose ideas and delusions (Tyrer and Shopsin 1982).
In depression, mood can range from one of sadness to a
profound melancholia, with a loss of interest in food, sex and
work. There is generally a lack in mental/physical energy and
initiative, together with poor concentration and decision-making.
Characteristically the person feels worst in the morning,
improving as the day progresses, and their sleep pattern may be
disturbed. Psychological symptoms may include feelings of
worthlessness and guilt, delusions of catastrophe,
hypochondriasis and paranoid ideas (Shaw et al. 1982). Suicide
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is not uncommon.
The concept of manic-depressive illness as a unification of
mania and depression into one illness was originally formulated
in the early 1900's by the German psychiatrist Kraepelin. This
was a broad categorisation embracing all severe depressive
syndromes, irrespective of whether mania occurred (Andreasen
1982). The primary feature of this disorder was defined as
being a change in mood - an elevation in the case of mania and a
lowering in depression. Any other symptoms were regarded as
being secondary to this change. The disorder was defined as
being relatively severe with recurrent bouts of illness inter-
spaced with periods of full remissio~ As the main feature of
the "anxiety states" was also a change in mood, these disorders
were sometimes grouped together under the broader heading of
"affective disorders", the classification of which varies, as
demonstrated later in this section.
Subsequent research indicated that biological changes
occurring in the affective disorders played a more central role
in the disease, and that the changes in mood were not such a
central feature. This led to an extension of the definition of
the disorder so that the central feature became "a profound
constitutional disturbance" with "changes in the cognitive,
affective and physiological functioning" (Hamilton 1982).
There are a large number of classifications of psychiatric
illness currently in existence. One of the two major systems
used clinically is that contained within the ninth "International
Classification of Diseases" (W.H.O. 1978, lCD-9). Section 296
pertaining to "affective psychoses" is summarised in Table 1.1••
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Table 1.1. Classification of affective psychoses in ICD-9
296 Affective Psychoses
296.0
296.1
296.2
296.3
296.4
296.5
296.6
296.8
296.9
Manic-depressive psychosis, manic type:- mental
disorders characterised by states of elation or
excitement out of keeping with the patients
circumstances and varying from enhanced liveliness
(hypomania) to violent, almost uncontrollable
excitement.
Manic-depressive psychosis, depressed type:- an
affective psychosis in which there is a widespread
depressed mood of gloom and wretchedness with some
de~ree of anxiety. There is often reduced activity but
there may be restlessness and agitation. There is a
marked tendency to recurrence.
Manic-depressive psychosis, circular type but currently
manic:- an affective psychosis l07hichhas appeared in
both the depressive and the manic form, either
alternating or separated by a period of normality, hut
in which the manic form is currently present. (The
manic phase is far less frequent than the depressive).
Manic-depressive psychosis, circular type hut currently
depressed:- circular type as above but in which the
depressive phase is currently present.
Manic-depressive psychosis, circular type, mixed:- an
affective psychosis in which both manic and depressive
symptoms are present at the same time.
Manic-depressive psychosis, circular type, current
condition not specified
Manic-depressive psychosis, other and unspecified
Other
Unspecified
Here affective psychoses, which are subdivided into nine types of
manic-depressive psychosis, are defined as, "Mental disorders,
usually recurrent, in which there is a severe disturbance of mood
(mostly compounded of depression and anxiety but also manifested
as elation and excitement) which is accompanied by one or more of
the following: delusions, perplexity, disturbed attitude to
self, disorder of perception and behaviour; these are all in
keeping with the patient's prevailing mood (as are hallucinations
when they occur). There is a strong tendency to suicide".
A more compact classification of affective disorders is given
in the third "Diagnostic and Statistical Manual of the American
Psychia tric Association" (1980, DSM-II I). In this latter
classification, major affective disorders are subdivided into
bipolar disorder where both mania and depression have occurred
(equivalent to circular types of manic-depressive psychosis in
the ICD-9), and major depression (or unipolar depression) where
no manic episodes have been seen. Bipolar disorder is further
subdivided into 3 groups, currently manic, currently depressed,
and mixed (for those people who cycle within a single episode).
There is no separate category for unipolar mania which is
generally classified under "bipolar disorder currently manic" as
many (but not all) manics eventually experience depression.
From the original broad grouping by Kraepelin of all severe
forms of affective disorder under the heading "manic-depressive
illness", current classifications such as those above now
separate the disorders on the basis of the occurrence of mania.
The widely accepted bipolar-unipolar distinction as opposed to a
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continuum, was originally proposed by Leonhard et al. in the late
1950's and has been validated by genetic studies, treatment
response studies and course of illness studies (reviewed by
Perris 1982). However the evidence for this is by no means
unequivocal and is discussed further in section 1.111•• This
thesis will be confined to examining bipolar manic-depressive
psychosis i.e. the illness where both mania and depression occur.
1.II. Occurrence and course of bipolar manic-depressive
psychosis
Much work on this aspect of the disorder has been carried out
by Perris, by Faris and Dunham, by Krauthammer and Klerman, and
by a European team headed by Angst. The data presented in this
section is a summary based on reviews by Boyd and Weissman
(1982), Hamilton (1979) and Shaw et al. (1982), which cover many
such studies. One main methodological problem emphasised in
these studies is that the data is from hospitalised patients and
that the course of the illness may be modified by drugs.
The morbid risk of bipolar manic-depressive psychosis for both
sexes has been found to range from 0.6 to 0.88% in industrialised
nations, with the annual incidence of new cases varying from
0.009 to 0.015% for men, and 0.007 to 0.03% for women. The
ra tio of women to men affected by the disease ranges from 1.3:1
to 2:1 (Boyd and Weissman 1982). Estimates of peak age of onset
vary from a range of 24 to 31.5 years with a modal age of 30
(Boyd and Weissman 1982) to a range of 20 to 39 years with a
median of 30 years (Hamilton 1979), whilst a median age of-onset
of 34.7 years is reported by Shaw et al. (1982).
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The range of age of onset extends from adolescence to old age and
is log-normally distributed.
The length of the cycles i.e. the interval between the onset
of one illness and the beginning of the next, tends to shorten
with the number of episodes and increasing age, whereas the
length of the manic or depressive episode increases. The mean
cycle length (or the mean first cycle length in the case of the
review by Hamilton), is approximately 33 months, with a mean
episodic duration of 4.4 months (Shaw et al. 1982, Hamilton
1919), and 50% of the episodes lying between 2.5 and 7.6 months
(Shaw et al. 1982). The chances of spontaneous remission from
recurrences are low although each episode of depression or mania
does tend to remit spontaneously, as seen before the advent of
effective treatments (Naylor - personal communication).
1.IlI. Life events and genetic influences in bipolar manic-
depressive psychosis
There have been many studies regarding the involvement of life
events in affective disorders. For the most part these studies
have been concerned with affective disorders in general, and
distinctions are not made between the different types. Paykel
(1982) has reviewed many such studies, the majority of which seem
to show an excess of life events prior to the first onset of
depression, when compared wi th ei ther the general popula tion,
medical or psychiatric patients. The events are often loss,
separation or threatening events but it would appear that if they
do playa precipitating role, it is likely to be as a result of
summation - a cumulative effect rather than an isolated incident.
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Other events which have also been implicated include viral
infections, serious medical illnesses, and hormonal upsets but
the relative contributions of such factors are difficult to
evaluate (Shaw et a1. 1982).
There is strong evidence for a genetic component in affective
disorders, based on family, twin and adoption studies, many of
which are covered in reviews by Gershon et al. (1976, 1977).
When the results from six studies were examined concerning the
morbid risk for first-degree relatives of bipolar and unipolar
probands, an increased familial prevalence of affective disorder
was found. The morbid risk of bipolar illness in first-degree
relatives of bipolar probands ranged from 2.8% to 10.2% with a
mean value of 6.9%, whereas that of unipolar illness ranged from
0.5% to 20.4% with a mean value of 7.6%. In contrast the mean
morbid risk for bipolar illness in first-degree relatives of
unipolar probands was 0.4% whilst that for unipolar illness was
6.0% (Gershon et al. 1976). Comparable morbid risk figures for
the general population with respect to affective disorder
(unipolar and bipolar) are approximately 2.4% (Nurnberger and
Gershon 1982). This data strongly suggests a common genetic
diathesis for unipolar and bipolar illnesses although one of the
studies included indicated a separate mode of inheritance,
showing few bipolar relatives of unipolar probands and vice versa
(Perris 1966).
More recently, as part of the "Yale University-National
Institute of Mental Health Collaborative Family Study of
Depression", Weissman et al. (1984) published results similar in
trend to the main body of results reviewed above i.e. bipolar
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probands having both bipolar and unipolar relatives whilst
unipolar probands show few bipolar relatives. This is further
support to the hypothesis of a common genetic pathway. Tsuang
et a!. (1985) also reached similar conclusions after analysing
the families of 100 bipolar probands and 225 unipolar probands
using a 2-thresho1d multifactorial polygenic model of familial
transmission as described by Reich et al. (1979). This model is
discussed further below. The results also suggested genetic
heterogeneity within affective disorders.
Data reviewed from 6 studies involving twins, also supports
the po ssibili ty of af fec tive illnesses being hered itary. The
overall concordance rate for monozygotic twins was 69.2% compared
wi th 13.3% for dizygotic twins (Gershon et al. 1976). A
concordance rate of 67% for affective illness in monozygotic
twins reared apart was also found. In 83 monozygotic twin pairs
reviewed, 25.3% were concordant for bipolar illness, 26.5% were
concordant for unipolar illness, 39.8% were not clearly
discordant and 8.4% had one member unipolar and the other bipolar
(Gershon et a1. 1976). This again is consistent with the idea
of a genetic transmission of manic-depressive illness. The
presence of monozygotic twins discordant for either presence of
affective illness or polarity of the illness suggests the
involvement of an environmental factor as well as the genetic one
suggested above, and/or a genotype which may be phenotypically
manifest as either unipolar illness or bipolar illness or no
illness at all in a monozygotic co-twin (Gershon et al. 1977).
In "adoption studies, which enable the separation of genetic
and environmental factors, Mend1ewicz and Rainer (1977) have
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reported that out of 29 bipolar adoptees, 28% of the biological
parents suffered from either bipolar or unipolar disorder
compared with 12% of the adoptive parents. In parents of non-
adopted bipolars the morbid risk was 21% which is comparable to
the 28% above, and the morbidity risk in biological or adoptive
parents of normal adoptees was 2% and 7% respectively, again
figures which are consistent with a genetic influence in
affective disorders. No explanation is given for the high
morbid risk values of the adoptive parents of the bipolar
adoptees and the adoptive and biological parents of normal
adoptees. These are much higher than the 0.6 to 0.88% reported
for the general population (previous section). No father-to-son
transmission of manic-depressive illness was seen in this study,
indicating a possible X-linkage.
The mode of tramsmission of affective disorders has not been
determined. Several genetic models have been put forward
proposing a single dominant gene with reduced penetrance (e.g
Winokur and Tanna 1969, Gershon and Bunney, Jr. 1976) although
controversy reigns as to whether the gene is autosomal or X-
linked. The possibility of X-linkage was initially based on the
finding that in some studies there were high rates of mother-son
transmission and virtually no father-son transmission (reviewed
by Nurnberger and Gershon 1982). However other studies have not
supported this. Studies such as those by Bucher and Elston
(1981) and Bucher et al. (1981) have reanalysed data from
previous studies using segregation analysis. The model used
allowed for factors such as variable age of onset and incomplete
penetrance but neither an autosomal or X-linked mode of
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transmission fitted the data.
The concept of bipolar and unipolar illnesses representing a
continuum of illness rather than distinct entities has resulted
in the use of multifactorial and single major locus threshold
models for affective disorder (Gershon et al. 1975, Reich et al.
1979, Baron et a!. 1981a,b, Gershon et a!. 1982). In the
multifactorial models, all environmental and genetic factors
involved in the genesis of the illness are regarded as being
additive and are grouped into one variable termed the "liability"
of the individual. This is distributed normally in the general
population, with thresholds which the liability must exceed
before the illness is manifest. In the version of the model
developed by Reich et al. (1979), there are three alternatives:-
the "Independent" model, the "Isocorrelational" model and the
"Environmental" model. The first of these corresponds to the
hypothesis that bipolar and unipolar illnesses have separate
aetiologies, with those individuals exceeding a threshold on the
unipolar liability distribution developing a unipolar disorder
and those individuals exceeding a threshold on the bipolar
liabili ty di stribution developing bipolar disorder. The
"Isocorrelational" model assumes that bipolar and unipolar
disorders share the same liability distribution i.e. they share
the same aetiological factors. There are two thresholds on this
distribution; those individuals exceeding the less extreme
threshold develop unipolar disorder whereas those exceeding the
more extreme threshold develop bipolar disorder. The
"Environmental" model proposes that bipolar and unipolar
illnesses are non-familial environmental variants of the same
9
process.
No tested model of genetic transmission consistently fits all
the data in the different studies (Gershon et a1. 1975, Gershon
et al. 1976, 1977, Sa char and Baron 1979, Baron et al. 1981a,b,
Gershon et al. 1982, Tsuang et al. 1985) although the majority of
the studies do seem to indicate a common genetic diathesis for
unipolar and bipolar illnesses. The suggested presence of
genetic heterogeneity and reduced penetrance, together with the
methodological difficulties involved in the diagnosis and
categorisation of the disorders possibly account for some of the
difficulties in modelling the data.
Even if the mode of transmission is not known it should still
be possible to predict the relative susceptibility of individuals
if a genetic marker were identified. Autosomal linkage studies
have produced conflicting reports regarding the ABO blood
grouping system and overall this seems an unlikely candidate when
reviewed (Gershon et al. 1977). Similar studies have been made
on the HLA tissue antigen system, again with conflicting results
which make it seem unlikely to be of any value as a genetic
marker. More recent studies have also not supported such a
linkage (Johnson et al. 1981, Suarez and Reich 1984).
Studies have also been carried out on possible linkage to X-
chromosome markers following the previously discussed hypothesis
that affective disorders may be X-linked. In a study by
Mendlewicz and Fleiss (1974), it was concluded that there was
close linkage wi th bipolar illness between both protan/ deutan
colour-blindness and the Xg blood group. This was disputed
however due to the large known chromosomal map distance between
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the Xg locus and the protan-deutan region which made it unlikely
that a linkage with both loci could be present (Gershon and
Bunney, Jr. 1976, Baron et a1. 1981b). In a review by Gershon
and Bunney (1976) they concluded that the relationship between
colour-blindness and bipolar disorder may be association rather
than true linkage. Close linkage of bipolar disorder with
protan/deutan colour-blindness was reported however by Baron
et a1. (1981b). Genetic heterogeneity was seen with two
homogeneous groups of close-linkage and non-linkage, a finding
similar to that of Gershon et a!. (1980). Mendlewicz et al.
(1980) have reported the possibility of a linkage with glucose-6-
phosphate dehydrogenase deficiency. Such a linkage would be
expected if the postulated linkage between bipolar illness and
colour-blindness was correct as this enzyme deficiency has been
shown to be linked to colour-blindness on the X-chromosome
(Mendlewicz et al. 1980).
A mutant protein, Pc 1 Duarte, has been found with increased
frequency in brain specimens taken at autopsy from individuals
with affective disorder (Comings 1979). The protein was most
common in the caudate, putamen, thalamus, pons and brainstem,
with a frequency of 72.7% in bipolar patients compared with 31.6%
in controls. Comings suggested that this protein may be a
product of a single major gene, combining aetiologically with
environmental factors. It was also found with increased
frequency in multiple sclerosis patients, an association that has
prompted the suggestion that Duarte protein may alter the host
response to a CNS viral infection.
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1.IV. Biological aetiology of bipolar manic-depressive
psychosis
Although there is evidence that bipolar manic-depressive
psychosis is genetic in origin, the resultant biological changes
which are responsible for the manifestation of the illness are
not known with certainty. Biological and pharmacological
abnormali ties seen during the course of the illness have
implicated:- 1). monoaminergic neurotransmission; 2). the neuro-
endocrine system; and 3). ion transport, as being the main areas
where the changes involved in the genesis of bipolar disorder may
possibly occur, not necessarily mutually exclusively. Many
studies have been carried out regarding each of these areas and
it is beyond the scope of this chapter to detail them all. A
synopsis of the research findings of these studies is presented
here, based on reviews and selected original articles as cited.
Note that the terms rubidium influx and potassium influx are used
interchangeably in this chapter - the reasons for this are
detailed in Chapter 3.
i). Aminergic neurotransmission:- The "amine hypothesis"
was put forward in the 1950's following the serendipitous
observation that some patients taking reserpine as an anti-
hypertensive, became severely depressed. This, together with
the knowledge that reserpine inhibited amine storage in the
nervous system, and the observation that amphetamines potentiated
the action of catecholaminergic neurones and improved mood, led
to the model: reduced noradrenaline levels ~ reduced
noradrenergic ac tivi ty ~ depression, and conversely, increased
noradrenergic activity ~ mania (Schildkraut 1965, Bunney, Jr.
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and Davis 1965, Schildkraut and Kety 1967). Later an
involvement of the serotoninergic pathways was proposed after the
discovery that tryptophan, the precursor of 5-hydroxytryptamine
(5-HT), accelerated the recovery of depressed patients when given
wi th monoamine oxidase inhi bi tors (MAOI' s), suggesting the
presence of reduced 5-HT activity in depression (from Shaw et al.
1982). The involvement of the 5-HT pathway was further
validated by a study which showed combined treatment with
imipramine and alphamethylparatyrosine (AMPT - inhibits
noradrenaline synthesis) led to recovery, whereas treatment with
imipramine and parachlorophenylalanine (PCPA - an inhibitor of
tryptophan hydroxylase) led to a deterioration of the illness
(Shopsin et al. 1975).
The main support for the involvement of cerebral monoamines in
affective disorders is pharmacological e vg , tricyclic
antidepressants such as imipramine, desipramine and amitriptyline
inhibit neuronal uptake of neurotransmitters to varying extents,
monoamine oxidase inhibitors (effective as antidepressants for a
few patients) such as phenelzine prevent the breakdown of
neurotransmitters, ECT is thought to act by increasing the levels
of monoamines in the brain but the mode of action is not clear,
and lithium (mainly prophylactic and antimanic but also
antidepressant) facilitates the neuronal uptake of noradrenaline
(for references see Bowman and Rand 1980). However many of the
treatments show a spectrum of effects and affect more than one
neurotransmission pathway e.g. tricyclics show anticholinergic
type side-effects, block alpha-receptors, and are
phosphodiesterase inhibitors, making the actions of such drugs
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more difficult to interpret (Bowman and Rand 19BO).
Factors difficult to reconcile with the "amine hypothesis"
include the discrepancy between the rapidity of action of the
tricyc1ics in inhibiting neuronal uptake mechanisms and the slow
onset of therapeutic effects (approx. 2-3 weeks), the lack of
correlation between the relative potencies of the tricyclics and
related drugs as antidepressants and their relative abilities at
inhibiting neuronal uptake (e.g iprindole is effective but does
not block amine uptake), the potentiation of catecholaminergic
neuronal activity by cocaine but the failure of cocaine to
reverse depressive symptoms, the failure of PCPA or reserpine
(depletes stored amines) in mimicking classical depressive
symptoms in normal subjects, and the effectiveness of lithium and
elec troconvulsi ve therapy as anti manic arid antidepressant
treatments respectively, despite having few or ill-defined
effects on aminergic neurotransmission (from Shaw et al. 1982,
Zis and Goodwin 1982). In addition, specific blockers of
noradrenaline uptake e.g. maprotiline, and of 5-HT e.g.
zimelidine, are both antidepressants and there is little or no
evidence that different patients respond to drugs affecting
different amine systems (Naylor - personal communication).
Difficulties in defining the mode of action of therapeutic drugs
largely arise from the diverse effects seen in acute or chronic
studies coupled with the fact that many of the actions reported
have not been shown clinically and caution must be exerted in
extrapolating to man.
Many studies have been carried out analysing the levels of 3-
methoxy-4-hydroxypheny1g1yco1 and vani11y1mande1ic acid (MHPG and
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VMA, major and minor metabolites respectively of noradrenaline),
homovanillic acid and dehydroxyphenylacetic acid (HVA and DOPAC,
major and minor metabolites respectively of dopamine) and 5-
hydroxyindoleacetic acid (5-HIAA, metabolite of 5-HT) in CSF and
urine of manic and depressed patients. Results of such studies
are largely inconsistent due to factors such as different age and
sex distribution of patients and controls within and between
studies, different diagnostic procedures, patient heterogeneity
with respect to bipolar and unipolar illness, sample sizes, diet,
phase differences and sample timing (Koslow et al. 1983). There
is also doubt about the validity of the above metabolites as
being representative of central or peripheral amine turnover (Zis
and Goodwin 1982). It must also be appreciated that if the
defect is limited to a very small part of the brain, studies such
as those above may not pick up such a small localised change.
Similarly changes that are seen may be secondary to the main
pathology.
In general, however, low levels of urinary MHPG have been
shown in some studies of depressed patients, with increasing
levels upon recovery or in mania (Gershon et al. 1977, Shaw
et al. 1982, Zis and Goodwin 1982). In depressed patients,
decreased CSF levels of 5-HlAA have been reported (Gershon et al.
1977, Bowman and Rand 1980, Zis and Goodwin 1982). Probenecid
treatment (blocks transport of HVA and 5-HIAA out of the CSF) has
indicated a decrease in both 5-HT and dopamine turnover in
depressed patients and in manics (Sachar and Baron 1979, Zis and
Goodwin 1982). More recently, a study involving 85 unipolar, 19
manic and 47 bipolar patients showed significantly increased CSF
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MHPG levels in mania, and an increased 24 hour urinary excretion
of VMA in both mania and depression (Koslow et al. 1983).
Significant increases were also seen in urinary noradrenaline and
adrenaline in unipolar patients, in adrenaline in bipolar
patients, and in noradrenaline in manics. The results of this
last study tend to suggest an excess of neurotransmitter rather
than a deficit.
Studies involving the use of amine precursors are also
equivocal. L-tryptophan has proved to be a useful
antidepressant in some studies but not others (Mindham 1982) and
potentiates MAOr's as previously mentioned. Some succes sin
treatment-resistant patients has been reported with 5-
hydroxy tryptophan (Shaw et al. 1982) but L-Dopa seems to produce
rather than ameliorate depressive symptoms (Mindham 1982).
With the realisation that many of the drugs effective in
either depression or mania do not appear to share a common mode
of action at the gross level, studies tended to be directed more
into looking at receptors, second messengers, and imbalances
between systems.
The main problem with receptor studies in clinical situations
is that they are peripheral and may not be representative of
central events. Extein et al. (1979) have reported a decreased
number of beta-adrenergic receptors in lymphocytes of manic and
depressed patients when compared with controls or euthymics,
with a concomitant decrease in isoproterenol-stimulated but not-
prostaglandin El-stimulated cAMP production. Lower values for
beta-receptor numbers have also been reported in virally
transformed lymphoblastoid cell lines of bipolar manic-depressive
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families (Wright et a!. 1984). Bi nding was decreased to less
than 50% of the mean family control values in 4 out of 6 manic-
depressive subjects and only lout of 18 non-psychiatric
controls. The subjects showing these decreases were confined to
3 famil ie sou t 0 f the 5 examin ed, sug gest in g genet ic
heterogeneity. Generally however. results of studies involving
beta-receptors are inconsistent, with possible explanations for
this including the variable half-life among lymphocyte
populations and the effect of physical activity on beta-receptor
number (Wood and Coppen 1985~
Variable findings have been reported concerning alpha2-
adrenergic receptors in platelets. possibly due to methodological
differences (Wood and Coppen 1985). No difference has been
reported for the Kd (the equilibrium dissociation constant for an
agonist or antagonist with its receptor sites i.e. the free
concentration of agonist or antagonist at which half the receptor
sites are bound) or Bmax (the maximum number of receptor sites
bound i.e. the total number of receptors) values of 3H-yohimbine
binding in depressives compared with controls (Stahl et al. 1983)
but increases in Bmax have also been reported (Garcia-Sevilla
et al. 1981, Cameron et al. 1984). decreasing upon treatment with
tricyclics (Garcia-Sevilla et a!. 1981). This latter finding
would support the hypothesis of a supersensitivity of a1pha2-
adrenergic receptors in depression, leading. in the case of
presynaptic a1pha2-receptors to a decreased availability of
noradrenaline. Further support for the idea that tricyc1ics act
by decreasing either the sensitivity or number of alpha2-
receptors is given by the findings of Charney et al. (1983) where
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the decrease in plasma MHPG following clonidine stimulation of
pre-synaptic alpha2-receptors, is attenuated by long-term
amitriptyline treatment. A sub-sensitivity of alpha2-receptors
however is suggested by the finding of Siever et al. (1984) where
the magnitude of the plasma MHPG response to clonidine is
significantly less in depressives than in controls.
Binding studies have shown a decrease in 5-HT2 receptors in
platelets after chronic antidepressant treatment, and a
significantly greater number of 5-HT2 receptors in the frontal
cortex of suicide victims compared with controls (Coppen and Wood
1985). A supersensitivity of 5-HT receptors in depression and
mania has also been proposed following findings that oral
administration of 5-HTP produces a larger increase in serum
cortisol levels in depressives and manics compared with controls;
a response augmented by Ii thium or MAOI's in manics and
Jepressives respectively but attenuated by tricyclics in
depressives (Meltzer et al. 1984a,b,c). This is consistent with
the idea that lithium acts by enhancing 5-HT2 receptor
sensitivity and tricyclics decrease the sensitivity. Uptake of
5-HT into platelets has also consistently been reported as being
decreased in depression, even following recovery (Wood and Coppen
1985). In several studies the tricyclic antidepressants
amitriptyline and desipramine have been shown to actually·
stimulate, rather than inhibit, uptake of 5-HT in some depressed
patients (Coppen and Wood 1985), with recovery being more evident
in the group of patients showing the stimulatory response. If
this was the mechanism by which tricyclics exerted their
therapeutic effect then the time lag between administration and
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therapeutic effect would be expected whilst the necessary build-
up of transmitter occurred within the nerve terminal.
A possible sub-grouping of depression based on the
relationship between drug response and pretreatment levels of
noradrenaline and metabolites has been proposed by Maas et al.
(1984). They found that in bipolar patients, normal to low
levels of noradrenaline and metabolites in urine were associated
with a high level of response to tricyclics. In unipolar
patients, low 5-HIAA levels and high normetanephrine levels were
associated with a good response to tricyclics. These findings
suggest that in one group of unipolar patients, a low
noradrenergic function is secondary to a primary change in the 5-
HT system whereas in a group of bipolar patients, the primary
change is in the noradrenergic system. However some patients
failed to fit into either category, implying that such an
analysis is either incomplete or incorrect.
Interest in the possible involvement of second messengers has
recently focused on the role of the phosphatidylinositol system
following the discovery that lithium interferes with the agonist-
dependent metabolism of inositol via inhibition of the hydrolysis
of inositol-I-phosphate (Allison et al. 1976, Berridge et al.
1982). If the stimulus were prolonged and further supplies of
inositol were not readily available, this could have the effect
of decreasing the response to, for example, alpha-adrenergic
agonists. This is examined further in Chapter 7.
Certainly from the evidence available, coupled with the
methodological differences between studies and the difficulty of
deciding which abnormalities are primary or secondary, it would
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appear that if the primary defect lies in the aminergic
neurotransmission systems, the biological abnormalities which are
manifest vary from patient to patient. This is possibly due to
genetic heterogeneity within the illness, possible sub-groups
within the illness having slightly different aetiologies, and the
complex interactions between the various neurotransmitter
systems. Alternatively it may be concluded that since so much
variation in amine metabolism is seen from patient to patient,
there is no common factor in this area which distinguishes
bipolars from normal, and that individual variations from normal
may be nothing more than random variations in a normal
population.
ii). Neuroendocrine function:- Many of the symptoms of
mania and depres sion are sugges tive of hypothala mic-pi tui tary
disfunction and this has been investigated in several studies
looking at neuroendocrine function. Results are difficult to
compare in many such tests due to the involvement of several
neurotransmitters and releasing factors in the regulation of
secretion of each hormone, the influence of variables such as
stress, age, sex, diet, and the circadian rhythms. Much work
needs to be done however before any possible underlying neuro-
transmitter disfunction can be elucidated.
The most commonly used test is the dexamethasone suppression
test (DST). Dexamethasone is a potent synthetic glucocorticoid
which suppresses plasma cortisol levels in normal individuals by
means of a negative feedback inhibition. Both abnormal and
normal dexamethasone suppression tests have been found in mania
(e.g. Godwin et al. 1984) whilst results for depression have been
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more consistent with approxima~ely 40-50% of patients with major
depression showing abnormal DST results, either non-suppression
or an early escape from suppression (Sachar 1982, Lowy et al.
1984). This is generally associated with cortisol
hypersecretion which appears to be secondary to ACTH
hypersecretion (Sachar 1982), but the physical signs of Cushing's
syndrome are not present, possibly due to a generalised decrease
in glucocorticoid receptor sensitivity and/or function. Non-
suppression with dexamethasone has also been correlated with a
decreased sensitivity of lymphocytes to glucocorticoid-induced
immunosuppression (Lowy et al. 1984).
Mitogen-induced lymphocyte proliferation has also been found
to be decreased in patients with major depression (Schleifer
et al. 1984), together with a generalised reduction in peripheral
lymphocyte numbers but the percentage of T and B-cells did not
differ compared with the controls. However no alteration in
lymphocyte function has also been reported (Sengar et al. 1982)
although medication was not witheld in this study and may have
had some effect upon the results.
Many studies have reported a deficient release of TSH in
response to TRH infusions (Sachar 1982) in depressed patients.
This response was not seen in all depressed patients however and
was more predominant amongst unipolar rather than bipolar
patients.
iii). Ion transport:- The unequal distribution of sodium
and potassium ions across cell membranes, i.e. high intracellular
potassium and extracellular sodium, and low extracellular
potassium and intracellular sodium, is achieved through a
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combination of selective membrane permeability and the
electrogenic sodium pump (Na+/K+-ATPase molecule) which in most
cell types is thought to extrude 3 sodium ions for every 2
potassium ions taken up (from Robinson 1975, Harrison and Lunt
1980). The greater permeability of the cell membrane to
potassium ions results in a negatively-charged membrane potential
(intracellular relative to extracellular). The maintenance of
these ion gradients is necessary for the generation and
propagation of impulses in excitable tissue.
Early observations of an increase in residual or intracellular
sodium during mania and depression, returning to normal upon
recovery, suggested a possible perturbation of ion transport in
manic-depressive psychosis (Coppen and Shaw 1963, Coppen et al.
1966). Similar findings were later reported by Naylor et al.
(1971) but Rybakowski et al. (1981b, 1983) found lower intra-
cellular levels of potassium and sodium during depression with a
decrease in plasma sodium upon recovery, and Frazer et al. (1983)
reported no significant differences in intracellular or extra-
cellular sodium levels during mania or depression. Whether the
alterations in ion concentrations are of aetiological importance
or are secondary to a change in mood is not clear. The majority
of such ion studies have been carried out using erythrocytes as
an easily accessible peripheral tissue, and whether any
abnormalities seen here reflect the situation in nervous tissue
would have to be further investigated.
Later studies involving the measurement of Na+/K+-ATPase
activity and ouabain-sensitive K+ influx (i.e. that proportion of
the potassium influx which is mediated by the sodium pump),
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largely using erythrocytes, are reviewed in detail in Chapter 6.
In summary, although results vary from study to study, the
majority of the findings are consistent with a lower total sodium
pump flux in mania and depression compared with remission (Naylor
1986), although whether remission values are also less than
controls is less clear. This lower activity appears to be due
to a lower activity per sodium pump molecule rather than to a
change in number of transport sites per cell, in both mania and
depression (Naylor et a1. 1980b). Many studies have
investigated the effects of lithium on Na+/K+-ATPase activity but
results are inconsistent and it has not been conclusively
determined whether any effect is seen (reviewed in Chapter 6).
Following the work by Cantley, Jr. et al. (1977) who had shown
that in vitro the vanadate ion is a powerful inhibitor of Na+/K+-
ATPase with a Ki (concentration producing half the maximal
inhibition) in the region of normal plasma vanadium
concentrations (although more recent measurements of plasma
vanadium are considerably lower - see later), Dick et al. (1980)
proposed that the factor in the plasma responsible for the
changes in sodium pump activity may be vanadium. Plasma
vanadium concentration as measured by atomic absorption
spectrometry was found to be increased significantly in manics,
and non-significantly in depressed patients when compared with
controls. A negative correlation with erythrocyte Na+/K+-ATPase
activity was seen (Dick et a1. 1980, Dick et al. 1982). In a
later study, manic patients had significantly raised levels of
vanadium in hair which fell towards control levels upon recovery
but had no significant differences in the blood or serum levels
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of vanadium. In contrast, depressed patients had raised levels
of vanadium in blood and serum which fell with recovery (Naylor
et al. 1984). These results probably reflect different aspects
of vanadium metabolism and in addition the measurements are those
of total vanadium, irrespective of oxidation state. A more
recent study has also supported the increased serum levels of
vanadium during depression, with means + S.D. of 0.061 + 0.025 uM
for depressed patients and 0.013 + 0.006 uM for healthy controls.
There was no correlation between vanadium level and type of
depression (i.e. neurotic or psychotic) within the depressed
group.
As vanadium given to normal subjects does not invariably
produce depression of mood (Naylor 1983), it was proposed that if
vanadium is an aetiological factor, manic-depressive patients
must have some abnormality, probably genetic, which would
increase their susceptibility to the actions of vanadium. The
production of new pump sites in response to increasing intra-
cellular sodium concentration has been shown to be dependent on
de novo protein synthesis in HeLa cells. Whether this was as a
result of alterations in transcription or translation was not
clear (Boardman et al. 1974, 1975b). To this end the ability of
lymphocytes from bipolar patients to increase their pump site
numbers in response to an increase in intracellular sodium.
concentration was examined. The results showed that lymphocytes
from bipolar patients had a significantly reduced ability to
synthesise new pump sites when compared with controls (Naylor and
Smith 1981a). Naylor suggested that this was indicative of a
defect in pump site control which renders the patient more
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vulnerable to vanadium and may predispose to manic-depressive
psychosis. However this theory does not explain the difference
between mania and depression or the onset and recovery of the
depressive and manic phases of the illness. Further discussion
of the possible involvement of vanadium in the aetiology of manic
depressive psychosis is given in Section LVII. after the
chemistry and biological actions of vanadium have been reviewed.
The effectiveness of lithium has been attributed to its
chemical similarity with sodium and potassium. Normally, under
steady-state conditions, the red blood cell lithium concentration
is approximately one third that of the plasma although
considerable interindividual variation is seen (Dorus et al.
1983, Dagher et a1. 1984). This concentration gradient is
primarily maintained by a lithium-sodium exchange (1:1), whereby
sodium entering the cell down its electrochemical gradient
exchanges with intracellular lithium. This transport system is
phloretin-sensitive, ouabain-insensitive and normally functions
as a sodium-sodium exchange (Dorus et al. 1983),
Considerable interindividual variation in the lithium ion
ratio (i.e. the ratio of red blood cell lithium concentration to
plasma lithium concentration) has been found in family studies
within the general population, with strong indications that
genetic factors are involved (Dorus et al. 1980). In a study
involving the first-degree relatives of 31 bipolar patients and
120 normals, segregation analysis indicated the involvement of an
autosomal major gene locus in influencing the lithium ion ratio
normally, the expression of which is modified by considerable
multifactorial variability. The allele at the major locus was
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associated with an elevated lithium ion ratio and an increased
risk of psychiatric hospitalisation amongst the relatives of the
bipolar patients (Dorus et al. 1983). A study involving 25 pairs
of monozygotic twins has shown that lithium ion ratios are
significantly greater in twins concordant for affective illness
compared with twins discordant for the illness (Verbanck and
Mendlewicz 1981). This suggests a membrane transport anomaly as
a possible susceptibility factor in subjects genetically disposed
to affective illness. However other factors are also important
in determining the lithium ion ratio, such as intestinal
absorption and renal excretion.
The Na+/K+-ATPase hypothesis based on the previously reviewed
data and put forward by EI-Mallakh (1983a), explains both mania
and depression on the basis of a reduced sodium pump activity.
In excitable cells this reduced activity of the sodium pump leads
to a depolarisation of the membrane potential towards the action
potential threshold and with the reduction in sodium extrusion by
the pump leading to increased intracellular sodium levels,
sodium-calcium exchange which is partly responsible for the
removal of intracellular calcium would be slower, resulting in
prolonged transmitter release. This increased neuronal activity
results in a period of mania. If the decrease in activity
continues so as to decrease the membrane potential beyond the
action potential threshold, depression occurs. This would imply
that a manic phase occurs every time preceding a depressed phase
but may not always be evident due to the rapidity of the change
in activity of the pump. However this hypothesis fails to take
into account the fact that most of the calcium involved in
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transmitter release is removed as a result of active calcium
transport (Bowman and Rand 1980) and that sodium-calcium exchange
plays only a small part. In addition, this hypothesis implies
that in depression the defect is more severe than in mania, which
is the opposite of the evidence from genetics. Indeed it would
make more sense to postulate that neuro-overactivity produces
depression, as for example a person in a depressive stupor
recovers rapidly following intravenous administration of sodium
amytal (Naylor - personal communication).
As a continuation of the above hypothesis, EI-Mallakh (1983b)
has explained the therapeutic action of lithium. As lithium
enters cells by lithium-sodium exchange or by diffusing in place
of sodium through sodium channels normally or during an action
potential, and is only extruded significantly by lithium-sodium
exchange which is dependent mainly on the extracellular sodium
concentration, it is preferentially accumulated in the more
active excitable cells where the influx rate of lithium exceeds
the efflux rate. This accumulation of intracellular lithium in
excitable cells leads to a decrease in sodium entry during
subsequent action potentials and an eventual reduction in
intracellular sodium, which in turn leads to increased calcium
extrusion via sodium-calcium exchange and decreased cellular
excitability, returning the membrane potential to normal. . This
hypothesis goes some of the way towards integrating the
catecholamine and ion transport hypotheses although the nature of
the endogenous factor responsible for the varied activity of the
sodium pump, the primary defect in the sodium pump of bipolar
patients, and the phasic nature of the illness are still not
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explained.
Perturbations in anion transport, namely erythrocyte phosphate
transport, have also been reported in bipolar and unipolar
patients (Szentistvanyi et a1. 1980). Plasma and erythrocyte
inorganic phosphate levels, passive phosphate transport and
transfer of inorganic phosphate into the membrane ATP pool but
not the cytosol pool were all significantly lower in the
depressed patients compared with the controls. No significant
difference was seen in ATP levels or in the rate of glucose
utilisation. Other membrane abnormalities have also been
reported e.g. calmodulin-activated Ca2+-ATPase activity in the
presence of lithium ions was greater in manic-depressives whether
or not treated with lithium previously, than in controls (Meltzer
and Kassir 1983), and in a study using fluorescent membrane
probes, Pettegrew et al. (1982) reported alterations in membrane
dynamics which indicated abnormalities in the hydrocarbon region
of erythrocyte membranes and lymphocyte cell surfaces in manic-
depressive patients. Overall it is possible that some
fundamental abnormality in cell membranes underlies all the above
observations with varied effects being seen from patient to
patient depending upon other possible predisposing factors.
Further discussion of the possible involvement of vanadium in
the aetiology of manic-depressive psychosis is given in the
following sections after a brief illustration of its chemistry
and occurrence.
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1.V. Chemistry and occurrence of vanadium
Vanadium, atomic number 23 and atomic weight 50.94, is a
transition element of Group Vb. Originally discovered by the
Swedish scientist Sefstrom in 1831 and named after "Vanadis", the
Scandinavian goddess of beauty, love, youth and lustre (Sage
1981, Nechay et a1. 1986), vanadium is a trace element found in
over 50 different minerals e.g. in combination with uranium and
radium as carnotite and roscoelite respectively, and occurs in
the earth's crust at a mean concentration of approximately 100
ppm (MARC Report 1976, Sage 1981). Main deposits are in
Scandinavia, South Africa and the USA (Sage 1981). It is also
found in some crude oils from where it is released in to the
atmosphere upon combustion. Its chief commercial uses are in
iron and steel alloys where it imparts ductility and shock
resistance, and as a catalyst in chemical processes (Cotton and
Wilkinson 1972, MARC Report 1976).
Oxidation states range from -1 to +5 but the most commonly
occurring are from +2 to +5. V2+ and V3+ are unstable and are
immediately oxidised to V4+ which is only stable in acidic pH as
the blue vanady1 cation, V02+. In oxygen or air, V4+ is readily
oxidised to V5+ and this is the oxidation state in which vanadium
normally exists under physiological condi tions (Ramasarma and
Crane 1981, Rubinson 1981).
The solution chemistry of V5+ ionic species is complex. It
is pH and concentration dependent as can be seen in Figure 1.1.,
with V5+ existing mainly as the monomeric orthovanadate anion,
V043- in the most basic solutions and as the monomeric
dioxovanadium cation, V02+, in the most acidic solutions. With
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an increase in concentration these species tend to polymerise
yielding e.g. tri-, tetra- and decavanadate ions, dependent upon
the pH (Cotton and Wilkinson 1972, Rubinson 1981). At the pH
and concentration present physiologically and in the absence of
any interfering effect from other ions, vanadium would be
expected to exist in the +5 oxidation state, largely as the
monomeric metavanadate ion, H2V04-. or more simply V03-, unless
reduced to the vanadyl ion V02+ intracellularly (Nechay et a1.
1986). Such a change results in not only an alteration of the
oxidation state of vanadium but also an alteration from a
negatively charged species to a positively charged species.
1.VI. Biological effects of vanadium
For the purpose of illustrating the biological distribution of
vanadium, the references cited are mainly review articles due to
the large amount of Ld tera ture on this aspec t , Regarding the
biological aspects of vanadium, this section is largely confined
to the vanadate ion as this is the most biologically active form
of vanadium (e.g. Schmitz et al. 1982), and is the species of
vanadium normally present physiologically unless intracellularly
reduced as discussed below. Original references cited here are
discussed in greater detail in the appropriate experimental
chapters of this thesis.
The essentiality of vanadium is well documented for some
organisms e.g. rat and chicken (Nielsen and Sandstead 1974,
Erdmann et al. 1984), with deficiency symptoms occurring at
dietary levels of less than 10-100 ng vanadium!g food. These
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include retardation of growth, bone malformation and impairment
of reproductive function. However Nechay et al. (1986) dispute
the essentiality of vanadium as being proven, due to
inconsistencies of other dietary factors in the various studies.
In man however, essentiality is less clear but the toxic effects
are well known, mainly due to industrial exposure via the lungs.
Most of the ingested vanadium is not absorbed. The primary
route of excretion for absorbed vanadium is via the kidney
(Nechay et al. 1986). Depression, bronchial spasm, vomiting,
diarrhoea, anaemia, inhibition of cholinesterase activity, and
death have all been reported (MARC Report 1976).
Tissue levels of vanadium vary from study to study depending
on the sensi tivi ty and accuracy of the analytical method used,
and the degree of contamination. The total body burden of an
adult human has variously been estimated in the range 100 ug to
43 mg, and the mean daily intake at between 10 ug and 4 mg
depending on the study (MARC Report 1976, Jandhya1a and Hom 1983,
Nechay et al. 1986). In man, vanadium tends to accumulate in
the kidneys (mainly cortex), liver, spleen and lungs (MARC Report
1976, Ramasarma and Crane 1981). Normal serum levels vary from
study to study with values ranging from 0.6 nM to 8 uM being
reported (Jandhyala and Hom 1983). More recent measurements
using the more sensitive and accurate technique of neutron
activation analysis have been in the range 2-20 nM (Erdmann
et al. 1984).
Many of the biological effects below have been attributed to
the similarity of the chemistry of vanadium and phosphorous e.g.
the v-o bond length is only about 1 Angstrom longer than the P-O
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bond length (Ramasarma and Crane 1981) and vanada te is able to
form a trigonal bipyramida1 structure which is analogous to the
proposed transition state of phosphate during enzymatic
hydrolysis (Lopez et al. 1976, Cantley, Jr. et al. 1978a).
However Rubinson (1981) believes that it is unlikely that
vanadate and phosphate have similar biological chemistries in
anything other than perhaps the simplest anion transport, as
profound chemical differences exist in the rate of ligand
exchange in their co-ordination complex chemistry.
Following the identification of sodium orthovanadate (Na3V04)
as the potent Na+/K+-ATPase inhibitor present as a contaminant in
commercially available "Sigma-grade" ATP prepared from equine
muscle (Josephson and Cantley, Jr. 1977, Cantley, Jr. et al.
1977, Quist and Hokin 1978), but not present in "Boehringer" ATP
or ATP prepared from yeast (Josephson and Cantley, Jr. 1977,
Beauge and Glynn 1977, 1978), vanadate has been extensively
investigated as a possible endogenous regulator of the sodium
pump.
In intact cells, vanadate was found to act from the
cytoplasmic side, unlike ouabain or other cardiac glycosides
(Cantley, Jr. et a1. 1978b, Cantley, Jr. and Aisen 1979). In
human erythrocytes, vanadate entered the cells with half the
affinity of phosphate (Kaff IV 60 mM for vanadate - the affinity
constant analogous to Kd at equilibrium Le. in this case, the
concentration where the uptake is half the maximum), and by the
same anion-exchange pathway, as evidenced by the inhibition of
vanadate entry by DIDS (4,4'-diisothiocyanatostilbene-
2,2'disulfonic acid) and by vanadate's competitive inhibition of
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phosphate entry (Cantley, Jr. et al. 1978b). However in cardiac
cells, uptake was postulated to be by a different saturable, non-
energy dependent pathway with a Kaff of 60-100 uM (Werdan et al.
1980). This was not competitively inhibited by phosphate.
Whereas the apparent Ki values for vanadate in isolated
Na+ /K+ -ATPase systems were very low e.g. 40 nM for dog kidney
under optimal conditions of high magnesium concentrations (25 mM)
and 100 nM under physiological conditions (Cantley, Jr. et al.
1977), and 1 uM for rabbit heart sarcolemma under physiological
conditions (Quist and Hokin 1978), it was higher in intact cells
e.g. 40 uM in human erythrocytes under physiological conditions
(Cantley, Jr. et al. 1978b). This discrepancy was attributed to
the intracellular reduction of the vanadate ion to the less
biologically active vanadyl ion and its subsequent binding to
intracellular proteins (Cantley, Jr. and Aisen 1979, Macara
et al. 1980). More recently the vanadyl ion has also been shown
to be a potent inhibitor of highly purified fractions of Na+/K+-
ATPase with a Ki of 10 uM, but no inhibitory action was seen
using more crude enzyme preparations (North and Post 1984).
+/ +Inhibition of Na K -ATPase by vanadate required the presence
of potassium ions (extracellularly in intact cells) and magnesium
ions (intracellularly in intact cells) which facilitated the
binding of vanadate although there was uncertainty about the
requirement for potassium ions (Josephson and Cantley, Jr. 1977,
Quist and Hokin 1978, Bond and Hudgins 1979, Beauge et al. 1980,
Robinson and Mercer 1981). Unlike ouabain, the inhibitory
action of vanadate was augmented by increasing the extracellular
potassium concentration (Beauge et a1. 1980). Decreasing the
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extracellular sodium concentration also augmented the inhibition
whilst ATP had a protective effect against inhibition (Josephson
and Cantley, Jr. 1977). Inhibition of the isolated enzyme was
totally reversed by millimolar concentrations of noradrenaline,
probably by complexation (Josephson and Cantley, Jr. 1977, Quist
and Hokin 1978).
A ouabain-like inhibition of potassium uptake and a
concomitant decrease in intracellular potassium concentration has
been seen in heart non-muscle cells from neonatal guinea-pigs and
chick embryos (Ki = 40 and 100 uM respectively), although the
alterations in potassium concentration were not as large as those
seen in the presence of ouabain, indicating the possibility of
other effects as well as the inhibition of the sodium pump
(Werdan et a1. 1982). However in heart muscle and non-muscle
cells prepared from neonatal rats, and in Girardi human heart
cells, vanadate stimulated both the ouabain-sensitive potassium
uptake (Kaff == 22, 140 and 34 uM respectively) and the sodium
influx, resulting in an increased intracellular potassium
concentration but no change in the sodium concentration (Werdan
et al. 1980, 1982), probably due to the increase in sodium
influx. This stimulation was seen despite the inhibition of the
isolated enzyme by vanadate. Positive inotropic effects and
chronotropic effects were also seen at these vanadium
concentrations (Werdan et al. 1980). This stimulation of the
ouabain-sensitive potassium flux was mimicked by insulin, and
incubation in vanadate, like insulin, stimulated the uptake of 2-
deoxy-D-glucose in these cells. This demonstration of a
ouabain-like inhibition and an insulin-mimetic stimulation of
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potassium uptake in the various cell types may be due to
differing reducing abilities, thereby resulting in either
predominantly vanadate ions which would inhibit the sodium pump,
or predominantly vanadyl ions which produce the insulin-mimetic
effect. Other as yet unknown membrane permeability differences
may also play a role in these results (Werdan et al. 1982).
The mode of action of vanadate in binding to the sodium pump
and thereby inhibiting it is complex and is discussed in more
detail in Chapter 3, together with the postulated conformational
changes involved in the normally operating sodium pump.
Essentially vanadate is considered to bind to ATP binding sites
and stabilise the enzyme in the (K)E2 conformation (Cantley, Jr.
et a1. 1978a, Karlish et a!. 1979).
When the oxidation of NADH was used to assay for Na+/K+-ATPase
activity, by coupling of the ATP hydrolysis to the oxidation of
NADH through pyruvate kinase and lactic dehydrogenase, vanadate
appeared to have a stimulatory rather than inhibitory action upon
Na+/K+-ATPase activity in a cat heart cell membrane preparation
(Erdmann et al. 1979a). It was later deduced that the decrease
in NADH induced by vanadate was not caused by stimulation of the
ATPase molecule but by an NADH-vanadate reductase possibly
present in the cardiac membranes (Erdmann et al. 1979b). In
a later study by Ramasarma et al. (1981), millimolar levels of
vanadate (probably decavanadate) stimulated the basal rate of
NADH oxidation 10-20 fold in mouse liver plasma membranes and pig
erythrocyte membranes, with oxygen as the acceptor, i.e. the
oxidation occurred not as a result of NADH-dependent reduction of
vanadate but as the result of a vanadate-stimulated NADH oxidase
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present in these membranes. This was inhibited by noradrenaline
with a Ki of approximately 2 uM, and also by superoxide dismutase
indicating a possible involvement of superoxide anions in the
effects of vanadate. Vanadate was also shown to be able to
oxidise NADH non-enzymically in this study. Such results show
that caution is needed in the interpretation of results produced
using such assays.
Initially vanadate's inhibitory action was thought to be
specific to the Na+/K+-ATPase following the claim that it was
ineffective on sarcoplasmic reticulum Ca2+-ATPase (Josephson and
Cantley, Jr. 1977). However it was later shown that the lack of
inhibition was due to a protective effect of low calcium
concentrations (O'Neal et al. 1979), and in the presence of the
ionophore A23187 vanadate was shown to inhibit rabbit muscle
sarcoplasmic reticulum Ca2+-ATPase. Several other ATPases have
also since been shown to be inhibited by vanadate e.g. Mg2+-
ATPase from ascites plasma membranes and the K+-ATPase of hog
gastric mucosal cell membranes (O'Neal et a1. 1979). However
mitochondrial ATPase was not inhibited (Josephson and Cantley,
Jr. 1977).
Ca2+-ATPase from erythrocyte membranes was inhibited by
.vanadate but with 3x less sensitivity than the Na+/K+-ATPase -
this inhibition also exhibited a requirement for magnesium and
potassium ions which appear to increase the apparent affinity of
the enzyme for vanadate (Bond and Hudgins 1980, Barrabin et al.
1980). Only calcium concentrations greater than 50 micromolar
resulted in a progressive reduction of the vanadate-induced
inhibition. Vanadate exerted its inhibitory action
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intracellularly and the potentiating effects of potassium and
magnesium were also both exerted intracellularly (Rossi et al.
1981). Similar inhibition of Ca2+-ATPase has been observed in
several other tissues e.g. squid axons, rat brain synaptosomes,
dog heart cells and kidneys - see Jandhyala and Hom 1983 for
references). In squid axons, DiPolo et a!. (1979) reported an
inhibition of uncoupled calcium efflux by vanadate but no
inhibition of sodium-calcium exchange suggesting that uncoupled
calcium efflux occurs via an ATP-driven pump and that sodium-
calcium exchange occurs via a different pathway.
Vanadate at micromolar levels has also been shown to inhibit a
variety of other enzymatic reactions involving phosphorylation
and dephosphorylation steps and these are reviewed in Chapter 4.
Vanadate was found to stimulate adenylate cyclase in several
tissues including human platelets and plasma membranes from rat
adipocytes, guinea pig hearts and turkey erythrocytes, (Schwabe
et a!. 1979, Krawietz et al. 1979, Krawietz et a1. 1982, Ajtai
et al. 1983). ~ values (the substrate concentration producing
half-maximal activation of the enzyme) ranged from 100 uM to 1 mM
and it was postulated that this stimulatory action may partly
underlie the positive inotropic effects seen with vanadate, as
described later. In adipocyte membranes, fluoride was shown to
have a greater maximal activating effect than vanadate on
adenylate cyclase, and the effects were not additive (Schwabe
et al. 1979). Beta-adrenergic agonists had no additive effect
on this vanadate-induced activation.
In guinea-pig heart membranes however, effects of vanadate and
fluoride were additive and increasing concentrations of vanadate
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in the presence of the non-hydrolysable analogue of GTP,
Gpp(NH)p, demonstrated a competitive effect (Krawietz et al.
1979). These results suggest that vanadate stimulates adenylate
cyclase by interacting with the guanine nucleotide regulatory
unit but by a different mechanism to fluoride. This mechanism
of action was also supported by the results of Krawietz et al.
(1982) using turkey erythrocytes, where like fluoride, vanadate
stimulation of adenylate cyclase involves the GTP regulatory unit
but by a different mechanism as although the effects of fluoride
and vanada te were not addi tive, the modification of the
regulatory unit by two separate agents resulted in different
consequences for fluoride- and vanadate-stimulated activity. At
optimal fluoride concentrations for activation (10 mM),
activation was inhibited by concentrations of vanadate greater
than 3 mM. No effect on beta agonist or antagonist binding was
seen (Krawietz et al. 1982).
It is known that stimulation of adenylate cyclase in broken
cell preparations does not necessarily imply increased cAMP
levels in intact cells (see Hackbarth et al. 1980 for
references). However increases in cAMP following treatment with
100 uM vanadate have been shown in e.g. cat papillary muscles
(Hackbarth et al. 1980) and frog skin epithelia (Cuthbert et al.
1980). No al tera tion in phosphodiesterase acti vi ty was seen.
In intact rabbit ventricular myocytes, no accumulation of
intracellular cAMP or inhibition of ouabain-sensitive potassium
influx was found until concentrations of vanadate greater than
0.5 mM when toxicity was also seen (Aiton and Cramb 1985).
These concentrations are higher than the levels at which positive
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inotropic effects are seen in the same preparation suggesting
that activation of adenylate cyclase or inhibition of the sodium
pump may not be involved in these effects. In contrast using
the broken cell membrane preparation, vanadate at concentrations
less than 100 uM (Km ~ 2 uM) stimulated adenylate cyclase
ac tivi ty upto 2-3 fold, with higher concentrations being
inhibitory (Ki - 0.5 mM, Aiton and Cramb 1985). Effects of
fluoride were not additive. Differences observed between the
two preparations may be due to the possible intracellular
reduction of vanadate in the whole cell preparation and/or to
permeability difficulties.
Whereas in rat adipocyte membranes there was no change in
phosphodiesterase activity with vanadate treatment (Schwabe
et a!. 1979), in intact adipocytes, activation of
phosphodiesterase was seen (Souness et al. 1985). From the
results it seems likely that this was due at least in part, to
the vanadyl ion rather than the vanadate ion.
Vanadate at micromolar levels has also been shown to inhibit
membrane phosphotyrosyl-protein phosphatase activity but not the
phosphoserine-specific activity, in A-431 cell membranes (Swarup
et al. 1982). This may explain the synergistic action of
vanadate wi th m! togens e.g. wi th epidermal growth factor (EGF)
resulting in enhanced DNA synthesis in human fibroblasts
(Carpenter 1981), since the initial interaction of EGF with its
receptor brings about an increased activity of a membrane protein
kinase which is tyrosine specific. Through its inhibitory
action, vanadate could possibly increase the level of
phosphotyrosine present in the phosphoproteins.
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The physiological effects of vanadate have largely been
attributed to its ability to inhibit Na+/K+-ATPase and/or
stimulate adenylate cyclase. A positive inotropic effect with
vanadate was observed in electrically-stimulated cat and guinea-
pig papillary muscles (Hackbarth et al. 1978, Borchard et al.
1979), and in ventricular muscle from rat, rabbit, guinea-pig and
cat, and in atria of rat and rabbit (Grupp et al. 1979, Schwartz
et al. 1980). Half maximal effects were seen at concentrations
of vanadate ranging from 20 uM to 500 uM. These effects were
reversible and were unaffected by beta agonists or antagonists.
At the same vanadate concentrations a marked activation of
adenylate cyclase has been described in some tissues (Grupp
et al. 1979) but not all (Aiton and Cramb 1985), making the
possible involvement of adenylate cyclase in the positive
inotropic response unclear. In contrast, a negative inotropic
effect was seen in guinea-pig and cat atria at concentrations
slightly lower than those producing the positive inotropic
response in the tissues above (Grupp et al. 1979, Borchard et al.
1979), and as the isolated enzyme from atria and ventricles in
these animals were both inhibited with a Ki of approximately 0.6
uM vanadate despite the differences in basal activity, this
effect was not due to differential effects of vanadate upon the
ATPase activity unless the tissues had different reducing
abilities. No inotropic effects were seen with vanadium in the
+3 or +4 oxidation state when tested on cat papillary muscles
(Schmitz et al. 1982).
The positive and negative inotropic actions of vanadate
correlated with a broadening and shortening of the action
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potential respectively in the guinea-pig but in the rat atria,
action potentials were also shortened despite the positive
inotropy. Although the time courses of the alterations in the
action potential duration were the same in both, the time course
for the development of the respective negative and positive
inotropism differed (Borchard et al. 1980). Borchard et al.
(1979, 1980) concluded that the inotropic effects of vanadate are
due to alterations in transmembrane potential, but not primarily
from the inhibition of the sodium pump. This was also supported
by the demonstration of positive inotropy and chronotropy even in
preparations where the sodium pump was stimulated by vanadate
(Werdan et a1. 1980).
When isolated heart preparations are electrically stimulated,
at least two different calcium pools are thought to be involved
in the contraction (Takeda et al. 1982). One is a superficial
pool predominant at high stimulation frequencies, which is
related to beat-ta-beat control of the force of contraction and
is inhibited by verapamil. The other pool is related to post-
rest potentiation of contraction and is inhibited by ryanodine.
In rat atria, increasing the frequency of stimulation led to
minor effects on the force of contraction whereas in guinea-pig
atria substantial increases in force were seen with each increase
in stimulation frequency (Takeda et al. 1982). This was
interpreted as being due to an Lnc rease.Ln the magnitude of the
superficial pool calcium at higher stimulatory frequencies in the
guinea-pig, but not in the rat. The effects of vanadate were
unaffected by the frequency of stimulation in the rat where it
produced a positive inotropism, but were greater at higher
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frequencies of stimulation in the guinea-pig, consistent with the
idea that vanadate affects the superficial calcium pool. In
contrast vanadate failed to modify the post-rest contraction.
It was concluded that the response of the vanadate-sensitive
calcium pool must be dependent on species and perhaps the area of
the heart (Takeda et a1. 1982).
Catalan et al. (1985) have described a vanadate-induced
activation of acetylcholinesterase (maximum at 100 uM) in
erythrocytes and rat ventricular strips.
contribute in some way to the inotropic effects.
The predominant effect of vanadate in vivo is vasoconstriction
This may also
suggesting that arterial smooth muscle has a greater sensitivity
to vanadate than does cardiac muscle. Myocardial contractility
was depressed and blood pressure increased in blood-perfused
organs from dogs, and in anaesthetised cats and dogs, resulting
in a negative inotropism and chronotropism (Schwartz et al. 1980,
Borchard et al. 1981). It was concluded that this was due to
coronary vasoconstriction at lower vanadate concentrations than
those at which the positive inotropic and chronotropic effects
were normally observed (Borchard et al. 1981). The mechanism of
this is not clear but may be due to an inhibition of the sodium
pump al though the concentrations needed to inhi bi t the enzyme
in vitro are much lower than those producing the
vasoconstriction, possibly due to reduction of the vanadate
(Schmitz et a1. 1982). However no effect on ouabain-sensitive
rubidium influx was seen in isolated vascular preparations at the
concentrations where vasoconstriction was produced (Huot et al.
1979). Similar results were obtained using rat vascular smooth
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muscle cells grown in vitro and this was not due to a lack of
sensitivity of the sodium pump in this tissue to vanadate, as the
isolated enzyme was inhibited (Searle et al. 1983). These
results make an involvement of the sodium pump in the
vasoconstriction produced by vanadate seem unlikely. In rat vas
deferens, the constrictive effects of vanadate (greater than 100
uM) were found to be dependent upon external calcium and were
blocked by the calcium antagonist nifedipine (Garcia et al. 1981)
indicating the possible involvement of Ca2+-ATPase.
Balfour et al. (1978) demonstrated a reversible potent
diuresis and natriuresis in rats following intravenous injection
of vanadate. There was no significant effect on urinary
potassium output. These results were confirmed by Day et al.
(1980) with the exception of the potassium excretion which they
found to be increased although the urinary potassium
concentration was decreased. Serum vanadium concentrations were
approximately 40 uM. No changes in GFR were seen, indicating
that the increased excretion of sodium was possibly due to a
decreased tubular reabsorption, probably proximally as vanadate
is accumulated in the renal cortex. This was also supported by
the finding of an increased calcium and phosphate excretion and a
non-additive effect of furosemide. Peritubu1ar vascular effects
may have also played a role due to the vasoconstrictory actions
of vanadate. Westenfelder et al. (1981), in a more extensive
study, found no change in potassium excretion and also suggested
that Na+/K+-ATPase activity in all the renal tubular segments was
affected with no change in adenylate cyclase activity.
In vitro, Kumar and Corder (1980), using isolated perfused rat
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kidney found that vanadate (0-32 uM) led to a dose-dependent
increase in GFR, urine flow, total peripheral resistance and
inhibition of sodium reabsorption. A post-capillary vaso-
constriction was postulated as both the changes in GFR and
vascular resistance occurred simultaneously. From several
studies it would appear that inhibition of the Na+/K+-ATPase is
largely responsible for the renal tubular effects of vanadate
(see Jandhyala and Hom 1983 for references). However in rats
fed on high vanadium diets, no effects were seen on basal Na+/K+-
ATPase activity despite extremely high renal levels of vanadium
(Higashino et a1. 1983). Vanadate also had no effect on the
stimula tion of sodi um pump acti vi ty which resulted as an
adaptation to chronic potassium loading.
Churchill and Churchill (1980) reported that vanadate (greater
than 5 uM), like ouabain, reduced basal as well as isoproterenol-
stimulated renin secretion in rat renal cortical slices and was
potentiated by external calcium. This suggests that an increase
in intracellular calcium resulting from a vanadate-induced
inhibition of Ca2+-ATPase and/or Na+/K+-ATPase mediates this
response. This is consistent with the idea that beta-adrenergic
stimulation of renin secretion is mediated by decreases in intra-
cellular calcium caused by stimulation of Ca2+-ATPase or Na+/K+-
ATPase.
In contrast however, anaesthetised cats and dogs produced a
decrease in both basal and furosemide-induced urine flow when
treated with a dose of vanadate comparable to that used in the
rat studies. This appeared to be due to a vasoconstriction
effect on renal blood vessels leading to a fall in glomerular
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capillary pressure and GFR (Larsen et al. 1979). It appears as
though in cats and dogs, renal vascular effects predominate over
tubular effects in a similar way that the ability of vanadium to
enhance myocardial contractility in vivo was diminished by its
ability to produce coronary vasoconstriction.
Vanadate has also been found to inhibit saltatory organelle
movement in permeabilised cultured human skin fibroblasts, at 10-
100 uM, possibly by inhibi ting a dynein-ATPase (Forman 1982).
In addition, chromosome movement in lysed mitotic PtKl cells was
inhibited at 10-100 uM (Cande and Wolniak 1978). No inhibition
of microtubule polymerisation or depolymerisation was seen and it
was thought that this effect was due to a reversible inhibition
of dynein-ATPase activity in the spindle. Micromolar
concentrations of vanadate also enhanced the stimulatory effect
of insulin on DNA synthesis in cultured mouse mammary gland
explants, but decreased that of lithium and had only a slight
effect by itself (Hori and Oka 1980). It was concluded that
insulin stimulation involves an ion-sensitive process and that
vanadate and lithium interact at some site which is important in
the regulation of this process.
There are many other diverse biological actions of the
vanadate ion, too numerous to mention here. These are covered
in reviews by Ramasarma and Crane (1981), Jandhyala and Hom
(1983), Boyd and Kustin (1984), Erdmann et a1. (1984) and Nechay
et al. (1986).
l.VII. Vanadium and bipolar manic-depressive psychosis
The previously discussed work of Naylor and his colleagues
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(see Section 1.IV.iii) indicated a reduced ability of manic-
depressive patients to produce new sodium pump sites in response
to increased intracellular sodium levels. This defect was
postulated to increase their vulnerability to a modifying plasma
factor tentatively suggested as vanadium or more specifically
vanadate, and further studies were carried out to test the
effects of altering cellular vanadate levels. In erythrocytes
it had been shown that most of the vanadate taken up was reduced
to the vanadyl ion which is much less biologically active
(Cantley, Jr. and Aisen 1979). Ascorbic acid (vitamin C) is
known to be effective in counteracting vanadium toxicity,
possibly by the reduction of the vanadate ion to the less
biologically active vanadyl ion (Adam-Vizi et al. 1981).
Following a single dose of ascorbic acid, both manic and
depressed patients were significantly better than following a
placebo (Naylor and Smith 1981 b). Similar improvements were
seen in patients on EDTA (chelates vanadium and is poorly
absorbed) plus reduced vanadium intake (Naylor and Smith 1981b)
and in patients taking methylene blue (reducing agent),
supporting the idea of an involvement of vanadium (Naylor et al.
19~1, Narsapur and Naylor 1983). In a later study however, the
combination of Vitamin C plus EDTA was as effective as the
standard antidepressant treatment amitriptyline, but in manic
patients was not as effective as the standard anti manic
treatment, lithium (Kay et al.1984). This is in keeping with
vanadium being more important in the aetiology of depression
rather than mania.
Phenothiazines, but not thioxanthines or tricyclic
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antidepressants were also able to catalyse the reduction of
vanadate to vanadyl in vitro and this was postulated as possibly
being the basis for part of their therapeutic action (Naylor and
Smith 1982). As vanadate is slow to dissociate from the Na+/K+-
ATPase molecules, this would account for the slow onset of action
of these drugs despite the rapid appearance of other effects such
as sedation (Naylor and Smith 1982).
The therapeutic action of lithium can also be explained on the
basis of an in~olvement of vanadium. Significantly higher
Na+/K+-ATPase activity/pump site was found in manic-depressive
patients taking lithium for over 6 months, when compared with
manic-depressives who had never taken lithium (Naylor et al.
1981), suggesting that lithium increases sodium pump activity and
not numbers in vivo. This was also supported in vitro as when
erythrocyte membranes from manic-depressive patients and normal
subjects were prepared and assayed for Na+/K+-ATPase activity in
varying concentrations of vanadate, the expected inhibition of
activity was seen with a Ki of approximately 0.3 uM. Addition
of lithium reduced the inhibitory effect of vanadate with a
maximum effect at approximately 6 mM lithium (Naylor et al.
1981). This could explain the above actions of lithium in vivo,
if vanadium concentrations were high enough to be inhibitory.
However MacDonald et al. (1982) were not able to confirm these
actions of lithium. This conflict in the results of many such
studies still has not been resolved.
Many of the results seen in studies investigating the amine
hypothesis are not irreconcilable wi th the Na+ /K+ -ATPase and
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vanadate hypothesis. There is considerable overlap between the
two areas as already indicated and additionally e.g.
neurotransmission is dependent upon a fully functioning ATPase
system and catecholamines have been shown to be able to activate
rat brain Na+/K+-ATPase, partly by a specific receptor-mediated
mechanism and partly by a non-specific mechanism (Wu and Phillis
1980). In additon, incubation with millimolar levels of
vanadate induced a loss of cholinergic binding sites in
homogenatesof rat corpus striatum (Danielsson et al. 1983) but a
greater number of muscarinic cholinergic receptors were found in
cultured skin fibroblasts of some manic-depressive patients and
their relatives, compared with controls (Nadi et al. 1984).
Subacute and chronic vanadium exposure has led to decreased
levels of noradrenaline and increases in dopamine and 5-HT in rat
brains (Witkowska and Brzezinski 1979). In mice, non-toxic
doses of vanadate have led to decreases in hypothalamic
noradrenaline and dopamine but no alterations in striatal
dopamine, the area where it is richest. This suggests that
vanadate selectively acts on adrenergic pathways with other
pathways being affected secondarily (Sharma et al. 1986).
Vanadate is bound by noradrenaline (Quist and Hokin 1978) and
vanadate-induced inhibition of both Na+/K+-ATPase and Ca2+-ATPase
in vitro can be reversed by catecholamines possibly by either a
complexation or an oxidation/reduction reaction (Josephson and
Cantley, Jr. 1977, O'Neal et a!. 1979). Vanadate is able to
oxidise noradrenaline and adrenaline thus producing the vanadyl
ion and inactivating the catecholamines (Cantley, Jr. et al.
1978a).
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From all the data reviewed here it is clear that the aetiology
of bipolar manic-depressive psychosis is likely to have a genetic
component but the primary biological perturbation underlying the
illness is impossible to define with certainty, due to
confounding secondary features and complex interactions.
However ion transport and cerebral monoamines are two of the most
likely candidates for the areas where a defect or defects may
lie.
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CHAPTER 2. THE EFFECTS OF CHRONIC VANADATE TREATMENT ON HELA
CELLS; CELL GROWTH. MORPHOLOGY. AND INTRACELLULAR REDUCTION OF
VANADATE
2.1. INTRODUCTION
2.I.i. Tissue culture
Tissue culture is used in many diverse areas of study a.g,
cell growth, ion transport, receptors, viral or bacterial
infection, immunology, genetics, cancer research, embryology,
drug actions and toxicology. The general term "tissue culture"
is concerned with the study of cells, tissues and organs
maintained in vitro. It encompasses:- a). organ culture - the
growth in vitro of tissues or the whole or parts of an organ in
conditions which allow the differentiation and preservation of
the original architecture and/or function; b). tissue culture -
the growth in vitro of tissue fragments in conditions which do
not necessarily preserve the original tissue structure; and c).
cell culture - the growth in vitro of cells which are no longer
organised into tissues (Paul 1970). Such systems allow the
study of cellular or tissue processes in a controlled
environment, free from the normal whole-body homeostatic
mechanisms and endocrine influences.
The first successful culture of organised tissue was carried
out by Roux in 1885 who maintained the neural plate of a
developing chick embryo in warm saline for several days, and
proved that the closure of the neural tube was controlled by the
constituent cells and not by structures normally surrounding it
in vivo (Parker 1961). Tissue fragments and cells isolated from
many parts of the body have since been cultivated, following the
development of suitable media which allow the maintenance of the
correct pH, osmolarity and concentrations of essential inorganic
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salts, vitamins, amino-acids and various growth factors.
A culture initiated from cells, tissues or organs taken
directly from an organism is termed a "primary culture". This
may survive for days or months either dividing or non-dividing
and eventually die, or may divide repeatedly and require sub-
culturing or passaging (the removal of cells to a new culture
vessel with fresh medium). The culture is then termed a
"primary cell line" which may die after several passages or may
become an "established cell line", with the apparent potential to
be sub-cultured indefinitely. This transition between the
primary and established state may occur gradually, or suddenly as
a result of "transformation" which can be monitored by the
appearance of a few colonies of rapidly-dividing cells which
become the predominant cell type. These cells often differ from
the primary cell line in several ways e.g. abnormal chromosome
number, loss of contact inhibition, shorter population doubling
times and sometimes a loss of specialised function.
Transformation can be either spontaneous or caused by agents such
as viruses or carcinogenic chemicals. In addition, primary cell
lines can be established from tumours and in this case often
behave as established cell lines from the start. Paradoxically,
many cell lines established from tumours frequently show better
retention of specialised function than those derived from normal
tissue (Paul 1970).
Established cell lines show essentially the same growth
kinetics as bacteria. After being seeded from a stationary
culture, there is a "lag phase" varying from hours to days before
growth begins. Growth then progresses steadily wi th the
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population doubling usually every 12 to 24 hours in the
"logarithmic phase". Following the exhaustion of a nutrient or
the accumulation of a toxic product, growth stops and the cells
enter the "stationary phase". The processes underlying the "lag
phase" are not known but may possibly be associated with the
removal of intracellular waste metabolites and/or replenishment
of essential intracellular metabolites (Paul 1970). Ra tes of
growth depend not only upon inherent properties of the cells but
also upon nutrient supply, seeding density and the proliferative
fraction of the cell population (Macieira-Coelho 1973),
In this project the preliminary investigations into the
cellular actions of vanadate were carried out using the
epithelial HeLa cell line. This line was originally derived
from human cervical carcinoma cells (Gey et al. 1952) and strains
exist which may be grown either in suspension or as a monolayer.
For the purposes of this study a monolayer strain was used. The
reasons for selecting the HeLa cell line were as follows:- a).
it is of human derivation which makes it more comparable with the
lymphoblastoid cell lines used later, although functionally
different cells; b). its routine use as the major human cell
line in this laboratory for several years, during which time the
optimum conditions for culture have been established; and c). the
thorough characterisation of the cation transport parameters in
this cell line which make it ideal for an investigation of the
effects of a compound such as vanadate upon ion transport. The
results obtained in this part of the study have then been used to
aid the interpretation of the results obtained in the second half
of the project, when the less-well characterised lymphoblastoid
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cell lines derived from manic-depressive patients were used.
2.!.!!. Cytotoxicity of vanadate
In any study of the effects of a compound upon parameters such
as ion transport, possible toxic effects must also be evaluated
in order that a distinction can be made between effects caused
directly by the compound and effects occurring secondarily to
toxici ty. Toxici ty as measured by a decrease in cell num bers
relative to controls, has been reported in Madin Darby bovine
kidney (MDBK) cells at micromolar levels of vanadate when
incubated for 24 hours (Bracken and Sharma 1985, Bracken et al.
1985). This was accompanied by a progressive change in cell
morphology from a polygonal form to bipolar, spindle-shaped cells
(Bracken et a!. 1985). Decreases in the incorporation of
thymidine into DNA and leucine into proteins were also reported
at toxic levels of vanadate, with leucine incorporation appearing
to be more sensitive to the actions of vanadate (Bracken and
Sharma 1985). Paradoxically, increased cellular levels of DNA
and protein were found. Possible explanations given for this
were decreased degradation rates of DNA and protein, decreased
rates of cell division and/or decreased precursor transport.
A decreased rate of exogenous and endogenous protein
degradation was reported in rat hepatocytes after 30 minutes
incubation in 10 mM vanadate (Seglen and Gordon 1981). This was
thought to be due to an inhibition of lysosomal cathepsins and
protein synthesis was not affected under these conditions. No
effects on cell viability were seen until after a 2 hour
incubation in 20 mM vanadate. At the same concentrations of
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vanadate as those producing an inhibition of protein degradation,
changes in the cellular morphology of hepatocytes were also seen
which were similar to those caused by cytochalasin, implicating
an action of vanadate upon cytoskeletal elements (Seglen and
Gordon 1981).
Shape changes in erythrocytes have also been described
following incubation in 20 mM vanadate for 2 hours at 2SoC.
More than 80% of the cells assumed equinocytic forms (Vives-
Corrons et al. 1981). The osmotic fragility and deformability
of these cells was also reduced. As the lateral mobility of
erythrocyte membrane proteins has been shown to be modified by
po1yphosphates such as 2,3-DPG, ATP and GTP, it was postulated
that vanadate may be affecting either the levels or regulatory
action of these compounds, resulting in changes in the membrane
skeletal organisation and hence the changes in shape and physical
properties of the cells.
Inhibition of saltatory organelle movement in permeabilised
fibroblasts has also been seen at vanadate levels from 10 uM to 1
mM (Forman 1982). At similar levels, chromosome movement was
inhi bi ted in lysed mitotic PtKl cells with no effect on
microtubule polymerisation (Cande and Wolniak 1978). Both these
effects were postulated as being due to an action of vanadate on
a dynein-like molecule.
A mitogenic action of vanadate has been reported in quiescent
human fibroblasts with an increase in cell numbers of 61% in the
presence of 4 uM vanadate for 48 hours, compared with an increase
of only 9% in the absence of vanadate (Carpenter 1981).
Toxicity was seen at vanadate concentrations greater than 40 uM.
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Vanadate also potentiated the mitogenic effect of EGF in these
cells as assesed by the increased incorporation of thymidine into
DNA (although total DNA levels were not measured), and at
concentrations of 2 - 10 uM potentiated the mitogenic action of
insulin on mammary gland exp1ants from mice but inhibited that of
lithium (Hori and Oka 1980). Vanadate by itself was only
slightly mitogenic in the latter tissue. It was postulated that
the stimulatory effect of insulin on cell division involves an
ion-sensitive process and that vanadate and lithium act at some
regulatory site in this process, possibly an ATPase molecule.
It is evident from the above examples that in a variety of
cell types, vanadate is capable of affecting many processes
involved in cell division and growth, each of which could cause
indirect effects upon ion transport in addition to any direct
effects which may be present.
2.I.11i. Intracellular reduction of vanadate
Any investigation of the cellular effects of vanadate is
complica ted by its intracellular reduc tion to the vanadyl ion.
In erythrocytes, uptake of vanadate was found to occur in two
distinct phases; a rapid initial uptake lasting 15-30 minutes
(to•S = 4 minutes) at an extracellular vanadate concentration of
250 uM, corresponding to chemical equilibration through the anion
exchange pathway, and a slower intracellular concentration of
vanadium by an energy-dependent uptake (to.S - 90-130 mins).
This has been shown to represent the intracellular reduction of
V5+ to V4+ and the subsequent stabilisation of the vanadium in
this form by binding to haemoglobin (Cantley, Jr. et al.1978b,
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Cantley, Jr. and Aisen 1979, Macara et al. 1980).
The reduction of vanadate in erythrocytes is thought to be
non-enzymatic and due to glutathione (GSH) rather than NADH, as
the rate of reduction by NADH is much slower. However a
vanadate-stimulated NADH oxidase has been shown to be present in
mouse liver plasma membranes and pig erythrocyte membranes
(Ramasarma et al. 1981) so it is possible that reduction may be
due to a combination of enzymatic and non-enzymatic mechanisms.
Intracellular reduction of vanadate has also been described in
rat adipocytes with .binding of the resultant vanadyl to GSH
(Degani et al. 1981). Again it was not clear whether reduction
was enzymatic or non-enzymatic.
Such a reduction would explain the resistance of the Na+/K+-
ATPase in intact cells to the inhibitory actions of vanadate as
already discussed in Chapter 1. Vanadyl is a much less powerful
inhibitor of this enzyme unless a highly purified membrane
preparation of the enzyme is used (North and Post 1984), although
the reasons for this are not known. Unlike vanadate, vanadyl
can be detected using electron spin resonance (ESR). Following
a ligand binding study and theoretical consideration of cellular
vanadium accumulation, Nechay et al. (1986) calculated that in
most cell types, less than 1% of intracellular V02+ is free, with
the intracellular binding accounting for the vanadium
accumula t Lon. Spontaneous oxidation of the vanadyl to vanadate
would be prevented by the binding~ By assuming that 90% of the
plasma V03 was bound to proteins, Nechay et al. (1986)
calculated that the free plasma concentration of V03 - would be
approximately 10-9M, resulting in an intracellular concentration
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of approximately 3 x 10-11M in the absence of active transport
(from Nernstian principles - Nechay et a1. 1986). Because of
the weaker intracellular binding of V03- compared with that of
V02+, the equilibrium favours reduction and subsequent binding of
the vanady1. The free concentrations of both vanadyl and
vanadate would thus be below those reported to have any effects
upon the Na+/K+-ATPase molecule under optimum conditions and
would therefore account for the resistance of intact cells to the
inhibitory actions of vanadate seen in membrane preparations.
From the above discussion it can be appreciated that it is
difficult to establish whether any effects seen in vanadate
treated cells are due to vanadate, vanadyl or to a depletion of
e-g NADH or GSH.
As previously mentioned vanadyl ions, unlike vanadate ions,
can be detected using ESR. A simplified view of the principles
of ESR is given below. A more detailed treatment can be found
in several textbooks such as those by Ayscough (1967), Gerson
(1970), Banwell (1972), and Straughan and Walker (1976).
Electrons in atoms and molecules move around the nucleus in
fixed orbitals and in addition have their own intrinsic spin.
Any such spinning or rotating particles act as magnetic dipoles
and tend to align themselves in the direction of an applied
magnetic field. This occurs in molecules and atoms with either
an unpaired electron e.g. N02, or two electrons with parallel
spins e.g. O2, which are said to be paramagnetic. It does not
occur in molecules and atoms which have electrons in closed
shells or associated in pairs with opposing spins so that their
magnetic dipoles cancel. These are said to be diamagnetic.
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There are two possible orientations of the unpaired electrons,
either parallel or anti-parallel to the inductive magnetic field.
Each orientation represents a discrete energy level.
Transitions or resonance between these levels (changes in spin
state) may be induced by interaction of the magnetic dipole of
the unpaired electrons with an oscillating magnetic field
accompanying electromagnetic radiation exerted perpendicularly to
an inductive magnetic field. These transitions can be studied
using ESR. Resonance conditions are dependent upon both the
frequency of the electromagnetic radiation and the strength of
the inductive magnetic field. These parameters can be related
to one another in a simple equation, hence either one may be kept
constant while the other is varied in order to establish the
resonance condition. Technically the magnetic field strength is
the parameter which is usually varied.
Generally ESR is used for examining the electronic structure
of molecules, particularly organic ones. However it can also be
used quantitatively. In ESR spectroscopy, microwave radiation
of constant frequency (usually 9000 - 10000 MHz corresponding to
a wavelength of approximately 3 cm i.e. in the Microwave X-band
region), is transmitted via copper tubing to the sample cavi ty
where energy is concentrated on the sample by multiple
reflections from the cavity walls. Electromagnets are located
on either side of the cavity so that the steady inductive
magnetic field and the oscillating field of the electromagnetic
radiation are mutually perpendicular. The strength of the
steady field is normally in the range of 3000 - 3500 gauss for
the resonance condition to be established in most samples at the
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electromagnetic radiation frequencies cited previously. A
crystal detector measures the intensity of the energy absorption
by the sample - this is increased as the magnetic field strength
approaches the value needed for resonance when unpaired electrons
move to a higher energy level absorbing energy in the process.
Energy is emitted if transition of the electrons is to a lower
energy level as occurs during relaxation. The magnitude of the
radiation absorbed is proportional to the electron population
difference between the two energy states. At a particular
wavelength and constant temperature, the population difference
between the energy states is a constant proportion of the total
number of unpaired electrons present. Hence it is possible to
relate the magnitude of the ESR signal to the concentration of
the sample. Normally the resultant plot is the derivative one
as this is technically better i.e. the rate of change of
absorption intensity with respect to the change in field strength
(y axis) against the field strength (x axis).
The complexity of an ESR spectrum (its hyperfine structure),
is determined by interactions between unpaired electrons and the
magnetic nucleus and is characteristic for each substance.
Vanadium in the +5 oxidation state, for example as the
metavanadate ion V03-, is diamagnetic and does not produce an ESR
spectrum whereas vanadium in the +4 oxidation state, for example
as the vanadyl ion V02+, is paramagnetic. The spectrum of V02+
is hyperfine with 8 bands of absorption or hyperfine lines each
separated by 120 gauss. Different spectra are produced
depending upon whether the vanadyl is bound or free unless
analysis is carried out at 77°K where the same signal is
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produced. An alternative method is to release the protein-bound
vanadyl using acid. This also has the added advantage of
reversing any hydrolysis which may have occurred, as vanadyl
hydroxide which forms at neutral pH is not detectable by ESR.
This is due to the fact that vanadium in the +4 oxidation state
requires a non-cubic field for observation by ESR, such as that
found in square pyramidal vanadyl type complexes (Sakurai et al.
1980). Vanadium in the +3 oxidation state is also paramagnetic
but a spectrum is not observable due to an internal electric
field effect (Sakurai et al. 1980).
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2.11. MATERIALS AND METHODS
2.11.i. Reagents
Reagents used were purchased from the following:-
Aldrich Chemical Company Ltd. (Gillingham, Dorset):-
(99% pure).
BDH Chemicals (Poole, Dorset):-
grade) and EDTA (Analar grade).
Coulter Electronics Ltd. (Luton, Beds.):- Isoton.
Edinburgh Cameras (Edinburgh, Scotland):- Ilford FP4, EM and
Concentrated HCl {Aristar
Pan F black and white films.
EMscope Laboratories Ltd. (London):-
supplies as detailed in Section 2.11.v ••
Flow Laboratories (Rickmansworth, Herts.):-
all electron microscopy
HeLa cells -
originally purchased in 1974 and subcultured and frozen at
intervals with stocks maintained in liquid nitroge~
Fluka (Switzerland):- VOS04.5H20 (98% pure).
Ci bco-Biocul t (Paisley, Scotland):- Basal Medium Eagle (BME)
tissue culture medium with Earle's salts, new-born calf serum, L-
glutamine (200 mM), kanamycin (lOmg/ml), Earle's balanced salt
solution (EBSS - Ca and Mg free), trypsin (2.5% w/v), and
"Nunclon" tissue culture plates (5 cm and 9 cm diameter).
Sigma (Poole, Dorset):- Ascorbic acid.
Water used for solutions was produced using a Milli-Q water
system (Millipore S.A.,France). All solutions were dispensed
using Gilson adjustable pipettes during experiments.
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2.II.U. Sub-culturing of HeLa cells
All routine tissue culture procedures were carried out using
standard aseptic techniques in a "Gelaire Class 100" laminar air
flow cabinet (Gelman Instruments).
autoclaved at 12loC (15 psi) before
All sterile glassware was
use. Medium was made from
powdered stocks, sterilised by passage through a 0.22 urn
Millipore filter and stored at 40C in sterile bottles. HeLa
cells were normally grown in BME with Earle's salts, supplemented
with 10% (v/v) new-born calf serum, 2 mM glutamine and 50 ug/ml
kanamycin (See Table 2.1.). All solutions were warmed to 370C
before use.
HeLa cells were normally maintained in a 120 glass Raux bottle
i.e. a Raux with 120 cm2 of flat growth surface. To subculture
cells from an existing monolayer, the growth medium was poured
off and the cells rinsed with approximately 4.5 mls of trypsin
solution (0.25% w/v in EBSS - Ca and Mg free - see Table 2.2.).
5 mls of the trypsin solution were then added to the bottle which
was sealed and incubated at 37°C for 5-10 minutes until the cells
were detached from the glass surface. The trypsin solution was
then neutralised with the addition of 45 mls of complete BME to
the bottle, and a single cell suspension was prepared by the
repeated syringing or "blasting" of the suspension through a
wide-bore (1-2 mm) needle. This procedure does not affect the
integrity of the cells. A 1 ml aliquot of the suspension was
then added to 19 mls of Isoton and the cell number, cell volume
and water content determined using a Coulter Counter Model ZF
with Channelyzer (C1000), interfaced to a Sharp MZ-80K personal
computer. Intracellular water was computed by assuming that 80%
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Table 2.1. Composition of Rasal Medium Eagle (RME) tissue
culture medium with Earle's salts
Inorganic Salts mgtl
CaCl2 (anhyd.) 200.00KCl 400.00
MgS04 (anhyd.) 97.67
NaCl 6800.00
NaHC03 2250.00NaH2P04·H2O 140.00
Other Components
D-Glucose 1000.00
Phenol Red 6.00
Sodium Succinate 100.00
Succinic Acid 75.00
Amino Acids
L-Arginine (HCI) 21.00
L-Cystine (2HCI) 15.65
L-Histidine HCl (H2O) 15.00L-Isoleucine 26.00
L-Leucine 26.00
L-Lysine HCI 36.47
L-Methionine 7.50
L-Phenylalanine 16.50
L-Threonine 24.00
L-Tryptophan 4.00
L-Tyrosine 18.00
L-Valine 23.50
Vitamins
Biotin 1.00
D-Ca Pantothenate 1.00
Choline Bitartrate 1.80
Folic Acid 1.00
i-Inositol 2.00
Nicotinamide 1.00
Pyridoxal HCI 1.00
Riboflavin 0.10
Thiamine HCI 1.00
In addition, the medium was supplemented with 10% (v/v) new-born
calf serum, 2mM L-glutamine and 50 ug/ml kanamycin before use.
Table 2.2. Composition of calcium and magnesium-free Earle's
Balanced Salt Solution (EBSS)
InorRanic Salts
NaCl
KCl
NaH2P04·2H20
NaHC03
m~dl
6800.00
400.00
158.00
2200.00
Other Components
Glucose
Phenol Red
1000.00
10.00
of the cell volume is water (Lamb and McCall 1972). This method
of measuring cell volume assumes that the volume is not affected
by trypsinisation.
An aliquot containing 5 x 106 cells was taken from the cell
suspension and added to 100-125 mls of fresh BME in a clean Roux.
This was equilibrated with a 95% air/5% CO2 mixture, sealed and
placed in the 370C hot room. The remaining cell suspension was
discarded or used for plating as described later. Usually after
about 5 days growth such a Roux would be confluent and ready for
sub-culturing (splitting) as above, with a normal yield of 40-50
x 106 cells.
2.U.iii. Plating of HeLa cells
After a cell suspension had been prepared as described in the
previous section, an appropriate amount was taken and further
diluted with BME to give a density of 0.11 x 106 cells/mI. This
was dispensed in 3 ml aliquots into 5 cm diameter sterile plastic
·'Nunclon" tissure culture plates. The plates were then stacked
in plastic boxes, equilibrated with 95% air/5% CO2 mixture,
sealed and incubated at 370C. Normally, for experiments in this
study, the medium was replaced on day 3 (day ° - the day of
-9 -4)plating) with fresh medium ± vanadate (10 M-IO M, minimising
any disruption to the cell monolayer. The plates appeared to be
nearly confluent (viewed on an Olympus CK inverted microscope)
when used in an experiment 24 hours after the medium change.
Vanadate-containing medium was prepared by dissolving Na3V04 in
an appropriate volume of BME to yield a IO-3M solution. Lower
concentrations were prepared by serial dilutions of this stock
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solu tion and usually stared for 24 hours before us e in orde r to
minimise the formation of decavanadate ions.
2.II.iv. Effect of 24 hours growth in vanadate upon HeLa cell
numbers
HeLa cells were plated out on 5 cm plates as described in the
previous section at 0.33 x 106 cells/plate (day 0). On day 3,
the plates were numbered and the medium was replaced with fresh
medium ± Na3V04 (10-9M-10-4M), each concentration in triplicate.
The plates were then incubated for a further 24 hours at the end
of which time they were transferred to a bench-top incubator at
37oC. For each plate in turn the medium was aspirated off, the
cells washed 4x with Krebs solution (pH 7.4 at 37oC, see Table
2.3.), and 1 ml of trypsin solution (0.25% w/v in EBSS - Ca and
Mg free) containing 2 mM EDTA was added. The plates were then
replaced on the incubator until the cells had detached whereupon
the trypsin was neutralised by addition of 2 mls of Krebs
solution. The cell suspension was then blasted through a wide-
bore needle producing a single-cell suspension, 1 ml of which was
taken and added to 19 mls of Isoton for the determination of cell
numbers as previously described. Using the appropriate dilution
factors etc., the total cell number/plate, the mean cell volume
and the total plate water were determined. The experiment was
repeated several times and the results analysed by Student's t-
test (unpaired) using the "Mini tab" statistical package on the
VAX mainframe computer. This experiment was also carried out
with incubation times of 3, 6 and 12 hours in vanadate-containing
growth medium.
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Table 2.3. Composition of Krebs solution
Component
NaCl
KC!
MgS04·7H20NaH2P04
KH2P04CaC12HC!
Tris Base
Glucose
mmoles/l
140.0
5.4
1.2
0.3
0.3
2.8
12.0
13.7
11.1
In addition the Krebs solution was supplemented with 1% (v/v)
new-born calf serum. The pH was adjusted to 7.4 at 37oC.
2.II.v. Effect of 24 hours growth in vanadate upon the
morphology of HeLa cells
HeLa cells were plated out as described in Section 2.11.iii.
and a sterile 1.5 x 1.5 cm glass coverslip was placed in the base
of each plate (day 0). The cells were then grown until day 3
when the medium was changed to BME ± Na3V04 (10-9M-10-4M) as
previously described, and then grown for a further 24 hours.
Following this, each coverslip was carefully removed from the
plate, washed in Krebs solution, and placed cell-side down on a
drop of Krebs solution on a clean labelled glass microscope
slide. The edges of the coverslips were sealed with nail
varnish to prevent evaporation and the cells were examined using
a Leitz Dialux 20 microscope with camera attachment, an objective
lens of x40 and x12.5 eyepiece lenses. Photographs were taken
using Ilford Pan F black and white film.
Transmission and scanning electron micrographs of HeLa cells
are also included in the "Results" section of this chapter to
illustrate the normal ultrastructure and morphology of HeLa
cells. Specimen preparation is only outlined here but further
details can be found in standard electron microscopy textbooks.
Briefly, for transmission electron microscopy, cells were
,grown on plates as previously described, trypsinised and a single
cell suspension prepared. This was fixed in gluteraldehyde,
osmicated, dehydrated in a series of alcohols and embedded in
Epon (Agar resin). Ultrathin (approx. 80 nm thick) sections
were cut using a Reichert OM.U2 ultramicrotome, collected on
copper grids, double stained with uranyl acetate and lead
citrate, and examined at magnifications ranging from x1900 to
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x91000 on a Philips 301 electron microscope at 60 kV.
Photographs were taken on Ilford EM film using the camera
incorporated in the microscope.
For scanning electron microscopy, cells were grown on glass
coverslips as previously described, fixed with gluteraldehyde,
osmicated, dehydrated in alcohols and then transferred to
acetone. After critical point drying, the samples were coated
with a thin layer (200 A) of gold in an Edwards High Vacuum
Coater and viewed in a Jeol JSM 35-CF scanning electron
microscope at magnifications ranging from x500 to x1500 at 15 kV.
Photographs were taken using a 35 mm camera attachment and Ilford
FP4 black and white film.
2.II.vi. Measurement of the intracellular reduction of vanadate
to vanadyl in HeLa cells
The measurement of total vanadium present in the cells may
have been possible using neutron activation analysis or atomic
absorption spectroscopy but the facilities were not available to
us, and the cost of radiolabelled vanadium together with its
short half-life prohibited radioisotopic uptake experiments.
For these reasons it was decided to measure the intracellular V4+
using ESR, reduce any V5+ present using ascorbic acid and measure
the resultant V4+ concentration. By a suitable subtraction the
amount of vanadium present in the +5 oxidation state could then
be determined.
Preliminary studies were carried out using absorption
spectroscopy, in order to evaluate the stability of solutions of
vanadate and vanadyl solutions under various conditions. This
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study was undertaken in order to find a suitable extraction
procedure which would not only precipitate the proteins but would
also maintain the true intracellular oxidation states of vanadium
during extraction. The method used was based on that of
Fitzgerald and Chasteen (1974) which involved an extraction using
hydrochloric acid in which the vanadyl ion is stable. The
stability of vanadate under these conditions was not detailed by
Fitzgerald and Chasteen (1974) but was investigated here. In
addition it was proposed to quantify the reduction of vanadate by
ascorbic acid under these conditions. Wherever possible, new
disposable plastic utensils were used in order to minimise
contamination.
Vanadyl-containing solutions were prepared by dissolving
vanadyl sulphate (VOS04) in 1M HCl to form a 10-2M solution which
was then serially diluted as required. Stability and
concentration of these solutions was monitored by absorption
spectroscopy using a Cecil CE 393 Digital Grating
Spectrophotometer (Series 2) and a molar extinction coefficient
of 17.6 at 750 nm (Chasteen et al. 1973). Absorbance was
monitored over a 24 hour period with the samples being stored at
4°C between readings. Vanadate-containing solutions were also
prepared by dissolving sodium orthovanadate (Na3V04) in 1M HCI to
form a 10-2M solution and serially diluting this stock as
necessary. The absorbance of these solutions was also measured
at 750 nm where V5+ ions show no absorbance; hence any
absorbance would be most likely indicative of reduction of the
V5+ ions to V4+ ions under the acidic conditions employed here.
A solution of 1o-2M Na3V04 in 1M HC1 containing 5 mM ascorbic
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acid was also prepared and the absorbance monitored at 750 nm in
order to check to what extent the ascorbic acid reduced the
vanadate to vanadyl ions.
A suspension of HeLa cells was prepared from a Roux as
described previously and diluted to 0.07 x 106 cells/ml with
fresh BME. This suspension was dispensed in 18 ml aliquots onto
9 cm diameter sterile plastic "Nunclon" tissue culture plates
which were then incubated at 370C (day 0). This seeding density
of 1.3 x 106 cells/9 em plate was found to yield plates with the
same degree of confluency as the 5 em plates seeded at 0.33 x 106
cells/plate used in the earlier experiments, but a smaller
extraction volume could be used on the 9 em plates thus
minimising dilution of intracellular contents.
On day 3, the medium was replaced with fresh medium ± Na3V04
(l0-9M-l0-4M) with 9 plates for each condition. Twenty-four
hours later, the medium was rapidly aspirated from 3 plates per
condition, the plates washed 4x with ice-cold Krebs solution (pH
7.4 at 40C), placed on ice and immediately 750 ul of 1M HCI (40C)
was added to each plate. The plates were swirled at intervals
to ensure constant coverage. After 30 minutes, the contents of
each extracted plate were removed using pasteur pipettes and
placed in disposable plastic test-tubes. These were centrifuged
in a Fisons MSE Coolspin for 15 minutes at 3,000 rpm, 4oC, the
supernatants pooled within each treatment condition in order to
obtain a suitable volume for analysis and the resultant samples
were stored on ice until analysed using ESR, 2-3 hours later.
Blanks were prepared by washing plates which had contained 10-4M
vanadate solution but no cells and extracting as above.
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For each treatment condition, 3 plates of cells were also
extracted as above but using 1M HCl containing 5 mM ascorbic acid
as the extractant. The remaining 3 plates per treatment
condition were used to ascertain cell numbers as described
previously with the exception that 2 mls of the trypsin solution
was used per plate and this was neutralised with 6 mls of Krebs.
200 ul of the resultant single cell suspension was added to 19.8
mls of Isoton for the determination of cell numbers.
Optimal conditions for ESR analysis were established using the
standardised VOS04 solutions prepared previously, both in 1M HCl
and in 1M HCl containing 5mM ascorbic acid to check for any
possible interference. Samples were run in triplicate (by Dr.
J. Walton of the University Chemistry Department) on a Bruker ER
200D system - the operating conditions were as given in the
appropria te figure legends in the following "Resul ts" sec tion.
The signal from a ruby mounted in the sample chamber was used as
an internal standard, and the results were normalised both with
respect to this signal and to the gain used for each experiment.
Samples were also run which were from blank plates containing
medium plus 10-4 Na3V04 which had been incubated for 24 hours as
if cells were present and the medium then acidified - this was to
check that the extracellular vanadate was not being reduced
during the incubation period. Also plates of cells not
previously treated with vanadate were extracted with 1M HCl
containing 10-4M Na3V04 in order to see if any non-enzymatic
reduction of the vanadate occurred during the extraction process.
A similar procedure was carried out with 1M HCl containing 10-4M
By comparison of the signal from this sample with that
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from a 10-4M VOS04 solution containing no cell precipitate, any
oxidation of the vanadyl ions occurring due to e.g. cellular
metabolites could be determined, together with any interference
of the ESR signal by soluble cellular products and/or adsorbance
of vanadyl to the protein precipitate.
As the actual ESR analysis was carried out courtesy of another
department and maximum use had to be made of the day available to
us, it was not possible to establish optimum conditions for
analysis before preparing and running the biological samples.
One previous run had been carried out using a standard solution
in order to check that detection of the vanadyl ion was possible
with the reported settings and the equipment available.
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2.III. RESULTS
2.III.i. Effects of 24 hours growth in vanadate upon HeLa cell
numbers
Incubation in vanadate-containing medium (10-9M-lO-4M)
produced no significant effects upon HeLa cell numbers with
incubation periods of 3 or 6 hours (results not shown). However
after 12 hours growth in vanadate, a very slight but significant
increase (3.4%) in cell numbers was seen at a vanadate
concentration of 10-8M, together with further slight but non-
significant increases at 10-7M and 10-6M (Figure 2.1. and Table
2.4.). At vanadate concentrations greater than 10-6M, cell
numbers tended to decrease down to and marginally below control
values, although non-significantly.
After 24 hours growth in vanadate, HeLa cell numbers were
decreased significantly (less than 10% decrease) at vanadate
concentrations from 10-9M to 10-6M (Figure 2.1. and Table 2.5.)
in a dose-independent fashion, increasing back to 1.3% above
control values at 3.2 x 10-6M v anadat e; Dose-dependent
decreases in cell numbers were seen at vanadate concentrations
above 3.2 x 10-6M with cell numbers decreasing to less than 60%
of control values at 4.6 x 10-5M vanadate.
in cell numbers was seen at IO-4M vanadate.
No further decrease
2.11I.ii. Effects of 24 hours growth in vanadate upon the
morphology of HeLa cells
Transmission and scanning electron micrographs of HeLa cells
are shown in Figures 2.2. and 2.3. respectively, illustrating the
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Figure 2.1. Effects on HeLa cell numbers of incubation in
vanadate-containin~ medium for 12 or 24 hours
Each point represents the mean ± S.E.M. of 3 experiments (24
hours) or 4 experiments (12 hours), each condition within each
experiment being performed in triplicate.
Figure 2.2. Transmission electron micrograph of a HeLa cell
2urn
Figure 2.3. Scanning electron micrograph of a HeLa cell
monolayer 10 urn
Table 2.4. Effect of 12 hours growth in vanadate on BeLa cell
numbers
The values below represent the mean ± S.E.M. of 4 experiments
with each condition being triplicated within each experiment.
Significance testing is by two-way analysis of variance.
[v5+] Mean cell number ± S.E.M. Level of
0
(M) (% of control) Significance
0 100.0 ± 0 -
10-9 9~.7 ± 1.7 N.S.
10-8 103.4 + 1.2 p<O.05
10-7 104.7 ± 3.0 N.S.
10-6 107.6 ± 3.7 N.S.
3.2 x 10-6 104.3 ± 2.6 N.S.
10-5 102.6 ± 3.9 N.S.
2.1 x 10-5 100.8 + 1.4 N.S.
4.6 x 10-5 98.7 + 2.3 N.S.
10-4 95.6 + 2.3 N.S.
Table 2.S. Effect of 24 hours growth in vanadate on HeLa cell
numbers
The values below represent the mean ± S.E.M. of 3 exp erLme nt s,
with each condition being triplicated within each experiment.
Significance testing is by two-way analysis of variance.
[vS+~ Mean cell number ± S.E.M. Level of
(M) (% of control) Significance
0 100.0 ± 0 -
10-9 90.6 + 2.4 p<O.Ol
10-S n.s ± 2.3 p<0.05
10-7 91.4 ± 3.0 p<0.05
10-6 97.9 + 0.6 p<0.05
3.2 x 10-6 101.3 + 3.4 N.S.
10-5 93.5 ± 3.3 N.S.
2.1 x 10-5 76.1 ± 6.4 p<O.05
4.6 x 10-5 59.4 ± 7.1 p<O.OOS
10-4 60.2 ± 7.9 p<O.OOS
general appearance of the cells. The transmission electron
micrograph shown in Figure 2.2. illustrates the irregular shape
of the cells showing numerous cytoplasmic protrusions. The cell
shown has a large lobulated nucleus with a prominent nucleolus
and densely staining chromatin around the nuclear periphery.
Often HeLa cells are multinucleate (not shown). Numerous
mitochondria are present with few cristae. Arrays of
endoplasmic reticulum can also be seen in the cytoplasm together
with densely staining multilamellar bodies. Upon examination at
higher magnification these appeared to be membrane-bound and
contained a circular array of membrane-like strands bordering a
central amorphous zone, also densely staining. The function of
these structures is not known unless possibly lysosomal-related.
The epithelial sheet-like appearance of the HeLa cells can be
seen in the scanning electron micrograph, showing the numerous
intercellular connections. In the more confluent areas the
divisions between individual cells are not entirely clear. The
electron micrographs were taken to illustrate the general
appearance of the cells. The effect of vanadate on cell
structure was only examined at the light microscope level.
Under the light microscope the sheet-like appearance is less
apparent (Figure 2.4.), possibly due to the fact that the cells
are unfixed and, despite precautions, may be undergoing some
shrinkage or drying whilst under examination. The control cells
appear polygonal in shape with a granular cytoplasm and prominent
nuclei. The majority of the cells have multiple nucleoli.
After treatment with vanadate (lO-4M) for 24 hours, the cells
appear to be much less confluent and more rounded (Figure 2.5.).
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Figure 2.4. Light micrograph of a HeLa cell monolayer
20um
Figure 2.5. Light micrograph of a HeLa cell monolayer after a
24 hour incubation in medium containing lo-4M vanadate
20um
with some spindle-shaped cells also present (not shown in this
picture). Refractility is also more evident around the cell
peripheries. Such changes in cell appearance were not evident
until vanadate concentrations greater than 10-SM.
a.rrr.t n. Intracellular reduction of vanadium (+5) to vanadium
(+4) in HeLa cells
Standard solutions of VOS04 in 1M HCI appeared to be stable to
oxidation over at least a 24 hour period as evidenced by no
change in their absorption at 750 nm.
solutions of Na3V04 in 1M HCl was
Similarly no reduction of
seen over a similar time
period, as indicated by a lack of absorption at 7S0 nm, The
addition of 5mM ascorbic acid to the vanadate solutions resulted
in a reduction of the vanadium (+5) to vanadium (+4) as monitored
by the appearance of a blue vanadyl solution and absorption at
750 n m, Reduction appeared to be incomplete with absorption
measurements being approximately 90% of those expected if the
total vanadate present had been reduced to vanadyl. Further
addition of ascorbic acid produced no additional increase in
absorption indicating that the reduction of vanadate was probably
complete.
The above discrepancy between the predicted and actual
absorption values could not be accounted for by a quenching
effect of ascorbic acid as no effect on absorption was seen when
ascorbic acid was added to standard vanadyl solutions.
Similarly the possible presence of vanadate was shown to have no
effect on the absorption of vanadyl solutions. Vanadyl sulphate
absorbs water readily and normally has varying amounts of water
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associated with it per molecule depending upon the manufacturer.
However possible inaccuracies in the concentration of the vanadyl
solutions due to variations in water content were also not
responsible for the discrepancy as the absorption values for
vanadyl sulphate solutions in this study agreed well with the
reported molar extinction coefficient (Chasteen et al. 1973) and
the water content was checked by drying down a sample. It was
also unlikely that the concentrations of the vanadate solutions
were inaccurate unless the manufacturer's purity specifications
were incorrect, as consistent results were obtained with
solutions prepared at various times. It is possible however
that the presence of different ligands in the two standard
vanadyl solutions prepared either by dissolution of vanadyl
sulphate or by reduction of sodium orthovanadate may be
responsible for the differences, as different molar extinction
coefficients have been reported for VOS04 and VOCI04 solutions
for example (Chasteen et al. 1973).
The ESR signal for a 10-4M solution of VOS04 in 1M HCI is
shown in Figure 2.6.. The characteristic hyperfine structure of
vanadyl solutions is shown, with 8 bands at intervals of
approximately 120 gauss. It was decided to use the 3rd band for
quantitation as it was the largest. However when samples were
run on the day of the experiment a few months later, considerable
interference with the signal was found as shown in Figure 2.7., a
biological sample, necessitating the use of the 2nd band for
quantitation. Such interference was seen with either standard
or biological samples and was traced to the quartz capillary
sample cell used in the analysis, probably due to an imperfection
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in the structure. This sample cell was a replacement for the
one used in the initial sample run which apparently had been
broken in the intervening time period.
The calibration graph for the ESR signal for various
concentrations of VOS04 is shown in Figure 2.8. with the lowest
detectable vanadyl standard being approximately 5 uM, in
agreement with Fitzgerald and Chasteen (1974). Although it was
possible to run only a few standards due to the time limitations,
the ESR signal over the concentration range used had previously
been shown to be linear (Fitzgerald and Chasteen 1974). A
regression line through the origin was plotted using the GLIM
statistical package on the VAX mainframe computer. Ascorbic
acid did not interfere with the signal. The "typical" signal
for a biological sample is shown in Figure 2.7., with the
hyperfine band used for quantitation indicated, although the
signal was magnified further before being measured. No signal
was detected from the blanks and the calculated intracellular
vanadyl concentrations resulting from incubation of HeLa cells in
vanadate-containing medium are given in Table 2.6.. The values
reported are per litre of cell water which assumes the vanadyl is
free, however some or all of it may be bound as discussed later.
Because of the necessary dilutions involved during extraction,
only the cells incubated in the two highest concentrations of
vanadate had detectable amounts of vanady1 present. There
appears to be no difference between the vanadyl concentrations
from cells extracted in 1M HCl and those extracted with 1M HCl
containing 5mM ascorbic acid, indicating that all the vanadium
present in the cells was in the +4 oxidation state. However it
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Calibration graph of various concentrations of
VOS04 in 1M HCI against the resultant ESR signal
The 2nd hyperfine band was used for quantitation. Signals were
nor~alised for a gain of 1.6 x 106 and an internal standard
height of 10 em. Equipment and operating conditions as detailed
in Figure 2.6. Points are the mean ± S.E.M. of 2 readings.
Table 2.6. Measurement by ESR of the intracellular
concentration of vanadium (+4) in HeLa cells, following
24 hours incubation in vanadium (+5)
The values below represent the mean ± S.E.M. of the results from
1 experiment, each condition within the experiment being
performed in triplicate.
[v5.g 0 Extractant Mean [v4+Ji ± S.E.H.
(M) (umo1es/lcw)
10-4 1M HCl 59~ ± 20
10-4 1M HC1/5~1 Ascorbic Acid 608 ± 14.7
4.6 x 10-5 1M HC! 256 ± 0
4.6 x 10-5 1M HC!/5mM Ascorbic Acid 258 ± 6.6
must be emphasised that this technique would not be sensitive
enough to measure any very small concentrations (less than
micromolar) of intracellular vanadate which may be present. As
previously discussed in Chapter 1, concentrations of vanadate
less than lO-6M would presumably be capable of causing some
inhibition of e.g. Na+ /K+-ATPase, and would not have been
detected in this experiment.
In addition the results show that the vanadium is accumulated
within the cells at a concentration some 5 to 6 times that of the
external medium. At the concentrations of vanadate used here,
the vanadium accumulated appears to be proportional to the
extracellular concentration i.e. a 2.2x increase in extracellular
vanadate concentration resulted in a 2.3x increase in intra-
cellular vanadium concentration.
When the acidified samples from the vanadate-containing medium
which had been incubated for 24 hours at 37 °c without cells were
analysed, there was too much interference from medium components
to detect any vanadyl that may have been present. Hence it was
impossible to establish whether or not any of the vanadate was
reduced extracellularly before entering the cells. No
difference was seen betweeen the signal from a standard solution
of VOS04 in 1M HCI and the signal resulting from cells extracted
with the same solution indicating that no oxidation of vanadyl
due to cellular metabolites occurred during the extraction,
and/or that vanadyl was not adsorbed to the protein precipitate.
-4However vanadyl was detected in cells extracted with 10 M Na3V04
in 1M HCI despite the fact that the samples were kept on ice,
with approximately 15% of the vanadate present in the 2.25 mls of
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tsample being reduced after 6 hours (1.e. '34 nmoles with
precipitated proteins from 39 x 106 cells). This indicates the
presence within the cells of acid-stable substances capable of
reducing vanadate non-enzymatically, as protein precipitation and
low temperatures would have been expected to have abolished any
enzymatic activity present in the intact cells.
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2.IV. DISCUSSION
The apparent toxicity of vanadate in HeLa cells after 24 hours
incubation appears to be similar to that previously described in
MDBK cells (Bracken et a1. 1985), both in time of onset and the
lowest effective dose. Slight differences were apparent however
e.g. a 5x increase in vanadate concentration from 2 x 10-5M to
10-4M was parallelled by an increase in cytotoxicity of 1.6x in
HeLa cells and 3.2x in MDBK cells. A plateau in response was
seen in both MDBK and HeLa cells where further increases in
extracellular vanadate produced no further increases in
cytotoxicity. This occurred at vanadate concentrations of 2 x
lO-4M and 4.6 x 10-5M in MDBK ann HeLa cells respectively, with
cell toxicity of 60-70% and 40% respectively, in spite of the
fact that the vanadium content of both the HeLa and MDBK cells
increased further at higher extracellular vanadate levels. Such
a plateau was also seen with respect to the vanadate-induced
inhibition of acid phosphatase in MDBK cells. It would appear
that there is a critical range of intracellular vanadium
concentrations below which cellular effects are not apparent, and
above which no further change is seen. This critical level is
obviously not reached until 12-24 hours in HeLa cells.
Whether the decrease in HeLa cell numbers with vanadate
treatment is due to cell death as a result of e.g. alterations in
protei n syn thesi s or degrada tion as has been shown to occur in
MDBK cells at similar concentrations (Bracken and Sharma 1985)
and in rat hepatocytes at higher concentrations (Seglen and
Gordon 1981), or is due to effects on cell division as shown in
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lysed mitotic PtK1 cells (Cande and Wolniak 1978) can not be
concluded without further investigation. The slight non-
significant stimulation of growth at lower vanadate levels,
especially after 12 hours incubation, may be related to the
mitogenic actions of vanadate as demonstrated in human
fibroblasts (Carpenter 1981). Toxicity was also seen in these
cells at similar vanadate concentrations as those producing
cytotoxicity in HeLa cells.
The changes in morphology of the HeLa cells occurring
concurrently with the cytotoxicity are also similar to those
described in MDBK cells (Bracken et al. 1985), although the
change in appearance of some cells to a bipolar spindle-type cell
may be due to the loss of cell-cell contact, promoting outgrowth
of cells to re-establish contact. This can often be seen in
less confluent cultures of HeLa cells. The possi bili ty of an
involvement of vanadate with cytoskeletal elements or
polyphosphates in causing the shape change as has been suggested
by Seglen and Gordon (1981) and Vives-Corrons et a1. (1981) can
not be ruled out however.
The interpretation of the effects of chronic vanadate
treatment is complicated by the fact that in HeLa cells, as in
many other cell types, vanadate is reduced intracellularly to the
vanadyl ion. The time course of reduction in HeLa cells has not
been determined. In erythrocytes for example, 250 uM vanadate
has been shown to equilibrate across the membrane within 15-30
minutes via the anion-exchange pathway (Cantley, Jr. et al.
1978b). This is followed by a slower intracellular accumulation
which is thought to be due to the subsequent intracellular
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reduction of the vanadate to vanady1 (Cantley, Jr. et al. 1978b,
Cantley, Jr. and Aisen 1979). The vanadyl is then stabilised by
binding to proteins, in this case haemoglobin. The rate-
limiting step in the accumulation is thought to be the
intracellular reduction. In an erythrocyte suspension incubated
in 1.14 mM vanadate, more than 90% of the vanadate had been
reduced within 23 hours, with an intracellular vanadium
concentration of 7.2 mM compared with 0.29 mM extraceUularly
(Macara et al. 1980). This is approximately 5x greater than the
5-6x accumulation shown in HeLa cells in this study and initial
extracellular vanadium concentrations were approximately 10-20x
greater than the concentrations used for the HeLa cells. At the
much lower vanadium concentrations normally present in man, the
ratio of whole blood to serum total vanadium concentration is
abou t 2:1 (Naylor - personal communica tion). Assuming a
haematocrit of approximately 50%, these erythrocytes in vivo have
a total vanadium concentration of approximately 3x that of the
serum. It would appear that the concentration of vanadium
within cells is not necessarily linearly related to the
extracellular concentrations, with a proportionately greater
accumulation occurring in erythrocytes at least, at higher
extracellular concentrations. The converse situation may have
been expected in view of the fact that the intracellular
reduction of vanadate is thought to be the rate-limiting step in
the accumulation and the reducing capability may be exceeded at
higher vanadate levels. The accumulation of vanadium in MDBK
cells however has been shown to be linearly proportional to the
extracellular concentration of vanadate over the range 20-1000 uM
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(Bracken et a1. 1985). This was also seen to be the case in
HeLa cells at the two vanadate concentrations used in the ESR
study. Obviously the uptake of vanadate is complex, probably
largely due to the intracellular reduction and subsequent binding
of vanadium. and may vary between cell types.
At a concentration of 10-4M vanadate for 24 hours, the
vanadium concentration of MDBK cells was approximately 2.5
nmoles/l06 cells, with a cytotoxicity of 50% (Bracken et al.
1985). In HeLa cells the vanadium concentration was
approximately 600 umoles/lcw (equivalent to 1.3 nmoles/106 cells)
with a cytotoxici ty of 40%., Al though the vanadium content is
comparable in the two cell types, the volumes of the MDBK cells
are not given and hence the intracellular concentrations of
vanadium may be different between the two cell types. possibly
accounting for any slight differences in cytotoxicity.
In rat adipocytes reduction was faster, appearing to have
stopped after 3-4 hours (Degani et al. 1981), although it was not
ascertained whether all the vanadate had been reduced.
Reduction of vanadate has been reported to occur enzymatically in
cardiac membranes (Erdmann et al. 1979b) but it appears as though
in erythrocytes at least, reduced glutathione (GSH) may be
responsible for the non-enzymatic reduction of vanadate.
Glucose starvation which decreases GSH levels led to a decrease
in the rate of vanadate uptake whereas glycolytic inhibitors had
no effect (Macara et a1. 1980). Paradoxically, an increase in
cellular GSH levels with increasing vanadate treatment was
demonstrated in MDBK cells (Bracken and Sharma 1985) although the
GSH/vanadium molar ratio decreased from 1.7 to 0.52 as toxicity
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increased at vanadate concentrations from 50 uM to 500 uM. This
increase in GSH levels was thought to be a compensatory response
to the initial depletion of GSH thought to occur as a result of
its role in the reduction of vanadate. From the results with
HeLa cells in this study it would appear that the intracellular
reduction of vanadate is due, at least in part, to non-enzymatic
processes as it occurs even after protein precipitation of the
cells with acid. This may be due to GSH as described above
since GSH is acid-stable.
Assuming that in HeLa cells the reduction is totally non-
enzymatic and proceeds at the same rate as the reduction of
vanadate by acid-extracted cells i.e. 34 nmoles/6 hours (cell
precipitate from 39 x 106 cells), the 600 umoles vanadyl/lcw (1.3
nmoles/l06 cells) in the HeLa cells treated with 10-4M vanadate,
would have been produced by reduction in approximately 9 hours.
This is probably a minimum estimate, as in intact cells, the
initial rate of uptake may limit the reduction in the first
instance. ~Additionally the reducing agent may be present at
much lower levels in the vanadate-treated cells as a result of
the vanadate treatment, than in the extracted control cells in
which the reduction rate of vanadate was measured, and also may
be compartmentalised in the intact cell being released upon
acidification. Furthermore, enzymatic reduction may also occur
in the intact cell and predictions involving the rate of
reduction if this were the case can not be made.
Assuming that reduction is slower than the 9 hours above, this
may account for the delay before toxic effects are seen if in
fact they are due not vanadate but to either vanady1 or
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indirectly as a result of the depletion of e.g GSH etc. In
addition if the effects are due to vanadyl they may be direct or
indirect as a result of binding to proteins as no distinction has
been made in this study between bound and free vanadyl.
Differences in cytotoxicity between the various cell types may be
as a result of different reducing abilities and hence possibly
different intracellular vanadium accumulation, or may be due to
differing sensitivites to the reduced vanadyl, and/or indirect
effects accompanying the reduction.
Further experiments which would be constructive if the
facilities and time were available would include the measurement
of the uptake of radiolabelled vanadium at various time points
and the characterisation of the uptake pathway (for example using
DIDS), measurement of GSH, NADH, protein synthesis and
degradation etc. The results here could also be improved by
further repetition, monitoring of possible loss of cellular
vanadium (using radio labelled vanadium) during the washing
procedure pre-extraction, be tt er ESR analysis using different
sample cells and frozen samples (to minimise cellular changes
occurring during extraction), and with the inclusion of more
vanadyl standards. Ideally these standards would all be
prepared using the acidic supernatant of acid-extracted cells in
order to check for any interference of soluble cell substances
which may not have precipitated out with the protein, or any
adsorbance of the vanadyl onto the proteins. Such effects are
unlikely however, based on the results with the lO-4M VOS04
standard which gave the same signal irrespective of whether or
not extracted cells were present.
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CHAPTER 3. THE EFFECTS OF CHRONIC VANADATE TREATMENT ON THE
VOLUME, ION CONTENTS, SODIUM PUMP NUMBERS, AND K+ INFLUX PATHWAYS
OF HELA CELLS
3.1. INTRODUCTION
The following section serves as a basic introduction to the
normal distribution of ions in cells. This is followed by a
more detailed description of the transport processes involved in
establishing and maintaining such a distribution, and an
examination of the effects of vanadate upon these transport
processes. Much of the information in the first two sections
has been taken from review articles or textbooks by Baker (1966),
De Weer (1985), Dudel (1983), Glynn (1968), Glynn and Karlish
(1975), Jorgensen (1982), Robinson (1975), and Skou (1985).
Original research articles, where used, are cited.
3.1.1. Ion distribution
The unequal distribution of ions across cell membranes Le.
generally high intracellular K+, high extracellular Na+, low
extracellular K+, and low intracellular Na+, results from a
combination of selective membrane permeability, the sodium pump
(Na+/K+-ATPase), and the presence of large impermeant anions such
as proteins, within the cells. The actual ion concentrations
vary with the type of cell. Normally the intracellular [K+] is
high (approx. 150 mM) compared with the extracellular (approx. 5
mM). As the membrane is freely permeable to K+, diffusion out
of the cell occurs down the concentration gradient. This
outward movement of K+ ions, which is not accompanied by an
equivalent movement of anions, leads to a charge separation
across the membrane giving rise to a potential difference with
the intracellular environment negatively charged relative to the
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extracellular. This results in an inwardly directed electrical
gradient for K+ and eventually an equilibrium is established
where the tendency for K+ to diffuse down its concentration
gradient out of the cell is balanced by the tendency of K+ to
diffuse down its electrical gradient into the cell. This is the
K+ equilibrium potential (EK) and is normally -90 mV
(intracellular negative) in most animal cell types.
In contrast, the intracellular [Na+] is normally low (approx.
15 mM) compared with extracellular (approx. 150 mM).
Consequently both the electrical and chemical gradients are
inwardly directed for Na+ and the equilibrium potential for Na+
(ENa) is normally +60 mV (intracellular positive). The overall
membrane potential (EM) i.e. when both Na+ and K+ are present, is
not an average of EK and ENa but is normally -80 mV
(intracellular negative). This is due to the relative
impermeability of the membrane to Na+ (approx. 100x less
permeable to Na+ than to K+). As a result of the selective
permeability of the membrane, the major determinant of the
resting potential is therefore K+.
A distribution of this type where neither Na+ or K+ is at
equilibrium would soon result in the running down of the ion
gradients but for the action of the sodium pump (Na+/K+-ATPase
molecule). In most cell types, sodium pumps within the membrane
maintain the ion gradients and hence the resting potential, by
extruding 3 Na+ ions from the cell and pumping 2 K+ ions into the
cell for each cycle of the pump (i.e. per molecule of ATP
hydrolysed). Normally the select ive permeabili ty of the
membrane plays a major role in establishing the negative membrane
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potential, with the electrogenic nature of the pump only
producing a slight hyperpolarisation (less than 10 mV) of the
membrane compared with if the pump were not electrogenic.
The membrane is also permeable to C1- ions which are usually
distributed in a reciprocal fashion to the K+ ions. ECI is
normally the same as EM since Cl- is usually distributed
passively across the membrane. The distribution of Cl- ions
adjusts in response to changes in membrane potential in such a
way that ECI remains equal to EM.
The maintenance of this pump-leak steady-state situation in
cells, and hence the unequal distribution of ions, is important
in many aspects of cellular function, e.g. in cell volume
regulation, regulation of intracellular [Ca2+] via Na/Ca
exchange, cotransport of sugars or amino acids, enzyme function,
and electrical activity. The diuretic-sensitive cotransport of
Na+, K+, and Cl- ions, which is present in many cells, is also
possibly involved in volume regulation. The activity of the
sodium pump and cotransport systems can be ascertained by
measuring the K+ influx of cells radioisotopically. By using
specific pharmacological inhibitors, the total K+ influx can be
partitioned into the 3 main K+ influx pathways:- i). the
ouabain-sensitive or sodium pump flux, ii). the diuretic-
sensitive or (Na+ + K+ + Cl-) cotransport flux, and iii). the
passive leak influx (Figure 3.1.). The properties of these are
discussed in turn in the following sections.
3.1.11. Major K+ influx pathways
a). Ouabain-sensitive (sodium pump) K+ inf1ux:- The sodium
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pump protein is a membrane-bound enzyme which utilises ATP to
transport ions across the membrane. In HeLa cells for example,
the ouabain-sensitive K+ influx normally accounts for
approximately 40% of the total K+ influx. The transport protein
consists of 0( and f' sub-units with molecular weights of about
100,000 and 50,000 respectively. Although there is controversy
about the polymerisation of these sub-units during purification,
the majority of views support a dimeric (i.e.0<2 ~ 2) complex as
being the functional sodium pump, transporting 3 Na+ ions
outwards and 2 K+ ions inwards for each molecule of ATP
hydrolysed (e.g. Glynn 1968, De Weer 1985).
Various models have been proposed regarding the conformational
changes involved in the hydrolysis of ATP and the translocation
of Na+ and K+ ions. The most widely accepted models are based
on the Albers-Post scheme proposed in the late 1960's which is
schematically represented in Figure 3.2. and outlined below (from
De Weer 1985).
The pump protein is thought to exist in 2 conformations, El
(high affinity for Na+) and E2 (high affinity for K+), which have
ion-binding sites facing the cytoplasm and extracellular medium
respectively. Both El and E2 exist in either unphosphory1ated
or phosphorylated forms with ElP possessing a high-energy bond
(~) which is able to rephosphory1ate ADP to ATP. ATP binds to
El with high affinity (Kd less than 1 uM) and, in the presence of
+ 2+Na and Mg which also bind to the enzyme, phosphorylates El to
With the ensuing conformational transition from El~P to
E2-P (favoured by the difference in energy), the Na+ ions are
released to the extracellular medium and K+ ions bind to the
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enzyme which still has Mg2+ associated with it. The binding of
extracellular K+ ions, which, unlike Na+, can be replaced by Li+,
Rb+ or Cs+ to varying extents, enhances the rate of
dephosphorylation of E2-P, with the K+ ion becoming "occluded" or
trapped in the enzyme (probably the translocation step). The
occluded (K)E2 form reverts very slowly to the El form, but
alternatively (K)E2 can bind ATP with low affinity (Kd - 0.3 mM)
and the rate of conversion of (K)E2.ATP to the El form is much
faster. The pathway taken depends upon the concentration of
available ATP. Thus the Na+ /K+ -ATPase kinetics are biphasic,
with both high and low Km values for ATP. Opinions are divided
as to whether there are 2 separate ATP binding sites with
different affinities on the C( -subunit, or whether there is one
site which has an affinity determined by the conformation of the
VC -subunit (e.g. Cantley et al. 1983, Askari and Huang 1985).
In further modifications to this model it has been proposed that
Na+ exists in an occluded form (Na)E1-P during its translocation
(Skou 1985).
Besides the "forward" pumping described above, the pump can
also run in reverse if the intracellular and extracellular ion
concentrations are reversed and the ADP and Pi concentrations
greatly exceed the intracellular ATP concentration. Provisions
are also made.in this model for "uncoupled" Na+ efflux in the
absence of extracellular K+ or Na+ (Na+-ATPase activity), Na+:Na+
exchange, and K+:K+ exchange which have been shown to occur in
some cells. A discussion of these modes is outwith the scope of
this chapter however.
The number of sodium pump molecules per cell varies depending
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on the cell type e.g. 100-200 per human erythrocyte (less than
1/u2) and 4.1 x 106/cell in rabbit kidney thick ascending limb
cells (approx. 4400/u2; De Weer 1985). A recycling process
occurs with pumps continually being removed and inserted into the
membrane e.g. in HeLa cells both these processes occur at a rate
of approxi ma tely 9%/hour. It is thought that cells can
"upregulate" their pump numbers in order to match the leak flux
but whether this is due to a change in the rate of
internalisation or of insertion, is not clear (Algerably et al.
1985). This is discussed further in Chapter 6.
Intracellular Na+ and extracellular K+ stimulate the pump
activity with sigmoidal kinetics (De Weer 1985).
is 15-25 mM depending on the cell type, and the pump is usually
only about 50-75% saturated with respect to extracellular K+ with
a Km of approximately 1.5 mM. As the extracellular Na+ is
decreased, the Km for extraceilular K+ decreases until in Na+-
free medium, the apparent affinity of the pump for extracellular
K+ is 5-l0x that in normal medium (De Weer 1985). This is
possi bly due to a simple competition of Na+ and K+ at the same
site.
Cardiac glycosides such as digitalis and ouabain are known to
bind extracellularly to theCC-subunit of the sodium pump in the
E2-P conformation, and inhibit the translocation of ions (Allen
et al. 1985, Forbush III 1983). This is antagonised by
extracellular K+ which normally accelerates the hydrolysis of E2-
P. Ouabain binds practically irreversibly and can be used in
the measurement of sodium pump numbers and activity as described
later in this chapter. .
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b). Diuretic-sensitive K+ influx:- In many diverse cell
types e.g. MDCK cells, Hela cells, avian erythrocytes and
flounder intestinal cells, a large proportion of the ouabain-
insensitive K+ influx is mediated by an electroneutral
cotransport with Na+ and Cl- ions, in a 1:1:2 stoichiometry.
This is inhibited by loop diuretics such as furosemide and
bumetanide. The properties of this transport system have
recently been reviewed by Saier, Jr. and Boyden (1984) and are
summarised below.
The operation of this transport system is dependent on the
simultaneous binding of Na+, K+ and Cl- ions to the transport
protein. Na+ can be replaced by li+, Cl- by Br-, and K+ by Rb+
and to a lesser extent, NH4+ and Cs+. Strong co-operativity
exists between the 3 ion binding sites with the apparent affinity
constants of each ion being influenced by the binding of the
other 2 ions. The system is readily bi-direc tional and it is
thought that the direction of net transport is determined by the
overall sum of the transmembrane chemical gradients for the 3
ions (Haas et al. 1982). Normally the system functions as a
passive exchanger with no net transport. Due to its
electroneutrality it does not affect the membrane potential and
in turn is not affected by the membrane potential.
ATP functions to activate the system but as the relationship
is not stoichiometric, the activation is thought to be due to a
protein-kinase mediated reaction. In some cell types, such as
turkey and frog erythrocytes, this is thought to be via a cAMP-
dependent system as, for example, it is stimulated by beta-
adrenergic agonists or cholera toxin, and is potentiated by IBMX.
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Such agents have also been shown to result in the phosphorylation
of a membrane protein of molecular weight about 240,000 which has
been postulated to be the transport protein. In MDCK cells
however, no involvement of cAMP has been found and it is thought
that a cAMP-independent protein kinase is involved.
In secretory epithelium, the diuretic-sensitive cotransport is
important in regulating chLorLde absorption or secretion. In
other cell types however, the role of the diuretic-sensitive
cotransport is uncertain. This arises largely from the
differences between cell types and the difficulties in
determining, for example, whether transport of ions is via a
cotransport molecule or two coupled exchangers such as the Na+/H+
or K+/H+, and Cl-/HC03- coupled exchangers present in Amphiuma
red blood cells (Cala 1980). Such coupling produces an overall
Na+ or K+ and Cl- transport but can be distinguished from the
diuretic-sensitive cotransport on the basis of sensitivity to
inhibitors such as amiloride and DIDS or SITS.
One of the postulated roles of the diuretic-sensitive
cotransport is in volume regulation. When duck erythrocytes,
for example, are placed in hypertonic solutions, the cells shrink
but return to control volumes with continued incubation. This
regulatory volume increase (RVI) has been attributed to the
diuretic-sensitive transport which increases producing a net
influx when the cells are placed in the hypertonic medium, thus
increasing ion concentrations intracellularly and restoring the
volume osmotically. However such an RVI is only seen if the
extracellular K+ is raised above physiological levels (Kregenow -
from Saier Jr. and Boyden 1984).
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In cells which exhibit no RVI e.g. HeLa cells or MDCK cells,
an increase in diuretic-sensitive flux is seen in response to
hyperosmotic medium, but this occurs in both the efflux and
influx and therefore produces no net flux (Tivey 1986). On the
basis of the increase in ion concentration in shrunken cells, it
would be predicted that a net efflux of ions would be produced,
resul ting in further shrinkage. The reason why this does not
occur is not clear but it is proposed that the ion contents
measured may not all be osmotically available.
Alternatively the diuretic-sensitive flux may not be
predominantly volume regulatory but be concerned with potassium
homeostasis (Duhm and Gobel 1984). This hypothesis is also
consistent with the observation in Ehrlich ascites tumour cells
of an electroneutral Na+ and Cl- cotransport which is diuretic-
sensitive, and is stimulated by cell shrinkage only in cells
which have previously been depleted of KCl (Hoffmann et al.
1983). The net influx of Na+ and Cl- causes a RVI. The
increased Na+ levels in turn stimulate the sodium pump resulting
in the restoration of intracellular K+ levels. The exact
stimulus for the increased influx and efflux is not known in
these cells.
In many cells, including He La cells, an initial increase in
cell volume caused by exposure to hypo-osmotic medium is reversed
by a loss of KCl together with osmotically-obliged water - a
regulatory volume decrease (RVD; Tivey 1986). This is
mediated by a passive increase in membrane K+ permeability but
whether this is diuretic-sensitive or due to other mechanisms
such as calcium-activated K+ channels is not clear and possibly
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depends upon the cell type.
c). Passive leak K+ influx:- This comprises the diffusion
of K+ ions down their electrical gradient into the cell, which
together wi th the influx through the sodium pump equals the K+
efflux down its concentration gradient, and an exchange diffusion
of K+ ions across the membrane. Overall these mechanisms result
in no overall net loss or gain of K+ by the cell unless e -g- the
membrane potential is altered.
3.I.iii. Vanadate and ion transport
There have been no reported studies of the effects of vanadate
on the diuretic-sensitive cotransport system. In contrast,
there have been many studies into the properties of vanadate as
an inhibitor of Na+/K+-ATPase, following its discovery as a
contaminant in commercial ATP supplies (Josephson and Cantley,
Jr. 1977, Cantley, Jr. et al. 1977, Quist and Hokin 1978). It
should be noted that it has been proposed that vanadium was
present "in the bottle" as the vanadyl ion and was slowly
oxidised when dissolved at physiological pH (Grantham and Glynn
1979). Thus some of the early results reported using the ATP
as the source of vanadate may be slightly in error as regards
the concentration of vanadate present. The studies concerning
the effects of vanadate on Na+/K+-ATPase in isolated enzyme
systems, its cellular uptake and subsequent reduction to vanadyl,
and the physiological effects of vanadate have been reviewed in
Chapter 1. It is proposed here to review in greater detail the
mode of action of vanadate in inhibiting the Na+/K+-ATPase
molecule, and the effects of vanadate on ion fluxes in the intact
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cell.
Inhibition of Na+/K+-ATPase by vanadate requires the presence
of potassium ions (extracellularly in intact cells) and magnesium
ions (intracellularly in intact cells) which facilitate the
binding of vanadate, although there is uncertainty about the
requirement for potassium ions (Josephson and Cantley, Jr. 1977,
Quist and Hokin 1978, Bond and Hudgins 1979, Beauge et al. 1980,
Robinson and Mercer 1981). Unlike ouabain, the inhibitory
action of vanadate is mediated intracellu1arly and is augmented
by increasing the extracellular potassium concentration (Beauge
et al.1980). The sites occupied by K+ and Mg2+ in augmenting
the inhibitory actions of vanadate are thought to be different to
those normally involved in their activation of the enzyme (Bond
and Hudgins 1979). Increasing the extracellular sodium
concentration antagonises the inhibition, possibly by displacing
K+ from its inhibitory site, and ATP has a protective effect
against inhibition (Josephson and Cantley, Jr. 1977, Bond and
Hudgins 1979). Inhibition of the isolated enzyme is totally
reversed by millimolar concentrations of noradrenaline, probably
by complexation (Josephson and Cantley, Jr~ 1977, Quist and Hokin
1978).
Assuming the model of 2 distinct sites with differing
affinities for ATP binding on the sodium pump is correct,
vanadate is considered to bind with low affinity (Kaff = 0.5 uM)
to a site which is probably the high affinity ATP site associated
with Na+-stimulated ATPase activity, and with high affinity (Kaff
- 4 nM, i.e. several fold higher affinity than that of phosphate)
to a site which is identical to that for low affinity ATP binding
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(Cantley, Jr. et al. 1978a). This is supported by ouabain
binding data, which shows that simultaneous vanadate treatment
with ouabain facilitates ouabain binding in a similar manner to
phosphate, but at micromolar concentrations of vanadate compared
with millimolar concentrations of phosphate (Hansen 1979).
However it has been reported that this facilitation is only seen
in the absence of K+ (Myers et al. 1979).· The inhibition of
Na+/K+-ATPase by vanadate is thought to be due to a stabilisation
of the enzyme in the (K)E2 conformation following hydrolysis of
the ATP (Cantley, Jr. et al. 1978a, Karlish et a!. 1979).
Few studies have been carried out which examine the effects of
vanadate on ion fluxes in intact cells and those which have been
done have utilised short incubation times. In rat vascular
smooth muscle cells cultured in vitro, no effect on the ouabain-
sensitive K+ influx was seen after 2 hours incubation in 10-5M
vanadate, despite the inhibition of the Na+/K+-ATPase enzyme in
disrupted cells with a Ki of 10-6M - 10-7M Searle et al. 1983).
Inhibition of the ouabain-sensitive K+ influx has been reported
in heart non-muscle cells from neonatal guinea-pigs and chick
embryos (Ki - 40 uM and 100 uM respectively) although the
decrease in intracellular [K+] was not as large as that found
with a similar ouabain-induced inhibition of flux (Werdan et al.
1982). However in heart muscle and non-muscle cells prepared
from neo-natal rats and in Girardi human heart cells, vanadate
stimulated both the ouabain-sensitive K+ influx (Kaff - 22, 140
and 34 uM respectively) and the Na+ influx. Thus an increase in
intracellular [K+] but no change in [Na+1 was seen (Werdan et al.
1980, 1982). It was postulated that the inhibitory action was
95
due to vanadate and that the stimulation was due to an insu1in-
mimetic effect of vanady1 formed by reduction of the vanadate.
The differences due to cell type were postulated as therefore
being due to differing reducing abilities. However vanadyl has
also been reported to have an inhibitory action on Na+/K+-ATPase
in very pure enzyme preparations, with no stimulation being
reported (North and Post 1984).
In mouse diaphragm muscle, vanadyl, like insulin, produces a
hyperpolarisation of 3 - 6 mV within minutes at concentrations of
10-6 - 10-5 M (Zemkova et al. 1982). At 10-4 and 10-3M vanadyl,
the hyperpolarisation was preceded by a transient depolarisation.
Vanadate had a similar effect but to a lesser extent, and only
after a delay attributed to its reduction to vanadyl. Increases
in intracellular [K+] of approximately 15 mM were seen before the
hyperpolarisation. The hyperpolarisation and increase in [K+]
was blocked by ouabain but was unaffected by the removal of
extracellular K+. It was proposed that the hyperpolarisation
was due either to a stimulatory effect of vanadyl on the pump
(the lack of effect of removal of extracellular K+ does not
support this), or that the binding of vanadyl to intracellular
proteins caused the release of bound K+ which resulted in an
increase in K+ concentration when measured using ion-selective
electrodes, and a consequent hyperpolarisation. In the latter
case the action of ouabain was postulated to be on the vanadyl
uptake. The effect of ouabain on the vanadate-induced
hyperpolarisation was not examined. Further research is
necessary to distinguish between or negate these possible
explanations.
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In NG108-15 mouse neuroblastoma-glioma hybrid cells, 20-30 mV
hyperpolarisations were seen with vanadate treatment with a ha1f-
maximally effective dose of 35 uM for Na3V04 and a to.S of 30
seconds (Lichtstein et al. 1982). Similar results were also
seen in various other cell types e.g. BHK cells and rat hepatoma
cells. Concomitantly a decrease in membrane resistance was seen
indicating an increased conductivity of one or more ions.
Ouabain had no effect on the hyperpolarisation, and extracellular
Na+ removal or high extracellular K+ also had no effect making it
unlikely that it was due either to a stimulation of the sodium
pump or an increase in K+ conductivity. The possibility that it
was due to an increased C1- uptake was not investigated.
In erythrocytes, an increase in K+ permeability was shown to
be due to a vanadate-induced inhibition of Ca2+-ATPase, producing
an elevated intracellular [Ca2+] and a stimulation of Ca2+-
dependent K+ efflux (Gardos effect; Fuhrmann et al. 1984).
EDTA abolished the effect. It is conceivable that a similar
mechanism may account for the hyperpolarisation in the cell lines
above. The increase in K+ permeability in erythrocytes was also
seen with vanadyl in the presence of EDTA and the ionophore
A23187. but it was thought that this was due to vanadyl
displacing Ca2+ from the EDTA. The Ca2+ then enters the cell
via the ionophore and produces a Ca2+ induced K+ permeability.
In Chapter 1 of this thesis, the possible involvement of a
perturbation in ion transport in the aetiology of manic
depressive psychosis has been reviewed, together with the
evidence for a role of vanadium in the illness. This chapter is
aimed at investigating the chronic effects of vanadium
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(vanadate/vanadyl) on cation transport in the relatively well-
characterised HeLa cell line. The results can then be used to
aid the interpretation of results obtained using the less well
characterised virally-transformed lymphoblastoid cell lines from
bipolar manic-depressive patients and control subjects.
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3.11. MATERIALS AND METHODS
3.11.1. Reagents
Reagents used were purchased from the following:-
Amershaa International (Amersham, Bucks.):- 3H-ouabain (42
C1/mmol), and 86Rb (200-240 mCi/mmol initially).
BDH Chemicals (Poole, Dorset):- EDTA and all the salts (Analar
grade) used in the Krebs solution, and "Cocktail TH scintillant.
Boots Chemists Ltd. (Nottingham):- Sorbitol.
Gibco-Biocult (Paisley, Scotland):-
as detailed in Section 2.11.1.
all tissue culture supplies
Sigma (Poole, Dorset):- Ouabain.
Bumetanide was a kind gift of Leo Laboratories, UK. Water
used for solutions was produced using a Milli-Q water system
(Millipore S.A., France). All solutions were dispensed using
Gilson adjustable pipettes during experiments.
3.II.ii. Effects of 24 hour vanadate treatment on the ion
contents of HeLa cells
Intracellular sodium and potassium concentrations can be
determined using radioisotopes. By placing the cells in a
solution containing either 42K or 22Na, and measuring the
radioactive content of the cells after the isotope has been
allowed to equilibrate across the cell membrane, the Ion contents
can be calculated. In practice this Is expensive and a flame
photometric method is often used (e.g. Aiton and Simmons 1983),
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as described below.
Plates of Hela cells were prepared as described in Section
2.II.iii. (0.33 x 106 cells/ 5 em plate - day 0), and the medium
replaced with fresh medium ± Na3V04 (lO-9_l0-4M) on day 3, with 6
plates for each condition. Twenty-four hours later, half the
plates in each treatment group were washed 4x in ice-cold
isosmotic sorbitol (Table 3.1.) to remove extracellular sodium
and potassium. Deionised water (5 m1s) was added to each plate
to lyse the cells and the plates left to extract for 2 hours at
20oC. The sodium and potassium concentrations of the extracts
were then determined sequentially using an EEL flame photometer
(Mark II) and appropriate standards (100 uM Na+ and K+), diluting
the samples if necessary. Suitable plate blanks were run,
consisting of cell-free plates containing medium which were
washed and extracted in the same way as the plates above.
The remaining plates for each treatment condition were used to
determine cell numbers, volumes and plate water as previously
described in Section 2.iv.. This use of plates run in parallel
was necessitated by the fact that the lysis of cells during
extraction of the ions precluded the use of the same plates for
the measurement of both ions and numbers. The ion contents were
calculated using the equation in Appendix 1 and expressed in
mmol/lcw or nmol/l06 cells.
Experiments were repeated on several occasions with each
condition in triplicate, and the results analysed by Student's t-
test (unpaired) using the "Mini tab" statistical package on the
VAX mainframe computer.
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Table 3.1. Composition of isosmotic sorbitol solution
Component
Sorbitol
He!
Tris Base
mmo1es/1
274.0
12.0
13.7
The pH of the solution was adjusted to 7.4 at 4oC.
s.rr.rrr. Effects of 24 hour vanadate treatment on sodium pump
site numbers of HeLa cells, as measured by 3H-ouabain binding
The method used here is based on those of Baker and Willis
(1970), and Boardman et al. (1972). There are two components of
ouabain binding; i). a "specific" component which is sensitive
to extracellular potassium concentration and saturates at low
concentrations of ouabain; and ii}. a "non-specific" component
which increases linearly with ouabain concentration (upto at
1eastlm M) and isin sen sitvet 0 ext race 11u1ar pot ass ium , Th e
saturable component is thought to represent the specific ouabain
binding to the sodium pump since binding correlates with the
inhibition of the potassium flux through the pump.
In practice, pump site numbers in HeLa cells are measured
using 3H-ouabain as a tracer in a Krebs solution containing 2 x
lO-7M cold (i.e. non-radioactive) ouabain. Total binding (i.e.
specific and non-specific) is measured using a potassium-free
Krebs solution (K-free Krebs) whilst the non-specific binding is
measured using a Krebs solution containing 15mM K+ (15K-
Krebs). By appropriate subtraction, the specific ouabain
binding can'then be estimated. The ouabain concentration of 2 x
10-7M is usually chosen for use with HeLa cells as being an
excess concentration where the specific and non-specific binding
can best be distinguished (Boardman et al. 1972). At this
ouabain concentration the non-specific binding is generally less
than 10% of the total binding. Wi th lower concentrations of
ouabain, much longer incubation periods are required for
saturation of the specific binding, and at higher concentrations
the non-specific binding comprises a higher proportion of the
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total binding, thus making the specific binding more difficult to
evaluate accurately. At 370C and with an incubation time of 20
minutes, specific binding saturates, and dissociation and pump
internalisation are insignificant (Lamb and Ogden 1977, Algerably
et al. 1985).
K-free Krebs was prepared as per normal Krebs (Table 2.3.)but
omitting the KCI, replacing the KH2P04 with NaH2P04' and using
dialysed new-born calf serum. 15K-Krebs was prepared by adding
the appropriate amount of 1M KCI to K-free Krebs. Ouabain
solutions were prepared by serial dilution of a 10-3M aqueous
stock solution which was stored at 40C in the dark. The
specific activity of the stock 3H-ouabain was 42 Ci/mmol.
Plates of HeLa cells were prepared as described in Section
2.ll.iii. with a seeding density of 0.33 x 106 cells/3 mls of BME
on 5 cm tissue culture plates (day 0). On day 3 the plates were
numbered and the medium was replaced with fresh medium ± Na3V04
(10-9M-10-4M), with 6 plates for each treatment condition.
Twenty-four hours later, half the plates from each treatment
condition were transferred to a bench-top incubator at 37°C. At
30 second intervals, each plate in turn was washed 4x in K-free
Krebs (37°C), the remaining solution aspirated off, the plate
replaced on the incubator and approximately 4 mls of radioactive
ouabain standard solution was added (2 x 10-7M ouabain in K-free
Krebs, containing 0.4 uCi of 3H-ouabain/ml) by syringe. All
additions and removals of solution were carried out at the same
point on the plate in order to minimise any disruption to the
cell monolayer. The plates were then incubated for 20 minutes
at 370C and at the appropriate 30 second intervals each plate was
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removed from the incubator and washed 4x (less than 20 secs in
total) in ice-cold Krebs (this washing procedure has previously
been shown to remove all the extracellular space marker l4C_
inulin - Aiton et al. 1981). To each plate, 1 ml of trypsin
solution (0.25% w/v in EBSS containing 2mM EDTA) was added. The
plates were then returned to the incubator until the cells
detached whereupon the trypsin was neutralised by the addition of
2 mls of Krebs to each plate.
For each plate in turn, a single cell suspension was prepared
by blasting and 1 ml was taken and added to 19 mls of Isoton for
the determination of cell numbers as previously described in
Section 2.II.iv•• 1 ml of each cell suspension was added to
scintillation vials containing 10 mls of scintillation fluid.
The scintillation vials were then capped, shaken and placed in a
Packard Tri-carb Liquid Scintillation Spectrometer 3255. After
allowing 1-2 hours for chemiluminescence to subside, the samples
were counted for 10 minutes or 10,000 counts thus keeping the
error below 1%. No quench correction was made for the varying
protein content of the samples as the influence was negligible
with the small quantities and range involved (Aiton - personal
communication) •
The same procedure was carried out on the remainder of the
plates using a similar radioactive ouabain solution but made up
in 15K-Krebs, and using 15K-Krebs for the washes. In both cases
blanks were run to account for any residual radioactivity left
after the washing. These consisted of cell-free plates to which
4 mis of radioactive standard solution was added and the plates
treated as described above. For standard counts (specific
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activity), 3 x 100 ul aliquots were taken from each standard
solution and added to scintillation vials containing 10 m1s of
scintillation fluid and 0.9 mls of 0.25% (w/v) trypsin
solution/Krebs mixture (1:2, v/v), mimicking the conditions
present in the other vials. Machine blanks were also run in
order to measure the machine background counts (normally less
than 20 cpm). These consisted of 3 vials each containing 10 mls
of scintillation fluid and 1 ml of the above trypsin/Krebs
mixture.
Total and non-specific binding, and consequently the specific
binding, was calculated according to the equation in Appendix 2.
The results were expressed as molecules of ouabain bound/cell.
Assuming that one molecule of ouabain binds per pump site (Baker
and Willis lQ72), this represents the number of sodium pump sites
per cell.
Experiments were repeated on several occasions, with each
treatment condition in triplicate. Results were analysed by
Student's t-test (unpaired) using the "Mini tab" statistical
package on the VAX mainframe computer.
In the light of the results (discussed later) which show a
vanadate-induced decrease in the specific ouabain binding, a time
course of ouabain binding (30 sees - 16 mins) was carried out on
cells previously incubated for 24 hours in the presence and
absence of vanadate. This was carried out in order to check
that the vanadate pretreatment was not altering the binding
kinetics of ouabain and producing an apparent decrease in the
number of binding sites. The method used was essentially the
same as that above, only with the incubation times in ouabain
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solution being varied and a vanadate concentration of lO-4M being
used for the 24 hour preincubation.
Another possibility, although unlikely, was that vanadate,
despite inhibiting the sodium pump from the intracellular side
unlike ouabain, may later have prevented access of ouabain to
some si t es, This may have produced a similar time course of
binding as in the untreated cells but with apparently less pump
sites. However this had previously been shown not to be the
case (Ai ton - personal communication) and was not investigated
further in this study.
3.II.iv. Effects of 24 hour vanadate treatment on potassium
(86Rb) influx in HeLa cells
As already described in the "Introduction" to this chapter,
there are three major pathways by which potassium enters cells;
i). a passive leak influx; ii). a diuretic-sensitive
cotransportj and iii). a ouabain-sensitive pathway via the
sodium pump. The magnitude of these individual pathways can be
measured using the radioactive tracer 86Rb (this is handled in
the same way as 42K when used in tracer amounts but has a half-
life of 18.7 days compared with 12.4 hours - Aiton et al. 1982),
as described by Aiton et a1. (1981). The term ·'K+ influx" will
be taken to include 86Rb influx for the purposes of this thesis.
By measuring the influx of 86Rb when the cells are incubated in
Krebs, the total potassium influx can be determined. By
measuring the influx in Krebs containing lO-3M ouabain and
subtracting the measured flux from the total flux, the ouabain-
sensitive component can be determined, and similarly for the
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diuretic-sensitive component using either 10-4M furosemide or
bumetanide. The passive leak influx can then be determined by
subtractions or by measuring the flux in the presence of both
ouabain and furosemide/bumetanide. The flux measurements must
be made over a short time period during the linear portion of the
uptake curve i.e. whilst back-diffusion of the tracer is still
negligible. In HeLa cells a period of less than 10 minutes is
usually used (Aiton et al. 1981).
It has previously been shown however, using HeLa and MDCK
cells, that there is a substantial stimulation of the cotransport
pathway by ouabain (Aiton and Simmons 1983). This may be
secondary to the inhibition of the flux through the sodium pump
and results in erroneous estimates of the ouabain-sensitive flux
if measured as above. In addition, high concentrations of
furosemide have been shown to inhibit the ouabain-sensitive flux
(Wiley and Cooper 1974). Although these interactive effects
predominate at longer time periods than are normally used in flux
measurements, it has been recommended that the total potassium
influx is measured as described, but that the ouabain-sensitive
and diuretic-sensitive pathways be measured using nitrate Krebs
(N03--Krebs; Aiton and Simmons 1983). This is a Krebs solution
in which the chloride has been replaced by nitrate which is not
transported by the cotransport pathway and hence inhibits it.
When the flux is measured using this solution and the appropriate
subtraction made, the chloride-dependent pathway (normally
equivalent to the diuretic-sensitive pathway in HeLa cells (Aiton
and Simmons 1983) can be measured, and the passive leak pathway
can be measured in N03--Krebs containing ouabain. By
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subtraction, the ouabain-sensitive pathway can be determined.
Plates of HeLa cells were prepared as decribed in Section
2.II.iii (0.33 x 106 cells/S em plate - day 0), and the medium
replaced with fresh medium ± Na3V04 (lO-9_l0-4M) on day 3, with 9
plates for each condition. Twenty-four hours later at
appropriate staggered intervals, the plates for one treatment
condition were transferred to a bench-top incubator at 370C. At
30 second intervals, the first 3 plates in turn were washed 4x in
Kr~bs (370C), aspirated and replaced on the incubator where 4 mls
of radioactive standard solution (Krebs containing 0.5 uCi of
86Rb/ml) was added with a syringe. The second three plates and
remaining three plates in the treatment group were treated
similarly except that they were washed with N03--Krebs (see Table
3.2. for composition) and the radioactive standard solutions
were, respectively, N03--Krebs containing 0.5 uCi of 86Rb/ml, and
the same but also containing 10-3M ouabain. The K+
concentration of both the N03-- and normal Krebs solutions were
checked by flame photometry before use (5.7 mM normally).
After 5 minutes incubation, the plates were removed from the
incubator at the appropriate time intervals and washed 4x (less
than 20 sees in total) with ice-cold Krebs (this procedure had
previously been shown to remove all of the extracellular marker
14C-inulin and less than 1% of intracellular 86Rb was lost -
Aiton et al. 1981). The plates were then returned to the
incubator where 1 ml of trypsin solution (0.25% w/v In EBSS
containing 2mM EDTA) was added to each plate. When the cells
were detached, the trypsin was neutralised by addition of 2 mls
of Krebs and a single cell suspension was prepared by blasting.
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Table 1.2. Composition of N03--Krebs solution
Comoonent
NaNO)
KNO)
MgS04·7H20NaH2P04KH P04
Ca~No)2
HNO)
Tris Base
Glucose
mmo1es/l
140.0
5.4
1.2
0.3
0.3
2.8
12.0
13.7
11.1
In addition the Krebs solution was supplemented with 1i. (v/v)
new-born calf serum. The pH was adjusted to 7.4 at 37oC.
For each plate in turn, 1 ml of the suspension was added to 19
mls of Isoton and used for the determination of cell numbers as
described in Section 2.II.iv•• 1 ml of each cell suspension was
also taken and added to 10 mls of water in a scintillation vial
and counted in a Packard Tricarb Liquid Scintillation
Spectrometer 3255 by the Cerenkov method. This is a method of
counting high-energy beta-emitters whereby particles of energy
greater than 300 KeV travelling through a medium such as water,
at a velocity greater than that of light in the same medium, emit
a photon of light.
scintillation counter.
The above procedu re wa s re pea ted for all the trea tmen t
This can be detected using a liquid
conditions. Plate blanks were run as previously describeci in
Section 3.I1.i11. and 3 x 100 u1 aliquots of each standard were
taken (for specific activity measurement) and added to 10 mls of
water and 0.9 mls of 0.25% (w/v) trypsin/Krebs mixture (1:2 v/v)
in scintillation vials, to ensure the same colour quenching.
These were counted as above. Machine blanks were also counted
by taking 3 x 1 mls of the above Krebs/trypsin mixture and adding
them to 10mls of water in scintillation vials.
Results were calculated according to the equation in Appendix
3 and expressed as mmol K+/lcw/min. or as nmol K+/106 cells/min.
for each flux pathway. Experiments were repeated on several
occasions, with each condition in triplicate. Results were
analysed by Student's t-test (unpaired) using the "Mini tab"
statistical package on the VAX mainframe computer.
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a.rrt , RESULTS
s.rn.r. Effect of 24 hours incubation in vanadate-containing
medium on the volume and intracellular (Na+] and (K+] of HeLa
cells
The effects of vanadate on the mean cell volume are shown in
Table 3.3. and Figure 3.3•• Slight but highly significant
increases in mean cell volume are produced at [VS+]o of lO-SM-
The increase is dose-dependent from [VS+]o of lO-SM to
4.6 x lO-SM but tends to decrease again towards control values at
lO-4M VS+, although still significantly elevated.
Changes in ion contents are not seen until higher
extracellular concentrations of vanadate than those producing the
earliest changes in volume. Highly significant increases in
[Na+]i are seen at [VS+]o of 4.6 x lO-5M and lO-4M with a maximum
increase of 133% at lO-4M VS+ if the results are expressed as
mmol/lcw, or an increase of 142% if the results are expressed as
nmol/106 cells (Table 3.4. and Figure 3.4.). The slight
differences in the magnitude of this change are due to the slight
change in cell volume with vanadate treatment.
No significant changes in intracellular K+ levels were seen if
expressed as mmol/lcw and only slightly significant increases at
[VS+]o of 4.6 x lO-SM and lO-4M, if expressed as nmol/106 cells
(Table 3.5. and Figure 3.4.). This apparent virtual lack of
significant effect of vanadate on [K+]i however, is due to the
variability of the results between experiments, as can be seen in
Figure 3.5. where the results from 8 individual experiments are
shown. In contrast to the intracellular sodium levels which
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Table 3.3. Effect of 24 hours growth in vanarlate on the mean
cell volume of HeLa cells
The values below represent the mean ± S.E.H. of A experiments,
wi th each condi tion being triplicated wi thin each experiment.
Significance testing relative to the control group is by
Stu':ent's t-tes t.
[V5+Jo Mean cell volume ± S.F..M. Level of
(M) (u3) Significance
0 2850 ± 29 -
3.2 x 10-6 2862 ± 22 N.S.
10-5 2927 ± 33 p 0.05
2.1 x 10-5 3034 ± 35 p<:O.OOl
4.6 x 10-5 3076 ± 30 p<O.OOl
10-4 2983 ± 46 p<0.05
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Figure 3.3. Effect of a 24 hour incubation in vanadate-
containing medium on the mean cell volume of HeLa cells
Each point represents the m ean ± S.E.M. of 8 experiments, with
each condition being triplicated within each experiment.
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Effect of a 24 hour incubation in vanadate-
containing medium on the intracellular [Na+] and [K+] of HeLa
cells
Each point represents the mean ± S.E.M. of 8 experiments, with
each condition being triplicated within each experiment.
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Effect of a 24 hour incubation in vanadate-
containing medium on the intracellular [K+l of HeLa cells
Each set of symbols represents the results from one
experiment with each point being the mean ± S.E.M. of triplicate
data. The error bars are omitted for clarity but in most cases
are less than 3% of the mean value.
were reproducible from experiment to experiment, potassium levels
were significantly increased, decreased or remained unaltered at
[VS+]o greater than 10-6M, depending upon the experiment. The
majority of the experiments do, however, tend to show a
significant increase in [K+] at 4.6 x 10-SM V5+, decreasing
slightly towards control values at 10-4M• In some cases these
changes occurred following a slight decrease in K+ levels at
lower [VS+]o' and hence the resultant level was not significantly
different from the control levels. When the resul ts from all
the experiments are averaged, vanadate appears to have little
effect on intracellular [K+] (Table 3.5. and Figure 3.4.), due to
this variability. No significant changes in either the volume
or ion contents of the cells were seen at extracellular
concentrations of vanadate from 10-9M to lO-6M (results not
shown) •
3.IH.H. Effect of 24 hours incubation in vanadate-containing
medium upon the sodium pump numbers (ouabain binding) of HeLa
cells
A progressive and significant decrease in the specific ouabain
binding (sodium pump number) of HeLa cells was seen at [VS+] 0
greater than 10-SM although there is not a linear relationship
between the dose and response (Table 3.6. and Figure 3.6.).
Overall a 20% decrease in pump sites/cell is seen at 10-4M VS+.
The results are not expressed per unit of cell surface area since
surface area would have to be calculated from the volume assuming
the cells are spherical. However it has been shown that
numerous filopodia protrude from the cell (Lamb and McCall 1972).
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Table 3.n. Effect of 24 hours growth in vanadate on the
specific ouabain binding of HeLa cells
The values below represent the mean ± S.E.H. of 5 experiments,
with each condition being triplicated within each experiment.
Si~nif1cance testing relative to the control group is by
Student's t-test.
[V5+)0 Mean specific ouabain Level of
binding + S.E.M.
(M) (x103 molec:les/cell) Significance
0 766 + 31 -
3.2 x 10-6 737 + 26 N.S.
10-5 698 ± 19 N.S.
2.1 x 10-5 666 + 19 p<0.05
4.6 x 10-5 651 + 30 p<0.05
10-4 611 + 23 p<0.005
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containing medium on the specific and non-specific ouabain
Each point represents the mean ± S.E.M. of 5 experiments with
each condition being triplicated within each experiment.
In addition as vanadate produces changes in cell volume, the
relationship between volume and surface area of these cells may
not remain the same if the morphology of the cells alters which
appears to be the case (see Chapter 2). The apparent decrease
in sodium pump numbers appears to be a real effect as the time
course of ouabain binding was the same in both control and
vanadate-treated cells (Figure 3.7.) indicating that the apparent
decrease was not due to a change in binding kinetics. No
significant change in non-specific ouabain binding was seen with
vanadate treatment (Table 3.7. and Figure 3.6.). The slight
increase in binding at 4.6 x lO-SM VS+ followed by a slight
oecrease at 10-4M VS+ (although not significantly different from
the control), parallels the changes in cell volume, and hence
possibly surface area, seen at these vanadate concentrations.
No significant changes in specific or non-specific ouabain
binding were seen at extracellular vanadate levels from 10-9M to
10-6M (results not shown).
3.III.!!i. Effect of 24 hours incubation in vanadate-containing
medium on the K+ influx pathways of HeLa cells
At [V5+]o greater than 10-6M, the total K+ influx of HeLa
cells was significantly reduced (Table 3.8. and Figure 3.8.).
The magnitude of the decrease was dose-dependent although not in
a linear fashion, and ranged from a 13% decrease at 3.2 x lO-6M
VS+ to a 30% (if expressed as mmol/lcw/min) or 18% (if expressed
as nmol/106 cells/min) decrease at lO-4M VS+. This decrease was
due to decreases, similar in magnitude to those above, in the
+ouabain-sensitive, chloride-dependent, and passive leak K influx
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Effect of a 24 hour incubation in vanadate-
containing medium on the time course of the specific ouabain
binding of HeLa cells
The experiment was performed 4 times and the graph illustrates
the results from one representative "experiment. Each point
represents the mean ± S.F..M. of triplicate data within the
experiment.
Table 3.7. Effect of 24 hours growth in vanadate on the non-
specific ouabain binding of HeLa cells
The values below represent the mean ± S.E.M. of 5 experiments,
with each condition being triplicated within each experiment.
Significance testing relative to the control ~roup is by
Student's t+t e s t ,
[V5+]o ~1ean non-specific ouabain Level of
binding + S.E.M.
(M) (xl03 molec~les/cel1) Significance
0 78 ± 5 -
3.2 x 10-6 70 ± 5 N.S.
10-5 71 ± 5 N.S.
2.1 x 10-5 75 ± 4 N.S.
4.6 x 10-5 80 ± 8 N.S.
10-4 70 ± 9 N.S.
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Figure 3.8. Effect of a 24 hour incubation in vanadate-
containin~ medium on the total, chloride-~ependent, ouabain-
sensitive, and passive leak K+ influx pathl~aysof HeLa cells
Each point represents the mean ± S.E.M. of 6 experiments with
each condition heing triplicated within each experiment.
pathways. Because the decrease was proportionately similar in
all of these pathways, their individual contribution to the total
e.g. the chloride-dependent pathway was inhibited to a greater
extent than the other pathways at 2.1 x 10-SM VS+.
The ouabain-sensitive K+ influx was significantly decreased at
3.2 x 10-6M VS+ and at 2.1 x 10-SM - 10-4M VS+ when expressed as
mmol/lcw/min, but only at 3.2 x 10-6 and 10-4M VS+ when expressed
as nmol/l06 cells/min (Table 3.9. and Figure 3.8.). The
chloride-dependent K+ influx was significantly decreased at
[VS+]o greater than 3.2 x lO-6M, irrespective of whether
expressed as per lcw or per 106 cells (Table 3.10. and Figure
flux remained the same at approximately 40%, SO% and 10%
respectively (Tables 3.9., 3.10., 3.11., and Figure 3.8.). This
was not the case at every level of vanadate treatment however
3.8.). The most significant decrease in the chloride-dependent
flux was seen at 2.1 x 10-SM vS+ as already mentioned.
Significant decreases in the passive leak K+ influx were seen at
10-SM, 4.6 x 10-SM and 10-4M VS+ (Table 3.11. and Figure 3.8.)
with the largest decrease at 10-SM. Similar results were seen
if the cotransport flux was measured using bumetanide rather than
N03 --Krebs. DIDS had no effect on the K+ influx. These
results indicate that the decrease was in the diuretic-sensitive
cotransport flux and not in any other chloride-dependent
potassium influx which may have been present in these cells.
No significant changes in any of the K+ influx pathways were
seen at extracellular vanadate concentrations from 10-9M to 10-7M
(results not shown).
The mean K+ influx per pump site is ideally determined by
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measuring the ouabain-sensitive influx and dividing it by the
sodium pump numbers determined during the same experiment. This
was impossible in this study due to the magnitude of such an
experiment. Hence the mean K+ influx through the sodium pump
was determined by dividing the individual ouabain-sensitive flux
results by the overall mean sodium pump number for each vanadate
treatment (Table 3.12.). Similar resul ts were obtained if the
mean flux results were divided by the individual ouabain-binding
results. As the ouabain binding and flux experiments had been
carried out alternately during the period of this part of the
study, the effect of any possible external variable in
influencing preferentially one parameter rather than the other
during, for example, the first half of this period, was kept to a
minimum.
There appears to be small but significant increases in the
flux per pump site at extracellular vanadate concentrations of
IO-5M to 4.6 x lO-5M with a non-significant increase at lO-4M
V5+. Such changes are due to the greater decreases seen in
sodium pump numbers compared with those seen in the ouabain-
send tive flux per cell.
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3.IV. DISCUSSION
The majori ty of the resul ts reported here show only slight,
although significant, changes in the parameters studied as a
result of a 24 hour incubation in vanadate-containing medium.
This is not unexpected in view of the fact that it has been shown
in the previous chapter that most if not all of the intracellular
vanadate is reduced to vanadyl within this time period, and
vanadyl is thought to be less biologically active generally than
vanadate. It is actually unlikely that vanadate is present in
any significant quantities in the HeLa cells, as if the reducing
capability of the cells was exceeded and vanadate accumulated
even at nanomolar levels, a similar degree of inhibition of the
Na+/K+-ATPase would be expected as that occurring in isolated
enzyme preparations (Josephson and Cantley, Jr. 1977). Such an
inhibition is not apparent in this study.
The biological actions of vanadyl are even less well
established than those of vanadate owing to its instability under
physiological conditions, unless bound within the cell. It is
also difficult to differentiate quantitatively between vanadate
and vanadyl at the low concentrations at which sp~cific
biological effects may occur. Indeed many cellular actions
previously attributed to vanadate may actually be caused 'by
vanadyl. Vanadyl inhibits Na+/K+-ATPase, although only in very
pure enzyme preparations (North and Post 1984). In addition, in
rat adipocytes a stimulation of glucose oxidation by vanadyl has
been reported (Shechter and Karlish 1980). The int racellular
reduction of vanadate to vanadyl together with the potential
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biological effects of vanadyl obviously makes the interpretation
of the results in this study more difficult.
The slight but significant changes in volume are first seen at
a lower concentration of vanadate (lO-SM) than that which
produces a significant change in intracellular ion concentration.
The reason for this discrepancy is not clear but can not be
accounted for on the basis of the variability of the
intracellular [K+] between experiments. When the results from
individual experiments are examined, no changes in [K+] at lO-5M
VS+ are seen. Similarly the uptake of vanadium by the cells
(see Chapter 2) would not have produced an increase in osmotic
pressure which would cause a significant volume change. The
variability of the intracellular [K+] values from experiment to
experiment is also difficult to explain when the remainder of the
parameters seem to show relatively consistent changes. Results
expressed either in terms of cell number or per litre of cell
water may differ in their significance relative to the control
group. This is due to the differences in cell volume at the
higher vanadate concentrations.
The changes in intracellular ions in this study can be further
analysed when examined in conjunction with the results obtained
for ouabain binding and K+ influx. Before this is done however,
some necessary assumptions which have had to be made and some
disadvantages of the techniques employed are discussed.
When using monolayer cultures of cells in radioisotopic
binding or uptake experiments, the assumption is made that the
bathing medium has equal access to both sides of the monolayer.
This assumption appears to be justified when using HeLa cells
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The difficulties involved in measuring the different flux
since the ouabain binding of intact cells is not significantly
different to that of a membrane preparation (Baker and Willis
1972).
pathways have been mentioned briefly in Section 3.II.iv ••
Inaccuracies can arise either from a stimulation of the
cotransport flux by ouabain as a result of sodium pump inhibition
(Aiton and Simmons 1983), or alternatively from the non-specific
furosemide, on the sodium pump (Wiley and Cooper 1974) and the \
inhibitory actions of the loop-diuretics, particularly
DIDS-sensi tive anion transport pathway (Geck et al. 1981).
These effects are seen over longer time periods than are commonly
used in flux experiments and can be largely circumvented by using ..'
the higher affinity loop-diuretic, bumetanide, at lower
concentrations where non-specific effects are less evident.
Alternatively, ouabain together with nitrate medium (where the
chloride has been replaced by nitrate) can be used. Nitrate is
an anion which behaves in a similar fashion to Cl- with the
notable exception that it is not transported by the diuretic-
sensitve cotransport pathway which it inhibits. Like Cl-,
nitrate is distributed passively in accordance with the membrane
potential although equilibration may not occur as rapidly,
resulting in transient fluctuations in membrane potential. The
use of Cl- to measure the diuretic-sensitive flux would not be
appropriate in cells which possess other significant CI--
dependent fluxes bu t this is not the case in HeLa cells (Aiton
and Simmons 1983).
Since the experiments have been performed in this study,
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incubation medium (Aiton - personal communica t Ion), In this
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concern has been expressed in several laboratories about the
possible production of free radicals in nitrate-containing
study the decrease seen in the Cl-dependent K+ influx was also
shown to occur in the bumetanide-sensitive K+ influx and DIDS was
without effect. These results illustrate the equivalence of the
Cl--dependent flux and the diuretic-sensitive flux, and the
absence of any other Cl--dependent K+ influx pathways. The use
of bumetanide and DIDS has confirmed the results obtained with
nitrate-containing medium in this study and ruled out the
possible ambiguity. Retrospectively, the use of bumetanide may
be a better option and potentially less likely to produce
problems.
The lack of a significant effect of vanadate on the non-
specific ouabain binding would be in accord with the small
(though significant) changes in volume and hence surface area of
the cells. The decrease in sodium pump numbers however, as
measured by specific ouabain binding, together with the
subsequent slight but significant decrease in the ouabain-
sensitive K+ influx, may account for the increased intracellular
Although the possibility that vanadate may have altered
the affinity of the pumps for ouabain binding can not be ruled
out without further experimentation, at the concentration of
ouabain used here the time course of binding appears to be very
similar in vanadate-treated and control cells, indicating a real
decrease in pump number.
The interpretation of the results is complicated by the toxic
effects of vana<iate/vanadyl described in Chapter 2, which
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together with other possible indirect actions, may mask any \
a combination of all these possibilities. For example, although I
I
direct actions of vanadate/vanadyl. The results obtained may be
a decrease in the ouabain-sensitive K+ influx was described, the
actual flux per pump was increased as the concomitant decrease in
sodium pump numbers was significantly greater. This stimulation
of flux per pump (approx. 10% increase - from 50 K+ ions
transported per pump per second to 56 per pump per second), was
probably caused by the increase in intracellular [Na+] resulting
from the decrease in total pump flux. However on the basis of
the known kinetics of activation of the sodium pump by the
elevated intracellular Na+, an increase in flux per pump of
approximately 50% would have been expected (De Weer 1985). This
discrepancy between the predicted results and actual findings
indicates an inhibition of the ouabain-sensitive flux by
vanadate/vanadyl, which is partially masked by the stimulation of
the flux by the raised intracellular [Na+]. However the
stimulation of flux per pump site was also seen at vanadate
concentrations which produced no change in internal sodium
levels. An alternative explanation is a possible stimulatory
action of vanadate/vanadyl on the ouabain-sensitive K+ influx, as
demonstrated by Werdan et al. (1980, 1982) using heart muscle and
non-muscle cells prepared from neo-natal rats, and Girardi human
heart cells. If this were to occur in HeLa cells at the lower
extracellular vanadate concentrations (10-5M), with inhibitory
actions predominating at the higher concentrations when a
stimulation due to raised sodium levels may also occur, this
could account for the changes seen.
llR
The increased intracellular sodium levels would in turn have
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been expected to produce only a slight, if any, up-regulation of
pump numbers at the concentrations of sodium seen in this study.
For example, with an ethacrynate-induced increase in
intracellular sodium concentration from 13 mM to 60 mM, the
specific ouabain binding of HeLa cells was only increased by 39%
(Boardman et a!. 1974). Whether a slight upregulation has
occurred in this study but is masked by the toxic or specific
action of vanadate/vanadyl in decreasing the sodium pump numbers
is not clear. Alternatively, possible up-regulation may not
occur if the toxicity seen in this study occurs as a result of a
generalised inhibition of protein synthesis. Such an inhibition
may also account for the rlecrease seen in pump sites.
The minimal effect of vanadate incubation on the ouabain-
sensitive K+ influx per cell which was similar to that described
in rat vascular smooth muscle cells cultured in vitro (Searle
et al. 1983), was not due to low intracellular vanadium
concentrations (see Chapter 2). It is likely that it was due to
the reduction of the vanadate to vanadyl as already discussed in
Chapter 2. However there is also the possibility that the
Na+/K+-ATPase enzyme in HeLa cells is resistant to vanadate. In
an attempt to establish that this was not the case, HeLa cell
membranes were prepared and assayed for ATPase activity.
However the ouabain-sensitive Na+/K+-ATPase activity was only a
very small fraction of the total ATPase activity present and
could not be studied in such a crude preparation. Although it
is relatively easy to purify up this enzyme in tissue homogenates
owing to the large amount of material present, it is much more
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difficult in cultured cells and this line of research was not
pursued further. Insensitivity to vanadate must therefore
remain a possibility, although this was not the case with the
isolated Na+/K+-ATPase from rat vascular smooth muscle cells for
example, despite the lack of effect of vanadate on ouabain-
sensitive ion transport in the intact cell (Searle et al. 1983).
The diuretic-sensitive K+ influx was also decreased in the
vanadate-treated cells although with greater significance
statistically than the decreases seen in the ouabain-sensitive
flux. Without measurements of the diuretic-sensitive K+ efflux
it is impossible to determine whether the decrease in cotransport
flux is a bidirectional decrease, or a unidirectional decrease
leading to a lowering of the intracellular rK+]. If the former
is the case, the decrease in the diuretic-sensitive flux seen in
the slightly swollen vanadate-treated HeLa cells may be the
opposite situation to the bidirectional increase in flux seen in
HeLa cells when shrunken (Tivey 1986), although the function of
it is not known. Such alterations in diuretic-sensitive flux
may be volume regulatory although this is normally asociated with
an increased efflux of KCI in swollen cells (Tivey 1986).
If however the decrease in diuretic-sensitive flux is
+unidirectional then it may be occurring in order to maintain K
homeostasis as proposed by Duhm and Gobel (1984). This would
imply that it is occurring to counteract an increased
intracellular [K+] and therefore is not likely to be the
explanation in this study. Alternatively the changes in
diuretic-sensitive flux may be non-specific effects seen as the
result of the toxicity.
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The very significant decrease in the passive leak K+ influx
occurring at an extracellular vanadate concentration of 10-SM may
be indicative of a reduced membrane permeabili ty to K+ or of a
perturbation of the membrane potential mediated by, for example,
an increased membrane permeability to Na+ ions. However this
can not be reconciled with the hyperpolarisation seen in various
cultured cell types with vanadate treatment (Lichtstein et al.
1982). The experiments in this thesis however utilised much
longer incubation times. The accumulation of vanadate within
the cells as vanadyl is not likely to have a direct effect on the
membrane potential itself at the concentrations present in this
study. It seems strange that the effects on the passive leak K+
influx occur predominantly at one single concentration of
vanadate, returning towards control values before decreasing
slightly again. It is possible that this change in the passive
leak K+ influx may be related to the toxicity as it is seen at a
vanadate concentration where effects on cell growth are first
produced, although non-significantly. Alternatively the
decrease in flux may possibly reflect some change in the cell
occurring as a consequence of the toxicity, or may be involved in
the causation of the toxicity.
In summary therefore, it is impossible to divide the results
shown here into those arising from direct or indirect actions of
vanadate/vanadyl. In addition, the reduction of vanadate to
vanadyl and the toxic effects seen are all confounding factors.
In view of the toxicity (see Chapter 2 ) which appears to be the
predominant effect, it is likely that many of the changes seen in
this study are secondary to toxicity. Additionally some of the
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effects may be secondary to ATP depletion for example, which
would directly affect the sodium pump and indirectly the
diuretic-sensitive cotransport pathway (Saier, Jr. and Boyden
1984). This possibility is explored and discussed in greater
detail in the following chapter.
A possible interaction between cell number and transmembrane
flux can not be excluded since the magnitude of the flux pathways
varies slightly with the day of culture normally. Whether this
is due to the actual differences in cell number per plate or is
due to the phase of growth (i.e. whether logarithmic or
stationary) on the different days of culture has not been
established. In either case such a variation is only slight and
would not be sufficient to account for the changes in flux seen
here with vanadate treatment, despite the varying cell numbers
with treatment level.
The overall conclusion based on the results presented in
Chapters 2 and 3 is that the changes seen after vanadate
incubation are probably largely due to vanadyl and may occur as a
result of secondary and/or toxic effects, rather than any
specific inhibitory actions on the transport pathways. A
combination of these actions is possible however. The cause of
the toxicity has been speculated upon already in Chapter 2.
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CHAPTER 4. MEASUREMENT OF INTRACELLULAR NUCLEOTIDES IN HELA
CELLS BEFORE AND AFTER CHRONIC VANADATE TREATMENT, USING HIGH
PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
4.1. INTRODUCTION
4.I.i. Biological importance of nucleotides
Nucleotides, the phosphate esters of nucleosides (a purine or
pyrimidine base linked to the pentose sugars D-ribose or 2-deoxy-
D-ribose), are important in many biochemical processes. For
example, they act as metabolic regulators, are precursors of the
nucleic acids DNA and RNA, and ATP is the universally important
energy-rich compound (Stryer 1981). Structural examples are
given in Figure 4.1••
The role of metabolism can be broadly defined as the produc-
tion of ATP, NADPH (to provide reducing power for the
biosynthesis of cell components from more oxidised precursors),
and macromolecular precursors. Metabolic regulation is largely
achieved by controlling the amounts of key enzymes, controlling
their catalytic activity (e.g. either through allosteric
inhibition or activation of the enzyme by a product, or through
covalent modifications of the enzyme, such as phosphorylation)
and by the compartmentalisation of the synthetic and degradative
pathways (Stryer 1981). The cellular energy status is also
important in metabolic regulation, although the concentration of
ATP alone has been found to be inadequate as a reflection of the
cellular energy balance (Sauer 1978, Matsumoto et al. 1979). A
more generally accepted index of energy status is the adenylate
energy charge, proposed by Atkinson and Walton in 1967 where:
[ATP] + 0.5 [ADP]
Energy charge =
[ATP] + [ADP] + [AMP]
123
AlP
HO OH
GMP
HO OH CDP
o 0
II II
-O-P-O-P-OCH
'I I
-0 -0 H
H
HO
NH&
1
N~C""'CH
I I
O=C..... ",CH
N
Figure 4.1. Structural examples of nucleotirles
Under control conditions this is normally in the range of 0.8
to 0.95 for most cells. As the conservation of ATP is a major
feature of metabolic regulation, a logical consequence of an
increase in energy charge would be the inhibition of ATP-
generating pathways and/or the stimulation of ATP-utilising path-
ways and this is indeed what occurs e.g. the affinity of
phosphofructokinase for fructose-6-phosphate is decreased by ATP
and enhanced by AMP or ADP depending upon the species (Atkinson
and Walton 1967). This response to a change in energy charge is
also increased as a result of feedback inhibition by citrate
(Shen et al. 1968).
Significant physiological correlation has been found in cul-
tured fibroblasts, between the energy charge and cellular
viability under starvation conditions (Calderwood et al. 1985).
No correlation was found however, between the energy charge and
cellular viability following exposure to heat. Matsumoto et al.
(1979) found a correlation between energy charge and the
dephosphorylation of AMP in cultured lymphoblastoid cell lines,
following the depletion of ATP as a result of the inhibition of
glycolysis and cellular respiration. This dephosphorylation did
not correlate with an elevated AMP concentration and appeared to
occur as a homeostatic mechanism, restoring the normal energy
charge. It occurred only when the adenylate energy charge
decreased to less than 0.6. Further examples of the involvement
of the energy charge in metabolic regulation have been discussed
by Atkinson (1968).
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4.I.ii. Nucleotides and ion transport
The dependence of the sodium pump (Na+/K+-ATPase) upon ATP has
been well documented (for reviews see e.g. Baker 1966, Glynn
1968, Glynn and Karlish 1975, De Weer 1985), albeit that
different isozymes exist which have differing affinities for ATP
(Sweadner 1985). Although it was originally thought that
approximately 50% of the body's total ATP production was used by
the Na+/K+-ATPase enzyme in maintaining cellular ion gradients,
this concept was based on measurements made on cut or homogenised
tissues. More recent measurements made using intact tissues,
organs or limbs have yielded lower estimates which are generally
nearer 10% than 50% (De Weer 1985).
Few studies have been carried out investigating the kinetics
of the activation of sodium transport by ATP in intact ,cells, due
,
1.
to the experimental difficulties involved. Using dialysed squid
axons, Beauge and DiPolo (1981) showed that the activation of Na+
efflux by ATP appeared to follow Michaelis-Menten kinetics with a
Km for ATP of 0.2 mM under phys iological condi t tons, Similar
results were found using canine cardiac sarcolemmal vesicles
(Philipson and Nishimoto 1983) with a Km value for ATP of 0.21
mM. A competitive inhibition of ATP-dependent Na+ transport by
ADP was also seen. It should be noted however, that in isolated
Na+/K+-ATPase preparations, biphasic Lineweaver-Burke plots have
been found indicating the existence of both high affinity sites
and low affinity sites for ATP, e.g. Km values for ATP were
approximately 1 uM and 0.5 mM respectively in rat brain
preparations (Robinson 1976) and ADP or CTP were both found to
competitively inhibit the ATP-dependent activation of Na+/K+-
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ATPase. Whether the high affinity and low affinity sites are
two distinct sites or are different states of the same catalytic
site is still the subject of much debate (e.g. Cantley, Jr.
et al. 1983, Askari and Huang 1985).
From the evidence presented recently in a review by Saier, Jr.
and Boyden (1984), it appears that the diuretic-sensitive
cotransport pathway also shows an ATP-dependency. However
rather than a stoichiometric relationship between ATP hydrolysis
and ion transport, it appears that ATP functions to activate the
system, possibly by a protein kinase-catalysed phosphorylation
mechanism which in some cell types is cAMP dependent. This has
been discussed in the previous chapter. Further experimental
evidence is needed to validate this hypothesis however.
4.I.iii. Vanadate and phosphoryl transfer enzymes
Vanada te has been shown to have inhi bi tory actions on Ca2+-
and Na+ /K+ -ATPases both in membrane preparations and in whole
cells from many tissues (for reviews see Ramasarma and Crane
1981, Jandhyala and Horn 1983, Erdmann et al. 1984),whilst in
previous chapters an inhibitory action on both the Na+/K+-ATPase
and diuretic-sensitive cotransport activities of Hela cells has
been demonstrated, although these may be non-specific effects as
cytotoxicity also occurred at these vanadate concentrations.
Inhibition by vanadate of some phosphoryl transfer enzymes
involved in glucose metabolism has also been reported. Examples
include rat liver microsomal glucose-6-phosphatase which was
totally inhibited at endogenous vanadate levels (Singh et al.
1981), yeast phosphoglucomutase and phosphoglycerate mutase which
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were totally inhibited by micromolar concentrations of vanadate,
and rabbit muscle hexokinase and phosphoglycerate kinase which
were only partially inhibited (Climent et a!. 1981). In red
blood cells vanadate caused a rapid breakdown of 2,3-
bisphosphoglycerate which in turn increased cellular pyruvate and
the cellular glycolytic flux (NinfaU et al. 1983).
The ability of vanadate to inhibit enzymes which catalyse
phosphoryl transfer has been attributed to its adoption of a
stable trigonal bipyramidal or distorted octahedral configuration
ligands. This structure is thought to resemble the proposed
when hydrated or chelated with oxygen, nitrogen or sulphur
transition state of phosphate during the reaction (Lopez et al.
1976). However Rubinson (1981) believes that this is not the
case as profound chemical differences exist between phosphate and ..
vanadate with regard to the rate of ligand exchange in their co-
ordination complex chemistry.
In addition, vanadyl, which is formed by the reduction of
vanadate, possesses many insulin-mimetic effects. As previously
described in Chapter 3, both vanadyl and insulin produce an
increase in intracellular potassium levels and a subsequent
slight hyperpolarisation within minutes in mouse diaphragm muscle
at 10-6 to 10-3M (Zemkova et a!. 1982). The exact mechanism
underlying this change is not known although stimulation of the'
sodium pump or effects on intracellularly bound potassium were
proposed as possibilities. The former possibility was unlikely
however, due to the lack of effect of removal of extracellular
potassium, although ouabain inhibited the above changes.
In rat adipocytes, Shechter and Karlish (1980) and Degani
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et al. (1981) have demonstrated a stimulation of glucose
oxidation by extracellularly applied vanadate (10-4M). Although
vanadate is known to inhibit Na+/K+-ATPase from many cells and
inhibition of this enzyme results in a stimulation of glucose
oxidation, the stimulation seen in adipocytes was due not to
vanadate but to the vanadyl formed by the intracellular
reduction of vanadate (Shechter and Karlish 1980, Degani et al.
1981). In adipocytes the rate of glucose oxidation is thought
to be limited by glucose uptake and it appears that vanadyl
exerts its action on the glucose uptake. In view of the known
inhibitory actions of vanadyl on alkaline phosphatase (Lopez
et al. 1976), it was suggested that these effects were due to an
inhibitory action of vanadyl (anrl/or insulin) on a cellular
phosphatase which in turn altered the degree of phosphorylation
of proteins involved in sugar transport (Shechter and Karlish
1980). An alternative proposal, based on the fact that in
adipocytes at least, GSH is involved in the reduction of
vanadate, is that the effects of the vanadate/vanadyl are related
to the intracellular redox potential (Degani et al. 1981). If
vanadate was to induce a peroxidative metabolism coupled to GSH
oxidation which leads finally to an increase in cellular NADP and
a decrease in NADPH, this would explain the accelerated flux
through the hexose monophosphate shunt. This would not explain
however, the stimulation of glucose oxidation also seen via the
Embden-Meyerhof pathway (Degani et a!. 1981).
As a result of the actions of vanadate/vanadyl illustrated
above, it is conceivable that vanadate treatment may produce
alterations in the cellular energy charge, and that this in turn
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may be at least partially responsible for some of the toxicity
seen in Chapter 2. Additionally, significant alterations in
nucleotide concentration may also affect ion transport. These
possibilities have been investigated here in HeLa cells using
high performance liquid chromatography (HPLC) to measure
intracellular nucleotide concentration.
4.I.iv. Quantification of nucleotides
Quantification of nucleotides can be achieved using enzymatic
techniques such as the bioluminescent luciferin-luciferase
reaction for ATP (Strehler 1974). Such assays are highly
sensitive and specific but it is only possible to measure one
nucleotide in any single assay. With HPLC it is possible to
obtain complete or nearly complete profiles of intracellular
nucleotides in each analysis, relatively quickly and free from
any interfering substances present in cell extracts. A brief
introduction of the principles of HPLC follows before the chroma-
"
tographic separation of nucleotides is presented. Further
information can be found in many standard texts, (e.g. Parris
1976, Knox et al. 1978, Pryde and Gilbert 1979, and Simpson
1976).
4.I.v. Historical development of high performance liquid
chromatography (HPLC)
In 1941, Martin and Synge published a paper which laid the
foundations of gas liquid chromatography (GLC) and high
performance liquid chromatography (HPLC). This led to the rapid
development of GLC but it was not until the late 1960's that the
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first high pressure liquid chromatograms were produced; by opera-
ting at higher pressures (5000 psi) the effects of high liquid
viscosities relative to gas velocities were overcome and analysis
times obtained which were comparable with GLC. The ability to
analyse thermally labile compounds together with improvements in
HPLC column packing materials leading to greater versatility in
application and lower operating pressures, has ensured that HPLC
is now used as widely as GLC.
4.I.vi. Chromatographic system
The components of a typical HPLC system are shown in Figure
4.2.. Basically the eluent or "mobile phase" from the solvent
reservoir is filtered by a short silica-containing preco1umn
(which also serves to saturate the eluent with silica and hence
protect the silica backbone of the main column from erosion) and
pumped under pressure through the main column - the "stationary
pha s e", A mixture of solutes injected is separated into
individual components on travelling down the column, monitored as
they pass through a detector and recorded as peaks on a chart
recorder. Peaks can be identified by co-chromatography with
standards, comparison of retention times (time taken to elute)
with standards under the same conditions, or by enzyme reactions
e.g. hexokinase quantitatively converts ATP to ADP and hence both
peaks can be identified. The most widely used detector is the
UV detector which measures the change in UV absorption as the
solute passes through the flow cell in a UV transparent solvent.
Other detection systems include refractive index detectors,
electrochemical detectors, radiochemical detectors, electron
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capture detectors and fluorimetric detectors.
4.I.vii. Principles of chromatographic separation
The chromatographic separation of two components depends on
their having different distribution ratios between the stationary
and mobile phases with separation being primarily achieved by
modifications of the mobile phase. Solvent molecules compete
with solute molecules for polar adsorption sites. The stronger
the interaction between the mobile and stationary phases the
weaker the solute adsorption will be and vice-versa. Solvents
are rated according to their strength of adsorption in the "e1uo-
tropic series". Table 4.1.shows a shortened form of an
e1uotropic series with alumina as the adsorbent but similar
series hold for other polar adsorbents such as silica.
referred to as the "solvent strength parameter" and has been
defined by Snyder as "the adsorption energy per unit area of
standard adsorbent" (Simpson 1976). The greater the polarity of
the solvent, the greater its adsorption energy. Thus the
polarity of an eluent mixture and hence the chromatographic
separation achieved can be altered by changing the ratios of the
eluent components or by substituting one component for a more or
less polar solvent. Secondary solvent factors such as pH are
also important. HPLC separations may be run isocratica11y i.e.
with a constant eluent composition, or they may be run in a
gradient mode where the mobile phase composition, pH or ionic
strength is varied during the run. There are also anum ber of
different types of stationary mode which allow the division of
HPLC into distinct modes although separations achieved are often
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Table 4.1. Eluotropic series for alumina (from Pryde and
Gilbert 1979).
Solvent
n-pentane
Isooctane
Cyclohexane
Carbon tetrachloride
Xylene
Toluene
Renzene
0.00
0.01
0.04
0.18
0.26
0.29
0.32
0.38
0.40
0.42
0.45
0.56
0.60
0.62
0.65
0.82
0.88
0.95
1.11
Diethyl ether
Chloroform
Methylene chloride
Tetrahydrofuran
Acetone
Methyl acetate
Aniline
Acetonitrile
Isopropanol
Ethanol
Methanol
Ethylene glycol
Acetic acid
Water
large
large
as a result of a combination of modes.
The four main modes are:
a). Adsorption chromatography which is useful for separating
non-polar or slightly polar organic molecules. The solutes are
eluted with an organic mobile phase e.g. hexane, down a column
packed with an adsorbent material evg , silica. Retention and
selectivity are caused by hydrogen bonding of polar groups on the
solute molecules with the surface silanols on the stationary
phase. The retention time is dependent upon the competition
between solute and solvent molecules for the adsorption sites and
hence an increase in polarity of the eluent will tend to elute
the solutes more quickly.
b). Reverse-phase chromatography which is especially useful
for the separation of highly polar molecules which would give
rise to long retention times in adsorption chromatography.
Basically the same principles apply but the roles are reversed
with a non-polar stationary phase and a polar mobile phase. The
most common combination is a hydrocarbon bonded surface e.g.
octadecylsilyl groups (ClSH37Si-) bound to silica, with a polar
eluent such as a methanol/water mixture. The hydrophobic nature
of the stationary phase ensures a greater affinity for the non-
polar solutes and thus polar molecules are eluted first.
c). Ion-exchange chromatography where charged solutes are
separated by interacting with ionic sites bonded or coated onto a
packing surface e.g. bonded quarternary ammonium groups for the
separation of anions. Solute ions having a greater charge or
charge density are attracted more strongly by the stationary
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charges of the opposite sign. Mobile phases are always aqueous
and by modifying the ionic strength or pH of the eluent, the
separation of the components can be modified. This mode is not
used as often as other modes due to the relative instability of
the currently available packing materials.
d). Ion-pair chr owa t ogeaphy is an alternative to the above
for the separation of polar molecules. This is based on the
principle of extracting a hydrophilic ionised sample from an
aqueous into an organic phase by "neutralising" its net charge
with a pairing ion of opposite charge. Normally the reverse-
phase mode is used. Examples of suitable ion-pairing reagents
include, for example, basic quarternary ammonium ions for the
separation of acidic anions, and sulphonic acid ions for the
separation of basic cations. The exact mechanism of separation
is not known but is thought to be a combination of i). the
formation of ion-pairs in the mobile phase and the resulting
increase in hydrophobic interaction with the stationary phase
causing retention, and ii). the coating of the stationary phase
with the ion-pairing agent and the adsorbed ions acting as an ion
exchanger (Tomlinson et al. 1978). Prime parameters which can
be varied to alter the retention and selectivity of the
separation are given in Table 4.2••
4.I.vil1. Quantification in HPLC
Peaks can be quantified either by measurement of their heights
or areas. With an integrator the measurement of areas is more
accurate. Obviously a reproducible volume must be injected
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Table 4.2. Adjustable variables in reverse-phase ion-pair HPLC
Variable
Nature of pairing
ion
Concentration of
pairing ion
Type of organic
modifier in the
mobile phase
Concentration of
organic modifier
Stationary phase
pH
Temperature
Ionic strength and
counter-ion concentration
Effect
Generally the more hydro-
phobic the pairing ion,
then the greater the
retention.
An increase in concentrat-
will increase retention to
a limit and further
increases will cause a
decrease in retention.
Retention will decrease as
the modifier becomes more
non-polar.
Retention decreases with
increasing modifier concn.
A more hydrophobic statio-
nary phase results in
greater retentio~
As pH changes, resulting
in more solute ionisation,
the retention increases.
Retention decreases as the
temperature increases.
Increased ionic strength
and counter-ion concn.
will lead to a reduction
in retention.
every time and this ls fairly easy with the current loop inject-
ion systems. However variations can still occur, e.g. due to
injection of an air bubble. The effects of variation in column
performance and in injection volume can be overcome by using an
internal standard. Such a compound should be well resolved, of
comparable peak dimensions, affected by any injection or column
variables to the same extent as the sample, recovered to the same
extent during extraction as the compounds of interest, and stable
and not naturally occurring in the samples being analysed. Thus
if all the samples are spiked with the same volume of internal
standard, the peak height ratio i.e. the peak height of x divided
by the peak height of the internal standard, should be constant
for any given concentration of x, whatever the injection volume.
Usually a calibration curve is constructed by analysing
standards, each spiked with the same amount of internal standard,
and plotting their concentration against peak height ratio.
Thus when an unknown sample is analysed in the same way, the peak
height ratios can be ascertained and hence by direct comparison
with the calibration curve, the concentration of the unknown can
be determined.
4.I.ix. HPLC separation of nucleotides
The nucleotides are strong acids and are ionised at pH values
of 3 or higher, due to the presence of the phosphate group(s)
(Brown et al. 1980). Obviously the number of negative charges
per nucleotide molecule is dependent upon the number of phosphate
moieties e.g. the triphosphates have three. At pH values
greater than 7 the nucleotides gain an additional negative charge
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due to secondary phosphate dissociation (Zakaria and Brown 1981).
Separation of nucleotides has been accomplished using anion-
exchange chromatography (D'Souza and Glueck 1977, Brown et a1.
1982, Pogo10tti and Santi 1982). Although satisfactory in terms
of separation, this mode of chromatography suffers from the
disadvantages of long retention times (40-120 minutes for the
triphosphates), lengthy equilibration periods and a limited
column life. Later separations involved the use of ion-pair
reverse-phase chromatography, allowing total analysis times of
less than 40 minutes (Brown et al. 1982, Ingebretsen et a1.
1982). In both these chromatographic modes the nucleotides were
extracted from cells or tissues using perchloric acid to precipi-
tate the proteins (so preventing column clogging and enzymatic
degradation of the nucleotides), and either tri-N-
octylamine/Freon mixture, dipotassium hydrogen phosphate or
potassium hydroxide was used to neutralise the extract and
precipitate the perchlorate. These methods of extraction were
found to result in good recoveries and stable, when frozen,
protein-free samples. The method used here is an ion-pair
reverse-phase method modified from that developed by Brown et al.
(1982)•
135
4.11. MATERIALS AND METHODS
4.II.i. Reagent s
Reagents used were purchased from the following:-
Aldrich Chemical Co. Ltd. (Gilingham, Dorset):-
BDH Chemicals (Poole, Dorset):- perchloric acid (PCA),
tetrabutylammonium hydroxide (TBA), KH2P04, KOH and K2C03 (Analar
grade), and methanol (HPLC grade).
Capital HPLC (Edinburgh):- Hypersil 5 ODS 15 cm x 4 mm i.d.
column fitted with zero dead volume fittings.
Gibco-Biocult (Paisley, Scotland):- all tissue culture supplies
as detailed in Chapter 2.
HPLC Technology (Macclesfield, Cheshire):-
x 4 mm i.d. column.
Sigma (Poole, Dorset):- AMP sodium salt, ADP sodium salt, ATP
Microsorb C18 15 cm
disodium salt, CTP sodium salt, GOP sodium salt, GTP sodium salt,
r-NAD, P-NADH disodium salt, ~-NADP sodium salt and ~-NADPH
tetrasodium salt.
Water used for solutions was produced using a Milli-Q water
system (Millipore S.A.,France). All solutions were dispensed
using Gilson adjustable pipettes during experiments.
4.II.ii. Chromatographic apparatus
The following apparatus comprised the chromatographic system.
Operating parameters are as described in the following "Methods"
sections.
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Pumps: Gilson Model 302 dual pumps with 5 ml pump
heads.
Manometer: Gilson Model 802 manometric module and
mixing chamber.
Detector: Gilson UV Holochrome detector, fitted with
an 11 ul flow cell. Wavelength setting
was 254 nm and sensitivity setting was 0.1
AUFS. A Rikadenki chart recorder was
used to monitor the appearance of peaks.
Gradient control
and peak analysis:
Apple lIe computer, Ka ga screen and dual
disc drives, linked to a Gilson Model 620
Data Master and NEC PC8023BE-N printer.
Injection: Rheodyne 7125 injection valve with 100 ul
loop. Hamilton injection syringes.
Columns: Initially a Microsorb C18 IS cm x 4 mm
i.d. column was used (HPLC Technology -
Macclesfield, Cheshire). Later changed
to a Hypersil 5 ODS 15 cm x 4 mm i.d.
column fitted with zero dead volume
endings (Capital HPLC - Edinburgh). Pre-
column packed with Lichroprep used in the
early stages.
4.II.iii. Separation of nucleotide standards
Separation of aqueous AMP, ADP and ATP standards (10 uH) was
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initially accomplished using the following format.
Flow rate: 1.5 ml/min.
Eluent A: O.lM KH2P04, 5 mM TBA, pH to 6.4 with 10M
KOH.
Eluent B: O.lM KH2P04, 5 mM TBA, 30% methanol (v/v),
pH to 6.4 with 10M KOH.
Time (mins.) %B
0.00 0
27.00 75
30.00 100
32.00 0
45.00 0
Reproducibility of the system was checked by repeated
injection of a solution of 10 uM ATP, ADP and AMP and examining
the peak areas and retention times. Sample stability and day to
day variation of the system was checked by freezing down a number
of aliquots of 10 uM ATP, ADP and AMP solution and injecting then
at intervals over a 3 week period. The detection limits of the
system were found by injecting progressively smaller
concentrations of nucleotides until integration of peak area was
no longer possible.
Calibration was achieved by chromatographing mixtures of
nucleotides at various concentrations, in triplicate. Maximum
concentrations used were: ATP - 100 uM, ADP - 20 uM, AMP - 20
uM, NAD - 40 uM and NADP - 40 uM. The higher maximum level of
ATP was chosen in order to reflect the higher anticipated
cellular levels compared with the other nucleotides. Peak areas
were then plotted against concentration for each nucleotide in
turn, and response factors calculated by regression analysis
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through the origin using the "GLIM" statistical package on the
VAX mainframe computer.
Due to the difficulties involved in finding a stable internal
standard which was not normally present in the biological
extracts and was well resolved from other peaks in the samples,
coupled with the inherent errors involved in spiking samples with
an insignificant volume of internal standard, it was decided to
adopt an alternative standardisation proceedure. The
consistency of the system response and the sample stability were
considered to be such that system performance could be adequately
monitored by injecting an aliquot of a If)uH solution of ATP, ADP
and AMP daily before any sample analysis. If the results were
in agreement with the previous calibration, analysis was begun.
If not in agreement, the system was recalibrated. Recalibration
was also carried out if any system parameter was altered, e.g.
new column, UV lamp etc.
4.II.iv. Chromatography of biological samples
In order to improve nucleotide separation, the gradient
profile was altered slightly as follows. The flow rate and
composition of the individual eluents A and B remained unchanged.
Time (mins.) %B
0.00
6.75
9.50
19.00
23.00
24.00
26.00
40.00
o
20
20
52.5
52.5
100
o
o
139
HeLa cells were cultured as described in Section 2.II.iii.
(0.33 x 106 cells/5 cm plate - day 0). Twenty-four hours later,
half the plates were used to determine cell numbers and plate
water. The medium was rapidly aspirated from the remaining
plates which were then placed on ice. 500 ul of 6% PCA (ice-
cold) was added to each plate in turn. The plates were
regularly tilted to prevent drying of any areas. After 30
minutes, 400 ul samples were removed from each plate and
neutralised by adding to 65 ul of 3M K2C03• The samples were
whirlimixed and left for 10 minutes before being centrifuged at
3,000 rpm, 4°C, for 15 minutes (MSE Coolspin - Fisons). The
resulting supernatant from each sample was then decanted and
frozen until analysed, usually within one week of preparation.
?lates containing medium without cells were extracted in a
similar manner and used as blanks. Before being injected,
samples were thawed out and filtered through 0.22 um Millipore
filters,
Identification of peaks from biological samples was
accomplished by co-chromatography with known nucleotide standards
and by comparison of retention times with standards. Stability
of the various nucleotides during the extraction process was
examined by extracting aqueous solutions of each nucleotide in
turn and analysing the resulting chromatograms.
Percentage recoveries of the nucleotides were determined by
extracting plates of cells which had been spiked with known
concentrations of nucleotide standards (10 ul), and chroma to-
graphing the resulting samples. By subtracting the peak areas
obtained when the plates were spiked with 10 ul water, from the
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peak areas when similar plates of cells were spiked with nucleo-
tides, the peak areas due to the nucleotide spikes were
determined. Using the response factors found from the calib-
ration graphs, the areas were converted to concentrations and
corrections made for the dilution of the plate water during the
extraction process. Comparison of the resulting values with the
theoretical values expected from each spike, yielded the percent-
age recovery for each nucleotide over a range of concentrations.
The samples for recovery studies were extracted on several days,
chromatographed at random and the results pooled. Significance
testing of the results was performed by Student's t+ t est
(unpaired) using the "Mini tab" statistical package on the VAX
mainframe computer.
4.II.v. Chromatographic analysis of HeLa cells treated with
vanadate
HeLa cells were plated as described in Section 2.11.i11. (0.33
x 106 cells/5 cm plate - day 0), and the medium replaced with
fresh medium ± Na3V04 (10-9_l0-4M) on day 3, with 6 plates for
each treatment condition. Twenty-four hours later, half the
plates in each treatment condition were used to determine the
cell numbers and plate water. The remaining plates were
extracted as described in the previous s~ction and frozen until
subsequent analysis. Suitable blanks were also run consisting
of cell-free plates containing similar medium and extracted as
above. Cellular concentrations of nucleotides were calculated
by converting the peak areas to concentrations using the current
response factors, and making the appropriate corrections for
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recovery and sample dilution. Resul ts were analysed by
Student's t-test (unpaired) using the "Minitab" statistical
package on the VAX mainframe computer.
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4.III. RESULTS
4.III.i. Equipment performance and separation of nucleotide
standards
The linear gradient profile of Brown et al. (1982) - see
Section 4.II.iii., proved to be adequate for the separation of
AMP, ADP and ATP in standard solutions but failed to resolve the
AMP peak from other, initially unidentified peaks, present in
biological extracts. Resolution was improved by modifying the
gradient as detailed in Section 4.II.iv. The separation of
nucleotide standards achieved using this gradient is illustrated
in Figure 4.3.. No peaks were seen in the blank sample runs.
Following the identification of the NAD, AMP, ADP and ATP
peaks in biological extracts, the system was calibrated for the
measurement of these four nucleotides. A good linear correla-
tion between peak area and injected amount was seen up to at
least the maximum concentrations injected in this study, i.e. ATP
- 100 uM, ADP - 20 uM, AMP - 20 uM and NAD - 40 uM (see Figures
4.4., 4.5., 4.6. and 4.7.), with standard errors of the gradient
of the fitted line ranging from ± 0.53% in the case of ATP to
1.1% in the case of ADP (n - 3 for each point on the lines).
Detection and integration limits for the four nucleotides were
all approximately 0.5 uM with a 100 ul injection loop, Le. 50
picomoles on column. Further increases in equipment sensitivity
could be achieved but only at the expense of increasing the
baseline noise, thus making the detection of peaks more
difficult.
Reproducibility of the system, as assessed by the repeated
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injection (n - 5) of a solution of 10 uM AMP, ADP and ATP and the
examination of the resulting peak areas and retention times, was
very good. Maximum standard errors of the mean of these peak
parameters were ± 1.4% and 1.1% respectively. Results of the
three week sample stability study, which also incorporated any
day to day variation in machine performance, were similar with
maximum values of ± 2.2% for the standard error of the mean of
the peak areas (n - 10). These results illustrate the
consistent machine performance both between- and within- days,
and also the stability of aqueous nucleotide samples when frozen.
Similar results were later obtained for frozen biological
extracts when assayed over a week long period.
4.III.ii. Extraction and chromatography of biological samples
Acid extraction of standard solutions of AMP, ADP, ATP, NAD
and NADP followed by chromatography yielded a single peak for
each solution, similar to those obtained upon chromatographing
unextracted standard solutions. NADH and NADPH however, were
acid-labile yielding several peaks after extraction with acid,
including a minor peak of ADP. As the major breakdown products
were not seen in biological extracts in this study, it was
concluded that the acid decomposition of NADH and NADPH made a
negligible contribution to the ADP pool in biological extracts.
The major break-down products of NADH have previously been
identified as adenosine and ADP-ribose (Brown et al. 1982).
A chromatogram of the nucleotide profile of HeLa cells is
shown in Figure 4.8. with all the peaks which were identified,
labelled. Despite the gradient modifications AMP, GDP and NADP
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Figure 4.8. Chromatographic profile of nucleotides in HeLa cells
were still not satisfactorily resolved on every occasion, partly
due to progressive column deterioration but largely due to the
small amounts present in extracted samples.
Nucleotide recoveries during extraction are shown in Table
4.3 •• No significant difference was found between the
percentage recovery and concentration of spike for each
nucleotide, so the results for the various spike concentrations
were pooled to give an overall mean % recovery for each
nucleotide. Due to their presence in low concentrations, NADP
was never resolved from GDP in chromatograms of biological
extracts.
studies.
For this reason NADP was not included in the recovery
Due to the low concentrations of AMP present in
hio1ogica1 extracts, combined with later resolution problems as a
result of column deterioration, measurement of A~IP was also
largely not possible. Recovery figures are available for AMP
however, as these studies were performed when the column was new,
although resolution was still occasionally lost even at this
time. As recovery studies were not performed for the remaining
identified nucleotides present in biological extracts, these
nucleotides can only be assessed qualitatively rather than
quantitatively. Some peaks still remain to be identified.
4.III.iii. Effects of vanadate upon nucleotide concentrations
in HeLa cells
The chromatographic profile of nucleotides from HeLa cells
treated for 24 hours with lO-4M vanadate can be seen in Figure
4.9 •• When comparing this chromatogram with the control
chromatogram i.e. Figure 4.8, it must be appreciated that the
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Table 4.3. Nuc1eotirle recoveries during extraction
Nucleotide [Spike] Mean i. recovery n Overall mean
(mmol/l) + S.E-H. i. recovery ± S.E.~I.
0.1 72.6 ± 1.3 4
0.2 76.4 ± 2.7 5 82.5 ± 2.8
NAD
0.4 88.6 ± 3.9 6 (n - 25)
1.0 88.0 ± 3.4 6
0.02 87.6 + 12.1 3
0.04 90.9 ± 5.3 3 88.4 ± 3.1
AMP
0.08 90.8 ± 5.8 5 (n ..16)
0.2 85.0 ± 4.6 5
0.05 92.1 ± 3.5 3
0.1 90.6 + 6.5 6 91.6 ± 2.0-ADP
0.2 90.2 ± 2.4 6 (n - 21)
0.5 93.8 ± 1.5 6
0.5 83.6 + 4.8 6
1.0 78.9 ± 2.7 6 80.0 ± 1.5
ATP
2.0 76.6 ± 1.3 6 (n - 24)
5.0 81.1 ± 1.6 6
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Figure 4.9. Chromatographic profile of nucleotides in HeLa
-4 .cells treated with 10 M vanadate for 24 hours
chromatogram in Figure 4.9. is the result of the extraction of a
plate containing at least 40% fewer cells. The effects of
vanadate upon cell numbers have been discussed in Chapter 2.
These effects have been taken into account when calculating
cellular nucleotide levels at various vanadate concentrations.
Treatment of HeLa cells with varying concentrations of
vanadate for 24 hours produced no significant changes in NAD or
ADP levels (Tables 4.4. and 4.5. and Figure 4.10.). The absence
of NAD data at the higher vanadate concentrations in one
experiment was due to the loss of resolution of CDP and NAD, as
illustrated in Figure 4.9. (c.f. Figure 4.8.). Significant
decreases in cellular ATP levels were seen at [VS+lo greater
than 10-5M (Table 4.6. and Figure 4.10.), 1.e. at those
concentrations where 24 hour vanadate treatment has previously
been shown to significantly decrease cell numbers (see Chapter
2). No significant change was seen at lowet vanadate
concentrations. These results are expressed as per litre of
cell water. Implicit in this statement is the assumption that
the nucleotides are freely distributed within the cell which may
not be the case as compartmentalisation may occur. If expressed
per cell, the results appear similar.
By comparing Figure 4.8. with 4.9., it is possible to obtain
qualitative. data on the other identified nucleotides, taking into
account the different numbers of cells in each chromatographed
extract. It appears that there is little or no change in the
AMP, NADP, GDP or GTP levels with vanadate treatment, and
possibly a slight increase in CTP levels.
Although it was not possible to calculate exact values for AMP
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TaMe 4.4. Effect of 24 hours growth in vanadate on r1An levels
in HeLa cells
The values are the mean of 3 experiments (* = 2 exp erLrien t s),
with each condition bein~ triplicated within each experiment.
Significanace testing relative to the control group is hy
Student's t-test.
[V5+]o Mean [NAD] ± S.E.M. Level of
(H) (mmol/lcw) Significance
0 1.34 + 0.12 --
10-9 1.35 + 0.09 N.S.
10-~ 1.27 ± 0.11 N.S.
10-7 1.36 ± 0.06 N.S.
10-6 1.25 + 0.01 N.S.
3.2 x 10-6 1.30 + 0.02 N.S.
10-5 1.37 + 0.07 N.S.-
2.1 x 10-5 *1.30 ± 0.08 N.S.
4.6 x 10-5 1.16 + 0.27* N.S.
10-1~ *1.67 + 0.38 N.S.
Table 4.5. Effect of 24 hours growth in vanadate on ADP levels
in HeLa cells
The values below are the mean of 3 experiments, with each
condition being triplicated within each experiment.
Significance testing relative to the control group is by
Student's t-test.
(V5+J Mean [ADP] ± S.E.M. Level of0
(M) (mmol/1cw) Significance
0 0.36±0.02 -
10-9 0.39 ± 0.03 N.S.
10-8 0.18 ± 0.03 N.S.
10-7 0.40 ± 0.01 N.S.
10-6 0.38 + 0.02 N.S.
3.2 x 10-6 0.38 ± 0.04 N.S.
10-5 0.40 ± 0.01 - . N.S.
2.1 x 10-5 0.34 + 0.04 N.S.
4.6 x 10-5 0.37 ± 0.04 N.S.
10-4 0.38 + 0.07 N.S.-
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Figure 4.10. Effect of 24 hours growth in vanadate on HeLa cell
nucleotide concentrations
Each point represents the mean ± S.E. of triplicate data from 3
experiments. Significance testing relative to the control group
is by Student's t-test.
Tahle 4.6. Effect of 24 hours growth in vanadate on ATP levels
in HeLa cells
The values are the mean of 3 experiments, with each condition
being triplicated within each experiment. Significance testing
relative to the control group is by Student's t-test.
[V5+]0 Mean [ATP] ± S.E.M. Level of
(M) (mmol/lcw) Significance
0 3.67 ± 0.12 -
10-9 3.76 ± 0.06 N.S.
10-8 3.57 ± 0.07 N.S.
10-7 3.68 ± 0.17 N.S.
10-6 3.52 ± 0.13 N.S.
3.2 x 10-6 3.64 + 0.06 N.S.
10-5 3.63 + 0.17 N.S.
2.1 x 10-5 3.05 ± 0.08 p<O.OOl
4.6 x 10-5 2.60 ± 0.13 p<O.OOl
1()-4 2.31 + 0.17 p<O.OOI
levels in the extracts, an upper estimate can be made as the peak
size appears to be just below the detection and integration
limits of 0.5 umo1/litre. Using dilution factors of
approximately 110 for the control cells and 160 for the cells
treated with 10-4M vanadate, (different factors due to different
cell numbers), together with a recovery figure of 88.4% (Table
4.3.), upper limits of 0.06 mmol/lcw and 0.09 mmol/lcw
respectively can be calculated. Using these figures as upper
limits and 0 mmol/lcw as a lower limit, a maximum and minimum
value for the energy charge can be calculated using the equation
given in Section 4.1.i.. Thus HeLa cells treated with 10-4M
vanadate for 24 hours can be assumed to have an energy charge in
the range 0.91 to 0.93 compared with the control cells where the
range is 0.93 to 0.96.
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4.IV. DISCUSSION
The HPLC method finally used to separate nucleotides in this
study is both sensitive and reproducible. It is comparable,
both in terms of retention times and resolution, with the
reverse-phase ion-pairing methods of Ingebretsen et al. (1982)
and Brown et al. (1982), but achieves better resolution overall
due to its slightly longer running time. When biological
samples were run, it was not always possible to resolve AMP, GDP
and NADP, partly due to the close proximity of their respective
retention times but also due to their low levels in the extracts.
Significant improvements were obtained by using a column with
zero dead volume fittings and by introducing a plateau into the
gradient profile. Further improvements in the method would be
realised if the samples were lyophilised in order to concentrate
them before being applied to the column, and also possibly if the
gradient was modified further. Problems in resolving CDP and
NAD were also encountered occassionally.
The %recoveryof the nucleotides varied depending upon the
nucleotide. This was also seen by Brown et al. (1982) who
reported higher recovery values following neutralisation of the
acid-extract with tri-N-octylamine in Freon, compared with the
precipitation method used here. This is presumably due to
adsorption of the nucleotides onto the precipitate to varying
extents. It should also be noted that any recovery study such
as this assumes that the spiked sample is recovered to the same
extent as the biological sample to which it is added. In the
case of nucleotides at least, this assumption is probably
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justified as the acid protein precipitation procedure would be
likely to release any compartmentalised/protein-bound nucleotides
that may be present in the cells. The extraction method can not
be used for NADH or NADPH however as they are unstable in the
acidic extrac tion condi tions employed here. It would be
necessary to perform a separate extraction procedure in order to
quantify these compounds.
As already discussed in the "Introduction" to this chapter,
the direct dependence of the sodium pump upon ATP is widely
recognised (e.g. Baker 1966, Glynn 1968). More recently it has
also been shown that the diuretic-sensitive cotransport pathway
is also dependent upon ATP albeit indirectly probably via a
protein kinase-mediated reaction (Saier, Jr. et a1. 1984). It
is possible therefore that vanadate/vanadyl may exert effects on
these transport systems by depleting ATP levels. This
discussion is mainly confined to the sodium pump flux as little
information is available concerning the effects of nucleotides on
the diuretic-sensitive fluxes.
A depletion of ATP (depending on its magnitude) would decrease
the pump flux directly and would also augment any inhibitory
action of vanadate (if present) on the sodium pump, as ATP
antagonises the vanadate-induced inhibition of the sodium pump
(Josephson and Cantley, Jr. 1977). As it is difficult to
investigate the kinetics of the activation by ATP of ion
transport via the Na+/K+-ATPase molecule in intact cells, most of
the studies have used either isolated enzyme systems (e.g.
Robinson 1976) or vesicular preparations and the results
extrapolated to intact cells. Whether the existence of both
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high and low affinity ATP binding sites is dependent upon the
tissue or depends upon the limitat~ons of the method employed is
not clear. For example a single Km value for ATP of 0.21 mM has
been reported for a canine cardiac sarcolemmal vesicular Na+/K+-
ATPase preparation (Philipson and Nishimoto 1983) whereas Km
values for ATP of 1 uM and 0.5 mM were reported for an isolated
enzyme preparation from rat brain (Robinson 1976). If similar
values are assumed to be valid in intact cells, the depletion of
ATP seen here at [V5+] 0 greater than 10-SM would probably have
little if any effect directly on the pump. However the
augmentation of the inhibitory action of vanadate upon the pump
is very much an unknown quanti ty as the majori ty if not all of
the intracellular vanadium has been shown to be in the vanadyl
form (Chapter 2), which is only inhibitory if highly purified
isolated enzyme preparations are used (North and Post 1984). It
is possible that very low concentrations of vanadate are present
in which case the ATP depletion may result in an increase in any
vanadate-induced sodium pump inhibition. As already discussed
in Chapter 3, it is not clear whether a specific inhibition of
flux per pump site is present anyway, due to the toxic effects
present coupled with a concomitant decrease in pump number and a
postulated stimulation of pump flux by increased intracellular
sodium levels.
Inhibitory actions of ADP upon the Na+/K+-ATPase active
transport system have been described by Apell et al. (1986).
Using Na+/K+-ATPase from rabbit kidney outer medulla incorporated
into artificial lipid vesicles, Apell et al. (1986) demonstrated
an inhibition of the active transport by ADP with a Ki of
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approximately 0.1 mM. The inhibition was virtually independent
of ATP concentration indicating that it was not likely to be due
to a competitive effect on nucleotide binding. Within the
framework of the Albers-Post model (described in Chapter 3), the
remaining possibility was that the inhibition was due to an
increase in the rate of the backward reaction NaElrvP + ADP
~NaE1ATP, caused by the increased ADP levels (Apell et al.
1986). However a competitive effect of ATP on the inhibition by
ADP has bee n described by Robinson (1976) for example, using an
isolated enzyme preparation from rat brain.
In this study no changes were seen in the intracellular ADP
concentration with vanadate treatment. However if the Ki values
reported above for ADP are equally applicable to intact cells it
would appear that in HeLa cells at any rate, ADP is normally
exerting a significant inhibitory effect on the sodium pump
ac'tivity. This is postulated as being the normal case in cells,
with ADP being part of a negative feedback system regulating pump
activity (Apell et al. 1986). A possible slight increase in CTP
levels was seen with vanadate treatment but this would have to be
quantified by performing appropriate recovery studies and hence
it is not clear to what extent this would affect the pump flux.
An increase in the peak eluting directly before GTP seems to
occur in the vanadate-treated cells. As the identity of this
peak is not known however, possible ramifications of an increase
can not be discussed.
It is also interesting to note that the decrease seen in ATP
was not associated with a concomitant increase in ADP and/or AMP.
The reason for this is not obvious. Whether the decrease in ATP
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concentration occurred as a result of a decreased production or
an increased utilisation, increased levels of ADP and AMP would
have been expected. It is possible that the lack of change in
AMP and ADP is due to a vanadate-induced increase in membrane
permeability which would allow the diffusion of AMP and ADP out
of the cell, but not the more polar ATP. This is unlikely
however, especially in view of the decrease in passive ion fluxes
seen at similar vanadate concentrations (Chapter 3).
It is also possible that the ATP levels may actually be no
different from the control values but appear to be reduced due to
a decrease in the percentage recovery. It is known for example,
that both vanadate and vanady1 form strong complexes with ATP
(Ramasarma and Crane 1981). If the complexed vanadate/vanady1
subsequently bound strongly to intracellular proteins in such a
way that acidification did not release the complex, this would
also yield lower ATP recoveries. This is highly unlikely as
acidification (with HCl rather than perch10ric acid) has been
shown to release intracellular vanady1 (Fitzgerald and Chasteen
1974). Formation of such a complex though raises the
possibility that whether or not any decrease in ATP levels is
present, the ATP may not be as available for utilisation if bound
to vanadate/vanady1 intracellularly to any significant extent.
'This may contribute towards the toxicity.
The decrease in ATP levels was only seen at [VS+]o greater
than 10-SM. Although the biggest changes 1n cell number and K+
influx pathways were also seen at similar vanadate
concentrations, smaller changes, which were 1n some cases
significant, were also seen at lower vanadate concentrations.
1S2
It would therefore appear that ATP may not be responsible for the
changes seen, but whether the effects on ATP are specific actions
of vanadate/vanadyl or occur secondarily to some other change is
not clear. The decrease in ATP does seem to occur slightly
after the decrease in cell numbers and therefore may be a
consequence of the toxicity. Further research in order to
clarify the situation should include studies involving time
courses of vanadate treatment to see in what order the changes
occur.
The lack of a significant change in the energy charge with
vanadate treatment despite the decrease in ATP levels is due to a
lack of concurrent change in ADP and AMP levels. The reason for
this, as discussed above, is not clear. On the basis of the
high energy charge, vanadate/vanadyl would be assumed to have had
no effect on the viability of the cells. In view of the marked
toxicity seen in terms of decrease in cell numbers, it is
unlikely that only some cells are susceptible to the toxic
actions of vanadate/vanadyl and the rest remain totally healthy.
Indeed in terms of changes in flux, ion contents and ATP levels,
there is clear indication that the cells remaining appear to be
showing signs of toxicity at the higher extracellular vanadate
levels. It is likely therefore that as demonstrated in cultured
fibroblasts following exposure to heat, there is little or no
correlation between cellular energy charge and viability
(Calderwood et al. 1985).
Whether the decrease in cell numbers (Chapter 2) seen with
vanadate treatment is due to cell death or decreased cell
division is not known. Since nucleotides are important as
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precursors of RNA and DNA and the intracellular concentrations of
nucleotides appear relatively unaltered with vanadate treatment,
it can be concluded that the decrease seen in cell numbers does
not occur as the result of a depletion of the precursors
important in cell division. Other possible causes of the
reduction in cell numbers with vanadate treatment have been
discussed in Chapter 2, in the light of the known biological
actions of vanadate and vanadyl. The inhibitory actions of
vanadate (and to some extent vanadyl) on enzymes involved in
phosphoryl transfer have been discussed in the "Introduction" to
this chapter. It is conceivable that such actions may be partly
responsible for the decrease in ATP levels, and/or playa role in
the toxicity. However it is predominantly vanadyl which is
present in the cell and the actions of vanadyl on such enzymes
are less well documented.
The likelihood that at least some of the reduction of vanadate
seen in HeLa cells is non-enzymatic has been discussed in Chapter
2. If this was due to the non-enzymatic oxidation of NADH for
example, as seen in mouse liver plasma membranes (Ramasarma
et al. 1981), although at high levels of vanadate and at low
rates, an increase in NAD levels and a decrease in NADH levels
may be expected. This would also be the case if a vanadate-
stimulated NADH oxidase is present in HeLa.cells, similar to that
seen in mouse liver plasma membranes (Ramasarma et a1. 1981).
Such an increase in NAD levels in vanadate-treated Hela cells was
not apparent until an extracellular [VS+] of 10-4M and even then
this was not significant. As already discussed it is not
possible to measure NADH levels using this method. If such
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effects on NAD and NADH had been present, this may have at least
partly explained the decreased ATP levels, as NADH/NAD is
important in ATP production via both glycolysis and the citric
acid cycle. Additionally such vanad~te-stimulated NADH oxidase
activity has been postulated to involve the production of free
radicals in mouse liver plasma membrane (Ramasarma et al. 1981)
and if a similar sort of mechanism was to occur in HeLa cells,
free radical production may account for the toxicity. However
decavanadate was probably responsible for these changes and there
are no reports on the production of free radicals by vanadyl
which appears to be the main species of vanadium present in HeLa
cells.
If, as occurs in erythrocytes (Macara et al. 1980), reduction
of vanadate in HeLa cells is due to GSH, there may be a reduction
in GSH levels. GSH is important in the prevention of
intracellular free radical formation (Stryer 1981). If GSH is
depleted free radical damage may result. Free radical formation
could also account for the decrease in ATP levels as non-specific
ATP hydrolysis can be caused by free radicals (Ramasarma and
Crane 1981). Further research should involve the measurement of
GSH in vanadate-treated cells and the investigation into possible
free radical formation.
In summary, the results in this chapter demonstrate little
effect of vanada te/vanadyl on nucleotide levels wi th the
exception of ATP which is reduced by approximately 40% at 10-4M
vanada teo Again it is impossible to conclude with certainty
whether vanadate or vanadyl is responsible for the changes,
although for reasons discussed in the previous chapter it is
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likely to be van ady L, Whether changes are secondary to other
mechanisms such as possible free radical formation is also not
clear. Because of the virtual lack of change in nucleotide
concentrations, it is unlikely that nucleotides playa role in
accounting for any of the changes seen in ion fluxes or cell
growth with vanadate treatment.
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CHAPTER 5. LONG-TERM CULTURE OF LYMPHOBLASTOID CELL LINES FROM
BIPOLAR MANIC-DEPRESSIVE PATIENTS AND CONTROLS; TRANSFORMATION,
GROWTH AND MORPHOLOGY
5.1. INTRODUCTION
5.I.i. Establishment of long-term lymphoblastoid cell lines
The fortuitous observation that phytohemagglutinin (PHA)
caused the transformation of peripheral lymphocytes to "blast-
like" mitotic cells (Nowell 1960), facilitated the investigation
of many genetically-determined diseases. However investigations
were still limited by the short life-span of such cells.
With the first successful long-term culture of lymphoid cells
from solid tumour and tumour fluid aspirates of patients with
Burki tt 's lymphoma, thus defining sui table culture condi tions
(Epstein and Barr 1964, Pulvertaft 1964), many cell lines from
patients with various lymphoproliferative disorders were
established, using tissue from tonsil, spleen, lymph node or
peripheral blood as the source of cells (reviewed by Glade and
Beratis 1976). Long-term cell lines were also established from
patients with infectious mononucleosis (glandular fever),
measles, mumps and herpes simplex. These cell lines, with the
exception of some of those derived from malignant tissue but with
the inclusion of those derived from Burkitt's lymphoma patients,
were all subsequently shown to harbour either Epstein-Barr virus
or its genome (Glade and Beratis 1976, Povey et al. 1980). This
virus was later shown to be responsible for the proliferation of
at least the majority of human B lymphoblastoid cell lines in
long-term culture. Consequently it was possible to culture
lymphocytes from healthy people with no evidence of previous
viral infection by cultivating the cells in the presence of
viable Epstein-Barr virus (Henle et al. 1967, Miller et al. 1971,
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Steel 1972).
The value of such cell lines in genetic research is now well
established with the demonstration of abnormal giant lysosomes in
cell lines from a patient with Chediak-Higashi syndrome and his
heterozygous father, and the persistence in culture of
the aetiological biochemical and/or chromosomal abnormalities in
cell lines from patients with e.g. Lesch-Nyhan syndrome,
citrullenemia, and maple-syrup urine disease (reviewed by Glade
and Beratis 1976). More recently, long-term lymphoblastoid cell
lines have been used to investigate a possible genetic
abnormality in beta-adrenergic receptors in patients with manic-
depressive psychosis (Wright et a1. 1984).
S.l.li. Characteristics of long-term lymphoblastoid cell lines
Lymphocytes consist of two major populations of cells which
have different properties and functions. B lymphocytes appear
to be bone-marrow derived and thymus-independent and are involved
in antibody and immunoglobulin production, whereas T lymphocytes
are bone-marrow derived but are thymus-dependent and are involved
with cell-mediated immunity. Based on the above properties
together with other membrane-associated differences, it appears
as though the lymphoblastoid cells in long-term culture are B
cell derived (Schneider and zur Hausen 1975, Glade and Beratis
1976). However the evidence is not clear-cut and it has been
suggested that the cultured cells represent an earlier stage of
differentiation with potential for both T and B cell function
(Glade and Beratis 1976).
The cells grow in suspension and resemble the immature "blast-
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like" PHA-stimulated peripheral lymphocytes. However a spectrum
of cell forms may be seen resembling e s g, lymphocytes,
lymphoblasts and stem cells. In most human B lymphoblastoid
cell lines, regardless of source, 0.1 to 5% of cells contain the
Epstein-Barr virus detectable by electron-microscopy or
immunofluorescence. Those lines with no morphologically
detectable virus contain the viral genome as shown using, for
example, nucleic acid hybridisation techniques (reviewed by Glade
and Beratis 1976).
The doubling time of the cells is generally between 24 to 48
hours with an apparently infinite life-span providing that
nutrient supplies are adequate. Most of the cells remain
diploid with more than 90% of cells in lines established from
chromosomally normal donors maintaining the normal karyotype
(Steel 1972, Glade and Beratis 1976). The majority of the cells
in lines established from patients with chromosomal abnormalities
have also maintained their karyotype in culture although slight
changes have been reported to occur sometimes in both normal and
abnormal karyotypes with time (reviewed by Glade and Beratis
1976). In 101 cell lines derived from individuals with no
lymphoproliferative malignancy and cultured for an average of
over 3 years, there was no evidence of a change in
electrophoretic phenotype at a single locus for many cytoplasmic
enzymes examined (Povey et al. 1980).
Interestingly, there is also evidence that enzymes which are
limited to certain internal organs and are not present in
peripheral lymphocytes may be present in cultured lymphoblastoid
cell lines e.g cystathionase (Glade and Beratis 1976). This may
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internal organs, thus alleviating the need for organ biopsies.
allow their use in the detection of enzymatic defects within
Advantages of using lymphoblastoid cell lines in genetic
\
research include:- a). they can be established from small
quantities of blood which is the most accessible peripheral
tissue; b). the cells are available in large numbers and are
genetically representative and stable; c). they have an
apparently unlimited lifespan; d). they can be easily stored in
liquid nitrogen; and e). they are free from any medication or
neuroendocrine influences. The major disadvantage is that these
cell lines are infected with Epstein-Barr virus. The role of
this virus in human disease is not entirely clear at present and
therefore the cell lines must be used with caution.
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5.11. MATERIALS AND METHODS
5.II.i. Reagents
Reagents used were purchased from the following:-
BOB Chemicals (Poole, Dorset):-
and NaR2P04.2R20 (Analar grade).
Edinburgh Cameras (Edinburgh, Scotland):- Agfachrome 1000 ASA
film.
EMs cope Laboratories Ltd. (London):- all electron microscope
supplies as detailed in Chapter 2.
Gibco-Biocult (Paisley, Scotland):- RPMI 1640 (REPES-buffered)
tissue culture medium, foetal calf serum, L-glutamine (200 mM), and
penicillin/streptomycin (5000 U/ml).
Sigma (Poole, Dorset):- ethidium bromide and acridine orange.
Surgikos Ltd. (Livingston, Scotland):- Presept disinfectant
tablets.
Water used for solutions was produced using a Milli-Q water
system (Millipore S.A., France).
S.U.H. Setting-up of lymphoblastoid cell lines
The cell lines used in this project are Epstein-Barr virally
transformed B lymphocytes which were provided by Dr. A. Wright of
the MRC Clinical and Population Cytogenetics Unit, Edinburgh
(control cell lines from non-psychiatrically ill subjects),
Professor T. Reich of Washington University, USA (cell lines from
manic-depressive patients and family members), ~nd Dr. G. ~.
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Naylor of the Psychiatry Dept., Ninewells Hospital, Dundee (1
control and 2 manic-depressive cell lines). The manic-
depressive patients in the USA from whom the cell lines were
established (probands), all fulfilled the criteria of severe
illness of early onset and a family history of affective disorder
in at least two generations. A complete family history was
recorded for each proband; however the clinical status of the
family members was unknown to me as part of a blind study. An
example of a "typical" family tree from a proband is shown in
Figure 5.1. and details of the cell lines are given in Table
5.1••
The cells had been originally transformed by co-cultivation
with Epstein-Barr virus as described by Steel (1972) and Wright
et al. (1984). Essentially, blood samples were centrifuged, the
plasma removed and the lymphocytes isolated on a Ficoll-Hypaque
gradient. These were then co-cultivated in a suitable medium
with either lethally-irradiated or sonicated cells infected with
Epstein-Barr virus. Transformation could be monitored by the
appearance of a pH change in the medium and usually occurred
within 4-8 weeks (Wright et al. 1984).
5.II.iii. Sub-culturing of lymphoblastoid cell lines
All procedures were carried out in a Gelaire laminar air flow
cabinet using aseptic techniques as described in Chapter 2.
Gloves were always worn and all media and glassware etc. was
discarded into Presept - a chlorinated disinfectant.
Cells were routinely grown at 370C in 125 ml medicine bottles
containing HEPES-buffered RPMI 1640, pH 7.3-7.4, supplemented
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Table 5.1. Details of the lymphoblastoid cell lines used in
this study
Cell Line Year of Birth Sex Status Source Established
Ale 1938 M Control E 1983
Cib 1940 F Control E 1983
Dil 1936 M Control E 1983
Fran 1965 M Control E 1984
Gavi 1969 M Control E 1984
Ged 1947 M Control 1<.: 1983
Jil 1938 M Control E 1983Mib 1Q15 F Control E 1983
Sep 1971 M Control E 1978
Tony 1909 M Control E 1984Twel ? F Control E 1984Wib 1944 M Control E 198301-01 1951 F Proband U 198402-01 1941 M Proband U 1984
05-01 1921 F Proband U 198406-01 1947 F 'Proband U 198407-01 1921 M Proband U 198408-01 1961 M Proband U 1984
08-02 1932 (P)F Unknown U 1985OR-03 1932 (pm Unknown U 1985
08-04 1959 (S)F Unknown U 1985
09-01 1938 F Proband U 1984
10-01 1944 F Proband U 1984
10-02 ? (C)M Unknown U 1984
10-03 1914 (P)M Unknown U 1984
10-04 1948 (S)M Unknown U 1984
10-05 1939 (H)M Unknown U 1984
10-06 1923 (P)F Unknown U 1984
13-01 1963 (?)F Unknown U 1984
14-01 1961 M Proband U 1984
15-01 1933 F Proband U 1984
17-01 1915 F Proband U 1984
Fleming 1960 F Control D 1982
Cox 1922 F Proband D 1982
Greig 1929 F Proband D 1982
Members of the same family have the same prefix e.g. 08-01, 08-02
etc. Relationship to the proband is given in O. Le.
(S)=Siblinp" (H)=Husband, (P)=Parent, and (C)=Child. For the
source, U=USA, E=Edinburgh, and D=Dundee, and for sex, M=ma1e and
F=female.
with 10i. (v/v) foetal calf serum, 2 mM L-g1utamine and 100 U/ml
of penicillin/streptomycin. The exact composition of this
growth medium is given in Table 5.2 •• The cells grew in
suspension and could be seen on the base of the bottle. Usually
the bottles contained between 5-15 x 106 cells in approximately
30 mls of medium. Optimum densities for growth appeared to be
within the range 0.1-1 x 106 cells/ml as outside these levels
growth appeared to slow or stop. Every 3 days the medium was
removed using pipettes and replaced with fresh medium. When the
change in medium pH became more rapid than normal, some cells
were discarded in order to maintain the cells at an optimum
density and under optimum conditions for growth. When larger
quantities of cells were required, cells were grown in 500 ml
bottles containing approximately 200 mls of medium and normally
about 30-60 x 106 cells. For experimental purposes, bottles of
cells were seeded at exact densities depending upon the
experiment as detailed in later chapters.
Cell viability was assesssed regularly using the nucleic acid-
specific dyes, ethidium bromide and acridine orange (Becton-
Dickinson FACS Systems information leaflet). Acridine orange
freely enters viable cells producing a green fluorescence whereas
ethidium bromide is excluded from viable cells but stains non-
viable cells fluorescent orange (Parks et al. 1979). By using
acridine orange/ethidium bromide the viable cells can be
distinguished from the non-viable cells.
A 100x stock solution of ethidium bromide/acridine orange was
prepared by dissolving 50 mg ethidium bromide and 15 mg acridine
orange in 1 ml of 95% (v/v) ethanol. This was then mixed with
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Table 5.2. Composition of RPMI 1640 (BEPES-buffered) tissue
culture medium
Inorganic Salts
Ca(N03)2·4H20KCI
MgS04
NaHC03Na2HP04 (anhyd.)
NaCI (varied slightly to adjust the osmolarity)
Other Components
D-Glucose
Glutathione (reduced)
Phenol Red
HEPES
Amino Acids
L-Arginine (free base)
L-Asparagine
L-Aspartic Acid
L-Cystine (2 BCI)
L-Glutamic Acid
L-Glutamine
Glycine
L-Histidine (free base)
L-Hydroxyproline
L-Isoleucine (Allo free)
L-Leucine (Methionine free)
L-Lysine HCI
L-Methionine
L-Phenyalanine
L-Proline (Hydroxy L-Proline free)
L-Serine
L-Threonine (Allo free)
L-Tryptophan
L-Tyrosine (Na salt)
L-Valine
Vitamins
Biotin
D-Ca Pantothenate
Choline Cl
Folic Acid
i-Inositol
Nicotinamide
Para-aminobenzoic Acid
Pyridoxine HCI
Riboflavin
Thiamine HCI
Vitamin Bl2
mgtl
100.01)
400.00
4R.84
2000.00
ROO.OO
6000.00
2000.00
1.00
5.00
5957.50
200.00
50.00
20.00
65.15
20.00
300.00
10.00
15.00
20.00
50.00
50.00
40.00
15.00
15.00
20.00
30.00
20.00
5.00
28.83
20.00
0.20
0.25
3.00
1.00
35.00
1.00
1.00
1.00
0.20
1.00
0.005
In addition, the medium was supplemented with 10% (v/v) foetal
calf serum, 2mM L-glutamine and 100 U/ml penicillin/streptomycin
before use.
49 mls of water and stored frozen in 1 ml aliquots. To make a
working solution, a 1 ml aliquot was thawed and diluted 1/100 in
phosphate buffered saline (0.291g NaH2P04.2H20, 4.524g
Na2HP04.12H20, 8.767g NaCl - made up to 1 litre with water and
the pH adjusted to 7.4). This had a working life of 1 month
when stored at 40C in an amber bottle. Equal volumes (25 ul) of
cell suspension (1-5 x 106 cells/ml) and stain solution were
mixed and a drop of this placed on a clean glass slide. This
was covered with a glass coverslip and examined on a Leitz Dialux
20 microscope with Ploemopak 2.4 fluorescence vertical
illuminator and camera attachment. The microscope was equipped
with an 12 filter block for fluoroscein (excitation 450-490 nm
and emission above 515 nm ), Specimens were routinely viewed
using a x25 objective lens with x12.5 eyepieces or a xSO oil-
immersion lens if photographs were being taken. Photographs
were taken using Agfachrome film, ASA 1000. Only those cell
lines with a viability greater than 95% were used in experiments.
Scanning and transmission electron micrographs of these cells
were also taken solely to illustrate their morphology and ultra-
structure. The method of preparation and examination was as
described for HeLa cells in Chapter 2 with the exception that for
scanning electron microscopy purposes, the lymphocytes were not
grown on glass coverslips but were sucked onto millipore filters
using a millipore filter holder and syringes. By carefully
introducing the cell suspension into one side of the filter
holder and simultaneously drawing the fluid out at the opposite
side, the cells were drawn onto the filter. Using this
technique, the cells were fixed and dehydrated in the holder
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using the syringes to introduce and withdraw the appropriate
solutions. The filter containing the cells was then removed
from the holder and treated in the same manner as the HeLa cell-
covered coverslip.
s.rr.r-. Growth curves of lymphoblastoid cell lines from manic-
depressive and control subjects
Cell lines from 5 manic-depressive probands and 5 controls
were taken at random as representative samples and seeded at
approxima tely 0.2 x 106 cells/ ml in 30 mls of fresh medium. 1
ml samples were taken at daily intervals over the next 6 days and
used to determine cell numbers and volumes using the Coulter
counter as described in Chapter 2. Replacement of 15 mls of the
medium with 15 mls of fresh medium was carried out after the
first 72 hours.
165
5.III. RESULTS
Figure 5.2. is a fluorescent micrograph showing the easily
distinguishable viable (green) and non-viable (orange) cells.
Within the cytoplasm of the viable cells can be seen fluorescent
orange inclusions; these are the lysosomes which stain orange
with acridine orange (Poole 1977). A cytoplas~ic protrusion
from one of the cells may possibly be the start of the formation
of a pseudopod involved in locomotion of these cells (McFarland
1969). Similar structures have been observed in these cultures
during routine examination. Figure 5.3. is a phase-contrast
micrograph illustrating the diverse range of sizes and shapes of
the cultured cells and also the clumping which often occurs
during cu.lt ur e,
Transmission and scanning electron micrographs illustrating
the general morphology of the cells are shown in Figures 5.4. and
5.5. respectively. The cells appear to have an irregular
outline and characteristic polarity with a large irregular
nucleus at one end and most of the cytoplasmic organelles at the
opposite end, as reported by Chandra et a!. (1968). There is a
high nuclear to cytoplasmic ratio. The oval-shaped mitochondria
contain few cristae and a few arrays of endoplasmic reticulum can
be seen dispersed throughout the cytoplasm. Polyribosomes are
also present. In the scanning electron micrograph numerous
microvilli can be seen projecting from the surface of the cells.
Some of these appear to be connecting adjacent cells.
The graph showing the growth rates of some of the manic-
depressive and control cell lines is given in Figure 5.6.
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Figure 5.2. Fluorescent micrograph of virally-transformed
lymphoblastoid cells stained with ethidium bromide/acridine
orange. Green = viable, orange = non-viable. 10um
Figure 5.3. Phase-contrast micrograph of virally-transformed
lymphoblastoid cells
30um
Figure 5.4. Transmission electron micrograph of a virally-
transformed lymphoblastoid cell 2·5um
Figure 5.5. Scanning electron micrograph of virally-transformed
lymphoblastoid cells 5um
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Growth rates of lymphoblastoid cell lines from 5
Manic-nepressive and 4 control suhjects
Although the study commenced with 10 cell lines, only the results
for 9 cell lines are presented as one was lost due to infection.
The majority of the cell lines appear to follow a pattern of a
slow initial growth during the first 24 hours after the starting
medium change, probably due to a time-lag in the early part of
this period which is inherent in many culture systems (Paul
1970). This is followed by a faster logarithmic phase over the
next 24 hours and then a slower or stationary phase as nutrients
are depleted. Essentially the same pattern is repeated after
the subsequent medium change although variations can be seen in
some cell lines e.g. Fran. There appear to be no obvious
differences in the growth patterns between the manic-depressive
and control groups, or based on age or sex, although variation
can be seen between individual cell lines with absolute
population doubling times ranging from 36 to 132 hours.
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S.IV. DISCUSSION
Ideally the cell lines used in this study would have all been
established in the same laboratory, at the same time, and with
age and sex-matched controls. However as we have nei ther the
facilities for transformation nor access to appropriate clinical
material, we have used the cell lines kindly supplied to us,
interpreting any results with the necessary caution and taking
into account any known differences. Although the cell lines had
been established in different laboratories, essentially the same
transformation technique was used in each case, as previously
described. In addition the cell lines had all been in culture
approximately the same length of time.
There seems to be no apparent difference between the growth
patterns of the manic-depressive and control cell lines used
here, as discussed in the previous section, although slight
differences do exist between individual cell lines. The reason
for this is not known but potential effects of these differences
must be borne in mind when interpreting any results. The range
of population doubling times of 36 to 132 hours is longer than
the 24 to 48 hours reported by Glade and Beratis (1976). This
may be due to either shorter periods of logarithmic growth and/or
slower rates of growth during the logarithmic phase, in the cell
lines used here. The actual reason for this is unknown but may
be due to differences in the composition of the medium used,
particularly with regard to serum concentration or composition.
Another point to take into account is that growth curves do
not provide exact information about the proliferative fraction of
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a cell population. A more accurate picture may be obtained if
growth curves are carried out concurrently with measurements of
the percentage of cells incorporating radioactive thymidine
(Macieira-Coelho 1973). The proliferative fraction of a cell
population is also influenced by the split ratio i.e. the ratio
of the number of cells per volume of medium after sub-culturing,
to the number of cells per volume of medium before sub-culturing
(Macieira-Coelho 1973). Such factors may explain the
discrepancies between the population doubling times in this study
where the initial split ratio was approximately 1:2 and the 72
hour split ratio was essentially 1:1, and those reported by Glade
and Beratis (1976) where the split ratio is not indicated. The
slight differences between the growth patterns after the initial
medium change and after the 72 hour medium change may also
possibly be explained on this basis.
169
CHAPTER 6. K+ FLUXES AND SODIUM PUMP NUMBERS IN LYMPHOBLASTOID
CELL LINES FROM BIPOLAR MANIC-DEPRESSIVE PATIENTS AND CONTROL
SUBJECTS; EFFECTS OF CHRONIC INCUBATION WITH OUABAIN, LITHIUM OR
VANADATE
6.1. INTRODUCTION
6.I.i. Cation transport in bipolar manic-depressive psychosis
The possible involvement of a perturbation in cation transport
in the aetiology of manic-depressive psychosis, together with the
postulated role of vanadium, have been reviewed in Chapter 1.
This section discusses in greater detail those studies which have
measured cation transport in manic-depressive illness. The
majority of these studies have used erythrocytes.
In a study by Naylor et al. (1973), the Na+/K+-ATPase activity
and ouabain-sensitive potassium influx of erythrocytes from
psychotically depressed patients, were found to increase
significantly upon recovery, in some but not all patients. This
study was based on 58 female patients with various types of
depressive illness. Since no control group was included in this
study, it was not possible to compare remission values with
control values. Similar findings have been reported for
Na+/K+-ATPase, Ca2+/Mg2+-ATPase and Mg2+-ATPase activities upon
recovery from depression, with the depressed values being 70%,
88% and 76% respectively of remission values and the remission
values being similar to those of normal controls (Rybakowski
et al. 1981). Lower ouabain-sensitive K+ and Na+ fluxes have
subsequently also been reported in manic patients compared with a
control group, although the two groups were not sex-matched
(Rybakowski et al. 1983). Thakar et a!. (1985) also found no
difference in sodium pump activity between euthymic patients and
controls. In some studies however, it appears that people
susceptible to manic-depressive psychosis may have lower sodium
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pump activities even when recovered, if compared with controls.
For example, the mean sodium pump activity as measured by active
sodium extrusion was found to be lower in bipolar patients during
the manic phase, and during remission, relative to healthy
individuals (Hokin-Neaverson et al. 1974).
Sengupta et a1. (1980) however, found a higher total Na+ /K+-
ATPase activity in erythrocyte membranes and platelets from manic
or depressed patients when compared with controls, although their
activity values were much different to values reported in other
studies. No alteration in the lithium-sodium exchange,
diuretic-sensitive cotransport or passive lithium, sodium or
potassium permeabilities was observed by Dagher et al. (1984) in
erythrocytes from either unipolar or bipolar patients. Sodium
pump activity however was greatly reduced both in lithium-treated
and non-treated bipolar patients compared with controls.
Whether this was due to lower pump numbers or activity per pump
was not ascertained. MacDonald et al. (1982) found that the
best correlation with mood was with the Ca2+-ATPase activity and
no correlation between sodium pump activity and mood was found by
Linno11a et a1. (1983). However, this latter study used only a
small group of patients and drug therapy was not controlled
between the groups.
Despi te differences in experimental methods, the results of
the majority of studies are consistent with a lower total sodium
pump flux in mania and depression compared to remission (Naylor
1986), although whether remission values are also lower than
controls is less clear.
The change in total Na+/K+-ATPase activity appeared to be due
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to a change in activity per sodium pump molecule rather than to a
change in the number of transport sites per cell in both manic
and depressed patients (Naylor et al. 1980). This study however
included only female patients who were not used as their own
controls but were compared with a recovered group, due to patient
non-compliance. Although differences existed between the groups
with respect to medication, it seemed unlikely that this was
responsible for the differences in pump activity seen. The fact
that the changes in total Na+/K+-ATPase activity were found to be
due to changes in activity of individual pump sites rather than
number is to be expected, both from the fact that mature
erythrocytes no longer possess the capacIty to synthesise
proteins, and from the rapidity and magnitude of the changes in
some cases (Naylor 1983). The changes therefore, were not
likely to be explained by the production of new erythrocytes with
a different number or activity of pump sites (Naylor 1983).
In erythrocytes from bipolar patients on lithium therapy
(commenced at a predetermined time independent of the mood
state), a significant increase in Na+/K+-ATPase activity together
with a non-significant increase in the active potassium influx
was seen, when compared with the same patients taking a placebo
(Naylor et al. 1974). There was no significant change in
intracellular sodium. This increase in sodium pump activity was
not seen in either controls or rats taking lithium (Naylor et al.
1977), but an increase in pump site numbers was seen in HeLa
cells when treated with lithium at a concentration 10-S0x that of
therapeutic levels (Boardman et al. 1975a). Similar changes in
Na+/K+-ATPase and Mg2+-ATPase activity, but not in Ca2+/Mg2+-
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ATPase activity, have also been reported in a lithium-treated
group of patients with affective disorder when compared with non-
lithium treated patients (Hesketh 1976).
If the increase in sodium pump activity brought about by
lithium was crucial to its therapeutic role, simultaneous
treatment with an inhibitor of the enzyme such as digoxin should
block the therapeutic effect. Chambers et al. (1982) showed
that this was indeed the case in manic patients. There were,
however, age differences between the lithium /digoxin and
lithium/placebo groups, but these were not thought to account for
the changes seen. However the results regarding effects of
lithium on Na+/K+-ATPase activity are equivocal since it has also
been reported that lithium treatment has no effect in vivo upon
Na+/K+-ATPase activity in patients (Linnoila et al. 1983). Nany
other studies have been carried out in this area but there is
still no consensus of opinion.
6.1.11. Postulated defects in cation transport in bipolar
manic-depressive psychosis
The possi bili ty that the reduced level of acti vi ty per pum p
site in manic and depressive patients is due to higher
concentrations of a "modifying factor", tentatively identified as
vanadium, has been reviewed in Chapter 1. It has been
postulated that if vanadium is an aetiological factor in manic-
.depressive psychosis, affected subjects must have some defect in
their sodium pumps, probably genetic, which renders them more
susceptible to the actions of vanadium, since vanadium given to
normal subjects does not invariably produce depression of mood
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(Naylor 1983). Naylor and Smith (1981) showed that lymphocytes
from female bipolar patients had a significantly reduced ability
to synthesise new pump sites in response to raised intracellular
sodium levels, when compared with control subjects, and proposed
that this is where the genetic defect lies, increasing the
susceptibility of affected individuals to the actions of
vanadium. The oxidation state of vanadium has not been
considered in these studies. The finding of a reduced activity
per pump site in erythrocytes from manic-depressive patients
(Naylor et al. 1980) would also point to a further defect which,
in view of the intracellular reduction of vanadate to the less
biologically active vanadyl, may be a defect in the reducing
capability of manic-depressive patients. Such hypotheses can
not totally explain the illness however, as they fail to account
for either the difference between mania and depression, or the
onset and spontaneous remission of the illness.
The problem with the studies described here is the possible
effects of medication, hospitalisation, diet etc. on the results.
In addition the research has been carried out on various types of
blood cell and results extrapolated to the brain. The use of
long-term lymphoblastoid cell lines as described in the previous
chapter will circumvent the first of these problems but there is
no (ethical) solution to the second. However there is
considerable evidence (reviewed in Chapter 1) that the illness is
genetic in origin. The use of lymphoblastoid cell lines in
research into genetically-determined diseases has been reviewed
in the previous chapter and as they possess the genetic material
of the individual it is possible that under stressed conditions
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any defect present in the brain cells may be manifest in these
cell lines grown in vitro. The remainder of this chapter will
be devoted to the examination of the ion contents, sodium pump
numbers, and K+ influx pathways in cell lines established from
control subjects and bipolar manic-depressive patients, under
basal and treated conditions. The treatment conditions include
growth in, a). lithium because of its therapeutic value in the
illness and its postulated effects on Na+ /K+-ATPasej b).
ouabain in order to stress the ion transport systems of the cells
through its effects on both sodium pump number and ouabain-
sensitive flux per pump site; and c). vanadate because of its
postulated involvement in the aetiology of the illness through
effects on the sodium pump, as already reviewed. With regard to
the treatment with vanadate, the previous chapters utilising HeLa
cells may be used to aid the interpretation of the results in
this chapter, although it is recognised that these are different
cell types and that a far from clear picture has emerged from the
study of the cellular actions of vanadate in the relatively well-
defined HeLa cells.
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6.11. MATERIALS AND METHODS
6.II.i. Reagents
Reagents used were purchased from the following:-
Aldrich Chemical Company Ltd. (Gillingham, Dorset):-
(99% pure).
Alfa Chemicals Ltd. (Wokingham, Berks.):- Versilube F50.
Amersham International (Amersham, Bucks.):- 86Rb (200-240
mCi/mmol initially).
BDH Chemicals (Poole, Dorset):- all the salts (Analar grade)
used in'the Krebs solution, LiCI, sucrose, and "Cocktail T"
scintillant.
Coulter Electronics Ltd. (Luton, Beds.):- Isoton.
Gibco-Biocult (Paisley, Scotland):- all tissue culture supplies
as detailed in Section 5.II.i ••
New England Nuclear (W. Germany):-
Sigma (Poole, Dorset):- Ouabain.
3H-ouabain (20.0 Ci/mmol).
Bumetanide was a kind gift of Leo Laboratories, UK. Water
used for solutions was produced using a Milli-Q water system
(Millipore S.A., France). All solutions were dispensed using
Gilson adjustable pipettes during experiments.
6.II.ii. Cell treatments
The rationale behind investigating the effects of ouabain,
lithium and vanadate on cation fluxes has already been discussed
in the "Introduction" to this chapter. The doses were
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established both from preliminary experiments and from the
Iiterature. Lithium was used at a concentration of 10-3M which
is in the middle of the range of therapeutic plasma levels in man
(0.6-1.5 mM; Bowman and Rand 1980). In this study LiCl was
used rather than the clinically prescribed Li2C03 as the
solubility of LiCl is greater. Ouabain was used at a
concentration of 10-8M since in preliminary experiments with the
lymphocyte cell lines, 10-8M ouabain produced a 30-40% decrease
in sodium pump numbers over 24 hours, without affecting the
cellular viabili ty. Vanadate was used at a concentration of
10-6M Na3V04' Although vanadate had no effect on sodium pump
numbers until concentrations greater than 10-5M when using HeLa
cells, toxic effects were also seen at these vanadate
concentrations. 10-6M was chosen as being lower than the toxic
levels but higher than normal blood concentrations, thus possibly
stressing the cells and exposing any inherent defects in cation
transport. The effects of these treatments on cellular
viability were checked and no detrimental effects were seen.
6.II.1ii. Effect of chronic ouabain, lithium or vanadate
treatment on sodium pump numbers (ouabain binding) of
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
The principles and validity of using ouabain binding to
ascertain sodium pump numbers have already been discussed.
Preparation of the solutions used experimentally and the routine
sub-culturing of the lymphoblastoid cell lines were also as
previously described.
177
Several preliminary studies were carried out in order to
establish a viable method for measuring ouabain binding in
lymphocytes. The resultant protocol is described first followed
by the steps taken to validate it. The following procedure was
carried out for each cell line in turn at various times
throughout the study. Cells were divided into 4 labelled
bottles, each containing 10-15 x 106 cells at a final density of
0.5 x 106 cells/ml, in either RPM! 1640 or RPM! 1640 containing
The bottles
of cells were incubated at 370C for 24 hours and then the
contents of each bottle were divided into 2 x 15 ml disposable
plastic tubes. One tube from each bottle was used to measure
the total ouabain binding and the other for non-specific binding.
The cells were centrifuged at 1000 rpm for 3 minutes (37oC; -
Fisons MSE Coolspin), the supernatant discarded and the cells
resuspended in approximately 10 mls of either K-free or 15K-Krebs
(37oC) as appropriate. The cells were centrifuged again and the
washing procedure was carried out twice more. The cells in each
tube were finally resuspended in 3 mls of the appropriate Krebs
solution.
From each tube, 3 x 900 ul aliquots were taken and put in RT
30 test tubes (Sterilin) which were then placed in a Techne Dri-
block at 37oC. At 5 second intervals, to each tube in turn, 100
ul of the appropriate lax radioactive standard solution (i.e. 2 x
10-6M ouabain in either K-free or 15K-Krebs, containing 5 uCi 3H-
ouabain/ml) was added, the tube whir Iimixed and then incubated
for 20 minutes at 37oC. At the end of the incubation period, 3
m1s of ice-cold 15K-Krebs was added to each tube and the tubes
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placed on ice. When this procedure had been carried out for all
the tubes, they were centrifuged at 1000 rpm for 3 minutes (40C;
Fisons MSE Coolspin), the supernatant discarded and the cells
resuspended in a further 3 mls of ice-cold 15K-Krebs. This
washing procedure was carried out a further 3x, with the cells in
each tube finally being resuspended in 750 ul of Krebs solution.
After whirlimixing, 200 ul of each cell suspension was added
to 19.8 mls of Isoton and used for the determination of cell
numbers as described in Section 2.II.iv•• 400 ul of each cell
suspension was added to scintillation vials containing 5 mls of
scintillation fluid. The vials were then capped, shaken and
placed in a Packard Tri-Carb Liquid Scintillation Spectrometer
Model 3255. After allowing 1-2 hours for chemiluminescence to
subside, the samples were counted for 10 minutes or 10,000 counts
thus keeping the error below 1%.
For standard counts (specific activity), 3 x 100 ul aliquots
of a 1 in 10 dilution of each of the lax radioactive standard
solutions were taken (equivalent to 100 ul of the final
incubation medium), and added to scintillation vials containing 5
mls of scintillation fluid and 300 ul of Krebs (ensures the same
quenching). These vials were cooled and counted as above.
Blanks were run to account for any residual radioactivity left
after the washing. These consisted of 3 tubes each containing 3
x 900 ul aliquots of one of the cell suspensions. To each tube,
100 ul of one of the radioactive standard solutions was added,
immediately followed by the addition of 3 mls of ice-cold l5K-
Krebs. These were washed as per the samples above and 400 ul
aliquots taken for radioactive counting, also as above. Machine
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blanks were run by counting vials containing 5 mls of scintillant
and 400 ul of Krebs. Usually the cell blanks were equivalent to
the machine blanks indicating the efficiency of the washing
procedure.
Total and non-specific binding, and consequently the specific
binding, were calculated according to the equation in Appendix 4,
and expressed as molecules of ouabain bound/cell. Assuming that
one molecule of ouabain binds per pump site (Baker and Willis
1972) this represents the number of sodium pumps per cell.
Experiments were repeated for each cell line on several
occasions, with each treatment condition in triplicate. Results
were analysed by Student's t-test using the "Minitab" statistical
package on the VAX mainframe computer.
During the preliminary experiments, cellular viabili ty was
monitored using ethidium bromide/acridine orange as described in
Chapter 5. No decline in viability was seen in all the cell
lines examined during all the procedures carried out.
In order to determine the appropriate incubation time i.e.
when binding had saturated, time courses of ouabain binding were
run at intervals over 30 minutes using a sample of 3 patient and
3 control cell lines. Once the appropriate time had been
decided upon (20 minutes), ouabain binding was measured over 20
and 25 minutes, in a sample of 3 patient and 3 control cell
lines, each of which had been divided up and incubated for 24
hours with either LiCI, ouabain or Na3V04 as previously
de scri bed. This was to check that the treatments had not
altered the rate of ouabain binding in such a way that binding
was no longer saturated within 20 minutes. Also, in order to
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check whether any of the treatment conditions prevented the
subsequent binding of ouabain to some pump sites, which may
produce the same results for the time course as seen with the
untreated condition but with apparently less pump sites, a sample
of 3 patient and 3 control cell lines were exposed to the various
treatments for 15 minutes before being washed and ouabain binding
measured. This assumes that any such change would be apparent
during this time period, without being superimposed on any
possible treatment-induced changes in sodium pump number seen
after longer periods.
In order to see if the seeding density of the cells affected
the sodium pump number, several cell lines were put up at various
densities and ouabain binding monitored 24 hours later. In the
light of the results, it was decided that all cell lines should
be seeded at the same density when carrying out ouabain-binding
experiments, if direct comparisons were to be made between cell
lines.
In the actual experiments, the ouabain binding of many cell
lines was measured simultaneously, necessitating some tubes being
left on ice for 20 minutes before being washed whilst some tubes
were only on ice for 30 seconds. During preliminary experiments
this was found to have no effect on ouabain binding.
6.II.iv. Effect of chronic ouabain, lithium or vanadate
treatment on the K+ influx pathways of lymphoblastoid cell lines
from bipolar manic-depressive patients and control subjects
The various K+ influx pathways and the principles involved in
their measurement have already been discussed in Chapter 3. The
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use of 86Rb as a tracer measuring K+ fluxes was also discussed
and the term K+ influx is used to here to represent that measured
using 86Rb• The preparation of the solutions used
experimentally and the routine sub-culturing of the
lymphoblastoid cell lines were also as described previously. In
order to measure the K+ influx in lymphocytes, a protocol was
devised which allowed the rapid removal of the radioactive medium
at the end of the incubation period. Repeated washing and
centrifugation steps were of little use since they were too slow
relative to the rapid efflux of K+ across the membrane during the
washes. By layering the radioactive cell suspension onto
Versilube F50 silicone oil in a microfuge tube and then
microfuging (Beckman Microfuge B) for 15 seconds, it was possible
to pellet the cells through the oil int6 isosmotic sucrose
(minimising cell lysis) at the bottom of the tube, thus
separating the cells from the radioactive solution. By rapidly
freezing the tube in liquid nitrogen, ion movements out of the
cells were terminated and the tip of the tube containing the cell
pellet could be cut off and used to determine the radioactive
content of the cells. The optimum relative amounts of Versilube
and cell suspension, and the optimum cell density of the
suspension were determined during preliminary studies, with
samples of the oil and interfaces being checked under the
microscope for the presence of cells. The optimum conditions
using a 450 ul microfuge tube (Sarstedt) were found to be a 100
ul layer of cell suspension, a 50 ul layer of Versilube and a 50
ul layer of isosmotic sucrose (0.25M). Cell suspensions
containing from 0.5 x 106 cells/ml to 5 x 106 cells/ml were tried
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and in every case complete passage through the oil of all the
cells was found. During preliminary flux experiments, samples
of the frozen oil and the sucrose layer above the cell pellet
were also taken and the radioactivity determined in order to
check for contamination and/or loss of cellular radioactivity.
For the flux experiments, each cell line used was split into 4
labelled bottles at a density of 0.2-0.7 x 106 cells/ml in 25 mls
of either RPMI, or RPMI containing one of 10-3M LiCl, 10-8M
The following procedure is described
for one bottle but was carried out for all of them in turn.
After 24 hours incubation at 37oC, 15 mls of the medium was
removed from the bottle by suction. The remaining cell
suspension was then poured into an appropriately labelled 15 ml
disposable plastic tube and centrifuged at 1000 rpm for 3 minutes
(370Cj Fisons MSE Coolspin). The supernatant was discarded and
approximately 10 mls of Krebs solution (370 C) was added to the
tube and the cells resuspended. This washing procedure was
carried out twice more with the cells finally being resuspended
in 4.5 mls of Krebs solution (370 C).
From this initial cell suspension, 3 x 250 ul aliquots were
taken and added to 19.75 m Is of lsoton for the determination of
cell numbers as described in Section 2.II.iv. (the cell density
of this initial suspension was multiplied by 0.9 to obtain the
cell density in the final suspension, due to the dilution
incurred by the addition of the radioactive solution). From the
remaining cell suspension, 12 x 180 ul aliquots were removed and
placed in Steri-G tubes (Sterilin) at 37°C in a Techne Dri-Block.
At 30 second intervals, 20 ul of the appropriate lOx radioactive
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standard solution was added to each tube in turn, the first 3
receiving Krebs containing 20 uCi 86Rb/ml, the second 3 receiving
Krebs containing 20 uCi 86Rb/ml and 10-3M bumetanide, the next 3
tubes receiving Krebs containing 20 uCi 86Rb/ml and 10-2M
ouabain, and the final 3 receiving Krebs containing 20 uCi
86Rb/ml, 10-3M bumetanide and 10-2M ouabain. The [K+] of the
Krebs had previously been checked by flame photometry (normally
5.7 mM). Immediately after the addition of the radioactive
solution, each tube was vortexed and incubated at 37°C for 12
minutes. For each tube in turn, 5-10 seconds prior to the end
of the incubation period and at the appropriate time intervals,
the contents of the tube were whirlimixed, and 100 ul of cell
suspension was layered onto the Versilube layer as previously
described (450 ul microfuge tubes containing 50 ul of 0.25M
sucrose covered by 50 ul of Versilube F50). The microfuge tube
was microfuged (Beckman Microfuge B) for 15 seconds then
immediately frozen in liquid nitrogen. This procedure was
carried out for each of the tubes in turn. The tips of the
frozen microfuge tubes containing the cell pellets were cut off
using a razor blade and placed in scintillation vials containing
10 mls of water. After shaking to ensure the cell pellet was
dispersed in the water, the samples were counted in a Packard
Tricarb Liquid Scintillation Spectrometer 3255 by the Cerenkov
method as described in Section 3.II.iv••
Standard counts were determined by taking 3 x 100 ul aliquots
from each of a 1 in 10 dilution of the lOx radioactive standards
(yields the specific activity of the final incubation medium).
These were added to scintillation vials containing 10 mls of
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water and the radioactive content determined as previously
described. Cell blanks, to account for the radioactivity
carried over between the cells, were prepared from each bottle of
cells (necessitated by the differing cell densities) by taking 3
x 180 ul aliquots of the initial cell suspensions in Krebs, and
placing them in Steri-G tubes (Sterilin) on ice. To each tube
in turn, 20 ul of one of the lOx radioactive standard solutions
was added and immediately the tube was whirlimixed, 100 ul of
cell suspension taken and microfuged through Versilube as for the
samples, the microfuge tube frozen, and the tip containing the
cell pellet taken for counting as above. Machine blanks were
prepared by adding 3 x 50 ul aliquots of sucrose to 10 mls of
water in scintillation vials and counting as above. The
presence of the microfuge tube tip had no effect on the counting
efficiency.
The above procedures were repeated for all the treatment
conditions. Results were calculated according to the equation
in Appendix 5 and expressed as mmol K+/lcw/min or as nmol K+/106
cells/min for each flux pathway. Experiments were repeated on 3
separate occasions for most cell lines, with each treatment
condition in triplicate. Results were analysed by Student's t-
test using the "Minitab" statistical package on the VAX mainframe
computer.
In order to determine the incubation time for the above
experiments, i.e. a time over which the uptake of 86Rb is linear --
and the efflux is therefore negligible, a sample of 6 cell lines
was used and total 86Rb uptake measured at intervals from 1 to
30 minutes. From this data (see the following "Resul ts"
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section), the time of 12 minutes was selected as being in the
linear portion of the uptake and also a convenient time for
handling the tubes generated by two treatment conditions of a
cell line.
The problems inherent in using either N03--Krebs or bumetanide
to measure the diuretic-sensitive K+ influx have already been
discussed in Chapter 3. Rather than assuming the equivalence of
these two methods for measuring the cotransport pathway in
lymphocytes, a sample of 2 cell lines were used and 86Rb influx
measured according to the experimental protocol developed, but
addi tionally using N03 --Krebs and N03 --Krebs containing 10-3M
ouabain (final concentration) with appropriate washes. From the
results (discussed later) it was decided that in lymphocytes, it
would be more appropriate to use bumetanide to measure the
cotransport pathway. Dose response curves of 3 cell lines to
bumetanide were studied using the experimental protocol develope~
but with various concentrations of bumetanide (final
concentrations - 10-7M to 10-4M). On the basis of these
results, a final concentration of 10-4M was chosen.
Four cell lines were also each seeded at various densities for
24 hours and the total 86Rb influx measured. As no significant
differences were seen within any cell line in the fluxes at the
different cell densities, cells were put up for experiments at a
density depending upon the number of cells available for each
cell line (usually 0.2-0.7 x 106 cells/ml). However, as a
precautionary measure, the experimental results were examined to
see if any dependence on cell seeding density became apparent
later. One cell line was also treated with 10-3M ouabain or
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lO-4M bumetanide for 12 minutes to see if any volume change
occurred during the incubation period, as the cell volumes used
in the calculation of flux were determined before the final
incubation stage.
6.II.v. Effect of chronic ouabain, lithium or vanadate
treatment on the intracellular Na+ contents of
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
When measuring ion contents of suspensions of cells,
centrifugation and washing steps are usually employed. Such a
procedure is successful with erythrocytes for example, due to
their relative impermeability and hence small loss of ions during
the removal of the extracellular fluid. Although spinning the
lymphocytes through oil into sucrose and washing with sorbitol
were both tried in attempts to remove the extracellular ions from
the cells, they met with little success due to contamination and
loss of intracellular ions respectively. Despite modifications
of the procedures tried, no progress was made and this line of
study had to be abandoned. The possibility of using radioactive
tracers equilibrated across the membrane to measure the ion
contents was considered but was not pursued further dUE!to the
prohibitive expense involved in such studies.
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6.111. RESULTS
6.III.i. Development of experimental protocols
The protocols developed and used to measure ouabain binding
and K+ influx in the lymphoblastoid cell lines have been detailed
in the preceding "Methods" section. The results of the
preliminary experiments upon which these methodologies are based
are reported here.
The time courses of ouabain binding for 3 bipolar and 3
control cell lines are shown in Figure 6.1.. Although slight
differences may exist in the rate of binding and the maximal
binding between the various cell lines, binding appears to
saturate within approximately 8 minutes in all the cell lines.
An incubation time of 20 minutes should thus allow the comparison
of ouabain binding values between the cell lines. The variable
length of time for which samples were left on ice (less than 20
minutes) before being washed after termination of their binding,
had no effect on either specific or non-specific ouabain binding.
Treatment with either ouabain, lithium or vanadate (24 hours) did
not appear to affect the time course of binding in the cell lines
examined and treatment with ouabain, lithium or vanadate (15
minutes) did not affect the maximal ouabain binding. It can be
assumed therefore that any differences seen in ouabain binding
with treatment are due to a change in sodium pump number,
providing that the dissociation rate of ouabain has not altered.
This is unlikely as ouabain binding can be regarded as being
practically irreversible in tissues from many species including
man. This has been shown to be the case for example, in non-
188
700
,.... 600
Q)
o.....
Cl)
Q)
~ 500
Q)
o
E
MO 400.....
X
'-.I
Cl
C
"0 300c
.c
c
co
.c 200co
::lo
o-o 100
CD
Q
en
Figure 6.1.
----- Control
- Bipolar
/+~
•
_)?f----------------- ;
.............~----------- -------- ----t
~
.::......
.': ~ ..,/;~ -------- __.1.------~---------------+, ,', l', ,
I "· '~'• , I· ,, I
, I,,,· ,
_------~ 05-01
t 10-01
Cib
Cox
Ged
Fran
o •
16 28 3220 .24o 4 8 12
Incubation time (mins.J
Time course of specific ouabain binding in
lyrnphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
Each point represents the mean + S.E.M. of triplicate data.
[ouabain] = 2.25 x 10-7M.
transformed lymphocytes (Boon et al. 1984).
The separation of the radioactive incubation medium from the
cells in the K+ influx experiments was made possible by the use
of Versilube F50 silicone oil. Although having a similar
specific gravity (approx. 1.04g/ml) to dibutylphthalate (which
the cells did not spin through), Versilube F50 has different
ionic properties and hence different cell surface interactions
prevail, allowing the separation. No contamination of the oil
or the sucrose by the radioactivity was seen. Time courses of
86Rb uptake by various lymphoblastoid cell lines are shown in
Figure 6.2 •• Uptake appears to be linear over at least the
first 15 minutes for most of the cell lines and upto 30 minutes
for some. The lack of linearity over the first 2 minutes is
probably due to the blank readings having a proportionately
greater effect on the lower time points. It is impossible to
obtain exact zero time points for the blanks due to the time
taken to layer the cells onto the oil. In effect they represent
approximately 10-15 seconds of flux but this is minimised by
performing the blanks at 40C. The effect of such blanks over a
12 minute flux period as used in this study will be negligible.
The cotransport fluxes measured using either bum etanide or
nitrate-Krebs were not equivalent, probably due to other Cl-
dependent K+ fluxes present in these cell lines. For this
reason and for the reasons discussed in Chapter 3, it was decided
to use bumetanide. A dose-response curve to bumetanide for 3
cell lines is shown in Figure 6.3.. 10-4M appeared to be
adequate to inhibit the flux and is also a level at which non-
specific effects are minimal. K+ influx appeared to be
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and control subjects
Each point represents the mean ± S.E.M. of triplicate data.
Incubation time in bumetanide was 12 minutes.
independent of cell seeding density in the cell lines examined
and therefore no exact seeding density was used. Any
differences found in the results were however examined with
respect to cell density as a precautionary measure, in view of
the variability in flux values as discussed in the following
sections. The use of ouabain or bumetanide to measure the
fluxes did not produce any changes in cell volume during the
incubation period, validating the use of the cell volumes
measured at the start of the incubation, in the calculation of
the results.
6.III.H. Basal values for the ouabain binding and 1(+ influx
pathways of lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The age distribution of the bipolar and control subjects at
the time the cell lines were established is shown in Figure 6.4.
for all the cell lines used throughout the study. There is no
significant difference between the two groups with mean values ±
S.E.M. of 38.3 ± 5.9 (n - 12 and 1 unknown) for the control
group, and 46.5 ± 4.2 (n - 13) for the bipolar patients, although
the control group has a greater range of values. Not all the
cell lines were used for both the ouabain binding and flux
measurements. The mean values for the age of the control group
used for ouabain binding was 37.5 + 7.1 (n - 10 and I unknown)
whilst that for the bipolar group was 46.2 ± 5.5 (n ...10). The
mean values for the age of the control group used for flux
measurements was 35.7 l' 5.7 (n = 11 and 1 unknown) whilst that
for the bipolar group was 47.3 ± 4.5 (n = 12). In both cases
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the age difference between the groups is not statistically
significant. The details of the cell lines with regard to age,
date of cell transformation etc. have been presented in the
previous chapter (Table 5.1.) and are discussed further in the
interpretation of the results in the following "Discussion"
section of this chapter.
Extensive day to day variation was seen in the results for
each cell line as demonstrated by the high standard errors when
the overall mean results for each individual cell line are
examined. This was particularly true for fluxes which varied by
as much as 100% from day to day. Error bars for the mean
experimental data for each cell line are omitted from the
distribution plots for the sake of clarity. Within a single
experiment they were normally less than 5% of the mean. A
summary of the mean values for the two groups of cell lines, of
all the parameters measured, is given at the beginning of the
individual data, in Table 6.1..
The mean cell volumes for each of the cell lines are shown in
Table 6.2. with the distribution of the individual experimental
values shown in Figure 6.5•• In both groups there is a
considerable spread of values wi th a higher mean value ± S.E.M.
for the bipolar group (1772 ± 166 u3) compared wi th the control
group (1582 ± 97 u3), but the difference is not statistically
significant. The three cell lines established by Naylor's
Dundee group (i.e. Fleming, Greig, and Cox) all have anomalously
high values, as do the cell lines 15-01, and 17-01. The excess
of these cell lines with anomalously high values in the bipolar
group compared wi th the con trol group largely account s for the
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Table 6.1. Basal values for volume, ouabain binding, and ~ influx
pathways of lymphoblastoid cell lines from bipolar manic-depressive
patients and control subjects
The results below are the mean values from 12 control and 12
bipolar cell lines. The mean value for each individual cell line
within these groups is derived from (usually) 3 experiments, with
each parameter measured in triplicate wi thin an experi men t ,
Significance testing of the results from the bipolar cell lines
relative to the control group is by Student's t-test.
Parameter Mean value + S.E.M. Level of
Control Bipolar Significance
Cell volume (u3) 1582 ± 97 1772 ± 166 N.S.
Total K+ influx 1.52 ± 0.15 1.43 ± 0.13 N.S.
(mmol/lcw/min)
Bumetanide-sensitive K+ 0.30 ± 0.06 0.30 ± 0.05 N.S.
influx (mmol/lcw/min)
Ouabain-sensitive K+ 1.01+0.11 0.98 + 0.08 N.S.
influx (mmol/lcw/min) -
Passive leak K+ influx 0.17 + 0.02 0.14 ± 0.02 N.S.
(mmol/lcw/min)
Total K+ influx 1.87 + 0.17 1.85 + 0.13 N.S.
(nmol/l06 cells/min)
Bumetanide-sensitive K+ 0.39 ± 0.07 0.35 ± 0.05 N.S.
influx (nmol/106 cells/min)
Ouabain-sengitive K+ 1.24+0.12 1.28 ±0.09 N.S.
influx (nmol/lO cells/min)
Passive 19ak K+ influx 0.23 ± 0.03 0.19 ± 0.03 N.S.
(nmol/lO cells/min)
Bumetanide-sensitive K+ 18.20 ± 3.07 18.38 ± 2.66 N.S.
influx (% of total)
Ouabain-sensitive K+ 67.68 + 2.91 70.47 + 2.78 N.S.-influx (% of total)
Passive leak K+ influx 11.7+1.01 9.38 + 1.24 N.S.
(% of total)
Specific ouabain binding 386 ± 37 507 ± 42 p<0.05
(xl03 molecules/cell) (n=ll) (n-lO) .
Non-specific ouabain binding 51 ± 5 66 ± 8 N.S.
(xl03 molecules/cell) (n=l1) (n:zl0)
.~
Table 6.2. Mean cell volumes of lymphoblastoid cell lines from
bipolar manic-depressive patients, relatives, and control
subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
volume being measured in triplicate within an experiment. The
upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
Cell line Mean cell volume ± S.E.M. 3(u )
Ale 1765 ± 122
Cib 1154 ± 138
Dil 1592 ± 139
Fleming 2323 ± 74
Fran 1298 ± 13
Gavi 1467 ± 39
Ged 1488 ± 7
J11 1268 ± 33
Sep 2031 ± 33
Tony 1592 ± 45
Twel 1327 ± 100
Wib 1674 ± 87
01-01 1643 '± 55
02-01 . 1129 ± 155
05-01 1176 ± 92
07-01 1267 + 36
08-01 1609 ± 61
09-01 1317 ± 67
10-01 1713 ± 40
14-01 1445 ± 130
15-01 2141 ± 0
17-01 2639 ± 46
Cox 2473 ± 118
Greig 2713 ± 69
08-02 1386 ± 113
08-03 1270 ± 73
08-04 '1547 ± 93
10-02 1693 ± 29
10-03 1538 ± 169
10-04 1377 ± 71
10-06 1352 ± 112
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Figure 6.5. Distribution of the mean cell volumes of
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. -indicates the mean'value for each
category of cell line.
difference seen in the mean volume.
The specific and non-specific ouabain-binding results are
given in Table 6.3. and Figure s 6.6. and 6.7.. The size s of the
ranges of values for specific binding are similar for both the
control and bipolar groups but the mean value is significantly
higher for the bipolar group (approx. 130% of the control group
value). This could be due to the higher (but non-significant)
values seen for the volumes (and hence possibly surface areas) of
the bipolar cells compared to the control cells. This is
unlikely however as if the approximation is made that the cells
are spherical, the mean difference in surface area of the bipolar
cells and control cells would only be approximately 7% compared
with the 30% difference seen in specific ouabain binding and in
addition an increase in the non-specific binding would be
expected. The limitations of such an approximation of surface
area have been discussed in Chapter 3 wi th regard to HeLa cells
and apply equally to lymphocytes.
Due to the variation in ouabain binding from experiment to
experiment coupled with the uncertainty of the cell surface
areas, it is impossible to calculate the density of the sodium
pumps per cell for each cell line. On the basis of the mean
values for each group it would appear that there are more sodium
pumps per unit of membrane in bipolar cells than in control
cells. It is possible under this analysis however that two
distinct populations of cells exist in the bipolar and/or control
groups, one of cell lines with more sodium pumps per unit of
surface area than the other population. However because of the
variability involved and the uncertainty of cell surface areas
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Table 6.3. Specific and non-specific ouabain binding values for
lymphoblastoid cell lines from bipolar manic-depressive patients,
relatives and control subjects
The values below are the mean of data from 3 experiments
(exceptin the cas e 0f Ale, M ib, TweI, and 10-05 - 2, 1, 1, and 1
respectively), with each parameter being measured in triplicate
within an experiment. The upper middle and lower groups
represent the cell lines from controls, bipolars and relatives
respectively.
Specific ouabain Non-specific ouabainCell line bi~ding + S.E.M. bi~ding + S.E.M.
(xlO molecules/cell) (xl0 mole~ules/cell)
Ale 350 ± 38 32 ± 1Cib 531 ± 37 90 ± 3Fleming 627 ± 136 54 ± 2Fran 289 ± 20 34 ± 3Gavi 311 ± 109 45 ± 4Ged 405 ± 50 62 ± 3Jil 440 ± 3 52 ± 8Mib 307 ± 14 53 ± 3Sep 460 ± 53 56 ± 5Tony 333 ± 64 38 ± 4Twel 198 ± 19 43 ± 3
01-01 549 ± 100 61 ± 505-01 395 ± 88 53 ± 1006-01 391 ± 63 46 + 607-01 ~30 ± 58 37 ± 208-01 467 ± 74 63 ± 1210-01 490 ± 124 50 ± 414-01 763 ± 125 125 ± 1915-01 456 ± 89 87 ± 417-01 662 ± 69 81 ± 12Cox 566 + 134 59 ± 13
08-02 358 ± 25 59 ± 1008-04 501 ± 154 72±1710-02 550 ± 124 47 ± 610-03 409 ± 64 31 ± 110-04 255 ± 24 33 ± 610-05 365 ± 9 58 ± 1010-06 403 ± 87 41 ± 5
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Figure 6.6. Distribution of the specific ouabain binding
results for lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The results are from 11 control and 10 bipolar cell lines.
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Distribution of the non-specific ouabain binding
manic-values for lymphoblastoid cell lines from bipolar
depressive patients and control subjects
The results are from 11 control and 10 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. _ indicates the mean value for each
category of cell line.
this is impossible to determine. As already mentioned, the cell
lines used for the measurement of the mean cell volumes (and the
fluxes) did not include all those used for the ouabain binding
studies. For example, the cell lines Mib, and 06-01 were
introduced for ouabain binding whilst the cell lines Dil, Wib,
02-01, 09-01 and Greig were withdrawn due to infection. These
substitutions make little difference to the mean cell volumes of
the groups with the exception of the withdrawal of Greig which is
one of the cell lines with an anomalously high mean cell volume.
This would have the effect of decreasing the difference seen in
cell volume between bipolar and control cells however and make
the possibility of higher cell volumes being responsible for the
larger number of pump sites per cell even less likely. In
addition it would be expected that the non-specific ouabain
binding would also be increased if the difference in specific
binding was solely due to increased cell volumes. There is no
significant difference in non-specific ouabain binding however,
between the two groups.
Because of the significantly increased values for specific
ouabain binding of bipolars compared with controls, the results
for the family members of two of the bipolar cell lines were
examined (Figures 6.8. and 6.9.). This approach should minimise
the influence of the genetic and environmental heterogeneity
present in the general population, and examine the possibility
that family members fall into sub-groups with differing sodium
pump numbers per cell, depending on their clinical status. This
is an oversimplification and is discussed further in the
following "~iscussion" section. Although there is variability
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Figure 6.9. Distribution of the specific ouabain binding values
for lymphoblastoid cell lines from a bipolar manic-depressive
patient and 5 relatives
Each point represents the mean of triplicate data from 1
experiment. The.individual results from 3 experiments (1 in ·the
case of 10-05) per cell line are shown.
in the day to day results seen for each cell line it would appear
that the values for 08-04 may be distributed relative to 08-01 in
a different way to those for 08-02, although one of the three
experimental results for 08-04 would not support this. If the
mean values are used, the cell lines are not significantly
different with respect to specific ouabain binding. For the
family members of 10-01 the picture is less clear as more
variability is seen in the values for the proband. The values
for the family members generally appear to be lower than those
for the proband although one very low value for the proband
complicates the analysis. Using the mean values, there is no
significant difference between 10-01 and the family members with
the exception of 10-04 which is significantly lower. The
possible relationship of the results to the clinical status of
the individual is discussed in the following "Ddscu ssLon"
section.
The values for the various K+ influx pathways are given in
Tables 6.4., 6.5., 6.6., and 6.7. with the relative contributions
of the individual pathways to the total flux being given in Table
6.8•• All the results are expressed only as mmol/lcw/min •• A
similar picture is seen if expressed as nmol/106 cells/min., as
the distributions are similar with the cells having the highest
values when expressed the former ·way generally having the higher
values if expressed the latter way. Expressing the results in
this way would also not be affected by the treatments as volumes
were unaltered by treatments. The distributions of the mean
experimental values per cell line (usually 3 experiments) are
given in Figures 6.10., 6.11., 6.12., and 6.13•• There are no
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Table 6.4. Total K+ influx of lymphoblastoid cell lines from
bipolar manic-depressive patients, relatives, and control
subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
the influx being measured in triplicate within an experiment.
The upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
Cell line Total K+ influx ± S.E.M.
(mmol/lcw/min.)
Ale 1.48 ± 0.47
Cib 1.35 ± 0.25
Dil 2.14 ± 0.22
Fleming 0.85 ± 0.13
Fran 2.38 ± 0.16
Gavi 1.91 ± 0.29
Ged 2.01 ± 0.18
Jil 1.81 ± 0.26
Sep 1.22 ± 0.14
Tony 1.22 ± 0.13
Twel 1.29 ± 0.42
Wib 0.62 ± 0.29
01-01 2.05 ± 0.43
02-01 1.31 ± 0.24
05-01 2.09 ± 0.43
07-01 1.60 ± 0.17
08-01 1.77 ± 0.13
09-01 1.83 ± 0.33
10-01 1.27 ± 0.36
14-01 1.29 ± 0.42
15-01 1.14 ± 0.00
17-01 1.21 ± 0.35
Cox 0.88 ± 0.13
Greig 0.67 ± 0.08
08-02 1.67 ± 0.22
08-03 1.57 ± 0.11
08-04 3.07 ± 0.21
10-02 1.60 ± 0.22
10-03 1.59 ± 0.24
10-04 1.16 ± 0.45
10-06 1.42 ± 0.17
Table 6.5. Bumetanide-sensitive K+ influx of lymphoblastoid
cell lines from bipolar manic-depressive patients, relatives, and
control subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
the influx being measured in tri plica te wi thin an experimen t ,
The upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
Cell line Bumetanide-sensitive K+ influx ± S .E.M.
(mmol/lcw/min.)
Ale 0.45 ± 0.20
Cib 0.16 ± 0.11
Dil 0.15 ± 0.09
Fleming 0.04 ± 0.04
Fran 0.64 ± 0.11
Gavi 0.38 ± 0.11
Ged 0.51 ± 0.06
Jil 0.32 ± 0.12
Sep 0.35 ± 0.01
Tony 0.35 ± 0.09
Twel 0.21 ± 0.03
Wib 0.00 ± 0.00
01-01 0.32 ± 0.22
02-01 0.38 ± 0.09
05-01 0.40 ± 0.18
07-01 0.48 ± 0.10
08-01 0.45 ± 0.11
09-01 0.52±0.11
10-01 0.27 + 0.09
14-01 0.32 ± 0.31
15-01 0.24 ± 0.00
17-01 0.15 ± 0.04
Cox 0.06 ± 0.05
Greig 0.01 ± 0.01
08-02 0.36 ± 0.16
08-03 0.27 ± 0.13
08-04 0.66 ± 0.13
10-02 0.40 ± 0.12
10-03 0.49 ± 0.17
10-04 0.33 ± 0.20
10-06 0.22 ± 0.04
Table 6.6. Ouabain-sensitive K+ influx of lymphoblastoid cell
lines from bipolar manic-depressive patients, relatives, and
control subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
the influx being measured in triplicate within an experiment.
The upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
Cell line Ouabain-sensitive K+ influx ± S.E.M.
(mmol/lcw/min.)
Ale 0.99 ± 0.28
Cib 1.06 ± 0.22
Dil 1.51 ± 0.15
Fleming 0.7l±0.12
Fran 1.55 ± 0.16
Gavi 1.29 ± 0.24
Ged 1.24 ± 0.09
Jl1 1.29 ± 0.22
Sep 0.66 ± 0.13
Tony 0.66 ± 0.07
TweI 0.75 ± 0.24
Wib 0.45 ± 0.21
01-01 1.46 ± 0.24
02-01 1.05 ± 0.13
05-01 1.34 ± 0.36
07-01 1.03 ± 0.04
08-01 1.14 + 0.10
09-01 1.21 ± 0.24
10-01 0.89 ± 0.23
14-01 0.73 ± 0.27
15-01 0.78 ± 0.00
17-01 0.78±0.19
Cox 0.72 ± 0.07
Greig 0.58 ± 0.07
08-02 1.00 ± 0.08
08-03 0.98 ± 0.08
08-04 2.00 ± 0.19
10-02 1.03 ± 0.11
10-03 1.04 ± 0.18
10-04 0.81 ± 0.25
10-06 1.07 ± 0.11
Table 6.7. Passive leak K+ influx of lymphoblastoid cell lines
from bipolar manic-depressive patients, relatives, and control
subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
the influx being measured in triplicate within an experiment.
The upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
Cell line Passive leak K+ influx ± S.E.M.
(mmol/lcw/min. )
Ale 0.11 ± 0.02
Cib 0.08 ± 0.04
Dil 0.24 ± 0.06
Fleming 0.12 ± 0.02
Fran 0.24 ± 0.04
Gavi 0.24 ± 0.04
Ged 0.24 ± 0.08
Jil 0.22 ± 0.04
Sep 0.14 ± 0.04
Tony 0.18 ± 0.03
!weI 0.19 ± 0.05
Wib 0.08 ± 0.09
01-01 0.16 ± 0.07
02-01 0.03 ± 0.01
05-01 0.29 ± 0.02
07-01 0.08 ± 0.05
08-01 0.23 ± 0.02
09-01 0.22 ± 0.01
10-01 0.12 + 0.06
14-01 0.12 ± 0.06
15-01 0.09 ± 0.00
17-01 0.21 ± 0.12
Cox 0.06 ± 0.04
Greig 0.07 ± 0.02
08-02 0.16 ± 0.02
08-03 0.24 ± 0.01
08-04 0.39 ± 0.02
10-02 0.13 ± 0.03
10-03 0.19 ± 0.03
10-04 0.07 ± 0.07
10-06 0.11 ± 0.01
Table 6.8. K+ influx pathways (% of total K+ influx) of
lymphoblastoid cell lines from bipolar manic-depressive patients,
relatives, and control subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
the influx being measured in triplicate within an experiment.
The upper, middle and lower groups represent the cell lines from
controls, bipolars and relatives respectively.
K+ influx pathways (% of total K+ influx) ± S.E.M.Cell line
Bumetanide-sensitive Ouabain-sensitive Passive leak
Ale 32.7 ± 11.5 69.4 ± 5.2 8.1 ± 1.1Cib 10.7 ± 6.0 79.4 ± 7.7 4.8 ± 2.5Dil 8.7 ± 5.2 70.6 ± 1.5 10.9 ± 2.2Fleming 3.8 ± 3.8 83.4 ± 2.4 14.5 ± 3.4Fran 26.5 ± 3.0 64.8 ± 3.2 9.8 ± 1.4Gavi 19.1 ± 2.5 67.2 ± 7.0 13.5 ± 3.7Ged 25.3 ± 0.8 62.2 ± 2.1 1L7 ± 2.8Ji1 16.7 ± 3.8 70.8 ± 2.0 12.4 ± 2.3Sep 30.0 ± 4.2 52.8 ± 5.5 12.4 ± 3.7Tony 27.5 ± 4.5 54.2 ± 3.4 14.8 ± 1.6Twel 17.4 ± 3.3 57.1 ± 4.2 18.2 ± 10.6Wib 0.0 ± 0.0 80.2 ± 12.2 9.3 ± 9.3
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Figure 6.10. Distribution of the total K+ influx values
(mmol/lcw Imin.) for lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. ---indicates the mean value for each
category of cell line.
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Figure 6.11. Distribution of the bumetanide-sensitive K+ influx
values (mmol/lcw/min.) for lymphoblastoid cell lines from bipolar
manic-depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. _ indicates the mean value for each
0.9
0.8
-; 0.7c:
E.....
== •0..... 0.60
E
E
'-'
x •:J 0.5 •-c: •
+ • •
~
Q) 0.4 •> • •-oW -c:Q) • -(/JI 0.3ID
"0 •c:
ca •-ID
E 0.2 •::::l
CD •• •
0.1
••
0 ••
Control Bipolar
Figure 6.11. Distribution of the bumetanide-sensitive K+ influx
values (mmol/lew/min.) for lymphoblastoid cell lines from bipolar
manic-depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. _ indicates the mean value for each
category of cell line.
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Figure 6.12. Distribution of the ouabain-sensitive K+ influx
values (mmol/lcw/min.) for lymphoblastoid cell lines from bipolar
manic-depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each.measurement being triplicated
within an experiment. ----indicates the mean value for each
category of cell line.
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Figure 6.13. Distribution of the passive leak K+ influx values
(mmol/lcw/min.) for lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. ---indicates the mean value for each
category of cell line.
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Figure 6.13. Distribution of the passive leak K+ influx values
(mmol/lcw/min.) for lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The results are from 12 control and 12 bipolar cell lines.
Each point represents the mean of results from 3 experiments
(usually) per cell line, with each measurement being triplicated
within an experiment. ---indicates the mean value for each
category of cell line.
significant differences between the control and bipolar groups in
any of the fluxes. Considerable variation in the actual values
of fluxes for the cell lines relative to one another can be seen,
together with considerable variation between experiments for each
individual cell line. In general the cell lines supplied by the
Dundee group tend to have bigger volumes, and lower bumetanide-
sensitive fluxes than the remainder of the cell lines.
It is meaningless to calculate the K+ flux per sodium pump
using the mean sodium pump numbers and flux values for each cell
line, due to the measurement of the K+ influx on different days
to the ouabain binding, and the variability from day to day
within each cell line. This could only done by measuring the
different parameters at the same time. The possibility of the
bipolar and control populations of cells containing sub-groups of
cell lines with different rates of pumping could also then be
examined.
6.Il1.iii. Effects of ouabain, lithium or vanadate treatment
(24 hours) on the ouabain binding and K+ influx pathways of
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
The results of the treatment studies are summarised in Tables
6.9. and 6.10•• Many cell lines show inconsistent results from
experiment to experiment. Little effect of either lithium or
vanadate is seen on either ouabain binding or any of the K+
influx pathways. Similarly, ouabain treatment produces no
effects on either the bumetanide-sensitive or passive leak
influxes. However, large and significant effects are seen with
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Table 6.9. Effects of ouabain, lithium or vanadate treatment
(24 hours) on the ouabain binding of lymphoblastoid cell lines
from bipolar manic-depressive patients and control subjects
The values below are the mean of data from 3 experiments
(except for Ale, Mib, Twel, and 10-05 - 2, 1, 1, and 1
respectively), with each parameter being measured in triplicate
within an experiment. Results are expressed as % of basal
values. Significance testing relative to the basal values is by
Student's t-test.
C Control . c..o.cs EJ No Significant change
B Bipolar
P<O.Ol
p<O.OOS D Inconsistent
R Relative p<OOO 1
Treatment and ouabain binding (% 01 basal) -t S.E.M.
ell
2
10-3M LiCI 10-8M ouabain -6 0~ la 10 M Na3V '1s ell
"i
Cl) o
o E
U Specilic Non-specific Specific Non-speciliC Specific Non-specilic
. ..- --Ale C 52.5 -t 10.1 75.1 "t 3.4
Cib C ··596 ± 2.9 -"57.3 :!" 4 II
leming C ··478 ± 5.9
C
.... .
74.8 ± 8.9Fran 64.1 ± 0.9 --
Gavi C ··S44 +6.5
Ged C ··5·2.9± 3.9 ···55.8 :!" 1.7
Jil C ··S35 t 4.2 ·"Se.lf 56
··S6.4 ± 2.8
••• + . 85.5 ~ 4.4Mib C -- 54.8 - 8.4
Sep C
•••• +
59.7 - 3.2
•••• + ...
59.8'! 7.2Tony C 4B.9 - 3.1
Twel C
•••• + - • 73.6 "± 10.339.6 - 6.5.
S9.B ~'2.701-01 B
05-01 B "60.2 t 7.7
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10-01 B ··l~.,+ 'I 'J
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B ··13.6 ! 3.5 ••• +15-01 69.9 _ 2.0..
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•••• +
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52.9 ! 2.5
..~
10-05 R - 33.5 ~ 1.3 61.3 ! 2.9
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Table 6.10. Effects of ouabain, lithium or vanadate treatment
(24 hours) on the K+ influx pathways of ly~phoblastoid cell lines
from bipolar manic-depressive patients and control subjects
The values below are the mean of data from 3 experiments
(except for Twel, Wib and 15-01 - 2, 2, and 1 respectively), with
each parameter being measured in triplicate within an experiment.
Results are expressed as % of basal values. Significance
testing relative to basal values is by Student's t-test.
C Control . p<005 G No sIgnificant change
B BIpolar p<O.Ot
p<0.005 D InconsistentR RelatIve p<O.OOt
Treatment and K+ influx (% 0' basal) ~ S.E.M.
til
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17-01 B - - - 49~9t6.0 - -
COl( B - - - -
Greig B - - - - ·46.5tl -
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08-03 R - ~82t16 - ·42.l~1
08-04 R - - rrO~3~ i67~sts - -
10-02 R - - - - -
10-03 R
10-04 R -
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ouabain treatment on the sodium pump number in all the bipolar
and control cell lines, and the ouabain-sensitive flux in about
half of the cell lines. It would appear therefore that with the
exception of Ged, about half of the cell lines in both groups
show a decrease in flux which is commensurate with the decrease
seen in pump numbers. The remainder of the cell lines show
inconsistent changes in the ouabain-sensitive K+ influx e.g.
decreasing in one experiment but not the next. The changes in
pump numbers are relatively consistent from experiment to
experiment unlike the flux results. Based on the 5 control and
4 bipolar cell lines which show a consistent decrease in the
ouabain-sensitive flux there does not appear to be a difference
between the two groups of cell lines with respect to the
magni tude of the decrease (Table 6.11.). There is a small but
non-significantly greater decrease seen in sodium pump numbers of
control cell lines compared with bipolars (54.3% of basal c.f.
59.5% respectively). No difference is seen between the groups
wi th respec t to the magni tude of the decreases in non-specific
ouabain binding with ouabain treatment although this is seen in
only 3 bipolar cell lines compared with 7 controls.
There does not appear to be a linear relationship however
between either the size of the basal ouabain flux or the basal
pump number, and the % inhibition of flux for the cell lines of
either group. If the individual data for the decrease in
specific ouabain binding is examined relative to the basal
ouabain binding values (Figure 6.14.), the overall correlation in
the control cell lines is positive i.e. the higher the basal
sodium pump number, the higher the number remaining per cell
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Table 6.11. Summary of the effects of ouabain treatment (IO-8M
- 24 hours) on the ouabain-sensitive K+ influx and ouabain
binding of lymphoblastoid cell lines from bipolar manic-
depressive patients and control subjects
The results below are the mean of data from the cell lines
which show consistently significant changes with ouabain
treatment. The changes were measured in 3 separate experiments
with each measurement being triplicated within an experiment.
Significance testing of the changes in the bipolar group relative
to the control is by Student's t-test.
Category n Ouabain-sensitive K+ influx Level of
(% of basal) ± S.E.M. Significance
Control 5 55.8 ± 6.2 -
Bipolar 4 68.9 ± 9.3 N.S.
Category n Specific ouabain binding Level of
(% of basal) ± S.E.M. Significance
Control 11 54.3 ± 2.2 -
Bipolar 10 59.5 ± 2.1 N.S.
Category n Non-specific ouabain binding Level of
(% of basal) + S.E.M. Significance
Control 7 66.6 ± 4.4 -
Bipolar 3 69.9 ± 0.03 N.S.
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Figure 6.14. Relationship between the specific ouabain binding
values before and after treatment with ouabain (10-8M - 24
hours), for lymphob1astoid cell lines from bipolar manic-
depressive patients and control subjects
The results are from 10 control and 9 bipolar cell lines.
Each point represents the mean of triplicate data from 1
experiment. The individual results from 3 experiments (usually)
per ceil line are shown.
after treatment. However for bipolar cell lines the correlation
is negative. In the case of both the control and the bipolar
group however the correlation coefficient is small (0.199, n ...
28, and -0.320, n - 29 respectively), and in neither case is
there a significant correlation between the parameters.
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6.IV. DISCUSSION
This is the first study in which cultured 1ymphob1astoid cell
lines have been used to elucidate the possible role of cation
transport in the aetiology of bipolar manic-depressive psychosis.
Ideally the cell lines used would all have been established in
the same laboratory at the same time, and with age-and sex-
matching of the control and patient groups. However this was
not possible for the reasons listed in the previous chapter.
Although there was no significant difference in the mean age of
the control and bipolar groups, the subjects were not matched for
age and there were also sex-differences between the groups. The
control and bipolar groups of cell lines used for the ouabain
binding studies had male:female ratios of 7:4 and 4:6
respectively, whilst the control and bipolar groups used in the
flux studies had male:female ratios of 9:3 and 4:8 respectively.
The effect of such differences on, for example, ouabain binding,
is not clear as although Erdmann and Hasse (1975) reported no
effect of age or sex on sodium pump number or affinity of ouabain
binding in human erythrocytes, Naylor et al. (1980) found lower
sodium pump numbers in erythrocytes from normal females over 50
years of age, than in a comparable group under 40 years old.
Whether this is a menopausal effect or related to ageing is not
clear. Such a correlation can not be seen in the female bipolar
cell lines used in this study, but it is conceivable that the
lack of age and sex matched controls in this study may influence
the results and this possibility must be borne in mind in their
interpretation.
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The other possible major external influence on this study is
the transformation of cell lines in different laboratories, with
all but one of the control cell lines being provided by a
different laboratory to the bipolar cell lines. Similar
protocols were used as discussed in the previous chapter and so
no difference would be expected. The majority of the cell lines
were established within a year of each other and so the time in
culture should be similar. It is notable that the cell lines
from the Dundee laboratory possess greater volumes than the
majority of the other cell lines and lower bumetanide-sensitive
K+ fluxes. The reason for this is not clear. As demonstrated
in the previous chapter there are slight differences in the rate
of growth between the various cell lines. This did not seem to
depend upon the clinical status of the cell line though and was
thought to have little influence over any differences seen
between bipolar and control cell lines.
In agreement with the results of Dagher et a1. (1984) using
erythrocytes, no difference was seen between bipolar and control
subjects in the diuretic-sensitive cotransport or passive leak K+
fluxes of the lymphob1astoid cell lines used in this study. In
contrast to the results of Dagher et al. (1984), Naylor et al.
(1973), Rybakowski et al. (1981, 1983), and Hokin-Neaverson
et al. (1974) using erythrocytes, no difference was found between
bipolar and control subjects as regards ouabain-sensitive flux
per cell. Rybakowski et al. (1981) and Thakar et al. (1985) did
not however find any difference between the Na+/K+-ATPase
activity of control subjects and bipolar patients in remission.
It is possible therefore that during depression and/or mania, the
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apparently normal level of activity of the sodium pump is altered
by either a change in susceptibility to some endogenous modifying
factor, or that an alteration in the level of a modifying factor
occurs. Whereas in the patient, parameters can be compared
during the depressed phase, the manic phase, and remission, and
can also be compared with non-psychiatric controls, the
lymphoblastoid cell lines used here are presumably outwith the
phasic nature of the illness if determined by some endogenous
factor, and correspond to the remission state of the patient.
If this is the case, a difference may not be seen in the
lymphoblastoid cell lines used here unless the cation transport
systems are experimentally stressed.
of the study are discussed later.
The higher mean number of sodium pumps per cell found in this
study in the bipolar lymphoblastoid cell lines compared with
control cell lines has not been reported before. Whether this
The results of this part
correlates with altered ion contents of the cells could not be
determined due to the difficulty in measuring ions. The finding
by Sengupta et al. (1980) of higher total Na+/K+-ATPase activity
in erythrocytes and platelets of manic and depressed patients may
have been due to a similarly increased number of sodium pumps per
cell but alternatively may have been due to an increased activity
per pump or to poor experimental.technique. Although it is not
possible to determine the exact flux per pump in this study due
to the variability from day to day in the parameters measured, if
the overall mean values for flux and sodium pump number in each
group are used, it would appear that the activity per pump is
reduced in bipolar cell lines compared with controls. The
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combination of higher pump numbers with reduced activity per pump
produces no overall difference in total ouabain-sensitive K+
influx per cell between bipolar and control cell lines. If this
is the case, whether the increased pump number is a homeostatic
mechanism to compensate for the reduced activity or vice versa is
not clear. By stressing the transport systems of the cells
using, for example, ouabain, and establishing whether or not
bipolar cell lines compensate by increasing their flux per pump,
it may be possible to differentiate between these possibilities.
This is purely speculative however, as it is impossible to say
whether this is a real difference in pump activity unless the
sodium pump numbers are determined on the cell lines at the same
time as the ouabain-sensitive flux. The report by Naylor et al.
(1980) of a lower activity per pump site in erythrocytes from
female manic and depressed patients compared with a recovered
group would be in agreement with such a finding although they
found no difference in sodium pump numbers.
The use of cell lines from family members of the proband
reduces the effects of environmental and genetic heterogeneity
present within the general population, on the results. The day
to day variability in the results complicates the analysis but if
the higher specific ouabain binding is used as a marker for the
illness, it would appear that 08-04 may be affected whereas 08-02
would be normal. The predictions in the family of 10-01 would
be more difficult due to the greater variation and may appear to
all be normal. Unfortunately the clinical status of the family
members have not yet been obtained from the double-blind study
instigated in the USA so these predictions can not be checked.
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As already reviewed in Chapter 1, whether the transmission of
bipolar manic depressive psychosis is polygenic or due to a
single gene is not clear. In addition the possibility of
genetic heterogeneity and/or reduced penetrance are complicating
factors and if this is the case a "marker" would not be expected
to be exclusively present in affected subjects but would occur
with greater frequency in this group compared with normal
individuals (Gershon et al. 1977). With the considerable
overlap of ouabain binding values for bipolar and control
subjects however, even if the day to day variation was not
present this paramater would probably be of little use as a
predictive aid but its·identification as a "marker" would be of
considerable help in determining the precise aetiology of the
illness and may be useful in predicting relative susceptibility
to the illness.
The source of the day to day variability in each cell line
during this study is not clear. In addition to the variation
seen in the basal values of the parameters measured, inconsistent
treatment effects were seen in many cell lines, with the
exception of the effect of ouabain on sodium pump number. The
effects of the various treatments are discussed further later in
this section. Such variation has also been reported in the
beta-adrenergic receptor numbers of these cell lines (Wright -
personal communication). The reason for the variation could not
be determined. Experiments were performed using the same
protocol each time and all medium changes were kept to the same
routine with the cell lines being exposed to identical conditions
in culture. The slight variations between the growth rates of
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the various cell lines would not explain the day to day
variations seen within the same cell line, and all medium changes
were kept to the same routine relative to the time of the
experiment in order to minimise possible differential effects of
the phase of growth of the cell lines. There did not appear to
be any relationship between the variation in flux measurements
and the variable seeding density of the cell lines. One obvious
candidate for the source of variation was the foetal calf serum.
However variation in results was seen even within the same batch
of serum and this was discounted. Retrospectively, in view of
such variation, it would be advisable to carry out the ouabain
binding studies on the same day as the flux measurements.
The effects of viral transformation on the para~eters measured
here have not been documented in the literature. Studies hy
Boon et al. (1984) and Pedersen and Klitgaard (1983) using non-
transformed lymphocytes show similar time courses of ouabain
binding to those found for the transformed lymphocytes in this
study. The number of sodium pumps per cell (37000 - 43000)
however is approximately one tenth of that found in transformed
lymphocytes and represents a density of approximately 200
sites/u2 of membrane, assuming the cells are perfect spheres.
The volume of the non-transformed cells is also considerably
smaller than that of the transformed cells i.e. 314 u3 compared
with 1582 u3• This is probably due to the reversion of the
lymphocytes to "blast-like" forms upon transformation and would
largely account for the differences in specific ouabain binding
per cell. However, assuming the cells are perfect spheres, the
density of the pump sites in the transformed cells would still be
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greater than that of the non-transformed i.e. 590 or 715 sites/u2
(control or bipolar respectively) versus 200 sites/u2• The
limitations of making such an approximation for cell surface area
have already been discussed in Chapter 3 and apply equally to
lymphocytes (see Figure 5.5 in Chapter 5). Whether this
difference in sodium pump density (wi~hin the limitations of the
approximation) is due solely to the viral transformation is not
clear. A 50% increase in sodium pump numbers has been found for
example in non-transformed lymphocytes cultured for 24 hours in
RPMI containing 10% foetal calf serum (Oh et al. 1983).
It must also be appreciated that the non-transformed
populations of cells used in these studies were a mixture of B
and T lymphocytes (probably mainly T) compared with the
transformed populations which are thought to be B in origin but
may represent an earlier stage in the development with the
potential to be either B or T cells (see Chapter 5). Whether
any differences exist between Band T lymphocytes with regard to
sodium pump number is not known. The change in volume seen with
transformation seems to be more pronounced in some cell lines
than others, particularly the cells supplied by Dundee. The
only obvious difference between these cell lines and the
remainder is their slightly longer period in culture.
The ouabain-sensitive 86Rb influx reported by Oh and Taylor
(1985) is considerably smaller per cell for non-transformed
lymphocytes (9.18 pmol/hr/l06 cells) and can not be accounted for
solely by the differences discussed above. If the K+ influx per
pump site is calculated using the results of the 86Rb influx and
ouabain binding studies of Oh and Taylor (1985) for the non-
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transformed lymphocytes (L.e, 9.18 pmol/106 cells/hr and 45,000
sites/cell) and the mean results for the control tranformed cell
lines in this study bearing in mind the variability, there
appears to be a large difference in the pump turnover rate with
approximately 2 K+ ions transported per site per minute in the
non-transformed lymphocytes compared with approximately 1950 in
the transformed lines. The flux values reported by Oh and
Taylor (1985) appear to be much lower than those reported in
other studies. For example Bui and Wiley (1981) report a
ouabain-sensitive K+ influx of 3.3 nmol/10G cells/hour in a mixed
lymphocyte population with an average cell volume of 211 u3•
The ouabain-sensitive K+ influx was found to represent
approximately 70% of the total K+ influx, in good agreement with
the figure of 68% found for transformed lymphocytes in this
study. Unfortunately sodium pump site numbers were not
determined in the study by Bui and Wiley (1981), but if the mean
figure of 40,000 sites per cell is used from the above studies by
Pedersen and Klitgaard (1983) and Boon et al. (1984), a pump
turnover rate of approximately 900 K+ ions transported per site
per minute is found. This may be an underestimate since
assuming the same sodium pump density per area of membrane in the
various studies, there are probably less pump sites per
lymphocyte in the study by Bui and Wiley (1981) due to their
smaller volume. It is possible that the units of measurement
quoted by Oh and Taylor (1985) should actually be nmol/10G
cells/hour in which case there is no difference between the flux
per pump in transformed and non-transformed cells. This
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uncertainty coupled with the variability of the flux results in
the transformed lymphocytes does not allow firm conclusions to be
drawn regarding the activity per sodium pump but it would appear
that if there are differences in activity per pump between
transformed and non-transformed lymphocytes, the transformed
lymphocytes have a greater flux per pump per minute by a factor
of 2 a t the most.
The diuretic-sensitive and passive le~k K+ pathways of the
lymphoblastoid cell lines used in this study are relatively small
and in some cases nearly zero. As already discussed in Chapter
3, the role of the diuretic-sensitive pathway is not entirely
clear and depends on the cell type e.g. it has been implicated in
volume regulation in duck erythrocytes under certain conditions
(Kregenow - from Saier Jr. and Boyden 1984). In non-transformed
lymphocytes however, it would appear that the RVD associated with
suspension in hypotonic medium is associated with a loss of KCl,
probably by independent pathways and in the case of K+, dependent
on Ca2+ (Grinstein et al. 1984). This occurs much more rapidly
in T lymphocytes compared with B lymphocytes. RVI is only seen
in lymphocytes if hypotonically pre-equilibrated and then
returned to isotonic medium (Grinstein et al. 1984). This is
due to an exchange of Na+ for H+ through an amiloride-sensitive
pathway, and an exchange of Cl- for HC03- similar to that seen in
Amphiuma red blood cells (Cala 1980). The diuretic-sensitive
pathway does not appear to be physiologically involved in volume
regulation in lymphocytes and judging by its magnitude relative
to the ouabain-sensitive pathway in lymphocytes its function may
be not only less apparent but also less important under control
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conditions.
The lack of effect of lithium treatment on either K+ influx or
ouabain binding may be due to the relatively short incubation (24
hours) compared with the time taken before therapeutic effects
are seen in patients. The delay between treatment onset and
therapeutic effects (2 - 3 weeks) is thought to be the time taken
for the blood lithium to reach therapeutic levels. If the
therapeutic effect of lithium is due to an induction of increased
Na+/K+-ATPase activity such as that reported in erythrocyte
membranes from lithium-treated bipolar patients (Naylor et al.
1974, Hesketh 1976), this may be due to either an increased
activity per pump or an increased number of pumps. Lithium has
been reported to produce an increased number of sodium pumps in
He La cells albeit at higher than therapeutic levels (Boardman
et al. 1975) within 24 hours. It is possible that at
therapeutic levels, longer than 24 hours is necessary before such
changes are seen. Future studies with the lymphocyte cell lines
involving longer treatment periods may reveal changes in sodium
pump numbers with lithium treatment and differences in response
between the control and bipolar groups.
Vanadate also produced no consistent effect on the
lymphoblastoid cell lines, despite using higher levels than
normally found in the blood. Based on the results of the
vanadate experiments using HeLa cells, no effect on fluxes would
have been expected, probably due to the intracellular reduction
of vanadate to vanadyl. Changes could have been no t ed if the
lymphoblastoid cell lines were less capable of reduction, or some
defect was present for example in the bipolar group conferring
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upon them a susceptibility to vanadium as suggested by Dick
et al. (1980). Based on the results in this study this does not
appear to be the case.
The effects of ouabain on sodium pump numbers were very
consistent and revealed no difference between the two groups of
cell lines. Only approximately half the cell lines which showed
this decrease in pump numbers showed a concomitant decrease in
the ouabain-sensitive flux. The cell lines showing the decrease
in flux were not confined to either of the two groups however and
the magnitude of the mean decrease was not significantly
different in either group. It is possible that if the ouabain
treatment had been continued over a longer time period, a
compensatory up-regulation of sodium pump numbers may have
occurred which may vary depending on whether control or bipolar.
There are a number of possible ways in which cation transport
may be involved in the aetiology of bipolar manic-depressive
psychosis:- i). differences may be present in basal values and
may account for the illness, ii). no difference may be present
in basal values but in bipolars and controls, susceptibility to
modifying factors may be different, iii). no difference in
either basal values or susceptibility may be present but levels
of endogenous modifying factors may be different in the two
groups. Alternatively any changes in ion transport in the
illness may be secondary to another change e.g. in the endocrine
system, which only occurs in the affected group. The reason for
the phasic nature of the illness is not clear. Based on the
results in this study, there seems to be a difference in basal
sodium pump site number but no difference in total ouabain-
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sensitive flux, hence it is unlikely that this single difference
is totally responsible for the disorder. Unless any possible
modifying factor has a specific action which is not seen with any
of the treatments used here, the second possibility is unlikely.
The third possibility has not been investigated in this study
with the exception of the possibility of vanadium as the
endogenous modifying factor. The involvement of vanadium is not
supported by this study but other modifying factors can not be
ruled out and changes in ion transport occurring secondarily to
some other change but being responsible for some of the symptoms
can also not be ruled out. In addition if the ouabain binding
and flux measurements were carried out on the same day, a clearer
picture may have emerged.
In summary therefore, no difference has been detected between
lymphoblastoid cell lines from control subjects and bipolar
patients as regards the K+ influx pathways although the
investigation was complicated by the considerable variation which
was seen from day to day in each cell line. The source of this
variation is not known. The bipolar group however have a higher
mean specific ouabain binding value which is statistically
significant. This may be due in part to the lack of age and
sex-matched controls and needs to be investigated further.
Transformation of the cells may also have influenced the sodium
pump number and differences can be found between transformed and
non-transformed cells, mos t notably in the cell volume. The
flux per pump site could not be determined due to the fact that
the flux experiments and ouabain binding measurements were
carried out on different days and the day to day variability made
209
the use of mean values questionable. Due to experimental
difficulties, the measurement of intracellular ions was not
possible. No consistent effect of vanadate or lithium (24
hours) was seen on ouabain binding or K+ influx, in either group.
The decrease in sodium pump numbers with ouabain treatment was
similar in both groups, both with respect to the number of cell
lines affected and the magnitude of the change. Overall no
difference was seen between the bipolar and control groups, in
the susceptibility of the cation transport systems to either
lit~ium, ouabain or vanadate, although significant differences in
basal pump numbers were found. What we can not conclude
directly from this study is whether or not transformation has
al tered any possible existing differences between bipolar and
control subjects with regard to cation transport, and whether the
results can be extrapolated to the brain.
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CHAPTER 7. PHOSPHATIDYLINOSITOL TURNOVER IN LYMPHOBLASTOID CELL
LINES FROM BIPOLAR MANIC-DEPRESSIVE PATIENTS AND CONTROL SUBJECTS
7.1. INTRODUCTION
7.I.i. Receptor signalling mechanisms
Cells employ various intracellular transduction or "2nd
messenger" systems which translate receptor-mediated information
such as the presence of hormones, growth factors,
neurotransmitters etc., into cellular responses. Probably the
best characterised of these systems is that involving cyclic AMP
in which binding of, for example, beta-adrenergic agonists to
receptors, activates the enzyme adenylate cyclase and results in
increased intracellular levels of the 2nd messenger, cyclic AMP.
This then mediates the cellular response.
Less well characterised, at least until fairly recently, is
the phosphatidylinositol (PtdIns or monophosphoinositide) system
whereby stimulation of, for example, alphal-adrenergic receptors,
provokes hydrolysis of membrane-bound inositol phospholipids and
a consequent increase in the level of the 2nd messenger,
inositol-l,4,5-trisphosphate (IP3). This results in a
mobilisation of Ca2+ and produces the appropriate cellular
response. A brief overview of this very complex system is
presented in the following sections, together with its possible
involvement in the aetiology of manic-depressive psychosis.
Further details can be found in the cited reviews and.references.
7.I.ii. Receptor-stimulated inositol phospholipid metabolism
Ptdlns consists of phosphatidate (diacylglycerol-3-phosphate;
i.e. a glycerol backbone with 2 fatty acid chains, usually
predominantly arachidonic and stearic acid in animal cells, and
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esterified to phosphoric acid) attached to the I-hydroxyl of myo-
inositol, a cyclic 6 carbon alcohol. Ptdlns is formed together
wi th CMP, by the enzyma tically-catalysed combina tion of CDP-
diacylglycerol with myo-inosito1 (Hawthorne 1982, Hokin 1985).
Of the possible stereoisomers, only the optically inactive myo-
inositol has been found in naturally-occurring Ptdlns and its
phosphorylated derivatives, phosphatidylinositol-4-phosphate
(Ptdlns(4)P or diphosphoinositide) and phosphatidylinositol-4,5-
bisphosphate (Ptdlns(4,5)P2 or triphosphoinositide; Hawthorne
1982). The structures and metabolism of these compounds are
shown in Figure 7.1.. The kinases responsible for the
sequential phosphorylation of the inositol ring both require
2+Mg , and the presence of the phosphate groups confers on the
polyphosphoinositides the property of being the most polar
phospholipids (Downes 1983). Phosphomonoesterases reverse this
phosphorylation and there is a constant futile cycling between
the 3 pools with the turnover of the whole pools occurring within
minutes in many cell types (Downes 1983, Berridge and Irvine
1984). Whether these enzymes are membrane-bound or soluble
appears to depend on the tissue (Michell 1975, Hokin 1985).
The inositol phospholipids usually account for less than 10%
of the total phospholipid in animal cells with the actual amount
varying depending on the tissue, and with Ptdlns representing
over 90% of this (Michell 1975, Hawthorne 1982, Hokin 1985,
Williamson 1986). Most of the di- and triphosphoinositides are
thought to be located within the plasma membrane, probably near
the inner face, together with a small amount of the Ptdlns; the
majority of the Ptdlns is in the endoplasmic reticulum (E.R.)
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where it is thought to be synthesised (Hawthorne 1982, Hokin
1985). Whether a closed cycle of Ptdlns transport exists
between the membrane and E.R. is not known (Hokin 1985).
The stimulation of phosphoinositide metabolism in response to
external stimuli was first identified by Hokin and Hokin in the
early 1950's using avian pancreas (reviewed by Hokin 1985) when
they demonstrated an increased incorporation of 32p into PtdIns,
following stimulation with acetylcholine. Subsequently,
stimulation of the hydrolysis of PtdIns(4,5)P2 has been
demonstrated in many tissues e.g. brain, parotid gland, liver,
platelets, adrenal cortex, and T-lymphob1astoid cells, involving
many receptor types e.g. muscarinic-cholinergic, serotoninergic,
alpha-adrenergic, histaminergic, phytohaemagglutinin (PHA), and
platelet derived growth factor (PDGF), to name but a few
(reviewed by Berridge and Irvine 1984, Hokin 1985). In 1975
Michell proposed that the stimulation of inositide metabolism was
a feature of those agonists which produced raised intracellular
[Ca2+] levels. This is true in the majority of cases, but
mobilisation of Ca2+ has been shown to occur without changes in
phosphoinositide metabolism (reviewed by Berridge and Irvine
1984). Michell's hypothesis accounted for the raised Ca2+ by
proposing a "gating" of Ca2+ through channels in the membrane as
a result of PtdIns hydrolsis (Michell 1975, Michell et al. 1981).
Subsequently however it has been shown that the Ca2+ release
appears to occur from intracellular stores and that hydrolysis of
PtdIns(4,5)P2 Is the initial event, as discussed below.
The proposed metabolism of the inositol phospholipids is shown
in Figure 7.1.. The agonist binding to the external receptor
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stimulates the hydrolysis of PtdIns(4,5)P2 by a phosphodiesterase
(PDE:- a phospholipase C) forming diacylglycerol (DAG) and the
water-soluble IP3 (Berridge and Irvine 1984, lHlliamson 1986).
Controversy exists as to whether this PDE is cytosolic or
membrane-bound (Hokin 1982, Hokin 1985, Plantavid et al. 1986),
and the mechanism of coupling of receptors to the PDE with the
resulting hydrolysis of the phosphoinositides is unclear. It is
possible that the agonist binding to the receptor induces a
conformational change in the receptor and perturbs the membrane
so that the PDE, whether membrane-bound or cytosolic, has access
to the substrate (Berridge and Irvine 1984, Plantavid et al.
1986). However it has also been proposed that the PDE activity
may be modulated by a GTP-binding protein in a similar fashion to
the coupling of adenylate cyclase activity with receptor
occupation (reviewed by Berridge and Irvine 1984, Williamson
1986).
The IP3 produced is then thought to bind to a specific
receptor on the E.R. and cause the release of Ca2+ (Berridge and
Irvine 1984). The Ca2+ released is thought to mediate the cell
response through changes in the activity of various proteins
including protein kinases, either directly or after binding to
calmodulin or other Ca2+-binding proteins (Downes 1983, Wi1lamson
1986). Spat et al. (1986) have demonstrated the presence of a
specific intracellular receptor for IP3 in permeabilised guinea-
pig hepatocytes and rabbit neutrophils. Binding to the receptor
is saturable, reversible and restricted to those inositol
phosphates such as inositol l,4,5-trisphosphate which had
previously been shown to invoke Ca2+ mobilisation.
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The removal of IP3 is accomplished by an inositol
trisphosphatase which results in the formation of inositol 1,4-
bisphosphate (IP2 • This is also hydrolysed forming inositol-1-
phosphate (lP), or in some cases inositol-4-phosphate, and
subsequently free inositol. The inositol then combines with the
COP-OAG formed from the OAG produced by the initial receptor-
stimulated PDE activity, to form Ptdlns. Thus the intracellular
levels of IP3 and OAG are determined by a balance between their
rate of formation and rate of removal (Berridge and Irvine 1984).
In many cases, a dissociation between the physiological
response and the phosphoinositide effects is seen at increasing
agonist concentrations (Hokin 1985), e.g. 5-HT stimulation of
salivary gland in Calliphora (Berridge et al. 1982). This is
thought to be due to the existence of spare receptors for the
agonist-induced response whereas the phospholipid effect
corresponds much more closely to receptor occupancy.
Initially, it was unclear whether the increased inositol
phospholipid metabolism following agonist stimulation occurred as
a consequence of the increased intracellular [Ca2+] or vice
versa. However, following the discovery by Michell et"al.
(1981) that in rat hepatocytes stimulated by antidiuretic hormone
(ADH or vasopressin), the decrease in PtdIns(4,5)P2 preceded the
change in PtdIns and was largely independent of extracellular
Ca2+, it appeared that the triphosphoinositide hydrolysis was the
initial event and preceded any changes in Ca2+. This has since
been confirmed in many other tissues (reviewed by Berridge and
Irvine 1984), although partial dependence on Ca2+ has also been
reported in some tissues (Berridge and Irvine 1984, Michell 1975,
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Michell et al. 1981, Michell 1982), together with an induction of
phosphoinositide hydrolysis by the ionophore A23187. However it
has recently been suggested that this latter effect in smooth
muscle is not due to increased Ca2+ but is due to increased
acetylcholine release (Hokin 1985). Such partial dependence on
Ca2+ is not irreconcilable with the model as it does not
constitute proof that a change in cytosol Ca2+ causes the change
in phosphoinositide metabolism (Michell et al. 1981, Michell
1982). For example, the phosphoinositide phosphodiesterases are
Ca2+ -dependent but do not require elevated Ca2+ levels and are
therefore not normally ratelimiting (Hokin 1985).
IP3 formation in Calliphora salivary glands has also been
shown to occur at least 1 second before the onset of the calcium-
dependent cellular response and led to the initial suggestion
that IP3 was the 2nd messenger (Berridge 1983, Berridge and
Irvine 1984). In addition IP3 has been demonstrated to form
before IP (the expected product of PtdIns hydrolysis) in for
example, Calliphora salivary glands (Berridge 1983), rat parotid
glands (Downes and Wusteman 1983), and human platelets (Siess and
Binder 1985), providing more evidence that PtdIns(4,5)P2 is the
primary substrate for the receptor. Other evidence which
indicates that Ca2+ mobilisation is a consequence of
phosphoinositide metabolism includes the fact that in human
platelet membranes, the phospholipase C responsible for the
hydrolysis of PtdIns(4,5)P2 to IP3 does not require increased
Ca2+ levels for activation (Plantavid et al. 1986). Similarly
in human neutrophils, IP3 production has been shown to occur at
basal intracellular [Ca2+1 (Di Virgilio et al. 1985). Results
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using carbachol-stimulated pel2 cells support phosphoinositide
hydrolysis and ea2+ mobilisation as being successive events with
ea2+ mobilisation occuring last, as the ea2+ signal can be
abolished without any effect on the inositol phosphate generation
(Vicentini et al. 1986). Lew et al. (1986) have shown tha t in
the human promyelocytic cell line HL-60, the receptor-triggered
PtdIns(4,S)bisphosphate phosphodiesterase activation does not
require elevated ea2+ levels, and elevated ea2+ levels above
micromolar decrease the agonist induced rise in inositol 1,4,5-
trisphosphate, thus acting as a negative feedback mechanism.
The release of intracel1ularly sequestered ea2+ is thought to
occur from the E.R. rather than the mitochondria and experiments
have indicated that it is due to a stimulation of ea2+ efflux
from the stores rather than an inhibition of uptake. Using
permeabilised cell models, IP3 has been shown to be a very potent.
sti mula tor of ea2+ release, producing half-maxi mal effects at
concentrations less than 1 uM in many cases. IP2 and IP are
however, ineffective (reviewed by Berridge and Irvine 1984).
The mobilisation of Ca2+ is thought to be an amplification step
and it has been calculated that in permeabilised liver cells,
each IP3 molecule releases at least 20 ea2+ ions (Berridge and
Irvine 1984). In order to maintain these raised intracellular
ea2+ levels long enough for the cellular response to be produced,
some inhibition of the ea2+-ATPase on the cell membrane is likely
as intracellular stores would not be sufficient to maintain these
levels for very long and therefore extracellular ea2+ is needed
to maintain the response (Hokin 1985, Williamson 1986). It has
been hypothesised that since PtdIns(4,5)P2 regulates membrane
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fluidity in erythrocytes (Sheetz et al. 1982), as it is consumed
during hydrolysis, this may perturb the membrane in such a way as
to alter Ca2+ removal across the membrane (Berridge and Irvine
1984). IP3 has also been shown to cause Ca2+ release from the
sarcoplasmic reticulum of rabbit skeletal muscle (Volpe et al.
1985) but the physiological implications of this are not yet
clear.
The situation has been further complicated by the discovery of
two naturally-occurring isomers of IP3 in carbachol-stimulated
rat parotid glands (Irvine et al. 1984), D-myo-inositoll,4,5-
trisphosphate and D- or L-myo-inositol 1,3,4-trisphosphate. The
kinetics of the production of these two isomers has been
investigated in·carbachol-stimulated (15 minutes), 3H-inositol-
loaded rat parotid gland, using HPLC to separate the isomers
(Irvine et al. 1985). The most marked increase in levels of the
1,4,5, isomer of IP3 occurs in the first 5 seconds with levels
then decLdnfngt;o control values and gradually increasing over
the following 15 minutes. The increased levels after 15 minutes
were abolished if an antagonist was introduced. In contrast,
the increase in the level of the 1,3,4 isomer was delayed, being
greater than that of the 1,4,5 isomer by 15 seconds and
continuing to rise at a faster rate over the following 15
minutes. If an antagonist was introduced, the levels did not
reach control values for at least 15 minutes. The specific
activities of these pools relative to each other were not known
however so caution must be exerted and exact magnitudes of
increases not known, but it appears that the 1,4,5 isomer appears
to behave more like a 2nd messenger. It is obvious though that
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the differing kinetics of the production of the two isomers will
complicate the analysis of IP3 production unless both are
examined as separated entities. For example, Downes and
Wusteman (1983) calculated that on the basis of the differing
rates of hydrolysis of IP3 and IP2' not all the IP2 could be
produced by IP3 and proposed an additional phosphodiesteratic
cleavage of Ptdlns(4)P forming IP2 to account for this. However
if the differing kinetics of the two IP3 isomers are taken into
account, this may not be the case. Most studies have failed to
differentiate between the two and the term IP3 will be used to
include both isomers unless otherwise indicated.
Batty et a1. (198S) have since found inositol 1,3,4,S-
tetrakisphosphate (IP4) in rat cerebral cortex after muscarinic
stimulation and this has been confirmed in GH4 cells by Heslop
et al. (198S), together with the presence of inositol
pentakisphosphate (IPS) and inositol hexakisphosphate (IP~. It
was postulated that these compounds were formed from the
successive phosphorylation of IP3 although formation as a result
of phosphodiesteratic attack on possible corresponding
polyphosphoinositides can not be ruled out. The possibility of
these compounds also having a role as 2nd messengers can not be
confirmed without further investigation. A specific inositol
1,4,S-trisphosphate kinase which produces inositol l,3,4,S-
tetrakisphosphate (IP4) has been found in rat liver, brain and
pancreas (Irvine et al. 1986). This kinase is ATP and Mg2+-
dependent and is thought to playa possible role in aiding the
curtailment of IP3 activity by forming first IP4' then the 1,3,4
isomer of IP) and then IP2 although this last step has not yet
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been established. In support of this hypothesis, it has been
shown using the human promyelocytic cell line HL-60, that
inositol 1,3,4-trisphosphate generation appears to be favoured
both by increased Ca2+ levels, and by increased inositoll,4,5-
trisphosphate levels (Lew et al. 1986).
nAG is also thought to function as a 2nd messenger as outlined
below. In many tissues an increase in cyclic GMP is seen with
the phosphoinositide response and this is thought to occur as a
consequence of the arachidonate released upon nAG breakdown
(Hokin 1985). The possibility of synergism between nAG, IP3 and
Ca2+ has been reviewed by Berridge and Irvine (lQR4), Nishizuka
(1984) and Hokin (1985).
Both IP3 and nAG, which is transiently produced as a result of
the inositol phospholipid metabolism before being presumably
recycled to form PtdIns, have been implicated in normal cellular
prolifera tion and prolifera tion occurring as a result of
oncogenic stimulation. For example, pnGF has been shown to
increase the formation of nAG and IP3 in Swiss 3T3 cells
(Hasegawa-Sasaki 1985). Both intracellular pH and [Ca2+] are
thought to be important in the regulation of cell growth. nAG
stimulates the Ca2+-activated membrane-bound enzyme, protein
kinase C by increasing its affinity for Ca2+ thereby activating
it without any change in intracellular Ca2+ levels (reviewed by
Nishizuka 1984, Hokin 1985). This enzyme has multifunctional
catalytic activity and one of its actions, either directly or
indirectly, is to produce an activation of the amiloride-
sensitive Na+/H+ exchanger, increasing the intracellular pH.
IP3 of course increases the intracellular [Ca2+]. Thus
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stimulation of the receptor by PDGF activates two signal pathways
which are thought to be involved in cellular proliferation
(Berridge and Irvine 1984). In addition, PDGF has been shown to
activate a PDGF-dependent tyrosine-specific protein kinase but
whether these actions are connected or act synergistically in
inducing cellular proliferation has not been determined
(Hasegawa-Sasaki 1985). Oncogenes may also produce similar
effects as it is known that the sis-oncogene codes for a protein
almost identical to PDGF, and the erb-B gene codes for a receptor
similar to that for EGF (Berridge and Irvine 1984, Hokin 1985).
In addi tion, the tumour promoting phorbol esters act on the
protein kinase e in a similar fashion to DAG and it has been
proposed that protein kinase e may be the receptor for tumour
promoters (Nishizuka 1984). The phorbo1 esters have also been
shown to phosphorylate proteins at tyrosine residues in
fibroblasts (Gilmore and Martin 1983). Protein kinase e is a
serine/threonine specific kinase and therefore it appears that
either other kinases are acted upon by DAG and TPA in addition to
kinase e, or that the activation of kinase e may result in the
activation, either directly or indirectly, of tyrosine-specific
kinases. The function of the phosphorylated protein is not
known. The reason why such effects on cell growth are not seen
with all the agents which stimulate hydrolysis of
phosphoinositides is not clear unless for example, the magnitude
of the effect is different due to a control defect, and/or
additional effects of these agents are also important e.g. the
tyrosine-specific kinase activity maY,be needed in addition to
the stimulation of inositol phospholipid metabolism. Nishizuka
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(1984) has speculated that in carcinogenic cells, the protein
kinase C may be a mutant uncontrolled form.
7.1.111. Possible role of phosphoinositides and inositol
phosphates in the aetiology of bipolar manic-depressive psychosis
Many of the initial studIes into inositol phospholipid
metabolism have measured incorporation of either 32p or 3H-
inositol into the various pools before and after agonist
stimulation. Initially, because of the difficulties of knowing
whether all the pools were in isotopic equilibrium and hence
whether changes in activity could be regarded as changes in pool
size, together with the simultaneous occurrence of both synthesis
and breakdown of the various pools, the results were difficult to
interpret. Following the discovery that lithium decreased the
concentration of myo-inosito1 in the cerebral cortex of rats
(Allison and Stewart 1971, Allison et al. 1976, Allison and
B1isner 1976), further studies revealed that this was most likely
due to an inhibition of the enzyme myo-inositol I-phosphatase
(Hallcher and Sherman 1980, Sherman et al. 1981). Lithium has
since been used as a selective inhibitor of this enzyme in many
studies of phosphoinositide metabolism as it allows the effects
of agonists to be visualised much more easily due to the
accumulation of IP and depletion of the inositol pool.
This action of lithium has obvious implications for the
aetiology of manic-depressive psychosis. As discussed in
Chapter 1, the actions of lithium which are responsible for its
therapeutic affects in this illness are not entirely clear and it
is possible that lithium may modify neurotransmitter-mediated
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responses in the brain via the PtdIns system. In several
tissues it has been shown that half-maximal effects of lithium on
IP accumulation and inositol depletion occur at approximately ImM
lithium (Berridge et al. 1982, Hokin 1985), Le. the therapeutic
concentration in man. In quiescent cells, little effect of
lithium is seen, and this has been ascribed to the low basal
turnover of the inositol phosphates. With increasing receptor
occupancy by 5-HT in the blowfly salivary gland (Berridge et al.
1982), increasing effects of lithium were seen, presumably due to
the increased inositol phospholipid metabolism with increasing
receptor occupancy as shown in ADH-stimulated rat hepatocytes for
example (Michell et al. 19A1). This may imply that lithium
preferentially affects those receptor pathways that are
abnormally active and may account for its effectiveness in both
mania and depression. The time lag before the onset of
therapeutic actions of lithium in man may be due largely to the
time taken for serum concentrations of lithium to reach
therapeutic levels but may also be due in part to the time taken
to deplete the intracellular inositol stores. Thus if
depression was due to e.g. a supersensitivity of receptors which
involve phosphoinositide metabolism, e.g. 5-HT or alpha-
adrenergic, as discussed in Chapter 1, continual agonist
stimulation in the presence of lithium may produce a depletion of
inositol and hence phosphoinositides, and eventually reduce the
receptor-mediated response (Berridge et al. 1982).
Many peripheral receptors where agonist stimulation promotes
phosphoinositide hydrolysis e.g. muscarinic in pancreas and
smooth muscle, are not susceptible to the actions of lithium
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(Berridge et al. 1982). This may be due to the fact that they
can readily replenish their inositol pool from extracellular
sources and it has been shown for example that the serum
[inositol] of rats increases with lithium treatment (Allison and
Stewart 1971, Allison and Blisner 1976). This may be a
protective effect for peripheral tissues. Inositol can not
however cross the blood-brain barrier (Margolis et al. 1971, from
Berridge et al. 1982) and brain cells must synthesise some of
their inositol from glucose via the L-isomer of inositol-l-
phosphate. The remainder is thought to be taken up across the
choroid plexus into the CSF (Spector 1976). Thus brain tissue
will be more susceptible to the actions of lithium, especially
any hyperactive pathways.
Using fluorescence spectroscopy, with fluorescent probes of
known affinity for specific regions of cell membranes, Pettegrew
et al. (1982) have demonstrated abnormalities of the hydrocarbon
region of the plasma membrane of erythrocyt~s and the surface of
lymphocyte plasma membranes, in manic-depressive patients. This
would also be in keeping with a possible role for phospholipids
in the aetiology of manic-depressive psychosis.
This part of the study is aimed at using the 1ymphoblastoid
cell lines from manic-depressive patients and control subjects
and examining them for any differences in the metabolism of
phosphoinositides and inositol phosphates which may possibly
underlie the illness. Speculation as to the possible defect in
the PtdIns system, if indeed there is one, is discussed at the
end of the chapter.
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7.11. MATERIALS AND METHODS
7.11.i. Reagents
Reagents used were purchased from the following:-
AIfa ChemIcals Ltd. (Wokingham, Be~s.):- Versilube FSO.
Aaersham International (Amersham, Bucks.):- D-myo-[2-
3H]1nositol (16.3 Ci/mmol), D-myo-[2-3H]lnositol I-phosphate (IP;
1.0 Ci/mmol), D-myo-[2-3H]Inositoll,4-bisphosphate (IP2; 1.0
Ci/mmol), and D-myo-[2-3H]lnositol 1,4,5-trisphosphate (IP3; 1.0
Ci/mmol).
BDH Chemicals (Poole, Dorset):-
H.COONH4, concentrated acetic and hydrochloric acids (all Analar
grade), methanol, acetone and chloroform (all chromatographic
grade), "Cocktail T·'scintillant, and Merck Kieselgel 60 HPTLC
(10 x 20 cm) and TLC (20 x 20 cm) plates.
Capi tal BPLC (Edinburgh, Scotland):-
Partisll 10 HPLC column.
250 x 4 mm i.d. SAX-
Coulter Electronics Ltd. (Luton, Beds.):- Isoton.
Cibco-Biocult (Paisley, Scotland):- all tissue culture supplies
as detailed in Section 5.II.i., and inositol-free RPMI-1640 (made
to order).
New England Nuclear (W. Germany):- D-myo-f2,3-3H] Inositol (54.5
CI/mmol) •
Si g m a (Poole, Dorset):- 2-p-toluidinylnaphthylene 6-sulfonate
(TNS), AMP, ADP, ATP, Ptdlns, Ptdlns(4)P, Ptdlns(4,5)P2, myo-
inositol, carbachol, noradrenaline, 5-HT, phytohemagglutinin
(PHA), pokeweed mitogen (PWM), concanavalin A (Con A), Phaseolus-
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coccineus lectin (PCo), phosphatidylcholine (PC), phosphatidyl-
ethanolamine (PE), phosphatidylglycerol (PG), phosphatidylserine
(PS), phosphatidic acid (PA), sphingomyelin (S), cholesterol (C),
lysophosphatidylserine (LPS), lysophosphatidylcholine (LPC),
lysophosphatidylethanolamine (LPE), and lysophosphatidylglycerol
(LPG).
Water used for solutions was produced using a Milli-Q water
system (Mi1lipore S.A.,France). All solutions were dispensed
using Gilson adjustable pipettes during experiments.
7.II.ii. Measurement of inositol uptake by lymphoblastoid cell
lines from bipolar manic-depressive patients and control subjects
In order to radiolabel all the intracellular inositol-
containing pools to such an extent that they could subsequently
be detected either by HPLC or TLC as appropriate, considerable
time was spent investigating methods of incorporating the maximum
amount of radiolabel into the cells. For expense reasons it was
not Possible to solely use 3H-inositol but rather to use a
mixture of labelled and unlabelled inositol. For similar
reasons it was also not possible to use the concentrations of
inositol normally present in the medium (1.94 x 10-4M), as the
specific activity of such solutions would have been too low for
adequate detection. Various preliminary experiments and their
results are outlined below, followed by the detailed experimental
protocol which was finally adopted.
In order to vary the inositol concentration of the medium,
inositol-free RPMI 1640 was purchased and the appropriate amount
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of inositol (either radiolabelled or unlabelled) added. The
composition of the complete RPM! 1640 medium (inositol-free) was
the same as standard RPM! 1640 (see Table 5.2.), with the
exception that the foetal calf serum used was dialysed before
being added. Initial incubations (15 minutes to 24 hours) using
RPM! containing 5 x 10-8M 3H-inositol (final concn. 5.1 mCi/mmol)
produced very low labelling of the cells (approx. 2500 cpm/l06
cells). This was thought to be due to a decrease in the
specific activity of the extracellular inositol due to the free
unlabelled inositol diffusing out of the cell down a
concentration gradient. For this reason, it was decided to pre-
incubate the cells in inositol-free RPM! 1640 before the
incubation in 3H-inositol, in an attempt to deplete the
intracellular "free" inositol pool. Long periods of inositol-
free pre-incubation (24 hours) resulted in a substantial loss of
cellular viability as assessed using ethidium bromide/acridine
orange (see Chapter 5). However 2 x 30 minute pre-incubations
in inositol-free RPM! were found to substantially increase the
radiolabelling of the cells, without affecting the cellular
viability.
Four cell lines were selected at random, preincubated in
inositol-free RPM! for 2 x 30 minutes and then incubated in RPM!
containing various concentrations of unlabelled inositol (10-8M -
2 x 10-4M) for 24 hours, at which point viability was assessed.
Satisfactory viability was maintained at extracellular inositol
concentrations of 3 x 10-7M, 10-6M and 2 x 10-4~f inositol during
this period, and as a resul tit was decided to label the cells
using 10-6M inositol over a 6 hour period, following the
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inositol-free pre-incubation. During the preliminary
experiments this consisted of RPM I 1640 containing 8.44 x 10-7M
unlabelled inositol and 2.5 uCi/ml of 3H-inositol (final inositol
concentration - 10-6M). During the later experiments, the
double-labelled inositol (N.E.N.) was used as detailed under
"Reagents". In this case, unlabelled inositol accounted for
9.53 x 10-7M inositol and 2.5 uCi/ml 3H-inositol accounted for
0.47 x lO-7M of the final 10-6M inositol medium. Both these
conditions were found to produce adequate labelling of the cells
without any possible compromise in viability.
The final protocol for measuring inositol uptake is described
below for one bottle of cells. Lymphoblastoid cell lines were
routinely cultured as described in Chapter 5. Twenty-four
hours prior to the experiment, the medium was changed as normal.
On the day of the experiment, 25 x 106 cells were placed in a 50
ml disposable plastic centrifuge tube, which was capped and
centrifuged at 1200 rpm for 3 minutes (37oC; Fi sons MSE
Coolspin). The supernatant was removed and the cells
resuspended in 25 mls of inositol-free RPMI 1640 (37oC). The
cells were washed in inositol-free medium a further 2x, finally
being resuspended in 25 mls of inositol-free medium and left to
incubate for 30 minutes at 37oC. At the end of this period, the
cells were washed once more in inositol-free medium and left at
37°C in inositol-free medium for a further 30 minutes. The
cells were then centrifuged again, the supernatant removed and
the cells resuspended in 3 m1s of RPMI containing 9.53 x 10-7M
unlabelled inositol. Immediately, 3 mls of 2x radioactive
standard solution (inositol-free RPMI containing 9.53 x 10-7M
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unlabelled inositol and 5.08 uCi 3H-inositol/ml) was added,
resulting in a final cell suspension of 3.5 - 4 x 106 cells/ml in
10-6M inositol.
Immediately following the addition of the radioactivity to the
cell suspension, 3 x 100 ul aliquots were layered onto 50 ul of
Versilube F50 silicone oil in 450 ul microfuge tubes. The cells
were then separated from the extracellular radioactivity by
microfuging them through the oil (15 seconds; Beckman Microfuge
B) into 50 ul of 0.25M sucrose, as described in the previous
chapter. The microfuge tubes were then placed in liquid
nitrogen until the end of the experiment. These served as
blanks, measuring the radioactivi ty trapped between the cells
when separated from the radioactive incubation medium by spinning
through oil. The cell suspension was then incubated at 370C.
Every hour following the start of the experiment, upto and
including 6 hours, 3 x 100 ul aliquots of cell suspension were
taken for the measurement of inositol uptake and spun through oil
as described above and the cell pellets frozen. At a convenient
time point during the experiment, 3 x 100 ul aliquots of cell
suspension were taken and each added to 19.9 mls of Isoton for
the determination of cell numbers, as previously described in
Chapter 2.
At the end of the uptake experiment, the tips were cut off the
frozen 450 ul microfuge tubes and placed in scintillation vials
containing 0.5 mls of water. When the frozen pellet had melted
into the water, 5 mls of scintillant was added to each vial, the
vials capped, shaken and the radioac tive content determined as
previously described. 3 x 50 ul aliquots of the 2x radioactive
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standard were also taken and counted in a similar way for the
determination of specific activity (each aliquot is equivalent to
100 ul of final incubation medium). Inositol uptake was
calculated using the equation in Appendix 6 and expressed as
ei ther umol/lcw or pmol/106 cells, per unitt ime. The
experiment was repeated only twice for each cell line due to the
cost and time involved, with each measurement being made in
triplicate within an experiment. Results were analysed by
Student's t-test using the "Minitab" statistical package on the
VAX mainframe computer.
7.rr.ui. Extraction and partitioning of the intracellular
water-soluble and lipid-soluble inositol-containing pools of
lymphoblastoid cell lines from bipolar manic-depressive patients
and control subjects
Cells were loaded with 3H-inositol as described in the
previous section, with aliquots being taken for blanks at zero
time and aliquots for extraction at 6 hours. In contrast to the
uptake experiment however, the aliquots were 500 ul in size and
were microfuged through 200 ul of Versilube F50 into 50 ul of
0.25M sucrose in 1.5 ml microfuge tubes (Sarstedt) before being
frozen in liquid nitrogen. The frozen samples were then
extracted using a a modification of the method of Shukla and
Hanahan (1982) and Shukla et al. (1985), as follows.
The tips of the microfuge tubes containing the cell pellets
were cut off and added to 1 ml of inositol-free RPMI (serum-free)
in 20 ml Quickfit tubes with ground glass stoppers. Immediately
3.75 mls of chloroform/methanol/ll.3M HCI (200:400:1.6 v/v)
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containing 1.33mM EDTA was added to each tube in turn which was
then stoppered and shaken thoroughly, releasing the pressure at
intervals. The tubes were then left at room temperature for 30
minutes and shaken periodically. At the end of this period,
1.25 mls of chloroform followed by 1.25 mls of water were added
to each tube which was then shaken thoroughly before being
centrifuged at 3000 rpm for 15 minutes (4°C;
Coolspin).
From each tube, 3 x 100 ul aliquots were taken from the
Fisons MSE
resultant upper aqueous phase (4.75 mls) and added to
scintillation vials containing 5 mls of scintillant. These were
capped, shaken and the radioactivity determined as described in
the previous section. The total radioactivity per upper phase
was calculated and expressed as cpm/l06 cells/6 hours or as
cpm/lcw/6 hours for each sample. The remainder of the upper
phase was removed using Pasteur pipettes, taking care not disturb
the interface, and stored at -20oC until analysed using HPLC, as
described later. The interface was discarded and 3 x 100 ul
aliquots of the lower lipid-soluble phase (2.5 mls) were added to
scintillation vials and allowed to evaporate (removes the
quenching effects of chloroform). 5 mls of scintillant was then
added to each vial, the vials capped, shaken, and the
radioactivity determined and expressed as described above. The
remainder of the lower phase was removed into clean glass test
tubes using Pasteur pipettes and evaporated to dryness in a
Techne Dri-block at 60oC, under a stream of ni trogen gas. The
lower phase was concentrated in the base of the tube by repeated
evaporation and resuspension in chloroform, using progressively
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smaller volumes of chloroform and washing the walls of the tube
in the process. The evaporated lower phase samples were then
stored at -20oC until analysed by TLC as described in the
following section.
Contamination of the lower phase by inositol from the upper
phase was assessed by extracting an aqueous solution of 3H-
inositol and taking aliquots of the lower phase for the
determination of radioactivity as described above. It was not
possible to assess the contamination of the upper phase by the
lower phase in a similar manner as the labelled inositol
compounds contained in the lower phase were either not available
commercially or were too expensive to purchase. For similar
reasons recovery studies were not carried out. This is
discussed further in the "Results" section of this chapter.
z.rr.i». Thin layer chromatographic (TLC) analysis of the
lipid-soluble phosphoinositide pools in lymphoblastoid cell lines
from bipolar manic-depressive patients and control subjects
Preliminary experiments failed to find a TLC method which
would separate the phosphoinositides from each other and from
other phospholipids. Hence the possibility of measuring the
size of the phosphoinositide pools by running the samples on TLC
plates, scraping off the relevant spots and analysing them for
phosphorus content was not feasible. Therefore it was decided
to use a method which would adequately separate PtdIns,
PtdIns(4)P and PtdIns(4,S)P2 from each other (although possibly
still contaminated with other phosphorus-containing compounds),
scrape the spots off the TLC plate and determine their
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radioactive content. The limitations of using radioactive
incorporation to examine the relative pool sizes are discussed
later in the chapter. The method finally used was based on that
of Shaikh and Palmer (1977) and Jolles et al. (1981) as described
below. Initial attempts at separating various lipid standards
as listed in the "Reagents" section (5 mg/ml in 1/2 (v/v)
chloroform/methanol), from the phosphoinositides (4 mg/ml in
90/9/1 (v/v) chloroform/methanol/1M HCl), were unsuccessful as
mentioned above, but separation of the phosphoinositides relative
to each other was achieved. The plate was prepared and samples
applied as follows, both for standards and biological samples.
Initially Kiese1gel 60 TLC plates (20 x 20 cm; Merck) were used
but in the final analyses the plates below were used. Similar
separations were achieved in both cases.
Kieselgel 60 HPTLC plates (10 x 20 cm; Merck) were
impregnated with a solution of potassium oxalate (1% w/v) in
methanol/water (2:3 v/v) and dried at room temperature. Before
sample application they were activated at l100C for 15 minutes.
The lower phase samples for TLC, prepared as described in the
previous section, were then resuspended in 5 ul of
chloroform/methanol/1M HCl (90/9/1, v/v), and spotted onto the
TLC plate at 1.5 em intervals using a Hamilton spiking syringe.
Each sample tube was washed out twice more with 5 ul of the above
solvent, and the washings applied to the appropriate sample spot
on the plate. Drying of the spots to minimise spread during
their application was accomplished by situating the TLC plate on
a bench-top incubator at 50°C and air-drying with a stream of N2•
Some samples were spiked with a mixture of standard PtdIns,
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Ptdlns(4)P, and Ptdlns(4,5)P2 (4 mg/ml) to aid the later
visualisation of the separated phosphoinositide spots when
present at very low concentrations. The plate was then run
using a chloroform/acetone/methanol/glacial acetic acid/ water
mixture (100:37.5:34.5:30:20 v/v) in a glass chamber which had
been pre-equilibrated with the solvent.
When the solvent front was approximately 2 em from the top of
the plate, the plate was removed, air dried, and sprayed with an
aqueous solution of lmM TNS (Shukla and Hanahan 1982). After
drying the plate at room temperature, the spots were visualised
under UV light, identified on the basis of the spiked samples and
the Rf values of the previously run standards, the relevant spots
marked and scraped off. Using a suction device attached to the
water tap, the silica from each lipid spot was sucked into
scintillation vials containing 0.5 mls of water. 5 mls of
scintillant was added to each and the radioactivity determined as
described in the previous section. The origin spots were also
scraped off and counted and used as another indicator of the
contamination of the lower phase by inositol. No quenching
effect of the silica was found.
Due to the difficulties of collecting all the lower phase,
together with the problems presented when attempting to wash the
tubes thoroughly with very low volumes of solvent after
evaporation of the samples to dryness, it was decided to use the
ratios of the radioactive counts (corrected for blanks)
contained in the mono-, di- and triphosphoinositide spots for
each sample as a measure of the relative radioactive proportions
present in the cells. By using the 3H-inositol content of the
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cells which was attributable to the lower phase as calculated
previously for each sample, together with these ratios, the
radioactive content of each phosphoinositide pool was determined
for each sample and expressed as either cpm/106 cells/6 hours or
as cpm/lcw/6 hours. The assumptions inherent in such a
calculation are discussed later in the chapter. This procedure
was carried out for all the triplicate samples of each cell line
within each experiment and was performed on only two separate
occassions for the majority of cell lines due to the time and
expense involved. Results were analysed by Student's t-test
using the "Minitab" statistical package on the VAX mainframe
computer.
7.II.v. High performance liquid chromatographic (HPLC) analysis
of the intracellular inositol phosphates of lymphoblastoid cell
lines from bipolar manic-depressive patients and control subjects
The method used to determine the basal lvels of lP, IP2 and
IP3 is a modification of that of Irvine et al. (1985) which is an
ion-exchange method. HPLC equipment is as detailed in Chapter 4
wi th the exceptions of the column which was a 250 x 4 mm i.d.
SAX-Partisil 10 column, and the sample loop which was 2 mls in
capacity. In addition the eluent containing the separated
inositol phosphates was collected using a Gilson Model 202
fraction collector with controller. Because the inositol
phosphates have no appreciable UV absorbance, the nucleotides
ATP, ADP and AMP which elute with a similar profile, were used as
intracellular markers for the separation of the inositol
phosphates during each run. During preliminary experiments to
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establish the method, which had to be modified considerably,
radioactive standard inositol phosphates and inositol were used
and all the fractions were collected into insert vials and
counted for radioactivity. Once a satisfactory and reproducible
separation was achieved, a programme was devised so that only the
fractions of interest were collected. The separation was
checked for each sample by monitoring the elution profile of the
above nucleotides using the UV detector (A - 254 nm). The
resultant gradient profile and fraction collector programme were
as below.
Eluents:- A: Water
B: 1.5 M Ammonium formate adjusted to pH 3.7 with
orthophosphoric acid.
Flow Rate:- 1.25 mIs/min.
Gradient ProfiIe:-
Time (mins) %B
o
1
26
31
33
40
o
o
100
100
o
o
Fraction Collector Programme:-
Fraction size: 0.25 mins (0.31 mIs)
Drain:- 2.0 mins.
Collect:- 4.0 mins.
Drain:- 4.5 mtns .
Collect:- 5.5 mins.
Drain:- 0.5 mins.
Collect:- 4.0 mins.
Drain:- 4.5 mins.
Collect :- 5.0 mins.
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The modifications to the initial method are discussed in the
"Results" section. The stored upper phase samples, prepared as
described in the previous sections, were filtered through 0.2 um
cellulose acetate Millipore filters before injection. The
fractions (0.31 mls) were collected in insert vials and 0.2 mls
of water added to each followed by 4 mls of scintillant. The
vials were then capped, shaken, inserted into scintillation vials
and the radioactivity determined as previously described. No
significant quenching of the count rates was found with
increasing concentrations of Eluent B.
7.II.VI. Determination of agonist-stimulated inositol phosphate
turnover in lymphoblastoid cell lines frOM bipolar rnanic-
depressive patients and control subjects
Potential agonists were assessed by preparing and loading the
cells with 3H-inositol as described before. Lithium chloride
was then added to the incubation medium to produce a final
concentration of 10 mM Li+ (to inhibit the hydrolysis of IP to
inositol) and the suspension was incubated at 370C for 15
minutes. Potential agonists were then added to the cell
suspension and incubated for a further 15 or 30 minutes. At the
end of this incubation period, 500 ul aliquots of the cells were
microfuged as described previously, frozen and extracted. The
upper phase samples were analsyed by HPLC to determine whether
any accumulation of IP had occurred. Agonists investigated were
carbachol (l0-3M), 5-HT (lO-4M), noradrenaline (l0-4M), PHA (50
ug/ml), PWM (50 ug/ml), PCo (50 ug/ml) anti Con A (50 ug/ml).
Unfortunately, as described in the following "Results" section,
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none of these potential agonists produced any effect on the
inositol phosphates of the lymphoblastoid cell lines. -As time
was limited, this area was not pursued further and the 3H_
inositol incorporation into the cells was examined under non-
stimulated conditions only.
r.rrr , RESULTS
The separation of phosphoinositide standards by TLC and
inositol phosphate standards by HPLC are shown in Figures 7.2.
and 7.3. respectively. As can be seen in Figure 7.2. the TLC
separation of phosphoinositides relative to each other has been
achieved with Rf values of 0.51, 0.40 and 0.34 for Ptdlns,
PtdIns(4)P and PtdIns(4,5)P2 respectively. The incomplete
separation from other phospholipids can also be seen illustrating
the need to analyse for radioactive incorporation rather than
measuring pool size by phosphorus determination. The HPLC
separation of inositol phosphate standards (Figure 7.3.)
illustrates their elution profile relative to the nucleotides
AMP, ADP, and ATP. The unknown peak eluting just prior to IP is
a contaminant present in the 3H-inositol stocks. The 1,4,5
isomer of IP3 was used as the radiolabelled 1,3,4 isomer of IP3
was not available commercially. In the original method of
Irvine et al. (1985), both isomers present in the cells were
separated. It is assumed that they would also be separated
using the modified method in this study which yields a comparable
chromatographic profile, although Eluent B had to be adjusted
from 1M ammonium formate to 1.5M and the gradient was also
adjusted in order to achieve this profile.
When biological samples were examined however, after being
loaded with 3H-inositol and extracted, only a radioactive
inositol peak was seen, with no detectable lP, IP2 or IP3 peaks.
Incubation with lithium and several potential agonists as
described in the "Methods" section failed to produce any
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Figure 7.2. TLC separation of lipid standards
Solvent conditions, lipid concentrations and abbreviations are
as described in the previous "Methods" section.
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Figure 7.3. HPLC separation of inositol and inositol phosphates
standards
Equipment and operating conditions are as described in the
previou~ "Methods" section.
detectable labelling in any of these inositol compounds. The
possible reasons for this lack of initial and stimulated
labelling of inositol phosphates are discussed in the following
"Discussion" section. Because of this, only the uptake of
inositol and basal incorporation into the phosphoinositide pools
was examined as these could be detected under these conditions.
During the extraction, the contamination of the lower phase by
inositol from the upper phase was negligible. As discussed
previously it was not possible to assess the contamination of the
upper phase by the lower phase due to the unavailability and/or
expense of standard radiolabelled phosphoinositides. For this
reason recovery studies were also not carried out and therefore
actual values may be slightly higher than the results given here.
However this does not affect comparisons made between cell lines
as recovery should be similar in all cases. The assumption that
the relative incoporation of radioisotope into the various
phosphoinositide pools is the same as that found in the sample
phosphoinositide spots on the TLC plate is justified providing
that recoveries of the phosphoinositides are similar. The
acidic solvent was used for the resuspensions as it has been
shown that lower recoveries of PtdIns(4,S)P2 result from tissue
if the extractant is neutral (Creba et al. 1983).
The inositol uptake measurements are shown in Figures 7.4. and
7.5., expressed as pmol/106 cells and umol/lcw respectively.
Error bars have been omitted for clarity but are usually less
than 5%. It is possible to quantify the results in this way as
the specific activity of the extracellular solution is known,
assuming that no dilution is occurring as a result of the
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unlabelled inositol diffusing out of the cells. Such a
diffusion is likely to be negligible, due to the inositol-free
pre-incubations. In the majority of cell lines, uptake appears
to be linear over the first 2 - 3 hours before appearing to slow
down although not reaching a plateau within the 6 hour period.
The cell line Tony is a notable exception with an uptake far
greater than any of the other cell lines although there is
considerable interindividual variation in both groups. Tony was
established from a person suffering from myeloma and the possible
importance of this is discussed later. For the overall analysis
of the results of the control group this cell line has been
omitted and is analysed separately.
When the results are expressed as pmol/106 cells, greater
uptake seems to occur in the bipolar cell lines compared with the
controls (with the exception of Tony) but this difference is
abolished if the results are expressed as umol/lcw and can be
explained in terms of the higher mean cell volumes of the bipolar
group compared with the control group (mean + S.E.M. - 1695 + 172
u3 vs 1104 + 70 u3 respectively). In view of the significantly
greater volume of the bipolar cell lines compared with the
control cell lines used in this part of the study, the
incorporation of 3H-inositol into the various intracellular and
membrane-bound pools has been 'expressed solely in terms of per
lew thus negating any effects of the differing volumes., This is
the most convenient way of normalising the data with respect to
cell size but although expressed in this way, this does not imply
that all the pools are freely distributed in the cytoplasm.
This is not the case, as discussed in the "Introduction" to this
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chapter. Although all the cell lines appear to accumulate
inositol to a much greater concentration than that of the
extracellular solution, this may not be the case depending upon
of the inosi tol is in the "free" inosi tol pool. This is
I
;
:!
I
I
the distribution within the intracellular pools i.e. whether most
examined below.
The distribution of radiolabelled inositol within the cells is
expressed as cpm/lcw rather than molar concentrations. This is
due to the limitations imposed by the presence of several
inositol-containing pools with interconversions as shown
previously in Figure 7.1.. Whether the specific activity of
each is equal to that of the extracellular solution and hence
whether the distribution of radiolabelled inositol reflects their
relative magnitudes, is determined by the rates of equilibration
between the various pools. This is discussed further later in
the chapter.
A summary of the incorporation of 3H-inositol into the various
intracellular pools of bipolar and control cell lines is shown in
Table 7.1.. The values for Tony are not included in this
analysis. The results have all been normalised for the same
standard counts so that they can be directly compared. If the
values for the individual cell lines are examined in Table 7.2.
with the distributions of each inositol-containing pool for each
cell line shown in Figures 7.6. to 7.10. inclusive, considerable
interindividual variation can be seen although the results from
experiment to experiment for each cell line are very consistent
in the majority of cases. There appears to be a much wider
range of inositol uptake values in the control group of cell
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Table 7.1. Incorporation of 3H-inositol into lymphoblastoid
cell lines from bipolar manic-depressive patients and control
subjects
The results below are the mean values ± S.E.M. from 5 control and
6 bipolar cell lines. The mean value for each individual cell
line within these groups is derived from (usually) 2 experiments,
with each parameter measured in triplicate within an experiment.
The results from the cell line Tony have been omitted from this
analysis. Significance testing of the results for the bipolar
group relative to the control group is by Student's t-test.
Parameter Mean value ± S.E.M. Level of
Control Bipolar Significance
Total uptake 26.58 ± 5.03 27.61 ± 2.47 N.S.
(xl09 cpm/lcw/6 hrs)
"Pree" inositol 19.09 + 4.85 22.33 ± 1.85 N.S.
(xl09 cpm/lcw/6 hrs)
PtdIns 6.25 ± 1.92 4.99 ± 0.92 N.S.
(xl09 cpm/lcw/6 hrs)
PtdIns(4)P 0.35 ± 0.06 0.23 ± 0.04 N.S.
(xl09 cpm/lcw/6 hrs)
P§dlns(4,5)P2 0.11 ± 0.03 0.05 ± 0.01 p<0.05(xl0 cpm/lcw/6 hrs)
"Free" inositol 69.5 ± 5.8 81.4 ± 2.5 p < 0.05(% of total uptake)
PtdIns 28.6 ± 5.5 17.7 ± 2.4 N.S.
(% of total uptake)
Ptdlns(4)P 1.5 ± 0.3 0.8 ± 0.1 p<0.05
(% of total uptake)
PtdIns(4,5)P2 0.4 ± 0.2 0.2 ± 0.03 N.S.(% of total uptake)
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Figure 7.6. Distribution of the values for the 3H-inositol
uptake of lymphoblastoid cell lines from bipolar manic-depressive
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Points represent the mean of triplicate data from 2
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- indicates the mean value for each group.
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lines than the bipolars although the average value is similar
(Figure 7.6.). The same picture can be seen in the
incorporation of 3H-inositol into the "free" inositol pool within
the cells (Figure 7.7), although the majority of the bipolar cell
lines appear to have greater incorporation into this pool,
compared with the controls. The difference is not significant
however. When the incorporation of 3H-inositol into the
phosphoinositide pools is examined, no significant difference is
seen between the two groups of cell lines with respect to PtdIns
and PtdIns(4)P although in the latter case the average value is
50% higher in the control group but not significantly so due to
the relatively large variation in values. An anomalously high
value is seen in the case of Ptdlns for the cell line Ged,
especially when compared with other cell lines which also have
higher incorporations into "free" inositol but much smaller
values for PtdIns. A significantly lower incorporation into
PtdIns(4,5)P2 is seen for the bipolar group despite their being
no difference in any of the other pools. If the ratios of the
incorporation of 3H-inositol into the PtdIns, PtdIns(4)P and
Ptdlns(4,5)P2 pools are examined for each of the cell lines in
the two groups and averaged they are (± S.E.M.), 100 : 5.3 (±
0.6) : 1.8 (± 0.5) respectively for the control group and 100 :
4.9 (± 0.5) : 1.1 (± 0.2) respec tively for the bipolar gr oup,
Thus there is no significant difference between the ratios for
each group. It is also interesting to note that although the
cell line Tony has a much greater inositol uptake and
incorporation into the "free" inositol pool, a proportionately
bigger incorporation into the phosphoinositides is not seen; in
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fact less radioactivity is incorporated into these pools.
When the incorporation of inositol into the various pools is
examined in terms of % of the total 3H-inositol uptake
.(summarised in Table 7.1. with individual data in Table 7.3. and
Figures 7.11. to 7.14. inclusive), significant differences are
seen between the two groups. Significantly more of the 3H-
inositol taken up by the cells is present in the "free" inositol
pool of bipolar cell lines compared with controls (81.4% as
opposed to 69.5%, p -e 0.05). Correspondingly there is a smaller
% incorporated into the phosphoinositide pools of the bipolar
group although this does not reach statistical significance
except in the case of Ptdlns(4)P, largely due to the presence of
the cell line Jil in the control group which behaves more like
the bipolar cell lines. This lower % incorporation of 3H-
inositol into the phosphoinositide pools is made even more
significant in view of the fact that the bipolar cell lines tend
to have greater incorporation into "free" inositol pools,
compared with controls, although non-significantly so. For
example, the mean (± S.E.M.) values for the incorporation into
the "free" inositol pools of the control and bipolar cell lines
are 19.09 + 4.85 (xl09 cpm/lcw/6 hours) and 22.33 + 1.85 (xl09
cpm/lcw/6 hours) respectively, whereas the values for the total
incorporation into the phosphoinositides as·a percentage of the
total uptake are 30.6 ± 5.8 and 18.7 ± 2.5 respectively. The
former figures just fail to reach statistical significance
largely due to the anomalous values for the cell line Jil, but
the latter figures are significantly different at the 5% level
and would have been even more significant but for the values for
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Figure 7.11. Distribution of the values for the percentage of
3H-inositol uptake incorporated into the "free" inositol pool of
lymphoblastoid cell lines from bipolar manic-depressive patients
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--- indicates the mean value for each group.
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JU. Tony was not included in this analysis due to its
anomalously high total uptake rendering its value as a control
dubious, but exhibits a similar but even more extreme low
incorporation of the radiolabel into the phosphoinositide pools.
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7.IV. DISCUSSION
Inositol has been shown to accumulate in a variety of
mammalian tissues including brain, spleen, kidney, and small
intestine, reaching intracellular concentrations in some cases,
of greater than 100x that of the extracellular fluid (Hauser
1969a). Normal mammalian plasma levels of "free" inositol have
been reported to be approximately O.lmM (Spector and Lorenzo
1975, Spector 1976). In rabbit brain, CSF levels of "free"
inositol have been found to be in the range 0.2 - 0.6mM, with
accumulation occurring by a saturable active transport process
thought to be located mainly at the blood-CSF barrier Le. the
choroid plexus, with little if any exchange occurring across the
blood-brain barrier (Spector and Lorenzo 1975, Spector 1976).
From the CSF, inositol appears to diffuse readily into the
extracellular space and enters the brain by a similar saturable
transport process (Spector and Lorenzo 1975). The turnover of
inositol in the brain (0.3%/hr) and the CSF (4%/hr) is much
slower than that in the choroid plexus (16%/hr). The transport
system responsible for inositol accumulation is half maximally
activated at an inositol concentration of O.lmM i.e. the normal
plasma levels (Spector and Lorenzo 1975). Approximately 50% of
the "free" inositol in the brain is thought to occur as a result
of uptake with the remainder being synthesised from glucose
(Spector 1976).
Analogous transport systems have been demonstrated in, for
example, rat kidney (Hauser 1969a,b), hamster small intestine
(Caspary and Crane 1970) and cultured retinal capillary pericytes
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(Li et a!. 1986). These transport systems have all been shown
to be saturable, Na+-dependent, ATP-dependent, ouabain-sensitive,
and phlorizin-sensitive. It has been suggested that the
transport of inositol is similar to that of sugars i.e. a
facilitated diffusion with Na+ with the energy-dependency being
du~ to the sodium pump activity necessary to maintain the
inwardly-directed Na+ gradient. It is not the same transport
system as that for sugars howeve~ with metabolisable sugars such
as glucose showing a non-competitive inhibition of inositol
uptake and inositol having no effect on the sugar transport
(Caspary and Crane 1970, Li et a1. 1986).
In the cultured retinal capillary pericytes, two transport
systems were found; one similar to that described above and a
minor pathway which was Na+ -independent and non-saturable (Li
et al. 1986). The uptake of inositol with time by the pericytes
appears very similar in appearance to that found in the majority
of lymphoblastoid cell lines in this study, although the time
courses are different with initial linearity over 30 minutes for
the pericytes and approximately 2-3 hours in the lymphocytes,
before the rate of uptake appears to decrease. The
extracellular concentrations of inositol were different however
i.e. SuM for the pericytes versus 1 uM in this study, and the
measurements were taken at greater intervals making the
assessment of linearity more difficult. Whether two such
separate transport systems for inositol are present in
lymphocytes can not be confirmed unless the sodium-dependency is
examined.
The total uptake 15 complex, presumably comprising an initial
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period where equilibration of the "free" inositol pool with the
extracellular solution occurs, superimposed on equilibrations of
the various intracellular inositol-containing pools. Obviously
with the 3H-inositol uptake values reached, most of which is
"free" inositol, accumulation is occurring. Assuming the "free"
inositol is freely distributed in the cytoplasm, inositol
accumulations of between 8 and 32x extracellular concentrations
are seen over 6 hours for the cell lines with the exception of
Tony which is approximately 100x. This anomaly is discussed
further below. The actual amounts may be greater than this as
some inositol may still have been present in the cells even after
the inositol-free washes. In comparison the pericytes were
shown to accumulate inositol intracellularly over 2 hours to a
concentration approximately 18x that of the extracellular SuM
inositol (Li et al. 1986).
It is not known what effect the use of lower than normal
concentrations of inositol in the incubation medium had on the
cells in this study (10-6M cf. 1.94 x lO-4M). Viability was not
affected over the duration of the experiment and it is therefore
assumed that no detrimental effects resulted. As mentioned
previously, such a reduction in concentrations was necessary in
order to achieve a satisfactory labelling of the cells with the
financial restrictions on the-amount of 3H-inositol used per
incubation. Similar reductions in inositol concentration have
been used in several other studies, for example, using rat
cerebral cortical slices (Brown et al. 1984) without any apparent
effects on the agonist-induced phosphoinositide hydrolysis.
Until all the radi01abelled inositol-containing pools are
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allowed to equilibrate with one another, their specific
activities will not be the same and hence the relative
radioactive contents would not reflect the pool sizes. Changes
in incorporation from one pool to another can thus be examined
but not expressed in absolute terms of changes in mass of the
inositol-containing pools if equilibrium has not been
established. Many studies have been carried out concerning the
PtdIns system using many different tissues from various species.
Varying incubation protocols measuring either the incorporation
of 32p or 3H-inositol have also been employed and generally the
assumption appears to be that equilibrium between the various
pools occurs fairly quickly i.e. within 30 - 60 minutes. With a
system in equilibrium and the use of lithium to inhibit inosito1-
l-phosphatase activity, the resulting accumulation of IP in
response to agonist-induced production of IP3 can be used to
monitor the production of IP3• However although equilibrium of
the phosphoinositide pools is usually established and hence
changes in radioactive content reflect changes in mass, the
inositol phosphates may not be in equilibrium with these and
hence changes in incorporation can only be examined qualitatively
rather than quantitatively. If the system is not in
equilibrium, movement of radioactivity from one pool to another
may partly represent a change in mass of the various pools but
may also be due to the equilibration process and if specific
activities are not equal, the changes can not be related to each
other.
In many studies equilibration has been assumed rather than
demonstrated. The evidence for equilibration occurring include
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the demonstrations that varying the concentration of 3H-inositol
produces a linear incorporation into lipid but a similar
percentage accumulation of inositol phosphates, (rat cerebral
cortex, 30 minutes; Brown et al. 1984), constant labelling of
the inositol-containing pools occurs with further incubation time
(rat hepatocytes, 70 minutes; Creba et al. 1983), (this may not
apply to the "free" inositol pool which may carryon accumulating
inositol from the extracellular medium although the specific
activities have reached equilibrium), and turnover times of only
a few minutes of the phosphoinositide pools and rapid
interconversions between Ptdlns and polyphosphoinositides (rat
parotid gland and various tissues; Downes and Wusteman 1983).
Assuming the lymphoblastoid cell lines behave similarly, the
inositol-containing pools should have equilibrated within the 6
hour incubation period used in this study in which case the
differences between the cell lines expressed in cpm can actually
be interpreted in terms of relative pool size.
If at equilibrium, the lower incorporation of 3H-inositol into
thephosphoinositides of the bipolar cell lines compared with the
controls may represent smaller pool sizes. Alternatively, if
the system is not at equilibrium, the differences in
incorporation of radioactivity may reflect differing levels of
enzyme activity or reduced levels of the CDP-DAG needed to
combine with the inositol to form PtdIns. In order to
investigate which if any of these possibilities are likely, it
would be necessary to establish whether the system is at
equilibrium by looking at the incorporation of radiolabel into
the various pools with time. Depending on the results it may be
250
necessary to attempt to isolate the enzymes responsible for the
synthesis of the phosphoinositides and examine for any
differences, and/or measure the levels of CDP-DAG. Less
reliability can be placed on the Ptdlns(4,5)P2 results as these
were very close to the background levels of radioactivity.
The fact that the ratios of the phosphoinositide pools
relative to each other are similar in both the bipolar and
control cells would point to similar enzyme activities in the two
groups of cell lines with the difference being in pool size, i.e.
the system is in equilibrium but further investigations are
needed to confirm this, for example, determining the
incorporation of 3H-inositol into the various phosphoinositide
pools with time.
The reservations expressed in the previous chapter regarding
age and sex differences in the control and bipolar groups apply
equally to the results in this chapter. The cell lines in this
part of the study consist of 5 male controls and 3 male and 3
female probands with mean ages ± S.E.M. of 32 ± 6.3 and 46 ± 8.7
respectively. Although not age or sex-matched, the differences
between the two groups are not likely to be due to this since the
results for the mixed-sex bipolar group would then be expected to
fall into 2 distinct groups rather than being tightly grouped.
It is also notable that the variation seen in this study is much
less than that found in the day to day measurements of the fluxes
as shown in Chapter 6. Similarly if the differences were due to
an artefact of transformation, it is very unlikely that such an
effect would divide the cell lines into two groups depending on
their clinical status.
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The reason for the apparently anomalous behaviour of the cell
line Tony is not clear. The control cell lines in this study
were all established from non-psychiatrically ill patients and
Tony was a myeloma patient. Whether this difference in inositol
uptake is related to this clinical condition is a possibility and
may be a very important finding if confirmed using cell lines
from similar patients. It is also interesting in this context,
that the cell line Gavi which was derived from a lymphoma
patient, does not show this anomalous uptake and incorporation.
One possibility is that it may be age-linked as the subject from
whom the cell line Tony was derived was 75 years old at the time
that the cell line was established. This is unlikely to be the
explanation however, as the proband from whom 17-01 was
established was a similar age, and 17-01 does not exhibit this
anomalous behaviour. Alternatively it could be a
transformation-induced artefact which occurred by chance. The
effects of EBV-transformation on the PtdIns system are not known
but it has been demonstrated for example in C3H10T1/2 cells that
chemical transformation enhances the labelling of
polyphosphoinositides and appears to increase the permeability of
the membrane, at least to phosphate (Kubota et al. 1986).
Whether or not such effects have occurred in the cell lines used
in this study is not known and hence any possible differences
which may exist in the PtdIns system in vivo between bipolars and
controls mayor may not be altered upon transformation.
Presumably any transformation-induced differences would be
unlikely to separate themselves into two groups depending on
clinical status unless mirroring the situation in vivo as
252
mentioned above. If the differences observed here between
bipolar and control cell lines reflect differences in vivo, it is
still not certain that these differences represent the situation
prevailing in the brain.
An alternative explanation for the anomalous behaviour of Tony
regarding uptake and to a lesser extent Jil regarding percentage
incorporation into the phosphoinositide pools, may be that this
is just random variation within the population and that with the
small samples used in this study, they appear anomalous. If
more samples were used, the anomaly may disappear since more such
apparently extreme examples may be seen. An extension to the
work done in this study would be to repeat the measurements using
more samples and also using the family members to see if any
predictive value of these differences is apparent when the
between-family heterogeneity within the population is removed.
Other improvements may be to use more cells and thereby aid the
detection of the phosphoinositides.
The failure to find agonist-stimulated inositol phosphate
metabolism may be due to either inappropriate choice of agonists
for the lymphocytes, transformation-induced alterations in the
PtdIns system, too low labelling of the cells, and/or too few
cells for adequate detection of the inositol ph~sphates.
Further studies should involve the use of more cells, more
agonists and if possible, increased labelling. The finding of
differences between the control and bipolar cell lines may also
be true for the inositol phosphates if investigated.
How the differences between bipolar and control cell lines
account for the nature of the illness and the therapeutic effects
253
of lithium is not clear until, for example, the extent of isotope
equilibration is unambiguously determined. If the difference is
in phosphoinositide pool size, it is possible that a smaller
signal will·be generated for each agonist event, depending on the
efficiencies of the enzymes responsible for the resynthesis of
the phosphoinositides, and/or that repeated stimulation may lead
more quickly to a depletion of phosphoinositide pools in bipolar
subjects. The same scenario may result if the differences are
due to abnormailities in the synthesis enzymes. If it is the
case that the illness is primarily due to a lower capacity for
2nd messenger production, it is difficult to see how the known
actions of lithium in inhibiting IP phosphatase would produce a
therapeutic effect unless the IP accumulated exerts a feedback
inhibition on the enzyme responsible for dephosphorylating IP3'
thus prolonging the IP3 signal and compensating for the lower
signal generation. However this would be eventually expected to
result in inositol depletion and a subsequent further decrease in
2nd messenger production.
In contrast to the original suggestion of Berridge et al.
(1982) that Ii thium may cause a depletion of cellular inositol
levels and hence the phosphoinositides, preferentially in
hyperactive pathways which may be responsible for the illness,
levels of PtdIns(4,5)P2 and presumably IP3 and DAG have been
shown to be maintained even in conditions of inositol depletion
in rat parotid acinar cells (Downes and Stone 1986). This is
presumably due to some homeostatic mechanism. However if the
levels or synthesis of phosphoinositides were also initially
decreased as shown in the bipolar cell lines, this together with
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lithium may overcome any homeostatic mechanisms and eventually
result in a reduced signalling capability. This hypothesis
therefore assumes that not only is there a defect in levels or
rate of synthesis of phosphoinositides in the illness but that
hyperactive pathways exist which are primarily responsible for
the illnes s, Although reduced phosphoinositide levels are
present these would not normally contribute to the illness and
would be maintained even in the hyperactive pathways, due to a
homeostatic mechanism. However in the presence of lithium these
would be depleted, unlike the controls where the initial levels
are higher, and would account for the therapeutic effect of
lithium in correcting the hyperactive pathways.
An extension of this would be to conclude that the decreased
phosphoinositide levels or rates of synthesis have occurred as
part of a "down-regulation" or "desensitisation" process in
response to neuronal hyperactivity. Alterna tively down-
regulation in response to a primary defect in the activity of
neuronal pathways may be present, and an accumulation of IP
caused by lithium treatment may compete with IP) for the receptor
which mediates the Ca2+ release. Spat et a1. (1986) have
demonstrated no effect of 10uM IP on IP3 binding but it is
possible that higher IP concentrations may be produced with
chronic lithium treatment and may produce some effect.
The possibility of an involvement of Na+/K+-ATPase in the
illness is also not ruled out and may occur secondarily to
alterations in the Ptdlns system as Ptdlns is known to be a
specific requirement in the normal activation of the sodium pump
(Roelofsen and Van Linde-Sibenius Trip 1981). For example the
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sodium pump number and/or activity has been shown to be decreased
in inositol-depleted KB cells (Charalampous 1971). This would
bring in the possibility that bipolars have an increased pump
number or activity and that lithium acts by decreasing the
inositol and hence PtdIns levels and corrects the defect. In
this study an increased pump number per cell was found in the
bipolar cell lines compared with controls but the activity was
not ascertained.
In summary therefore, it would appear that there is no
difference between bipolar and control subjects regarding
inositol uptake. There is however a significantly reduced
percentage incorporation of the inositol into the
phosphoinositides of the bipolar cell lines, although whether
this reflects differences in pool sizes or enzyme activity has
yet to be determined. Further studies would involve a
determination of isotopic equilibration. Possible hypotheses
have been discussed which attempt to integrate the findings of
this study with the therapeutic action of lithium. The results
need to be validated using age and sex-matched controls and
repeated using larger sample sizes, together with family members.
Whether there are differences between lithium responders and non-
responders would also be of interest. The explanation for the
phasic nature of the illness if the PtdIns system is involved in
the aetiology of the illness is not apparent.
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CHAPTER 8. CONCLUDING REMARKS
From the general review of the symptoms, classification,
occurrence and possible aetiologies of bipolar manic-depressive
psychosis presented in Chapter 1, it is clear that the illness is
complex and the underlying pathology poorly understood.
Although the weight of evidence strongly implicates a genetic
aetiology, the mode of inheritance is far from clear. This is
also true for the corresponding biological defect(s) which
is(are) responsible for the resulting manifestation of the
illness.
The main areas in which the defect has been postulated to
occur are in neurotransmission, the endocrine system, and in
cation transport. Naylor has proposed that manic-depressive
patients possess a genetic defect in the sodium pump (Na+/K+-
ATPase), which results in an increased susceptibility to an
endogenous "regulating factor". This factor has been
tentatively identified as vanadium, following the finding of
increased plasma/serum vanadium levels in affected individuals,
and the demonstration of the potent inhibition of isolated
Na+/K+-ATPase enzyme preparations by vanadate (VS+). This
thesis has addressed this possibility by firstly determining the
effects of vanadate on cation transport in whole cells, using the
well-characterised HeLa cell line. Following this, cation
transport in virally-transformed lymphoblastoid cell lines from
13 bipolar manic-depressive patients and 13 control subjects has
been examined, under normal conditions and after treatment for 24
hours with lithium, ouabain or vanadate. In addition, the
possibility that the defect may lie in the phosphatidylinositol
system which is involved in 2nd messenger production, has also
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been investigated. The findings of the various parts of this
study and their interpretation in conjunction with each other,
are summarised below.
In HeLa cells, vanadate only produced significant alterations
in the K+ influx pathways at extracellular levels of vanadate
where toxic effects were also apparent. The lack of effect of
vanadate at concentrati~ns less than.lO-5M was most likely the
result of the intracellular reduction of vanadate to the less
biologically active, vanadyl (V4+), as shown using ESR. It is
also likely that the changes in cation flux, which were
generalised and not specific to anyone transport pathway,
occurred secondarily to the toxicity. Whether the toxicity is
due to vanadyl, either directly or indirectly, or is due to, for
example, a depletion of GSH as a result of the intracellular
reduction, is not known. No change in energy charge was seen
with vanadate treatment although ATP levels were significantly
decreased by 40% at 10-4M vanadate. This change also seemed to
occur as a consequence of the toxicity. From these results, it
would appear that vanadate, at the concentrations normally
present in the blood, would have no effect on cation transport in
whole cells, due to its reduction to vanadyl. At increased
levels, toxicity prevails. This would therefore indicate that
if vanadate is responsible for the perturbations in cation
transport described in manic-depressive psychosis, affected
individuals must have some defect which makes them more
susceptible to vanadate. Possible examples of such a defect
could be a decreased reducing ability or an increased
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susceptibility of the sodium pump to the inhibitory actions of
either vanadate or vanadyl.
With the lymphoblastoid cell lines, the only difference seen
between the bipolar and control cell lines regarding cation
transport was in the number of sodium pumps per cell. The mean
value for the bipolar group of cell lines is approximately 30%
greater than that for the control group. The ouabain-sensitive
K+ influx was similar in both groups although there was
considerable variation between cell ~ines with respect to flux
values. Treatment with lithium (la-3M) or vanadate (lO-6M)
produced either no change or inconsistent actions on sodium pump
site number or cation flux. Ouabain (IO-8M) produced a decrease
in sodium pump numbers in all the cell lines. The decrease was
to 54.3% of basal values in the control cell lines, and to 59.5%
in the bipolar group, a non-significant difference. Only half
of the cell lines in both groups showed a concomitant decrease in
the ouabain-sensitive flux per cell.
The conclusion to be drawn from these results would seem to be
that there is no defect in the sodium pumps of manic-depresive
patients which would render them more susceptible to .the actions
of vanadate, even when present at levels much greater than those
normally present in plasma. In.addition treatment with ouabain
has also revealed no differences in response, and lithium
treatment at therapeutic levels did not alter the sodium pump
activity in either group of cells. It is possible that the
kinetics of activation of the sodium pump may be different
between the two groups but this was impossible to determine
without measurement of intracellular ions. Another possibility
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is that a longer time period for treatment is needed before a
defect becomes apparent. For example there may be differences
in the up-regulation of sodium pumps in response to chronic,
partial inhibition. It is unlikely that the basal difference in
pump number between the two groups is responsible for the illness
since the cation fluxes were similar. These differences may be
important if occurring in conjunction with some other defect, as
yet not elucidated.
When the phosphatidylinositol system was examined, the uptake
of inositol appeared to be similar in both groups, with the
exception of one control cell line (Tony). However the
percentage incorporation into the phosphoinositide pools was
significantly lower in bipolar individuals than in controls.
Whether this reflects differences in pool size or differences in
enzyme activity can not be defined without further studies to
determine the degree of isotopic equilibration between the
various inositol-containing pools. The possible implications of
these findings have been discussed in depth in the preceding
chapter.
The finding for one of the control cell lines (Tony) of a much
greater inosi tol uptake, together wi th a proportiona tely much
smaller incorporation of inositol into the phosphoinositides, is
interesting. The reasons for this difference are not clear but
may have possible implications in another field as the individual
from whom this cell line was established was a myeloma patient.
This warrants further investigation if other such cell lines can
be obtained.
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The use of lymphoblastoid cell lines to study genetically-
determined illnesses has been discussed previously.
Potentially, they are also of use in the study of manic-
depressive psychosis and have revealed differences between the
control and affected subjects. However, the possibility that
other differences exist in vivo but have been masked as a result
of the lymphocyte transformation process, can not be ruled out.
In addition, the results have to be interpreted with caution in
view of the lack of age and sex-matched controls. Such cell
lines have, however, enabled the investigation of various cation
transport parameters and the phosphatidylinositol system, in a
model-system free from any effects of medication. The
differences revealed between the control and bipolar cell lines
warrant further investigation, to inclu~e in particular. the use
of cell lines from unaffected and affected relatives. This
could help to determine the predictive value and possible role of
these differences in the aetiology of bipolar manic-depressive
psychosis.
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APPENDICES
APPENDIX 1
Calculation of intracellular ion contents of HeLa cells (see
Chapter 3.11.)
Normally the flame photometer was set to a 50% of scale
reading with a standard containing 100 uM Na+ and K+. If the
sample reading was A,
Ion concentration - (vol. water added + pl. water) x 2(A - blank)
pl. water x 1000
where: ion concentration is in mmol/lcw
vol.water added = 5000 ul
pl. water = the mean plate water for that treatment
condition (ul)
A - the sample reading in units
blank - the mean reading from the blank plates
2 - the conversion factor from units on the scale to
umol/l (100 uM standard was set to 50% of scale)
1000 - the factor needed to convert urnol/l to mmol/l
A further dilution factor could be introduced into the
calculation if the sample needed diluting before being measured.
The calculation was repeated for each ion and each plate in turn,
using the appropriate plate water in each case as ascertained
from the plates run in parallel.
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APPENDIX 2
Calculation of ouabain binding values of HeLa cells (see Chapter
3.II.)
Binding - A x ratio x Avogadro's no. x {ouabain] x std. vol.
cell no. x B
where: binding is in molecules/cell.
A - counts per minute (cpm) per plate sample minus the
mean plate blank (cpm)
ratio = total soln. volume on plate = 3
volume taken for radioactive counting
Avogadro's no. = 6.02 x 1023 (molecules/mole)
{ouabain] = 2.12 x 10-7}1 (200 nM is cold ouabain and 12
nM is 3H-ouabain)
std. vol. - the volume of standard taken for radioactive
counting (litres) i.e. 10-4
cell no. - the number of cells per plate
B - mean std. counts (cpm) minus the mean machine blank
(cpm)
This was carried out for each of the plates in turn using the
appropriate standard counts depending upon whether incubated in
15K or K-free Krebs, and the appropriate cell numbers. Within
each treatment group, the mean of the 15K (non-specific) binding
results was subtracted from each of the correspondingly treated
K-free plates yielding the specific ouabain binding figures which
were then meaned within each treatment group.
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APPENDIX 3
Calculation of the K+ influx in HeLa cells (see Chapter 3.11.)
K+ influx - A x std. vol. x ratio x [K+)~
flux time x B x plate cell water
where: influx is in mmol K+/lcw/min. (lcw is litres of cell
water)
A - cpm per plate sample minus the mean plate blank (cpm)
std. vol. - the volume of staniard taken for counting
(litres) Le. 10-
ratio - total soIn. volume on plate = 3
volume taken for radioactive counting
[K+)o = potassium concentration of the Krebs or N03--Krebs incubation medium Le. 5.7mM, checked
H6 flame photometry. The contribution from the
Rb was negligible.
Flux time - 4.S (minutes)
B - mean std counts (cpm) minus the mean machine blank (cpm)
plate cell water - the total volume of the cell water for
the plate in question, in litres.
This was repeated for each plate in turn using the appropriate
standards. The above influx could be converted to nmol K+/106
cells/min by multiplying by O.B (converts per litre of cell water
to per litre of cells assuming that BO% of t~e cell volume is
water), multiplying by the mean cell volume (u ) and multiplying
by 10-3• This latter factor is a composite c~mprised of a
factor of 10-lS to convert from per litre to per u , a factor of
106 to convert mmoles to nmoles, and a factor of 106 to convert
from per cell to per 106 cells.
Results from triplicate plates were then meaned and by the
appropriate subtraction, the magnitudes of the different flux
pathways were seen.
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APPENDIX 4
Calculation of ouabain binding values of lymphocyte cell lines
(see Chapter 6.11.)
Binding - A x ratio x Avogadro's no. x (ouabain] x std. vol.
cell no. x B
where: binding is in molecules/cell
A = counts per minute (cpm) per 400 ul cell sample minus
the mean cell blank
ratio = total soln. vol in the tube = 1.875
volume taken for radioactive counting
Avo~adro's no. = 6.02 x 1023 (molecules/mole)
(ouabain] = 2.25 x 10-7M (200 nM is cold ouabain and 25
nM is 3H-ouabain)
std. vol. - the volume of the 1 in 10 dilution of lOx
standard taken lor radioactive counting
(litres) i.e. 10-
cell no. - the number of cells per tube
B - mean std. counts (cpm) minus the mean machine blank
(cpm)
This was carried out for each of the tubes in turn using the
appropriate standard counts depending upon whether incubated in
15K or K-free Krebs, and the appropriate cell numbers. Within
each treatment group, the mean.of the 15K (non-specific) binding
results was subtracted from each of the correspondingly treated
K-free plates yielding the specific ouabain binding figures which
were then meaned within each treatment group.
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APPENDIX 5
Calculation of the K+ influx of lymphocyte cell lines (see
Chapter 6.11.)
K+ influx· A x std. vol. x ratio x [K+]o
flux time x B x tube cell water
where: influx is in mmol K+ /lcw/min. (lew is litres of cell
water)
A = cpm per 100 ul cell sample minus the mean cell blank
for that condition
std. vo l, - the volume of the 1 in 10 dilution of lOx st~Y).dard
taken for radioactive counting (litres) i.e. 10
ratio - total soln. volume in the tube = 2
volume taken for radioactive counting
[K+]o - potassium concentration of the Krebs or N03--Krebs incubation medium Le. S.7mM, checked by
flame photometry. The contribution from the
86Rb was negligible.
Flux time - 12 (minutes)
B - mean std. counts (cpm) minus the mean machine blank
(cpm)
tube cell water - the total volume of the cell water for
the tube in question (litres)
This was repeated for each tube in turn using the appropriate
standards r: blanks. The above influx could be converted to
nmol K+/lO cells/min by multiplying by 0.8 (converts per litre
of cell water to per litre of cells assuming that 80% of the cell
volume is water), multiplying by the mean cell volume (u3) and
multiplying by 10-. This latter factor is a composite
c~mprised of a fa%tor of 10-15 to convert from per litre to per
u ~ a factor of 10 to convert mmoles to nmoles, and a factor of
10 to convert from per cell to per 106 cells.
Results from triplicate tubes were then meaned and by the
appropriate subtractions, the magnitudes of the different flux
pathways were ascertained.
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APPENDIX 6
Calculation of the total inositol uptake in 6 hours of
lyrophoblastoid cell lines from bipolar manic-depressive patients
and control subjects
Uptake - A x 10 x {inositol] x std. vol. x 106
Cell water x B
where: Uptake is in umoles/lcw/6 hours
A = cpm per 100 u1 microfuge sample minus the mean blank
B = standard counts minus the mean machine blank
10 ..conversion factor to correct the sample counts to
per ml of suspension
[inositol} - 10-6 (M)
std. vol. = 10-4 (litres)
106 - conversion factor to convert moles to umoles
Cell water - the cell water (litres) per rol of cell
suspension
The above procedure was carried out for each sample in turn using
the appropriate values for cell water depeniing on the sample.
The results could be converted to pmoles/lO cells/6 hours by
multiplying by the cell water (litres). dividing by the cell
number per ml of suspension. mul~iplYing by 106 to convert umoles
to pmoles. and multiplying by 10 to convert to per 106 cells.
267
REFERENCES
ADAM-VIZI. A., VARADI, G. & SIMON, P. (1981). Reduction of
vanadate by ascorbic acid and noradrenaline in synaptosomes. J.
Neurochem., 36(5): 1616-1620.
AITON, J.F., CHIPPERFIELD, A.R., LAMB, J.F., OGDEN, P. s SIMMONS,
N.L. (1981). Occurrence of passive furosemide-sensitive
transmembrane potassium transport in cultured cells. Biochim.
Biophys. Acta, 646: 389-398.
AITON, J.F., BROWN,C.D.A., OGDEN, P. & SIMMONS, N.L. (1982). K+
transport in "tight" epithelial monolayers of MOCKcells. J.
Membr. BioI., 65: 99-109.
AITON, J.F. s SIMMONS, N.L. (1983). Effect of ouabain upon
diuretic-sensitive K+ transport in cultured cells. Evidence for
separate modes of operation of the transporter. Biochim.
Biophys. Acta, 734: 279-289.
AITON, J.F. & CRAMB, G. (1985). The effects of vanadate on
rabbit ventricular muscle adenylate cyclase and sodium pump
activi ties. Biochem. Pharmaco1., 34(9): 1543-1548.
AJTAI, K., TUKA, K. s BIRO, E.N.A. (1983).
human platelet adenylate cyclase by vanadate.
371-376.
The activation of
Thromb. Res., 29:
ALGERABLY, N., LA~1B, J.F., OGDEN, P., OWLER, D. & TENANG, E.M.
(1985). The turnover of sodium pumps in human cultured cells,
and its significance for the actions of cardiac glycosides. In
"The Sodium Pump", e d, Glynn, 1. & Ellory, C., The Company of
Biologists Ltd, London.
ALLEN, D.G., EISNER, D.A. & WRAY, S.C. (1985). Birthday present
for digitalis. Nature, 316: 674-675.
ALLISON, J.H. & STEWART,M.A. (1971). Reduced brain inositol in
lithium-treated rats. Nature, 233: 267-268.
ALLISON, J.H. s BLISNER, M.E. (1976). Inhibition of the effect
of lithium on brain inositol by atropine and scopolamine.
Biochem. Biophys. Res. Commun., 68(4): 1332 -1338.
ALLISON, J.H., BLISNER, M.E., HOLLAND, W.H., HIPPS, P.P. &
SHERMAN, W.R. (1976). Increased brain myo-inositol I-phosphate
in lithium-treated rats. Biochem. Biophys. Res. Commun., 71(2):
664-670.
AMERICAN PSYCHIATRIC ASSOCIATION (1980). "Diagnostic and
Statistical Manual of Mental Disorders", 3rd edition, American
Psychiatric Association, Washington, D.C., USA.
ANDREASEN,N.C. (1982). Concepts, diagnosis and classification.
In "Handbook of Affective Disorders", ed. Paykel, E.S., Churchill
Livingstone, Edinburgh.
268
APELL, H.J., NELSON, M.T., MARCUS, M.M. s LAUGER, P. (1986).
Effects of ATP, ADP and inorganic phosphate on the transport rate
of the Na+, KT-pump. Biochim. Biophys. Acta, 857: 105-115.
ASKARI, A. & HUANG,W.H. (1985). The low-affinity ATP site and
the reaction mechanism of Na,K-ATPase. In "The Sodium Pump",
ed. Glynn, I. & Ellory, C., The Company of Biologists Ltd.,
London.
ATKINSON, D.E. s WALTON, G.M. (1967).
conservation in metabolic regulation.
3239-3241.
Adenosine triphosphate
J. BioI. Chem., 242(13):
ATKINSON, D.E. (1968). The energy charge of the adenylate pool
as a regulatory parameter. Interaction with feedback modifiers.
Biochemistry, 7(11): 4030-4034.
AYSCOUGH,P.B. (1967). "Electron Spin Resonance in Chemistry",
Methuen & Co. Ltd., London.
BAKER,P.F. (1966). The sodium pump. Endeavour, 25: 166-172.
BAKER, P.F. & WILLIS, J.S. (1972). Binding of the cardiac
glycoside ouabain to intact cells. J. Physiol., 224: 441-462.
BALFOUR, W.E., GRANTHAM,J.J. s GLYNN, I.M. (1978). Vanadate-
stimulated natriuresis. Nature, 275: 768.
BANWELL,C.N. (1972). "Fundamentals of Molecular Spectroscopy",
2nd edition, McGraw-Hill Book Company (UK) Ltd., Maidenhead,
Berks.
BARON, M., KLOTZ, J., MENDLEWICZ, J. & RAINER, J •. (1981a).
Multiple-threshold transmission of affective disorders. Arch.
Gen. Psychiatry, 38: 79-84.
BARON, M., RAINER, J.D. & RISCH, N. (1981b). X-linkage in
bipolar affective illness. Perspectives on genetic
heterogeneity, pedigree analysis and the X-chromosome map. J.
Affective Disord., 3: 141-157.
BARRABIN, H., GARRAHAN, P.J. s REGA, A.F. (1980). Vanadate
inhibition of the Ca2+-ATPase from human red cell membranes.
Biochim. Biophys. Acta, 600: 796-804.
BATTY, I.R., NAHORSKI, S.R. & IRVINE, R.F. (1985). Rapid
formation of inositol 1,3,4,5-tetrakisphosphate following
muscarinic receptor stimulation of rat cerebral cortical slices.
Biochem. J., 232: 211-215.
BEAUGE, L.A. s GLYNN, I.M. (1977). A modifier of (Na+ + K+)
ATPase in commercial ATP. Nature, 268: 355-356.
269
BEAUGE, L.A. & GLYNN, I.M. (1978). Commercial ATP containing
traces of vanadate alters the response of (Na+ + K+)ATPase to
external potassium. Nature, 272: 551-552.
BEAUGE, L.A., CAVIERES, J.J., GLYNN, I.M. & GRANTHAM, J.J.
(1980). The effects of vanadate on the fluxes of sodium and
potassium ions through the sodium pump. J. Physiol., 301: 7-23.
BEAUGE, L. & DiPOLO, R. (1981). The effects of ATP on the
interactions between monovalent cations and the sodium pump in
dialysed squid axons. J. Physiol., 314: 457-480.
BECTON-DICKINSON FACS SYSTEMS Information Source Book.
BERRIDGE, M.J., DOWNES, C.P. & HANLEY, M.R. (1982). Li thium
amplifies agonist-dependent phosphatidylinositol responses in
brain and salivary glands. Biochem. J., 206: 587-595.
BERRIDGE, M.J. (1983). Rapid accumulation of inositol
trisphosphate reveals that agonists hydrolyse
polyphosphoinositides instead of phosphatidylinositol. Biochem •
.:!.:.' 212: 849-858.
BERRIDGE, M.J. & IRVINE, R.F. (l9B4). Inositol trisphosphate, a
novel second messenger in cellular signal transduction. Nature,
312: 315-321.
BOARDMAN, L.J., LAMB, J.F. s McCALL, D. (1972). Uptake of
[3H]ouabain and Na pump turnover rates in cells cultured in
ouabain. J. Physiol., 225: 619-635.
BOARDMAN, L., HUETT, M., LAMB, J.F., NEWTON, J.P. & POLSON, J.M.
(1974). Evidence for the genetic control of the sodium pump
density in HeLa cells. J. Physiol., 241: 771-794.
BOARDMAN, L.J., HUME, S.P., LAMB, J.F. & POLSON, J. (1975a).
Effect of growth in lithium on ouabain binding, Na-K-ATPase and
Na and K transport in HeLa cells. J. Physiol., 244: 677-682.
BOARDMAN, L., HUME, S.P., LAMB, J.F., McCALL, D., NEWTON, J.P. &
POLSON, J.M. (1975). Genetic control of sodium pump density. In
"Developmental and Physiological Correlates of Cardiac Muscle",
e d, Lieberman, M. & Sano, T., Raven Press, New York.
BOND, G.H. & HUDGINS, P.M. (1979). Kinetics of inhibition of
Na,K-ATPase by Mg2+, K+, and vanadate. Biochemistry, 18(2):
325-331.
BOND, G.H. s HUDGINS, P.M. (1980). Inhibition of red cell Ca2+-
ATPase by vanadate. Biochim. Biophys. Acta, 600: 781-790.
BOON, N.A., OH, V.M.S., TAYLOR, E.A., JOHANSEN, T., ARONSON, J.K.
& GRAHAME-SMITH, D.G. (1984). Measurement of specific [3H]_
ouabain binding to different types of human leucocytes. Br. J.
Clin. Pharmacol., 18: 153-161.
270
BORCHARD, U., FOX, A.A.L., GREEFF, K. & SCHLIEPER, P. (1979).
Negative and positive inotropic action of vanadate on atrial and
ventricular myocardium. Nature, 279: 339-341.
BORCHARD, U., FOX, A.A.L., GREEFF, K. s SCHLIEPER, P. (1980).
Influence of vanadate on electrophysiological and contractile
parameters of atrial myocardium. Basic. Res. Cardiol., 75: 423-
427.
BORCHARD, U., GREEFF, K., HAFNER, D., NOACK, E. & ROJSATHAPORN,
K. (1981). Effects of vanadate on heart and circulation. J.
Cardiovasc. Pharmacol., 3: 510-521.
BOWMAN, W.C. & RAND, M.J. (1980). "Textbook of Pharmacology",
2nd edition, Blackwell Scientific Publications, Oxford.
BOYD, D.W. & KUSTIN, K. (1984). Vanadium: a versatile
biochemical effector with an elusive biological function. Adv.
Inorg. Biochem., 6: 311-365.
BOYD, J.H. s WEISSMAN, M.M. (1982). Epidemiology. In "Handbook
of Affective Disorders", ed. Paykel, E.S., Churchill Livingstone,
Edinburgh.
BRACKEN, W.M. & SHARMA, R.P. (1985). Cytotoxicity-related
alterations of selected cellular functions after in vitro
vanadate exposure. Biochem. Pharmacol., 34(14): 2465-2470.
BRACKEN, W.M., SHARMA, R.P. & ELSNER, Y.Y. (1985). Vanadium
accumulation and subcellular distribution in relation to vanadate
induced cytotoxicity in vitro. Cell BioI. Toxico1., 1(4): 259-
268.
BROWN, E., KENDALL, D.A. s NAHORSKI, S.R. (1984). Inositol
phospholipid hydrolysis in rat cerebral cortical slices: I.
Receptor characterisation. J. Neurochem., 42(5): 1379-1387.
BROWN, E.G., NEWTON, R.P. & SHAW, N.M. (1982). Analysis of the
free nucleotide pools of mammalian tissues by high-pressure
liquid chromatography. Anal. Biochem., 123: 378-388.
BROWN, P.R., KRSTULOVIC, A.M. & HARTWICK, R.A. (1980). Current
state of the art in the HPLC analyses of free nucleotides,
nucleosides, and bases in biological fluids. Adv. Chromatogr.,
18: 102-138.
BUCHER, K.D. & ELSTON, R.C. (1981). The transmission of manic
depressive illness - I. Theory, description of the model and
summary of the results. J. Psychiatr. Res., 16: 53-63.
BUCHER, K.D., ELSTON, R.C., GREEN, R., WHYBROW, P., HELZER, J.,
REICH, T., CLAYTON, P. & WINOKUR, G. (1981). The transmission of
manic depressive illness - II. Segregation analysis of three sets
of family data. J. Psychiatr. Res., 16: 65-78.
271
BUI, A.H. & WILEY, J.S. (1981). Cation fluxes and volume
regulation by human lymphocytes. J. Cell. Pbys LoL;, 108: 47-54.
BUNNEY, Jr., W.E. & DAVIS, J.M. (1965). Norepinephrine in
depressive reactions. Arch. Gen. Psychiatry, 13: 483-494.
CALA, P.M. (1980). Volume regulation by Amphiuma red blood
cells. The membrane potential and its implications regarding
the nature of the ion-flux pathways. J. Gen. Physiol., 76: 683-
708.
CALDER'~OOD, S.K., BUMP, E.A., STEVENSON, M.A., VANKERSEN, I. &
HAHN, G.M. (1985). Investigation of adenylate energy charge,
phosphorylation potential, and ATP concentration in cells
stressed with starvation and heat. J. Cell. Physiol., 124: 261-
268.
CAMERON, O.G., SMITH, C.B., HOLLINGSWORTH, P.J., NESSE, R.M. &
CURTIS, G.C. (1984). Platelet alpha2-adrenergic receptor binding
and plasma catecholamines before and during imipramine treatment
in patients with panic anxiety. Arch. Gen. Psychiatry, 41:
1144-1148.
CANDE,w.z. & HOLNIAK, S.M. (1978). Chromosome movement in lysed
mitotic cells is inhibited by vanadate. J. Cell. Biol., 79:
573-580.
CANTLEY, .r-., LoC., JOSEPHSON, L., WARNER, R., YANAGISAWA,M.,
LECHENE, C. & GUIDOTTI, G. (1977). Vanadate is a potent (Na,K)-
ATPase inhibitor found in ATP deriv~d from muscle. J. BioI.
Chern., 252: 7421-7423.
CANTLEY, .re., L.C., CANTLEY, L.G. & JOSEPHSON, L. (1978a). A
characterization of vanadate interactions with the (Na,K)-ATPase.
Mechanistic and regulatory implications. J. BioI. Chem., 253:
7361-7368.
CANTLEY, .re., L.C., RESH, M.D. & GUIDOTTI, G. (1978b). Vanadate
inhibits the red cell (Na+, K+)ATPase from the cytoplasmic side.
Nature, 272: 552-554.
CANTLEY, .re., L.C. & AlSEN, P. (1979). The fate of cytoplasmic
vanadium. Implications on (Na,K)-ATPase inhibition. J. Bio!.
Chem., 254: 1781-1784.
CANTLEY, .re., L.C., CARILLI, C.T., SMITH, R.Le & PERLMAN, D.
(1983). Conformational changes of Na,K-ATPase necessary for
transport. Curro Top. Membr. Transp., 19: 315-322.
CARPENTER,G. (1981). Vanadate, epidermal growth factor and the
stimulation of DNA synthesis. Biochem. Biophys. Res. Commun.,
102(4): 1115-1121.
272
CARRERAS, J., BARTRONS, R. & GRISOLIA, S. (1980). Vanadate
inhibits 2,3-bisphosphoglycerate dependent phosphoglycerate
mutases but does not affect the 2,3-bisphosphoglycerate
independent phosphoglycerate mutases. Biochem. Biophys. Res.
Commun., 96(3): 1267-1273.
CASPARY, W.F. & CRANE, R.K. (1970). Active transport of myo-
inositol and its relation to the sugar transport system in
hamster small intestine. Biochim. Biophys. Acta, 203: 308-316.
CATALAN, R.E., MARTINEZ, A.M., ARAGONES, M.D. & GODOY, J.E.
(1985). Activation of acetylcholinesterase by vanadate.
Neuropharmacology, 24(11): 1119-1122.
CHAMBERS, C.A., SMITH, A.H.W. & NAYLOR, G.J. (1982). The effect
of digoxin on the response to lithium therapy in mania.
Psycho I. Med., 12: 57-60.
CHANDRA, S., MOORE, G.E. & BRANDT, P.M. (1968). Similarity
between leukocyte cultures from cancerous and noncancerous human
subjects: an electron microscopic study. Cancer. Res., 28:
1982-1989.
CHARALAMPOUS, F.C. (1971). Metabolic functions of myo-d nosdtoL
VIII. Role of inositol in Na+-K+ transport and in Na+- and K+-
ac t Lva t ed adenosine triphosphatase of KB cells. J. BioI. Chem-,
246(2): 455-46 o.
CHARNEY, D.S., HENINGER, G.R. & STERNBERG, D.E. (1983). Al pha2-
adrenergic receptor sensitivity and the mechanism of action of
antidepressant therapy. The effect of long-term amitriptyline
treatment. Br. J. Psychiatry., 142: 265-275.
CHASTEEN, N.D., DeKOCH, R.J., ROGERS, B.L. & HANNA, M.W. (1973).
Use of the vanadyl (IV) ion as a new spectroscopic probe of metal
binding to proteins. Vanadyl insulin. J. Am. Chem. Soc-,
95(4): 1301-1309.
CHURCHILL, P.C. & CHURCHILL, M.C. (1980). Vanadate inhibits
renin secretion from rat kidney slices. J. Pharmacol. Exp.
Ther., 213(1): 144-149.
CLIMENT, F., BARTRONS, R., PONS, G. & CARRERAS, J. (1981).
Effect of vanadate on phosphoryl transfer enzymes involved in
glucose metabolism. Biochem. Biophys. Res. Commun., 101(2):
570-576.
COMINGS, D.E. (1979). Pc 1 Duarte, a common polymorphism of a
human brain protein and its relationship to depressive disease
and multiple sclerosis. Nature, 277: 28-32.
CONRI, C., SIl-tONOFF, M., FLEURY, B. s MOREAU, F. (1986). Does
vanadium playa role in depressive states? BioI. Psychiatry,
21: 546-548.
273
COPPEN, A. & SHAW, D.M. (1963). Mineral metabolism in
melancholia. Br. Med. J., 2: 1439-1444.
COPPEN, A., SHAW, D.M., MALLESON, A. & COSTAIN, R. (1966).
Mineral metabolism in mania. Br. Med. J., 1: 71-75.
COPPEN, A. & WOOD, K. (1985). The biology of depressive illness:
5-HT and other matters. In "Psychopharmacology: Recent Advances
and Future Prospects" ed. Iversen, S.D., Oxford University Press,
Oxford.
COTTON, F.A. & WILKINSON, G. (1972). "Advanced Inorganic
Chemistry - A Comprehensive Text", 3rd edition, Interscience=-~~~~~~~~~--------------Publishers, New York.
CREBA, J.A., DOWNES, C.P., HAWKINS, P.T., BREWSTER, G., MICHELL,
R.H. & KIRK, C.J. (1983). Rapid breakdown of
phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-
bisphos~hate in rat hepatocytes stimulated by vasopressin and
other Ca +-mohilising hormones. Biochem. J., 212: 733-747.
CUTHBERT, A.W., HERRERA, F.C., SCHUZ, A.D. s WILSON, S.A. (1980).
Increase in epithelial cyclic adenosine 3',5'-monophosphate
following vanadate. Br. J. Pharmacal., 69: 8-10.
DAGHER, G., GAY, C., BROSSARD, M., FERAY, J.C., OLIE, J.P.,
GARAY, R.P., LOO, H. & MEYER, P. (1984). Lithium, sodium and
potassium transport in erythrocytes of manic-depressive patients.
Acta. Psychiatr. Scand., 69: 24-36.
DANIELS SON, E., UNDEN, A. & BARTFAI, T. (1983). Orthovanadate
induces loss of muscarinic cholinergic binding sites. Biochem.
Biophys. Res. Commun., 110(2): 567-572.
DAY, H., MIDDENDORF, D., LUKERT, B., HEINZ, A. & GRANTHAM, J.
(1980). The renal response to intravenous vanadate in rats. J.
Lab. Clin. Med., 96: 382-395.
DEGANI, H., GOCHIN, M., KARLISH, S.J.D. & SHECHTER, Y. (1981).
Electron paramagnetic resonance studies and insulin-like effects
of vanadium in rat adipocytes. Biochemistry, 20: 5795-5799.
DE WEER, P. (1985). Cellular sodium-potassium transport. In
"The Kidney: Physiology and Pathophysiology", ed. Seldin, D.W. &
Giebisch,·G. Raven Press, New York.
DICK, D.A.T., DICK, E.G. & NAYLOR, G.J. (1980).
concentration in manic-depressive illness. J.
24P.
Plasma vanadium
Physiol., 310:
DICK, D.A.T., NAYLOR, G.J. & DICK, E.G. (1982). Plasma vanadium
concentration in manic-depressive illness. Psychol. Med., 12:
533-537.
274
DIPOLO, R., ROJAS, H.R. & BEAUGE, L. (1979). Vanadate inhibits
uncoupled Ca efflux but not Na-Ca exchange in squid axons.
Nature, 281: 228-229.
DI VIRGILIO, F., VICENTINI, L.M., TREVES, S., RIZ, G. & POZZAN,
T. (1985). Inositol phosphate formation in fMe t-Leu-Phe-
stimulated human neutrophils does not require an increase in the
cytosolic free Ca2+ concentration. Biochem. J., 229: 361-367.
DORUS, E., PANDEY, G.N., SHAUGHNESSY,R. & DAVIS, J.M. (1980).
Lithium transport across the RBCmembrane. A study of genetic
factors. Arch. Gen. Psychiatry, 37: 80-81.
DORUS, E., COX, N.J., GIBBONS, R.D., SHAUGHNESSY, R., PANDEY,
G.N. & CLONINGER, C.R. (1983). Lithium ion transport and
affective disorders within families of bipolar patients.
Identification of a major gene locus. Arch. Gen. Psychiatry,
40: 545-552.
DOWNES, C.P. (1983). Inositol phospholipids and
neurotransmitter-receptor signalling mechanisms. Trends
Neurosc1., Aug. 1983: 313-316.
DO\-1NES, C.P. & UUSTEMAN, M.M. (l9f\3). Breakdown of
po1yphosphoinositides and not phosphatidy1inositol accounts for
muscarinic agonist-stimulated inositol phospholipid metabolism in
rat parotid glands. Biochem. J., 216: 633-640.
DOWNES,C.P. & STONE, M.A. (1986). Lithium-induced reduction in
intracellular inositol supply in cholinergically stimulated
parotid gland. Biochem. J., 234: 199-204.
D'SOUZA, 1. & GLUECK, H.I. (1977). Measurement of nucleotide
pools in platelets using high pressure liquid chromatography.
Thromb. Haemostasis, 38: 990-1001.
DUDEL, J. (1983). Function of nerve cells. In "Human
Physiology", ed, Schmidt, R.F. & Thews, G., Springer-Verlag,
Berlin.
DUHM,J. & GOBEL, B.O. (1984). Role of the furosemide-sensitive
Na+/K+ transport system in determining the steady-state Na+ and
K+ content and volume of human erythrocytes in vitro and in vivo.
J. Membr. BioI., 77: 243-254.
EL-MALLAKH,R.S. (1983a). The Na,K-ATPase hypothesis for manic-
depression. I. General considerations. Med. Hypotheses, 12:
253-268.
EL-MALLA.T(H,R.S. (1983b). The Na,K-ATPase hypothesis for manic-
depression. II. The mechanism of action of lithium. Med.
Hypotheses, 12: 269-282.
275
EPSTEIN, M.A. & BARR, Y.M. (1964). Cultivation in vitro of human
lymphoblasts from Burkitt's malignant lymphoma. Lancet, Feb.
1st: 252-253.
ERDMANN, E. & HASSE, w. (1975).
binding to human erythrocyte
Physiol., 251: 671-682.
Quantitative aspects of ouabain
and cardiac membranes. J.
ERDMANN, E., KRAWIETZ, W., PHILIPP, G., HACKBARTH, I., SCHMITZ+
w. & SCHOLZ, H. (1979a). Stimulatory effect of vanadate on (Na
+ K+)-ATPase activity and on 3H-ouabain-binding in a cat heart
cell membrane preparation. Nature, 278: 459-461.
ERDMANN, E., KRAWIETZ, W., PHILIPP, G., HACKBARTH, I., SCH~nTZ,
W., SCHOLZ, H. & CRANE, F.L. (1979b). Purified cardiac cell
membranes with high (Na+ + K+)ATPase activity contain significant
NADH-vanadate reductase activity. Nature, 282: 335-336.
ERDMANN, E., WERDAN, K., KRAWIETZ, W., SCHMITZ, W. & SCHOLZ, H.
(1984). Vanadate and its significance in biochemistry and
pharmacology. Biochem. Pharmacol., 33(7): 945-950.
EXTEIN, I., TALLMAN, J., SHITH, C.C. & GOODWIN, F.K. (1979).
Changes in lymphocyte beta-adrenergic receptors in depression and
mania. Psychiatry Res., 1: 191-197.
FITZGERALD, J.J. & CHASTEEN, N.D. (1974). Determination of the
vanadium content of protein solutions by electron paramagnetic
resonance spectroscopy. Anal. Biochem., 60: 170-180.
FORBUSH III, B. (1983). Cardiotonic steroid binding to Na,K-
ATPase. Curro Top. Membr. Trans., 19: 167-201.
FORMAN, D.S. (1982). Vanadate inhibits saltatory organelle
movement in a permeabilized cell model. Exp. Cell Re s,, 141:
139-147.
FRAZER, A., RAMSEY, T.A., SWANN, A., BOWDEN, C., BRUNSWICK, D.,
GARVER, D. & SECUNDA, S. (19B3). Plasma and erythrocyte
electrolytes in affective disorders. J. Affective Disord., 5:
103-113.
FUHRMANN, G.F., HUTTERMANN, J. & KNAUF, P.A. (1984). The
mechanism of vanadium action on selective K+ permeability in
human erythrocytes. Biochim. Biophys. Acta, 769: 130-140.
GARCIA, A.G., JURKIEWICZ, A. & JURKIEWICZ, N.H. (1981).
Contractile effect of vanadate and other vanadium compounos on
the rat vas deferens. Eur. J. Pharmacol., 70: 17-23.
GARCIA-SEVILLA, J.A., ZIS, A.P., HOLLINGSWORTH, P.J., GREDEN,
J.F. & SMITH, C.B. (1981). Platelet alpha2-a~renergic receptors
in major depressive disorder. Binding of tritiated clonidine
before and after tricyclic antidepressant drug treatment. Arch.
Gen. Psychiatry, 38: 1327-1333.
276
GECK. P•• HEINZ. E. & PFEIFFER. B. (1981). Influence of high
ceiling diuretics on ion fluxes and cell volume of Ehrlich
ascites tumour cells. Scand. Audiol. Suppl •• 14: 25-36.
GERSHON. E.S., BARON, M. & LECKMAN, J.F. (1975). Genetic models
of the transmission of affective disorders. J. Psychiatr. Res.,
12: 301-317.
GERSHON, E.S. & BUNNEY, Jr., W.E. (1976). The question of X-
linkage in bipolar manic-depressive illness. J. Psychiatr.
Res., 13: 99-117.
GERSHON, E.S., BUNNEY, Jr., W.E., LECKMAN, J.F•• VAN EERDEWEGH,
M. & DEBAUCHE, B.A. (1976). The inheritance of affective
disorders: a review of data and of hypotheses. Behav. Genet ••
6(3): 227-261.
GERSHON, E.S., TARGUM, S.D., KESSLER. L.R., MAZURE. C.M. &
BUNNEY, Jr., W.E. (l977). Genetic studies and biologic
strategies in the affective disorders. Prog. Med. Genet.,
2(NS): 101-164.
GERSHON. E.S., MENDLEWICZ, J., GASTPAR. M., BECH, P., GOLDIN,
L.R., KIELHOLZ, P., RAFAELSEN, O.J., VARTANIAN, F. & BUNNEY, Jr.,
W.E. (19RO). A collaborative study of genetic linkage of bipolar
manic-depressive illness and red/green colorblindness. A project
of the biological psychiatry collaborative program of the World
Health Organisation. Acta. Psychiatr. Scand., 61: 319-338.
GERSHON, E.S., HAMOVIT, J., GUROFF, J.J., DIBBLE, E., LECKMAN,
J.F., SCEERY, W., TARGUM, S.D., NURNBERGER, JR., J.I., GOLDIN,
L.R. & BUNNEY, Jr., W.E. (1982). A family study of
schizoaffective, bipolar I, bipolar II, unipolar, and normal
control probands. Arch. Gen. Psychiatry, 39: 1157-1167.
GERSON, F. (l970). "High Resolution E.S.R. Spectroscopy
Chemical Topics for Students, Book 1", ed. Foerst, W. &
Grunewald, H., John Wiley & Sons Ltd., Germany.
GEY, G.O., COFFMAN, W.D. & KUBICEK, M.T. (1952). Tissue culture
studies of the proliferative capacity of cervical carcinoma and
normal epithelium. Cancer Res., 12: 264-265.
GILMORE, T. & MARTIN, G.S. (1983). Phorbol ester and
diacylglycerol induce protein phosphorylation at tyrosine.
Nature, 306: 487-490.
GLADE, P.R. & BERATIS, N.G. (1976).
lines in the study of human genetics.
1-48.
Long-term lymphoid cell
Prog. Med. Genet., leNS):
GLYNN, I.M. (1968). Membrane adenosine triphosphatase and cation
transport. Br. Med. Bull., 24(2): 165-169.
277
GLYNN, r.x. & KARLISH, S.J.D. (197S). The sodium pump.
Rev. Physiol., 37: 13-53.
Annu.
GODWIN, C.D., GREENBERG, L.B. & SHUKLA, s. (1984). Consistent
dexamethasone suppression test results with mania and depression
in bipolar illness. Am. J. Psychiatry, 141: 1263-126S.
GOTH, A. (1984). "Medical Pharmacology - Principles and
Concepts", The C.V. Mosby Company, St. Louis.
GRANTHAM, J.J. t; GLYNN, I.M. (1979).
determinants of inhibition by vanadium.
236(6): F530-F535.
Renal Na,K-ATPase:
Am. J. Physio!.,
GRINSTEIN, S., ROTHSTEIN, A., SARKADI, B. & GELFAND, E.W. (1984).
Responses of lymphocytes to anisotonic media: volume-regulating
behavior. Am. J. Physio1., 246: C204-C21S.
GRUPP, G., GRUPP, I., JOHNSON, C.L., WALLICK, E.T. & SCHWARTZ, A.
(1979). Effects of vanadate on cardiac contraction and adenylate
cyclase. Biochem. Biophys. Res. Commun., 88(2): 440-447.
HAAS, M., SCHMIDT III, W.F. & MCMANUS, T.J. (1982).
Catecholamine-stimulated ion transport in duck red cells.
Gradient effects in electrically neutral rNa + K + 2CI] co-
transport. J. Gen. Physiol., 80: 12S-147.
HACKBARTH, I., SCH~lITZ, W., SCHOLZ, H., ERDMANN, E., KRMlIETZ, W.
& PHILIPP, G. (1978). Positive inotropism of vanadate in cat
papillary muscle. Nature, 275: 67.
HACKBARTH, I., SCHMITZ, W., SCHOLZ, H., WETZEL, E., ERDMANN, E.,
KRAWIETZ, W. & PHILIPP, G. (1980). Stimulatory effect of
vanadate on cyclic AMP levels in cat papillary muscle. Biochem.
Pharmaco1., 29: 1429-1432.
HAMILTON, M. (1979). Mania and depression: classification,
description and course. In "Psychopharmacology of Affective
Disorders·, edt Paykel, E.S. & Coppen, A., Oxford University
Press, Oxford.
HAMILTON, M. (1982). Symptoms and assessment of depression. In
"Handbook of Affective Disorders", edt Paykel, E.S., Churchill
Livingstone, Edinburgh.
HALLCHER, L.M. & SHERMAN, W.R. (1980). The effects of lithium
ion and other agents on the activity of myo-inositol-1-
phosphatase from bovine brain. J. Bioi. Chern., 255(22): 10896-
10901.
HANSEN, O. (1979). Facilitation of ouabain binding to (Na+ +
K+)-ATPase by vanadate at in vivo concentrations. Biochim.
Biophys. Acta, 568: 265-269.
278
HARRISO~, R. & LUNT, G.G. (1980). "Biological Membranes - Their
Structure and Function", 2nd edition, Blackie, Glasgow.
HASEGAWA-SASAKI, H. (1985). Early changes in inositol lipids and
their metabolites induced by platelet-derived growth factor in
quiescent Swiss mouse 3T3 cells. Biochem. J., 232: 99-109.
HAUSER, G. (1969a). Myo-inositol transport in slices of rat
kidney cortex. I. Effect of incubation conditions and
inhibitors. Biochim. Biophys. Acta, 173: 257-266.
HAUSER, G. (1969b). Myo-inositol transport in slices of rat
kidney cortex. II. Effect of the ionic composition of the
medium. Biochim. Biophys. Acta, 173: 267-276.
HAWTHORNE, J.N. (1982). Inositol phospholipids. In
"Phospholipids", New Comprehensive Biochemistry, Volume 4, ed.
Hawthorne, J.N. & Ansell, G.B., Elsevier, Holland.
HENLE, W., DIEHL, V., KOHN, G., zur HAUSEN, H. & HENLE, G.
(1967). Herpe s+t y pe vi rus and chromo some marker in normal
leukocytes after growth with irradiated Burkitt cells. Science,
157: 1064-1065.
HESKETH, J.E. (1976). Changes in men b ran e adenosine
triphosphatases on administration of lithium salts in vivo.
Biochem. Soc. Trans., 4: 328-330.
HESLOP, J.P., IRVINE, R.F., TASHJIAN, Jr, A.H. & BERRIDGE, M.J.
(1985). Inositol tetrakis- and pentakisphosphates in GH4 cells.J. Exp. BioI., 119: 395-401.
HIGASHINO, H., BOGDEN, J.D., LAVENHAR, M.A., BAUMAN, Jr., J.W.,
HIROTSU, T. & AVIV, A. (1983). Vanadium, Na-K-ATPase, and
potassium adaptation in the rat. Am. J. Physiol., 244: Fl05-
FIll.
HOFFMANN, E.K., SJOHOLM, C. & SIMONSEN, L.O. (1983). Na+, CI-
cotransport in Ehrlich ascites tumor cells activated during
volume regulation (regulatory volume increase). J. Membr.
BioI., 76: 269-280.
HOKIN, L.E. (1985). Receptors and phosphoinositide-generated
second messengers. Annu. Rev. Biochem., 54: 205-235.
HOKIN-NEAVERSON, M., SPIEGEL, D.A. & LEWIS, W.C. (1974).
Deficiency of erythrocyte sodium pump activity in bipolar manic-
depressive psychosis. Life. Sci., 15: 1739-1748.
HORI, C. & OKA, T. (1980). Vanadate enhances the stimulatory
action of insulin on DNA synthesis in cultured mouse mammary
gland. Biochim. Biophys. Acta, 610: 235-240.
279
HUOT, S., MULDOON, S., PAMNANI, M., CLOUGH, D. & HADDY, F.J.
(1979). Effects of sodium vanadate (Na3V04) on wall tension and
Na+-KT pump activity in isolated canine saphenous vein. Fed.
Proc., 38: 1036. ----
INGEBRETSEN, O.C., BAKKEN, A.M., SEGADAL, L. & FARSTAD, M.
(1982). Determination of adenine nucleotides and inosine in
human myocard by ion-pair reversed-phase high-performance liquid
chromatography. J. Chromatogr., 242: 119-126.
IRVINE, R.F., LETCHER, A.J., LANDER, D.J. s DOWNES, C.P. (1984).
Inositol trisphosphates in carbachol-stimulated rat parotid
glands. Biochem. J., 223: 237-243.
IRVINE, R.F., ANGGARD, E.E., LETCHER, A.J. s DOWNES, C.P. (1985).
Metabolism of inositol 1,4,5-trisphosphate and inositol 1,3,4-
trisphosphate in rat parotid glands. Biochem. J., 229: 505-511.
IRVINE, R.F., LETCHER, A.J., HESLOP, J.P. & BERRIDGE, M.J.
(1986). The inositol tris/tetrakisphosphate pathway -
demonstration of Ins(1,4,5)P3 3-kinase activity in animaltissues. Nature, 320: 631-634.
JANDHYALA, B.S. s HOM, G.J. (1983).
pharmacological properties of vanadium.
1340.
Physiological and
Life Sc1., 33: 1325-
JOHNSON, G.F.S., HUNT, G.E., ROBERTSON, S. s DORAN, T.J•.(1981).
A linkage study of manic-depressive disorder with HLA antigens,
blood groups, serum proteins and red cell enzymes. J.
Affective. Disord., 3: 43-58.
JOLLES, J., ZWIERS, H., DEKKER, A., WIRTZ, K.W.A. & GISPEN, W.H.
(1981). Corticotrophin-(1~24-tetracosapeptide affects protein
phosphorylation and polyphosphoinositide metabolism in rat brain.
Biochem. J., 194: 283-291.
JORGENSEN, P.L. (1982). Mechanism of the Na+, K+ pump. Protein
structure and conformations of the pure (Na+ + K+)-ATPase.
Biochim. Biophys. Acta, 694: 27-68.
JOSEPHSON, L. & CANTLEY, Jr., L.C. (1977). Isolation of a potent
(Na-K)ATPase inhibitor from striated muscle. Biochemistry,
16(21): 4572-4577.
KARLISH, S.J.D., BEAUGE, L.A. & GLYNN, I.M. (1979). Vanadate
inhibits (Na+ + K+)ATPase by blocking a conformational change of
the unphosphorylated form. Nature, 282: 333-335.
KAY, D.S.G., NAYLOR, G.J., SMITH, A.H.W. & GREENWOOD, C. (1984).
The therapeutic effect of ascorbic acid and EDTA in manic-
depressive psychosis: double-blind comparisons with standard
treatments. Psychol. Med., 14: 533-539.
280
KNOX, J.H., DONE, J.N., FELL, A.F., GILBERT, M.T., PRYDE, A. &
WALL, R.A. (1978). "High Performance Liquid Chromatography",
Edinburgh University Press, Edinburgh.
KOSLOW, S.H., MAAS, J.W., BOWDEN, C.L., DAVIS, J.M., HANIN, I. s
JAVAID, J. (1983). CSF and urinary biogenic amines and
metabolites in depression and mania. A controlled, univariate
analysis. Arch. Gen. Psychiatry, 40: 999-1010.
KRAWIETZ, W., WERDAN, K. & ERDMANN, E. (1979). Stimulatory
effect of vanadate on the adenylate cyclase of cardiac tissue.
Biochem. Pharmacol., 28: 2517-2520.
KRAWIETZ, W., DOWNS, Jr., R.W., SPIEGEL, A.M. & AURBACH, G.D.
(1982). Vanadate stimulates adenylate cyclase via the guanine
nucleotide regulatory protein by a mechanism differing from that
of fluoride. Biochem. Pharmacol., 31: 843-848.
KUBOTA, Y., INOUE, H. & YOSHIOKA, T. (l986). Increased labelling
of polyphosphoinositide in chemically transformed cell line.
Biochim. Biophys. Acta, 875: 1-5.
KUMAR, A. & CORDER, C.N. (1980). Diuretic and vasoconstrictor
effects of sodium orthovanadate on the isolated perfused rat
kidney. J. Pharmacol. Exp. Ther., 213(1): 85-90.
LAMB, J.F. & McCALL, D. (1972). Effect of prolonged ouabain
treatment on Na, K, Cl and Ca concentration and fluxes in
cultured human cells. J. Physiol., 225: 599-617.
LAMB, J.F. & OGDEN, P. (1977). The turnover of sodium pumps in
HeLa cells. J. Physiol., 269: 79p.
LARSEN, J.A., THOMSEN, 0.0. & HANSEN, O. (l979). Vanada te-
induced oliguria in the anesthetized cat. Acta. Physiol.
Scand., 106: 495-496. ----_....---
LEW, P.D., MONOD, A., KRAUSE, K.H., WALDVOGEL, F.A., BIDEN, T.J.
& SCHLEGEL, w. (1986). The role of cytosolic free calcium in the
generation of inositol 1,4,5-trisphosphate and inositol 1,3,4-
trisphosphate in HL-60 cells. J. BioI. Chern., 261(28): 13121-
13127.
LI, W., CHAN, L.S., KHATAMI, M. & ROCKEY, J.H. (1986). Non-
competitive inhibition of myo-inositol transport in cultured
bovine retinal capillary pericytes by glucose and reversal by
Sorbinil. Biochim. Biophys. Acta, 857: 198-208.
LICHTSTEIN, D., MULLIKIN-KILPATRICK, D. & BLUME, A.J. (1982).
Hyperpolarization of neuroblastoma-glioma hybrid NG108-15 by
vanadium ions. Proc. Nat. Acad. Sci., 79: 4202-4206.
281
LINNOILA, M., MacDONALD, E., REINILA, M., LEROY, A., RUBINOW,
D.R. & GOODWIN, F.K. (1983). RBC membrane adenosine
triphosphatase activities in patients with major affective
disorders. Arch. Gen. Psychiatry, 40: 1021-1026.
LOPEZ, V., STEVENS, T. & LINDQUIST, R.N. (1976). Vanadium ion
inhibition of alkaline phosphatase-catalyzed phosphate ester
hydrolysis. Arch. Biochem. Biophys., 175: 31-38.
LOWY, M.T., REDER, A.T., ANTEL, J.P. & MELTZER, H.Y. (1984).
Glucocorticoid resistance in depression: the dexamethasone
suppression test and lymphocyte sensitivity to dexamethasone.
Am. J. Psychiatry, 141: 1365-1370.
MAAS, J.W., KOSLOW, S.H., KATZ, M.M., BOWDEN, C.L., GIBBONS,
R.L., STOKES, P.E., ROBINS, E. & DAVIS, J.M. (1984).
Pretreatment neurotransmitter metabolite levels and response to
tricyclic antidepressant drugs. Am. J. Psychiatry, 141: 1159-
1171.
MACARA, I.G., KUSTIN, K. & CANTLEY, Jr., L.C. (1980).
Glutathione reduces cytoplasmic vanadate. Mechanism and
physiological implications. Biochim. Biophys. Acta, 629: 95-106.
MacDONALD, E., LeROY, A. & LINNOILA, M. (1982). Failure of
lithium to counteract vanadate-induced inhibition of red blood
cell membrane Na+,K+-ATPase. Lancet, Oct. 2nd: 774.
MACIEIRA-COELHO, A. (1973). Cell cycle analysis - mammalian
cells. In "Tissue Culture - Methods and Applications", e d,
Kruse, Jr., P.F. & Patterson, Jr., M.K., Academic Press, London.
MATSUMOTO, S.S., RAIVIO, K.O. & SEEGMILLER, J.E. (1979). Adenine
nucleotide degradation during energy depletion in human
lymphoblasts. Adenosine accumulation and adenylate energy
charge correlation. J. BioI. Chem., 254(18): 8956-8962.
McFARLAND, w. (1969). Microspikes on the lymphocyte uropod.
Science, 613: 818-820.
MELTZER, H.L. & KASSIR, S. (1983). Abnormal calmodulin-activated
CaATPase in manic-depressive subjects. J. Psychiatr. Res., 17:
29-35.
MELTZER, H.Y., LOWY, M., ROBERTSON, A., GOODNICK, P. & PERLINE,
R. (1984a). Effect of 5-hydroxytryptophan on serum cortisol
levels in major affective disorders. I. Enhanced response in
depression and mania. Arch. Gen. Psychiatry, 41: 366-374.
MELTZER, H.Y., PERLINE, R., TRICOU, B.J., LOWY, M. & ROBERTSON,
A. (1984b). Effect of 5-hydroxytryptophan on serum cortisol
levels in major affective disorders. II. Relation to suicide,
psychosis, and depressive symptoms. Arch. Gen. Psychiatry, 41:
379-387.
282
MELTZER, H.Y., LOWY, M., ROBERTSON, A., GOODNICK, P. & PERLINE,
R. (1984c). Effect of 5-hydroxytryptophan on serum cortisol
levels in major affective disorders. III. Effect of
antidepressants and lithium carbonate. Arch. Gen. Psychiatry,
41: 391-397.
MENDLEWICZ, J. & FLEISS, J.L. (1974). Linkage studies with X-
chromosome markers in bipolar (manic-depressive) and unipolar
(depressive) illnesses. BioI. Psychiatry, 9(3): 261-294.
MENDLEWICZ, J. & RAINER, J.D. (1977). Adoption study supporting
genetic transmission in manic-depressive illness. Nature, 268:
327-329.
MENDLEWICZ, J., LINKOWSKI, P. & WILMOTTE, J. (1980). Linkage
between glucose-6-phosphate dehydrogenase deficiency and manic-
depressive psychosis. Brit. J. Psychiatry, 137: 337-342.
MICHELL, R.H. (1975). Inosi tol phospholipids and cell surface
receptor function. Biochim. Biophys. Acta, 415: 81-147.
MICHELL, R.l-I., KIRK, C.J., JONES, t.M., DOWNES, C.P. s CREBA,
J.A. (1981). The stimulation of inositol lipid m e t a bo Lds m that
accompanies calcium mobilization in stimulated cells: defined
characteristics and unanswered questions. Philos. Trans. R.
Soc. Lond. B, 296: 123-137.
MICHELL, R.H. (1982). Is phosphatidylinositol really out of the
calcium gate? Nature, 296: 492-493.
MILLER, G., LISCO, H., KOHN, H.I. & STITT, D. (1971).
Establishment of cell lines from normal adult human blood
leukocytes by exposure to Epstein-Barr virus and neutralization
by human sera with Epstein-Barr virus antibody. Proc. Soc. Exp.
BioI. Med., 137: 1459-1465.
MINDHAM, R.H.S. (1982). Tricyclic antidepressants and amine
precursors. In "Handbook of Affective Disorders", ed. Paykel,
E.S., Churchill Livingstone, Edinburgh.
MONITORINGANDASSESSMENTRESEARCHCENTRE(MARC)TECHNICALREPORT
(1976). "Vanadium in the Environment". MARC, Chelsea College,
London.
MYERS, T.D., BOERTH, R.C. & POST, a.t., (1979). Effects of
vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
Biochim. Biophys. Acta, 558: 99-107.
NADI, N.S., NURNBERGER,J.I. & GERSHON, E.S. (1984). Muscarinic
cholinergic receptors on skin fibroblasts in familial affective
disorder. New. Eng. J. Med., 311(4): 225-230.
NARSAPUR, S.L. & NAYLOR, G.J. (1983). Methylene blue. A
possible treatment for manic depressive psychosis. J.
Affective. Disord., 5: 155-161.
283
NAYLOR, G.J., McNAMEE, H.B. & MOODY, J.P. (1971). Changes in
erythrocyte sodium and potassium on recovery from a depressive
illness. Brit. J. Psychiatry, 118: 219-223.
NAYLOR, G.J., DICK, D.A.T., DICK, E.G., LE POIDEVIN, D. & WHYTE,
S.F. (1973). Erythrocyte membrane cation carrier in depressive
illness. Psycho1. Med., 3: 502-508.
NAYLOR, G.J., DICK, D.A.T., DICK, E.G. & MOODY, J.P. (1974).
Lithium therapy and erythrocyte membrane cation carrier.
Psychopharmacologia, 37: 81-86.
NAYLOR, G.J., SMITH, A., BOARDMAN,L.J., DICK, D.A.T., DICK, E.G.
& DICK, P. (1977). Lithium and erythrocyte membrane cation
carrier studies in normal and manic depressive subjects.
Psycho!. Med., 7: 229-233.
NAYLOR, G.J., DICK, E.G., SMITH, A.H.W., DICK, D.A.T., McHARG,
A.M. & CHAMBERS, C.A. (1980a). Changes in erythrocyte membrane
cation carrier with age in women. Gerontology, 26: 327-329.
NAYLOR, G.J., SHITH, A.H.W., DICK, E.G., DICK, D.A.T., McHARG,
A.~f. s CHA~BERS, C.A. (1980b). Erythrocyte membrane cation
carrier in manic-depressive psychosis. Psychol. Med., 10: 521-
525.
NAYLOR, G.J., DICK, D.A.T., JOR~STON, B.B., HOPt.JOOD, S.E., DICK,
E.G., SMITH, A.H.W. & KAY, D. (1981). Possible explanation for
therapeutic action of lithium, and a possible substitute
(methylene blue). Lancet, Nov. 21st: 1175-1176.
NAYLOR, G.J. & SMITH, A.H.W. (1981a). Defective genetic control
of sodium-pump density in manic depressive psychosis. Psychol.
Med., 11: 257-263.
NAYLOR, G.J. & SMITH, A.H.W. (1981 b). Vanadium:
aetiological factor in manic depressive illness.
Med., 11: 249-256.
NAYLOR, G.J. & SMITH, A.H.W.(1982). Reduction of vanadate, a
possible explanation of the effect of phenothiazines in manic-
depressive psychosis. Lancet, Feb. 13th: 395-396.
a possible
Psycho!.
NAYLOR, G.J. (1983). Vanadium and affective disorders. BioI.
Psychiatry, 18(1): 103-112.
NAYLOR, G.J., SMITH, A.H.W., BRYCE-S~nTH, D. & WARD, N.I. (1984).
Tissue vanadium levels in manic-depressive psychosis. Psycho1.
Med., 14: 767-772.
NAYLOR, G.J. (1986). Vanadium and the sodium pump in manic
depressive psychosis. In "The Biology of Depression", ed.
Deakin, J.F.W., Gaskell, London.
284
NECHAY, B.R., NANNINGA, L.B., NECHAY, P.S.E., POST, R.L.,
GRANTHAM, J.J., MACARA, I.G., KUBENA, L.F., PHILLIPS, T.D. &
NIELSEN, F.H. (1986). Role of vanadium in biology. Fed. Proc.,
45(2): 123-132.
NIELSEN, F.H. & SANDSTEAD, H.H. (1974). Are nickel, vanadium,
silicon, fluorine, and tin essential for man? A review. Am.
J. Clin. Nut r , , 27: 515-520.
NINFALI, P., ACCORSI, A., FAZI, A., PALMA, F. & FORNAINI, G.
(1983). Vanadate affects glucose metabolism of human
erythrocytes. Arch. Biochem. Biophys., 226(2): 441-447.
NISRIZUKA, Y. (1984). The role of protein kinase C in cell
surface signal transduction and tumour promotion. Nature, 308:
693-698.
NORTH, P. & POST, R.L. (1984). Inhibition of (Na,K)-ATPase by
tetravalent vanadium. J. BioI. Chem., 259(8): 4971-4978.
~OWELL, P.C. (1960). Phytohemagglutinin: an ini tiator of
mitosis in cultures of normal human leukocytes. Cancer Res., 20:
462-468.
NURNBERGER, .r.r , & GERSHON, E.S. (1982). Genetics. In
"Handhook of Affective Disorders", ed. Paykel, E.S., Churchill
Livingstone, Edinburgh.
OR, V.M.S., TAYLOR, E.A., BOON, N.A., ARONSON, J.K. & GRAHAME-
SMITH, D.G. (1984). Stimulation of tritiated-ouabain binding to
intact human lymphocytes by normal human and fetal calf serum.
Br. J. Clin. Pharmacol., 15: 618P.
OH, V.M.S. & TAYLOR, E.A. (\985). Effects of corticosteroids on
rubidium-86 uptake and [ H)-ouabain binding in intact human
lymphocytes in vitro. Proc. Brit. Pharmacol. Soc. meeting
at Cardiff, 10-12 April 1985, P116.
O'NEAL, S.G., RHOADS, D.B. & RACKER, E. (1979). Vanadate
inhibition of sarcoplasmic reticulum Ca2+-ATPase and other
ATPases. Biochem. Biophys. Res. Commun., 89(3): 845-850.
PARKER, R.C. (1961). "Methods of Tissue Culture", 3rd edition,
Roeber Medical Division, Harper and Row, USA.
PARKS, D.R., BRYAN, V.M., 01, V.T. & HERZENBERG, L.A. (1979).
Antigen-specific identification and cloning of hybridomas with a
fluorescence-activated cell sorter. Proc. Nat. Acad. scL,
76(4): 1962-1966.
PARRIS, N.A. (1976). "Instrumental liquid ch r oma t og r a phy",
Elsevier, Holland.
PAUL. J. (1970). "Cell and Tissue Culture", 4th edition, E & S
Livingstone Ltd., Edinburgh.
285
PAYKEL, E.S. (1982). Life events and early environment. In
"Handbook of Affective Disorders", ed. Paykel, E.S., Churchill
Livingstone, Edinburgh.
PEDERSEN, K.E. & KLITGAARD, N.A. (1983). The characteristics of
r3HJ-ouabain binding to human lymphocytes. Br. J. Clin.
Pharmacol., 15: 657-665.
PERRIS, C. (1966). A study of bipolar (manic-depressive) and
unipolar recurrent depressive psychoses. Acta. Psychiatr.
Scand., 42: supple 194.
PERRIS, C.,(1982). The distinction between bipolar and unipolar
affective disorders. In "Handbook of Affective Disorders", e d,
Paykel, E.S., Churchill Livingstone, Edinburgh.
PETTEGREW, J.W., NICHOLS, J.S., MINSHEW, N.J., RUSH, A.J. &
STEWART, R.M. (1982). Membrane biophysical studies of
lymphocytes and erythrocytes in manic-depressive illness. J.
Affective Disord., 4: 237-247.
PHILIPSON, K.D. & NISHIMOTO, A.Y. (1983).
transport in cardiac sarcolemmal vesicles.
Acta, 733: 133-141.
ATP-dependent ~a+
Biochim. Biophys.
PLANTAVID, x,; ROSSIGNOL, L., CHAP, H. & DOUSTE-BLAZY, L. (1986).
Studies of endogenous polyphosphoinositide hydrolysis in human
platelet membranes. Evidence that polyphosphoinositides remain
inaccessible to phosphodiesterase in the native membrane.
Biochlm. Blophys. Acta, 875: 147-156.
POGOLOTTI, Jr., A.L. & SANTI, D.V. (1982). High-pressure liquid
chromatography-ultraviolet analysis of intracellular nucleotides.
Anal. Biochem., 126: 335-345.
POOLE, A.R. (1977). The detection of lysosomes by vital staining
with acridine orange. In "Lysosomes: A Laboratory Handbook",
2nd edition, ed. Dingle, J.T., Elsevier/North Holland Biomedical
Press, Amsterdam.
POVEY, S., ARTHUR, J.E., STEEL, M. & KLEIN, G. (1980).
Differences in genetic stability between human cell lines from
patients with and without lymphoreticular malignancy. Ann. Hum.
Genet., 44: 119-133.
PRYDE, A. & GILBERT, M.T. (1979). "Applications of high-
performance liquid chromatography", Chapman and Hall, London.
PULVERTAFT, R.J.V. (1964). Cytology of Burkitt's tumour (African
lymphoma). Lancet, Feb. 1st: 238-240.
QUIST, E.E. & MOKIN, L.E. (1978). The presence of two (Na+ +
K+)-ATPase inhibitors in equine muscle ATP: vanadate and a
dithioerythrlto1-dependent inhibitor. Biochim. Biophys. Acta,
511: 202-212.
286
RAMASARMA, T. & CRANE, F.L. (1981). Does vanadium play a role in
cellular regulation? Curro Top. Cell. Regul., 20: 247-301.
RAMASARMA, T., MacKELLAR, W.C. & CRANE, F.L. (1981). Vanadate-
stimulated NADH oxidation in plasma membrane. Biochim. Biophys.
Acta, 646: 88-98.
REICH, T., RICE, J., CLONINGER, C.R., WETTE, R. & JAMES, J.
(1979). The use of multiple thresholds and segregation analysis
in analyzing the phenotypic heterogeneity of multifactorial
traits. Ann. Hum. Genet., 42: 371-389.
ROBINSON, J.D. (1976). Substrate sites of the (Na+ + K+)-
dependent ATPase. Biochim. Biophys. Acta, 429: 1006-1019.
ROBINSON, J.D. & MERCER, R.W. (1981). Vanadate binding to the
(Na + K)-ATPase. J. Bioenerg. Biomembr., 13(5/6): 205-218.
ROBINSON, J.R. (1975). "A Prelude to Physiology", Blackwell
Scientific Publications, Oxford.
ROELOFSEN, B. & VAN LI~DE-SIBENIUS TRIP, M. (1981). The fraction
of phosphatidylinositol that activates the (Na+ + K+)-ATPase in
rabbit kidney microsomes is closely associated with the enzyme
protein. Biochim. Biophys. Acta, 647: 302-306.
ROSSI, J.P.F.C., GARRAHAN" P.J. & REGA, A.F. (1981). Vanadate
inhibition of active Ca'+ transport across human red cell
membranes. Biochim. Biophys. Acta, 648: 145-150.
RUBINSON, K.A. (1981). Concerning the form of biochemically
active vanadium. Proc. R. Soc. Lond. B, 212: 65-84.
RYBAKOWSKI, J., POTOK, E. & STRZYZEWSKI, W. (1981a). Erythrocyte
membrane adenosine triphosphatase activities in patients with
endogenous depression and healthy subjects. Eur. J. Clin.
Invest., 11: 61-64.
RYBAKOWSKI, J., STRZYZEWSKI, W., SZAJNERMAN, Z. & ROZEK, B.
(1981b). Evaluation of the water-electrolyte balance
(erythrocyte model) in the course of endogenous depression.
Psychiatr. Pol., 15(3): 243-249.
RYBAKOWSKI, J., POTOK, E. & STRZYZEWSKI, W. (1983). Decreased
activity of ouabain-dependent sodium and potassium fluxes in
erythrocytes during depression and mania. Act. Nerv. Super. 25:
72-74. '
SACHAR, E.J. & BARON, M. (1979). The biology of affective
disorders. Annu. Rev. Neurosci., 2: 505-518.
SACHAR, E.J. (1982). Endocrine abnormalities in depression. In
"Handbook of Affective Disorders", ed. Paykel, E.S., Churchill
Livingstone, Edinburgh.
287
SAGE, A.M. (1981). The history and applications of vanadium.
Foote Notes, 44(2): 2-20.
SAIER, .r-., M.H. & BOYDEN, D.A. (1984). Mechani s m, regulation
and physiological significance of the loop diuretic-sensitive
NaCl/KCl symport system in animal cells. Mol. Cell. Biochem.,
59: 11-32.
SAKURAI, H., SHIMOMURA, S., FUKUZAlJA, K. & ISHIZU, K. (1980).
Detection of oxovanadium (IV) and characterization of its ligand
environment in subcellular fractions of the liver of rats treated
with pentavalent vanadium (V). Biochim. Biophys. Res.
Commun., 96(1): 293-298.
SAUER, loA. (1978). Control of adenosine monophosphate
catabolism in mouse ascites tumor cells. Cancer Res., 38: 1057-
1063.
SCHILDKRAUT, J.J. (1965). The catecholamine hypothesis of
affective disorders: a review of supporting evidence. Am. J.
Psychiatry, 122: 509-522.
SCHILDKRAUT, J.J. & KETY, S.S. (1967). Biogenic amines and
emotion. Science, 156: 21-30.
SCHLEIFER, S.J., KELLER, S.E., HEYERSON, A.T., RASKIN, M.J.,
DAVIS, K.L. s STEIN, M. (1984). Lymphocyte function in major
depressive disorder. Arch. Gen. Psychiatry, 41: 484-486.
SCHMITZ, W., SCHOLZ, H., ERDMANN, E., KRAWIETZ, W. & WERDAN, K.
(1982). Effect of vanadium in the +5, +4 and +3 oxidation states
on cardiac force of contraction, adenylate cyclase and (Na+ +
K+)-ATPase activity. Biochem. Pharmacol., 31(23): 3853-3860.
SCHNEIDER, U. & zur HAUSEN, H. (1975). Epstein-Barr virus-
induced transformation of human leukocytes after cell
fractionation. Int. J. Cancer, 15: 59-66.
SCHWABE, U., PUCHSTEIN, C., HANNEMANN,H. & SOCHTIG, E. (1979).
Activation of adenylate cyclase by vanadate. Nature, 277: 143-
145.
SCHWARTZ, A., ADAMS, R.J., GRUPP, I., GRUPP, G., HOLROYDE, M.J.,
MILLARD, R.W., SOLARO, R.J. & WALLICK, E.T. (1980). Effects of
vanadate on myocardial function. Basic. Res. Cardiol., 75:' 444-
451.
SEARLE, B.M., HIGASHINO, H., KHALIL, F., BOGDEN, J.D., TOKUSHIGE,
A., TAl-IURA, H., KINO, M. s AVIV, A. (1983). Vanadate effect on
the Na,K-ATPase and the Na-K pump in in vitro-grown rat vascular
smooth muscle cells. Circ. Res., 53: 186-191.
SEGLE~, P.O. & GORDON, P.B. (1981). Vanadate inhibits protein
degradation in isolated rat hepatocytes. J. BioI. Chern.,
256(15): 7699-7701.
2RR
SENGAR, D.P.S., WATERS, B.G.H., DUNNE, J.V. & BOUER, I.M. (1982).
Lymphocyte subpopulations and mitogenic responses of lymphocytes
in manic-depressive disorders. BioI. Psychiatry, 17: 1017-1022.
SENGUPTA, N., DATTA, S.C., SENGUPTA, D. & BAL, S. (1980).
Platelet and erythrocyte-membrane adenosine triphosphatase
activity in depressive and manic-depressive illness. Psychiatry
Res., 3: 337-344.
SHAIKH, N.A. & PALMER, F.B.St.C. (1977). Phosphoinosi tide
kinases in chick brain and sciatic nerve, a developmental study.
J. Neurochem., 28: 395-402.
SHARMA, R.P., COULOMBE, Jr., R.A. & SRISUCHART, B. (1986).
Effects of dietary vanadium exposure on levels of regional brain
neurot ransm itter s and their metabolites. Biochem. Pharmacol.,
35(3): 461-465.
SHAW, D.M., KELLAM, A.M.P. & MOTTRAM, R.F., (e d sv), (1982).
Affective disorders. In "Brain Sciences in Psychiatry",
Butterworth & Co. Ltd., London.
SHECHTER, Y. & KARLISH, S.J.D. (1980). Insulin-like stimulation
of glucose oxidation in rat adipocytes by vanadyl (IV) ions.
Nature, 284: 556-558.
SHEETZ, M.P., FEBBRORIELLO, P. & KOPPEL, D.E. (1982).
Triphosphoinositide increases glycoprotein lateral mobility in
erythrocyte membranes. Nature, 296: 91-93.
SHEN, L.C., FALL, L., WALTON, G.M. & ATKINSON,
Interaction between energy charge and metabolite
the regulation of enzymes of amphibolic
Phosphofructokinase and pyruvate dehydrogenase.
7(11): 4041-4045.
D.E. (1968).
modulation in
sequences.
Biochemistry,
SHERMAN, W.R., LEAVITT, A.L., HONCHAR, M.P., HALLCHER, L.M. &
PHILLIPS, B.E. (1981). Evidence that lithium alters
phosphoinositide metabolism: chronic administration elevates
primarily D-myo-inositol-l-phosphate in cerebral cortex of the
rat. J. Neurochem., 36(6): 1947-1951.
SHOPS IN, B., GERSHON, S., GOLDSTEIN, M., FRIEDMAN, E. & WILK, S.
(1975). Use of synthesis inhibitors in defining a role for
biogenic amines during imipramine treatment in depressed
patients. Psychopharmacol. Commun. ,1(2): 239-249.
SHUKLA, S.D. & HANAHAN, D.J. (1982). AGEPC (platelet activating
factor) induced stimulation of rabbit platelets: effects on
phosphatidylinositol, di- and triphosphoinositides and
phospha tidlc acid metabolism. Biochem. Biophys. Res. Commun.,
106(3): 697-703.
289
SHUKLA, S.D., SERGEANT, S. & KIM, H.D. (1985). [3H]Inositol
incorporation into phosphoinositides of pig reticulocytes.
Biochim. Biophys. Acta, 821: 305-309.
SIESS, W. & BINDER, H. (1985). Thrombin induces the rapid
formation of inositol bisphosphate and inositol trisphosphate in
human platelets. FEBS Lett., 180(1): 107-112.
SIEVER, L.J., UHDE, T.W., JIMERSON, D.C., POST, R.M., LAKE, C.R.
& MURPHY,D.L. (1984). Plasma cortisol responses to cIonfd Ine in
depressed patients and controls. Evidence for a possible
alteration in noradrenergic-neuroendocrine relationships. Arch.
Gen. Psychiatry, 41: 63-68.
SIMPSON, C.F. (ed.). (1976). "Practical High Performance Liquid
Chromatography", Heyden and Son Ltd., London.
SINGH, J., NORDLIE, R.C. & JORGENSON, R.A. (1981). Vanadate: a
potent inhibitor of multifunctional glucose-6-phosphatase.
Biochim. Biophys. Acta, 678: 477-482.
SKOU, J.C. (1985). Considerations on the reaction me chan Ls m of
the Na,K-ATPase. In "The Sodium Pump", ed, Glynn, I. & E'l Lory ,
C., The Company of Biologists Ltd., London.
SOUNESS, J.E., THOMPSON, J. & STRADA. S.J. (1985). Adipocyte
cyclic nucleotide phosphodiesterase activation by vanadate. J.
Cyclic Nucleotide Protein Phosphorylation Res., 10(4); 383-396.-
SPAT, A., BRADFORD, P.G., McKINNEY, J.S., RUBIN, R.P. & PUTNEY,
Jr., J.W. (1986). A saturable receptor for 32P-inositol-l,4,5-
trisphosphate in hepatocytes and neutrophils. Nature, 319: 514-
516.
SPECTOR, R. & LORENZO, A.V. (1975). Myo-inositol transport in
the central nervous system. Am. J. Physiol., 228(5): 1510-1518.
SPECTOR, R. (1976). The specifici ty and sulfhydryl sensiti vi ty
of the inositol transport system of the central nervous system.
J. Neurochem., 27: 229-236.
STAHL, S.M., LEMOINE, P.M., CIARANELLO, R.D. & BERGER, P.A.
(1983). Platelet alpha2-adrenergic receptor sensitivity in major
depressive disorder. Psychiatry Res., 10: 157-164.
STEEL, C.M. (1972). Human lymphoblastoid cell lines.
cultivation technique for establishment of new lines.
Cancer Inst., 48: 623-628.
III. Co-
J. Nat.
STRAUGHAN, B.P. & WALKER, S., (e ds.) , (1976). "Spectroscopy-
Volume 1", Chapman & Hall Ltd., London.
290
STREHLER, B.L. (1974). Adenosine-S'-triphosphate and creatine
phosphate. Determination with luciferase. In "Methods of
Enzymatic Analysis - Volume 4", 2nd edition, ed. Bergmeyer, H.U.
Verlag Chemie, Germany.
STRYER, L. (1981). "Biochemistry", 2nd edition, W.H. Freeman and
Company, San Francisco.
SUAREZ, B.K. & REICH, T~ (1984). HLA and major affective
disorder. Arch. Gen. Psychiatry, 41: 22-27.
SWARUP, G., COHEN, S. & GARBERS, D.L. (1982). Inhibition of
membrane phosphotyrosyl-protein phosphatase activity by vanadate.
Biochem. Biophys. Res. Commun., 107(3): ll04-1109.
SWEADNER, K.J. (1985). Enzymatic properties of separated
isozymes of the Na,K-ATPase. Substrate affinities, kinetic
cooperativity, and, ion transport stoichiometry. J. Bioi.
Chem., 260(21): ll508-11S13.
SZENTISTVANYI, I., JANKA, Z. & RIMANOCZY,A. (1980). Alteration
of erythrocyte phosphate transport in primary depressive
disorders. J. Affective. Disord., 2: 229-238.
TAKEDA, K., TEHMA, K. & AKERA, T. (1982). Inotropic effects of
vanadate in isolated rat and guinea-pig heart under conditions
which modify calcium pools involved in contractile activation.
J. Pharmacol. Exp. Ther., 222: 132-139.
THAKAR, J.H., LAPIERRE, Y.D. & WATERS, B.G. (1985). Erythrocyte
membrane sodium-potassium and magnesium ATPase in primary
affective disorder. Bioi. Psychiatry, 20: 734-740.
TIVEY, D.R. (1986).
and MDCKCells".
"Passive Potassium Fluxes in Cultured HeLa
Thesis (Ph.D.), University of St. Andrews.
TOMLINSON, E., JEFFERIES, T.M. & RILEY, C.M. (1978). Ion-pair
high-performance liquid chromatography. J. Chromatogr., 159:
315-358.
TSUANG, M.T., FARAONE, S.V. & FLEMING, J.A. (1985). Familial
transmission of major affective disorders - is there evidence
supporting the distinction between unipolar and bipolar
disorders? Br. J. Psychiatry, 146: 268-271.
TYRER, S. & SHOPSIN, B. (1982). Symptoms and assessment of
mania. In "Handbook of Affective Disorders", ed. Paykel, E.S.,
Churchill Livingstone, Edinburgh.
VERBANCK,P.M.P. & HENDLEWICZ, J. (1981). Cell membrane anomaly
in genetically determined manic-depressive illness.
Neouropsychobiology, 7: 185-187.
291
VICENTINI, L.M., AMBROSINI, A., DI VIRGILIO, F., MELDOLESI, J. &
POZZAN, T. (1986). Activation of muscarinic receptors in PC12
cells - correlation between cytosolic CaZ+ rise and
phosphoinositide hydrolysis. Biochem. J., 234: 555-562.
VIVES-CORRONS, J.L., JOU, J.M., ESTER, A., IBARS, M., CARRERAS,
J., BARTRONS, R., CLIMENT, F. & GRISOLIA, S. (1981). Vanadate
increases oxygen affinity and affects enzyme activities and
membrane properties of erythrocytes. Biochem. Biophys. Res.
Commun., 103(1): 111-117.
VOLPE, P., SALVIATI, G., DI VIRGILIO, F. & POZZAN, T. (1985).
Inosi tol 1,4 ,5-trisphospha te induces calcium release from
sarcoplasmic reticulum of skeletal muscle. Nature, 316: 347-
349.
WEISSMAN, M.M., GERSHON, E.S., KIDD, K.K., PRUSOFF, B.A.,
LECKMAN, J.F., DIBBLE, E., HAMOVIT, J., THOMPSON, W.D., PAULS,
D.A. & GUROFF, J.J. (1984). Psychiatric disorders in the
relatives of probands with affective disorders. The Yale
University-National Institute of Mental Health Collaborative
Study. Arch. Gen. Psychiatry, 41: 13-21.
l1ERDAN, K., BAURIEDEL, G., BOZSIK, M., KRA1HETZ, W. s ERDMANN,E.
09RO). Effects of vanadate in cultured rat heart muscle cells.
Vanadate transport, intracellular binding and vanadate-induced
changes in beating and in active cation flux. Biochim. Biophys.
Acts, 597: 364-383.
WERDAN, K., BAURIEDEL, G., FISCHER, B., KRAWIETZ, W., ERDMANN,
E., SCHMITZ, W. & SCHOLZ, H. (1982). Stimulatory (insulin-
mimetic) and inhibitory (ouabain-like) action of vanadate on
potassium uptake and cellular sodium and potassium in heart cells
in culture. Biochim. Biophys. Acta., 687: 79-93.
WESTENFELDER, C., HAMBURGER,R.K. & GARCIA, M.E. (1981). Effect
of vanadate on renal tubular function in rats. Am. J. Physio!.,
240: F522-F529.
WILEY, J.S. & COOPER, R.A. (1974). A furosemide-sensi ti ve
cotransport of sodium plus potassium in the human red cell.
J. Clin. Invest., 53: 745-755.
WILLIAMSON, J.R. (1986). Inositol lipid metabolism and
intracellular signalling mechanisms. News Physiol. Sci., 1: 72-
76.
WINOKUR, G. & TANNA, V.L. (1969). Possible role of X-linked
dominant factor in manic depressive disease. Dis. Nerv.
Syst., 30(2): R9-94.
WITKOWSKA, D. & BRZEZINSKI, J. (1979). Alteration of brain
noradrenaline, dopamine and 5-hydroxytryptamine levels during
vanadiu~ poisoning. Pol. J. Pharmacol. Pharm., 31: 393-398.
292
WOOD, K. & COPPEN, A. (19R5). Platelet transport and receptor
sites in depressive illness. In "Psychopharmacology: Recent
Advances and Future Prospects", ed. Iversen, S.D., Oxford
University Press, Oxford.
WORLD HEALTH ORGANISATION (1978). Mental disorders: Glossary
and guide to their classification in accordance with the ninth
revision of the "International Classification of Diseases".
W .H.O., Geneva.
WRIGHT, AS., CRICHTON, D.N., LOUDON, J.B., MORTEN, J.E.N. &
STEEL, C.M. (1984). Beta-adrenoceptor binding defects in cell
lines from families with manic-depressive disorder. Ann. Hum.
Genet., 48: 201-214.
WU, P.H. & PHILLIS, J.W. (1980). Characterization of receptor-
mediated catecholamine activation of rat brain cortical Na+-K+-
ATPase. Int. J. Biochem., 12: 353-359.
ZAKARIA, M. & BROWN, P.R. (1981).
chromatography of nucleotides,
Chromato~r., 226: 267-290.
High-performance liquid column
nucleosides and bases. J.
ZEMKOVA, H., TEISINGER, J. & VYSKOCIL, F. (19R2). The comparison
of vanadyl (IV) and insulin-induced hyperpolarization of the
mammalian muscle cell. Biochim. Biophys. Acta., 720: 405-410.
ZIS, A.P. & GOODWIN, F.K. (1982). The amine hypothesis. In
"Handbook of Affective Disorders", ed. Paykel, E.S., Churchill
Livingstone, Edinburgh.
293
